col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


2792 Results       Page 1

 [1]  [2] [ Next > ]
Frontiers Media SA: Frontiers in Immunology
  original article Date Title Authors   All Authors
1 [GO] 2026―Jun―15 Case Report: Metastatic right ventricular tumor and pulmonary embolism from cervical cancer post COVID-19 infection Yuemei Yang, Xiaohui Zhu, Danli Hu
2 [GO] 2026―Jun―15 Severity-associated cross-reactive anti-sarbecovirus antibody responses in COVID-19 convalescents and isolation of a dual-targeting monoclonal antibody with cross-neutralizing activity Qian Wu, Ling Niu, Yueyang Zhang, Tan Tan, Yuchen Yang, Shuang Li, et al. (+5)
3 [GO] 2026―Jun―12 SARS-CoV-2-host and interactions: the dual roles of E3 ubiquitin ligases and ubiquitin-like modification mechanisms in viral infection Jingyi Fu, Zhizhong Mi, Zhaolong Li
4 [GO] 2026―Jun―12 Predictive biomarkers of COVID-19 impact in renal transplant patients: an exploratory proteomic and cytokine analysis Ayodele Alaiya, Maha Al-Mozaini, Zakia Shinwari, Abdulaziz Alzayed, Ibtihaj Alsharif, Rabab Allam, et al. (+9)
5 [GO] 2026―Jun―11 CXCR3 ameliorates neutrophil-dependent disease severity in SARS-CoV-2 infection by regulating CD4+ T cell recruitment Md Jashim Uddin, Claire Fleming, Nick R. Natale, Duncan Hart, Brett Moreau, Anthony Day, et al. (+2)
6 [GO] 2026―Jun―11 Safety and antibody responses to inactivated COVID-19 vaccines among elderly patients with COPD: a prospective cohort study Xuan Deng, Lijuan Xu, Lifeng Chen, Pinjing Sun, Hexiang Jia, Renping Shu, et al. (+3)
7 [GO] 2026―Jun―11 Common and rare variants in complement genes as biomarkers of COVID-19 infection and severity. A lesson to learn for emerging pathogens María Eugenia De La Morena-Barrio, Ana Van Den Rym, Olga Escorial Sanz, Fernando Corvillo, Rosario García-Sánchez, Laura González-Sánchez, et al. (+15)
8 [GO] 2026―Jun―05 Development of Nipah virus mRNA vaccine for pandemic preparedness Jeong-In Kim, Munazza Fatima, Eun-Hye Seo, Pil-Gu Park, Kee-Jong Hong
9 [GO] 2026―Jun―04 Long-term protective potency of AAV vector-based SARS-CoV-2 prophylaxis in mice and non-human primates Ekaterina I. Ryabova, Artem A. Derkaev, Ilias B. Esmagambetov, Mikhail A. Dovgiy, Ilya V. Gordeychuk, Inna V. Shuliakova, et al. (+13)
10 [GO] 2026―Jun―04 COVID-19 mRNA vaccines: a prospective outlook from technological innovation to clinical practice Junqi Ma, Huoying Chen, Yunyi He, Yuye Huang, Xianlong Duan, Qiliang Liu, et al. (+2)
11 [GO] 2026―Jun―03 Immunogenetic modulation of endothelial inflammation by the LIPG -384A/C promoter variant influences COVID-19 severity HariOm Singh, Aishwarya Nair, Meenakshi Bhattacharya, Gaurav Tripathi, Shamama Nishat, Abdullah F. AlAsmari, Nemat Ali
12 [GO] 2026―May―29 Preliminary evaluation of a DDA cationic liposome-based pulmonary mucosal immunization platform carrying a SARS-CoV-2 spike-derived branched peptide Zhifa Xia, Zhenyong Yang, Zhenwei Shi, Songtao Huang, Fenghua Xu
13 [GO] 2026―May―29 MEK1/2 inhibitor ATR-002 reshapes host transcriptome and modulates immune regulatory genes in SARS-CoV-2 infection Franziska Rodner, Klaus Schughart, Stephan Ludwig, André Schreiber
14 [GO] 2026―May―28 TLR7 polymorphisms are associated with COVID-19 susceptibility and severity Edyta Paradowska, Katarzyna D. Kania, Dariusz Jarych, Damian Mikulski, Elżbieta Jabłonowska, Daria A. Haręża, Kamila Wójcik-Cichy
15 [GO] 2026―May―28 Clinical characteristics and antibody responses to Omicron variants among pregnant women in China during the December 2022-April 2023 COVID-19 pandemic wave Ruijing Bao, Lanxin Ma, Rongrong Dai, Xinyu Liu, Nani Xu, He Fang, et al. (+3)
16 [GO] 2026―May―27 Helminth infection modulates the immunogenicity of COVID-19 vaccines in mice without compromising protective efficacy Jinpeng Su, Youssef Hamway, Daniele Mistretta, Bo-Hung Liao, Zhe Ma, Julia Schluckebier, et al. (+15)
17 [GO] 2026―May―25 Explainable machine learning-based mortality risk stratification for older adults with COVID-19: pinpointing core immunological biomarkers and revealing dose-threshold effects Lin Luo, Lin Wang, Hao Wang, Hui Li, Ting Liu, Sha Yu
18 [GO] 2026―May―25 Case Report: Successful treatment of recurrent COVID-19 with intravenous immunoglobulin in a patient with rituximab-induced B-cell depletion and restoration of Fc-mediated effector functions Hee Bum Jo, Jong Su Kang, Sungim Choi, Seong Yeon Park
19 [GO] 2026―May―25 Serum cytokine profiling reveals CXCL10 (IP-10) as a major predictor of severe COVID-19 outcomes in hospitalized patients during the first pandemic wave in Italy Anita Muglia, Daniele Petrone, Ilaria Schiavoni, Letizia Santinelli, Pasqualina Leone, Antonino Bella, et al. (+6)
20 [GO] 2026―May―22 Dynamic hyperinflammatory response assessment using HIC scores in COVID-19: application to a large series of patients receiving anakinra Shirkhan Amikishiyev, Rabia Deniz, Mehmet Guven Gunver, Sarvan Aghamuradov, Nevzat Koca, Burak Ince, et al. (+11)
21 [GO] 2026―May―21 Multi-omics analysis of long COVID (post-COVID-19 condition) reveals persistent mitochondrial dysfunction, suppressed oxidative phosphorylation, and immune dysregulation Alexia Tasoula, Shehbeel Arif, Ethan Waisberg, Lucas Bauer, Elizabeth Aslinger, Joseph W. Guarnieri
22 [GO] 2026―May―20 CORSA study finds spike-specific blunted immune responses in lymphoma patients after SARS-CoV-2 vaccine Lucia Mazzotti, Gerardo Musuraca, Fabio Affaticati, Esther Bartholomeus, Diana Campillo-Davo, Carole Faghel, et al. (+15)
23 [GO] 2026―May―20 Deep learning-assisted, pathogenesis-informed lung histopathology scoring in preclinical mouse models of SARS-CoV-2 and influenza A infection Hyeok-Won An, Hyeon Ah Kim, Tae Hun Ha, Sang Hyeok Seok, Yu Jin Lee, Na Yun Lee, et al. (+6)
24 [GO] 2026―May―18 Humoral and cell mediated immune response to SARS-CoV-2 vaccination in patients with immune-mediated diseases Dorey A. Glenn, Yichun Hu, Meghan E. Free, Lakshmanane Premkumar, Tara M. Narowski, Grayson M. Coleman, et al. (+8)
25 [GO] 2026―May―13 Complement activation in patients with post-acute sequelae after SARS-CoV-2 infection Madlene Holmqvist, Dick J. Sjöström, Katherine Carlson, Birgitta Gullstrand, Anders A. Bengtsson, Robin Kahn, et al. (+4)
26 [GO] 2026―May―05 Preclinical evaluation of a multi-epitope mRNA vaccine platform for broad and durable SARS-CoV-2 protection Laura Marcos-Villar, Beatriz Perdiguero, Laura Sin, Enrique Álvarez, Sara Flores, José M. Casasnovas, et al. (+7)
27 [GO] 2026―May―04 De novo COVID-19-associated insulin resistance drives dysregulated neutrophil extracellular trap formation (NETosis) four months after infection Sergio Sanhueza, Camilo Cabrera, Romina Quiroga, Bárbara Antilef, Camila Muñoz, Agustín Vera, et al. (+18)
28 [GO] 2026―May―01 Determinants of success and failure of antibody-based strategies against respiratory viruses: insights from RSV and SARS-CoV-2 Hai Guo, Hongshu Wang, Shutong Wu, Haonan Lin, Guosong Wang, Qiang Pu
29 [GO] 2026―May―01 Fc-mediated antibody functions are associated with disease severity in COVID-19 Sungim Choi, Jong Su Kang, Jaehwan You, Man-Seong Park, Hee Bum Jo, Ji-Soo Kwon, et al. (+2)
30 [GO] 2026―Apr―30 Safety, immunogenicity, and long COVID outcomes following inactivated COVID-19 vaccine boosters in elderly Chinese: a prospective cohort study Rongrong Dai, Qianhui Hua, Xinyu Liu, Lanxin Ma, Ruijing Bao, Huijun Lei, et al. (+6)
31 [GO] 2026―Apr―27 N-terminal pyroglutamylation of an HLA-A24-restricted immunodominant epitope enhances SARS-CoV-2-specific T-cell responses Yoshiki Aritsu, Masahiro Kitabatake, Amiri Kurose, Hiroshi Hamana, Takeshi Nakama, Kyoko Yamada, et al. (+14)
32 [GO] 2026―Apr―24 Post-booster longitudinal plasma proteomic changes following BNT162b2 COVID-19 vaccination in Qatar Sana Bentebbal, Ahmed Zaqout, Bakhita Meqbel, Ilham Bensmail, Abdullah Aldushain, Alberto de la Fuente, et al. (+18)
33 [GO] 2026―Apr―23 Correction: Persistence of SARS CoV-2 S1 protein in CD16+ monocytes in post-acute sequelae of COVID-19 (PASC) up to 15 months post-infection Bruce K. Patterson, Edgar B. Francisco, Ram Yogendra, Emily Long, Amruta Pise, Hallison Rodrigues, et al. (+11)
34 [GO] 2026―Apr―17 Respiratory epithelial cells as central mediators of immune crosstalk in SARS-CoV-2 infection Xingjian Liu, Zhefen Mai, Lingbin Sun, Liqiang Deng, Moushen Tang, Geng Li, Xiaoyi Yang
35 [GO] 2026―Apr―16 COVID-19 vaccination and clinical outcomes of immune checkpoint inhibitors therapy in cancer patients: a meta-analysis of real-world studies Hongyan Xi, Meichao Li, Jinhai Shen, Yuxuan Lin, Beibei Wang, Qingyun Yu, et al. (+2)
36 [GO] 2026―Apr―13 Drugs against broad-spectrum of coronaviruses Shaoli Huang, Xihe Zhang, Wenying Luo, YueHao Yao, Juan Hu, Xaoyan Wang, Hongwu Xin
37 [GO] 2026―Apr―10 Antiphospholipid antibody production in pregnant women with SARS-CoV-2 infection and its impact on maternal and fetal outcomes Shenglong Ye, Yilin Wang, Jingjing Yang, Yang Zhang, Zhe Chen, Ran Hu, et al. (+3)
38 [GO] 2026―Apr―10 Long-term immune profiling of COVID-19 recovered patients: effects of disease severity and vaccination Thomas F. Marandu, Lwitiho Sudi, Bernard Mbwele, Abdilahi Kiula, Mohamed Zahir Alimohamed, Pauline Sylvester, et al. (+7)
39 [GO] 2026―Apr―07 Cytokine-driven modulation of peripheral immune cell populations in Coronavirus disease 2019 patients Tanaka Arthur Choto, Bongiwe Ndlovu, Thajasvarie Naicker, Takafira Mduluza
40 [GO] 2026―Apr―07 Impact of COVID-19 on the epidemiological features of mycoplasma pneumoniae infection in children with community-acquired pneumonia in Ganzhou, China Guihua Lai, Zhiyong Lai, Jungao Huang, Fucheng Peng, Qiying Gu
41 [GO] 2026―Apr―02 Retrospective neutralization analysis of SARS-CoV-2 variants in early pandemic sera Mohamed Mahdi, Aya S. Al-Muffti, Tamás Richárd Linkner, Noémi Miltner, Olena Misák, István Várkonyi, József Tőzsér
42 [GO] 2026―Apr―01 Reduced COVID-19 severity in Africa: a systematic review of host genetic and immunological responses to SARS-CoV-2 infection Gloria Pokuaa Manu, Joseph H. K. Bonney, Flavia Kaduni Bawa, Peter Kojo Quashie, Kwadwo Asamoah Kusi, Linda Eva Amoah
43 [GO] 2026―Mar―31 Thymidine phosphorylase promotes SARS-CoV-2 spike protein-driven lung tumor development Cayleigh Wallace, Alex Gileles-Hillel, Amelia Cox, David Gozal, Wei Li, Hong Yue
44 [GO] 2026―Mar―31 Real-world immune dynamics following COVID-19 vaccination and breakthrough infection: a paired-sample study in Zhejiang Province, China Yuxin Hu, Youhong Weng, Xiaodong Li, Yihua Huang, Jinren Pan, Yahan Wu, et al. (+10)
45 [GO] 2026―Mar―25 Profiling of SARS-CoV-2 virus shedding, antibody neutralization, and T-cell receptor repertoires in a large, multi-center cohort of young adults with varied prior exposures Andrew Fiore-Gartland, Koshlan Mayer-Blackwell, James Stray, Moni Neradilek, April Lo, Alex Hannah, et al. (+15)
46 [GO] 2026―Mar―23 Broadly neutralizing single-domain antibody targeting the spike NTD displays therapeutic efficacy against diverse SARS-CoV-2 variants Anastasia I. Korobkova, Irina A. Favorskaya, Inna V. Shuliakova, Anna A. Iliukhina, Daria M. Grousova, Irina A. Alekseeva, et al. (+12)
47 [GO] 2026―Mar―23 Extracellular vesicles as key biomarkers in COVID-19: insights into disease severity and mortality through CD86 and other immune markers Lou Soret, Coralie L. Guerin, Joseph Roux de Bezieux, Katharine Rus, Léa Guyonnet, Georges Abi Abdallah, et al. (+9)
48 [GO] 2026―Mar―19 Immune correlates underlying small fiber neuropathy presenting as vaccine-associated post-acute SARS- coronavirus syndrome Alessandro Limongelli, Federica Bozzano, Alireza Hajabbas Farshchi, Margherita Bellucci, Martina Bavastro, Chiara Castellano, et al. (+10)
49 [GO] 2026―Mar―19 Safety and immunogenicity of 13-Valent pneumococcal conjugate vaccine in healthy infants in Shanghai during the COVID-19 pandemic: a prospective cohort study Lijing Xin, Liang Hong, Sijie Wang, Xiaohua Qian, Yue Li
50 [GO] 2026―Mar―18 Associated uncertainty estimation during the validation process of TCID50 and FRNT neutralization assays against SARS-CoV-2 variants, used in population surveillance research and correlates of protection Edgar Reyna-Rosas, Milton Nieto-Ponce, Andrea Palencia-Reyes, Carlos Blancas-Ruíz, Claudia Carranza, Martha Torres, Horacio Zamudio-Meza
51 [GO] 2026―Mar―17 Pustular psoriasis flare following COVID-19 infection: a case report and literature review Eri Ohta, Etsuko Okada, Yu Sawada
52 [GO] 2026―Mar―16 The cytokine signature in multiple sclerosis: a study during the SARS-CoV-2 pandemic Marco Puthenparampil, Annachiara Marin, Federica De Napoli, Alessandro Di Paola, Annamaria Valentina Mauceri, Susanna Ruggero, et al. (+5)
53 [GO] 2026―Mar―16 Exploring the timeline and network interplay of immune mediators in COVID-19 patients according to disease outcome Gabriel Macedo Costa Guimarães, Christiane Costa-Pereira, Renan da Silva Faustino, Lilian Santos Alves, Fabiana Rabe Carvalho, Thalia Medeiros, et al. (+7)
54 [GO] 2026―Mar―16 The impact of the COVID-19 pandemic on the epidemiology, clinical manifestations and molecular characteristics of Mycoplasma pneumoniae Luoman Yan, Hengheng Fu, Haiyan Zhang, Hao Dong, Junjie Chen, Lin Yu, Lei Zhang
55 [GO] 2026―Mar―11 Age-dependent immune profiles and variant-driven humoral alterations across two SARS-CoV-2 epidemic phases Mingyan Dai, Nana Guo, Yajing Wu, Shiyou Liu, Guangyue Han, Xu Han, Qi Li
56 [GO] 2026―Mar―11 Convergent hub pathways targeted by IAV, SARS-CoV-2, and RSV in type II alveolar epithelial cells: molecular mechanisms and therapeutic implications Kaixuan Zhang, Sudi Zhu, Mengyu Zhang, Henggui Hu, Shuguo Qin, Huihui Li, et al. (+2)
57 [GO] 2026―Mar―10 Immunization with MVA-based vaccines protects K18-hACE2 mice from SARS-CoV-2 infection-associated inflammatory lesions in brains Małgorzata Rosiak, Sabrina Clever, Eva Leitzen, Georg Beythien, Lukas Mathias Michaely, Sandra Lockow, et al. (+11)
58 [GO] 2026―Mar―10 Imbalanced immune cell network and suboptimal cell activation: signatures associated with disease severity in vaccine-naïve COVID-19 patients Ranferi Ocaña-Guzman, Elvira Piten-Isidro, Julio Flores-Gonzalez, Lucero A. Ramon-Luing, Perla M. Del Rio-Estrada, Ramcés Falfán-Valencia, et al. (+4)
59 [GO] 2026―Mar―09 SARS-CoV-2 spike S1-mediated HIF-2α activation in retinal endothelial cells suggests a mechanism contributing to post-COVID endothelial dysfunction Andrea Ribeiro, Timon Wallraven, Maciej Lech, Kristina Adorjan, Hans Christian Stubbe, Martina Seifert, et al. (+4)
60 [GO] 2026―Mar―09 Dysregulated NK-cell gene expression defines the enduring symptoms of long COVID-19 Urvi Ray, Antje Schulze Selting, Roshan Priyarangana Perera, Zhiqi Yang, Vladislav Lysenkov, Siri Göpel, et al. (+6)
61 [GO] 2026―Mar―06 The genetic basis of the immune response to SARS-CoV-2 infection and vaccination in the Italian municipality of Vo’ Ettore Zapparoli, Enrico Lavezzo, Hélène Tonnelé, Fabio Simeoni, Jing Guo, Klaudia Walter, et al. (+15)
62 [GO] 2026―Mar―04 Association of plasma ferritin and plasma iron at time of vaccination with the immune response to SARS-CoV-2 vaccination: a longitudinal cohort study Giulia Pestoni, Dominik Menges, Craig Fenwick, Pornpimol Scheuchzer, Julia Braun, Sarah R. Haile, et al. (+7)
63 [GO] 2026―Mar―04 Sex differences in vaccine-induced immunity in mice immunized with integrase-defective lentiviral vector delivering the SARS-CoV-2 Spike protein Iole Farina, Alessandra Gallinaro, Martina Borghi, Maria Franca Pirillo, Chiara Falce, Andrea Canitano, et al. (+6)
64 [GO] 2026―Mar―04 Impaired mucosal IgA response to SARS-CoV-2 in patients with inborn errors of immunity Fanglei Zuo, Samaneh Delavari, Sima Shokri, Yating Wang, Farhad Abolnezhadian, Sara Iranparast, et al. (+5)
65 [GO] 2026―Mar―04 Case Report: A 69-year-old woman with dermatopathic lymphadenopathy and hypercalcemia after COVID-19 infection Danli Hu, Yanchun Li, Shen Shen
66 [GO] 2026―Mar―02 Cytokine profiles, genetic polymorphisms, and systemic inflammatory markers in type 1 diabetes patients with COVID-19: IL-18 a predictor of disease severity Mohammed Yousif Abdullah, Ahmed Baligh Laaribi, Wafa Babay, Farah Abdulkhaleq Khattab Alhaddad, Asma Mehri, Hadda-Imene Ouzari, Sonia Marghali
67 [GO] 2026―Feb―27 Could β-glucans enhance the immune response to SARS-CoV-2 vaccine by inducing trained immunity and boosting neutralizing antibody production? Márjorie de Assis Golim, Patrícia Valério Orlandi Falbo, Aline Márcia Marques Braz, Rafael Plana Simões, Rejane Maria Tommasini Grotto, Beatriz Furtado Pegatin, et al. (+2)
68 [GO] 2026―Feb―27 Akkermansia muciniphila primes lung-resident antiviral immunity via the gut-lung axis during SARS-CoV-2 infection Gi-Cheon Kim, Jun-Soo Do, Sung-Hee Kim, Jong-Hwi Yoon, Jiseon Kim, Donghun Jeon, et al. (+10)
69 [GO] 2026―Feb―26 Principal component analysis of cytokine signature in COVID-19 and Long COVID Zoia R. Korobova, Areg A. Totolian
70 [GO] 2026―Feb―25 Single-cell analysis reveals immune remodeling of monocytes, NK cells, T cell exhaustion, and Galectin-9-associated depletion of gamma delta and mucosal-associated invariant T cells in Long COVID with ME/CFS Shima Shahbaz, Najmeh Bozorgmehr, Amirhossein Rahmati, Amal Abouda, Hussain Syed, Mohammed Osman, Shokrollah Elahi
71 [GO] 2026―Feb―25 Early rise in nasal secretory IgA associated with shorter duration of SARS-CoV-2 virus shedding in an acute infection cohort Caroline Brackett, Lu Zhang, Bich T. N. Do, Saman Baral, Leigh H. Fisher, William O. Hahn, et al. (+8)
72 [GO] 2026―Feb―25 Characterization of subchronic lung and brain consequences caused by mouse-adapted SARS-CoV-2 and influenza A infection of C57BL6 mice Joshua Currey, Chenxiao Wang, Meredith G. Mayer, Yilin Chen, Ana Karina Nisperuza Vidal, Michaela J. Allen, et al. (+13)
73 [GO] 2026―Feb―25 Identification of metabolic signatures of immune response following mRNA and inactivated vaccines against COVID-19: a systematic review Andrzej Wasilewski, Agata Serrafi
74 [GO] 2026―Feb―24 Relationship between COVID-19 and “three inflammations and one deafness”: a systematic review and meta-analysis Lisha Liu, Hong Zhao, Jing Qiao, Nai Liu, Wei Tao, Shengli Wei
75 [GO] 2026―Feb―23 Plasma proteomic profile reveals persistent immune activation in post-acute sequelae of SARS-CoV-2 infection Serena Fineschi, Joakim Klar, Jens Schuster, Jonas Bergquist, Niklas Dahl
76 [GO] 2026―Feb―23 Harnessing SARS-CoV-2 immunity to promote antitumor responses through intratumoral vaccination and adoptive transfer Manar Darwish, Mais Eyouni, Mohammed Yassir Khan, Rofidah Alsaggaf, Rahaf Alharbi, Haya Hawbani, et al. (+10)
77 [GO] 2026―Feb―20 mRNA-based SARS-CoV-2 vaccines: intracellular processing and aggregation of the encoded spike protein as a mechanistic contributor to cardiac cellular stress Rolf Schreckenberg, Nadine Woitasky, Nadja Itani, Laureen Czech, Anita C. Windhorst, Malte Juchem, et al. (+4)
78 [GO] 2026―Feb―19 400 AU/mL IgG protective threshold against SARS-CoV-2 XBB reinfection in Chinese inactivated vaccine recipients: implications for booster vaccination Zhiying Yin, Mengcheng Yin, Fei Zhao, Canya Fu, Wenjie Xu, Quanjun Fang, et al. (+3)
79 [GO] 2026―Feb―19 MERS-CoV and SARS-CoV-1 proteins inhibit the IFN-α JAK/STAT pathway of epithelial cells, via IFN-λ-induced USP18 Yamei Zhang, Nigel J. Stevenson
80 [GO] 2026―Feb―13 Correction: Promiscuous class II-binding SARS-CoV-2-nuc derived vaccine-peptide induced extensive conventional, innate and unconventional T cell responses Naomi Krickeberg, Hans-Georg Rammensee, Karin Schilbach
81 [GO] 2026―Feb―11 Proteomic profiling of circulating extracellular vesicles from COVID-19 patients and their impact on innate Vdelta2 T-cell response Claudia Montaldo, Eleonora Cimini, Eleonora Tartaglia, Manuela Antonioli, Veronica Bordoni, Stefania Notari, et al. (+10)
82 [GO] 2026―Feb―10 Case Report: Pemphigus following COVID-19 mRNA vaccination: two cases achieving long-term remission without relapse Yuri Fukunaga, Natsuko Saito-Sasaki, Eri Ohta, Yu Sawada
83 [GO] 2026―Feb―06 Editorial: Community series in SARS-CoV-2 variants, B lymphocytes, and autoreactivity, volume II Marko Z. Radic, Moncef Zouali
84 [GO] 2026―Feb―06 Association of SARS-CoV-2 infection with long-lasting increase in circulating IL-32 levels Lorenzo Miano, Elena Sinopoli, Alessandro Cherubini, Chiara Suffritti, Serena Pelusi, Fatima Rahmeh, et al. (+8)
85 [GO] 2026―Feb―05 Possible role of pre-vaccination T-lymphocyte subpopulations in the antibody response to COVID-19 vaccines in children undergoing chemotherapy Csaba Péterfia, Zsolt I. Komlósi, Zoltán Pós, Nikolett Lupsa, Nóra Fekete, Katalin Böröcz, et al. (+15)
86 [GO] 2026―Feb―04 Innate and adaptive immune patterns in hospitalised COVID-19 patients: a framework for precision monitoring in viral and inflammatory syndromes Salvatore Corrao, Raffaella Mallaci Bocchio, Salvatore Scibetta, Antonella Montalbano, Giuseppe Natoli, Luigi Calvo, et al. (+2)
87 [GO] 2026―Feb―03 Homoeriodictyol, targeting the bitter taste receptor TAS2R14, lowers the secretion of pro-inflammatory chemokines upon treatment with SARS-CoV-2 peptide pools in human peripheral blood mononuclear cells Barbara Danzer, Gaby Andersen, Kristin Kahlenberg, Veronika Somoza
88 [GO] 2026―Feb―03 Synergistic immune protection of exosomal T-cell epitope vaccine and antibody-inducing vaccine against SARS-CoV-2 in highly humanized mice Anran Shen, Suyue Zhu, Min Li, Yu Zhao, Yandan Wu, Yue Zhang, et al. (+7)
89 [GO] 2026―Feb―02 Neuroinflammatory and transcriptional dynamics during SARS-CoV-2 infection in KRT18-hACE2 mouse brain Dae-Gyun Ahn, Nhu Thi Quynh Mai, Da-Jin Jeong, Byoung-San Moon
90 [GO] 2026―Jan―29 Disturbed regulation of immunothrombosis in cerebral ischemia associated with SARS-CoV-2 infection Richard Plem, Nicole de Buhr, Rabea Imker, Silke Akhdar, Marita Meurer, Christine S. Falk, et al. (+11)
91 [GO] 2026―Jan―29 Long-term cellular and humoral responses to SARS-CoV-2 vaccinations in patients with solid malignancies undergoing chemotherapy Andrew Liu, Brian Necela, Zhuo Li, Davitte Cogen, Mikolaj A. Wieczorek, Ashita Mummareddy, et al. (+11)
92 [GO] 2026―Jan―27 Comparable immune escape capacity for NB.1 with that of JN.1 variant and survey of infection with severe acute respiratory syndrome coronavirus 2 variants among Chinese Felis silvestris catus Youhua Yuan, Yiman Geng, Qiyuan Zhu, Bingfu Sun, Junhong Xu, Xiaohuan Mao, et al. (+5)
93 [GO] 2026―Jan―26 Trivalent coronavirus vaccines elicit broad-spectrum immunity in mice and attenuate respiratory viral load in golden hamsters Xiuli Shen, Jiangshan He, Maoshun Liu, Xinyu Zhang, Peijia Wang, Yiming Shao
94 [GO] 2026―Jan―23 CMTM8 variants influence BNT162b2 COVID-19 vaccination response by regulating granulocytic/polymorphonuclear myeloid-derived suppressor cell activity Alessandro Testori, Antonella Mulas, Mara Marongiu, Valeria Orré, Monia Lobina, Maria Grazia Piras, et al. (+11)
95 [GO] 2026―Jan―22 Structure-guided design of a bivalent SARS-CoV-2 mRNA vaccine with NTD stabilizing mutations enhances broad immunity Jinah Yeo, Mi-ran Yun, Seo-Yeon Kim, Jong-Hyun Seok, Ji Hyang Jeon, Taeyoung Lee, et al. (+5)
96 [GO] 2026―Jan―20 NLRP3 inflammasome activation in astrocytes restricts SARS-CoV-2 through gasdermin-D-driven IL-1β release Ingrid S. de Farias, Márcia Duarte-Barbosa, Natalia Salazar, Robert Andreata-Santos, Victoria Weise L. de Lucena, Juliana T. Maricato, et al. (+3)
97 [GO] 2026―Jan―15 SARS-CoV-2 spike antibodies cross-react with dengue virus and enhance infection in vitro and in vivo Kamini Jakhar, Sudipta Sonar, Gagandeep Singh, Tejeswara Rao Asuru, Garima Joshi, Nisha Beniwal, et al. (+23)
98 [GO] 2026―Jan―13 Editorial: Community series in research advances of tuberculosis vaccine and its implication on COVID-19, volume III Wenping Gong, Ashok Aspatwar, Jianping Xie, Hao Li
99 [GO] 2026―Jan―12 Susceptibility of broad reactivity nanobodies to resistance mutations in the S2 domain of SARS-CoV-2 predicted by yeast display deep mutational scanning Christina R. Ball, Walter Ramage, Ryan Mate, Simon E. Hufton
100 [GO] 2026―Jan―12 SARS-CoV-2 evolution enhances endocytic uptake while preserving TMPRSS2-dependent fusion Clara L. Magnus, Zeliha Hamed Jaber, Andreas Hiergeist, Lisa Arnold, Harriet Marchel, Antonia Lamprecht, et al. (+15)
101 [GO] 2026―Jan―09 Viral glycoprotein-mediated entry and antibody-mediated immunity in HIV-1 and SARS-CoV-2 infection Michael W. Grunst, Wenwei Li, Walther Mothes
102 [GO] 2026―Jan―08 Pilot proteomic analysis of immune dysregulation in dengue with prior SARS-CoV-2 infection Elizabeth Cruz-Altamirano, Miguel Angel Mayoral-Chávez, Luis Román Ramírez-Palacios, Luz Maria Quirino-Vela, Diego Sait Cruz-Hernández, Sergio Roberto Aguilar-Ruíz, Juan Alpuche
103 [GO] 2026―Jan―08 Assessing the endothelium’s role in COVID-19 severity using the HUVEC model Sanzio Silva Santana, Sètondji Cocou Modeste Alexandre Yahouédéhou, Corynne Stéphanie Ahouéfa Adanho, Jéssica Rebouças Silva, Hayna Malta Santos, Cynara Gomes Barbosa, et al. (+5)
104 [GO] 2026―Jan―07 Acetylsalicylic acid disrupts SARS-CoV-2 spike protein glycosylation and selectively impairs binding to ACE2 Luca Perico, Alessandra Bovio, Susanna Tomasoni, Piera Trionfini, Domenico Cerullo, Daniela Corna, et al. (+5)
105 [GO] 2026―Jan―07 Contrasting immune responses in COVID-19: insights from healthcare workers and infected patients on plasmablast, pDC, and NK cell dynamics Laura Martín-Pedraza, Eulalia Rodríguez-Martín, Erick De La Torre-Tarazona, Elena Moreno, Roberto Pariente-Rodríguez, Paulette Esperanza Walo-Delgado, et al. (+13)
106 [GO] 2026―Jan―06 Dual role of ACE2 in regulating inflammation triggered by Omicron S1 and other SARS-CoV-2 Spike variants Annamaria Pedoto, Juan M. Lozano-Gil, María Ocaña-Esparza, Ana M. Conesa-Hernández, Sergio Candel, María L. Cayuela, et al. (+2)
107 [GO] 2026―Jan―06 Gender-based differences in telomere attrition and long-term respiratory dysfunction in COVID-19 ICU survivors one year post-infection: implications for aging-associated pulmonary decline Raquel Behar-Lagares, Ana Virseda-Berdices, Óscar Martínez-González, Rafael Blancas, Eva Manteiga, Paula Muñoz-García, et al. (+7)
108 [GO] 2026―Jan―06 The endothelial-immunothrombotic storm in viral sepsis: lessons from COVID-19 Kaihuan Zhou, Yin Chen, Jielong Pang, Jianfeng Zhang, Junyu Lu
109 [GO] 2026―Jan―05 Patient-reported improvements from use of IMC-2 alone and IMC-2 and Paxlovid® in a Long COVID cohort: a case series William L. Pridgen, David Putrino
110 [GO] 2026―Jan―05 The metabolic-immune interface of obesity in Covid-19: a role for angiotensin ii and inflammatory cytokines Cíntia Maria Rodrigues, Juliane Duarte Santos, Bruna Carolina Chaves Garcia, Marcelo Henrique Fernandes Ottoni, Karine Beatriz Costa, Marina Luiza Baêta Costa, et al. (+5)
111 [GO] 2026―Jan―02 Temporal dynamics of SARS-CoV-2 antibodies and IgG subclasses following multiple doses and diverse COVID-19 vaccine combinations Julia Meyer, Achim Hoerauf, Aleksandra Elzbieta Dubiel, Peđa Kovačević, Anika Trudić, Dragan Primorac, et al. (+3)
112 [GO] 2025―Dec―19 Longitudinal immune profiling uncovers regulatory T cell signatures associated with the progression of COVID-19 Camila Kossack, Felipe Bravo, Francisco Fuentes-Villalobos, Claudio Quevedo, Matías A. Medina, Raúl Riquelme, et al. (+6)
113 [GO] 2025―Dec―17 COVID-19 vaccination induces cross-reactive dengue virus antibodies with altered isotype profiles and in vitro antibody-dependent enhancement Sebastian Reinig, Chin Kuo, Sheng-Yu Huang, Kuei-Ching Hsiung, Po-Kai Chen, Etsuro Ito, et al. (+4)
114 [GO] 2025―Dec―16 COVID-19-associated delayed-onset MuSK-positive myasthenia gravis presenting solely with respiratory failure: a case report Xiao-Guang Cao, Jun-xi Ni, Xiong-feng Zhu, Hua-dong Meng, Chong-jian Huang
115 [GO] 2025―Dec―11 Autoantibodies in long COVID in a black/mixed population compared with recovered and pre-pandemic controls Jessica de Jesus Silva, Laila Sampaio Horta, Sayonara Melo Viana, Ana Beatriz Cazé, Isabela S. Oliveira, Mariana M. Pereira, et al. (+17)
116 [GO] 2025―Dec―11 IL-33 and IL-3 synergistically induce CD25 expression on human basophils without functional IL-2 signaling: a potential marker of severe COVID-19 Sruthi Vijaya Retnakumar, Suraj Chandrabhan Singh, Camille Chauvin, Jagadeesh Bayry
117 [GO] 2025―Dec―10 MRI-negative myelitis, especially after COVID-19: a case report and literature review Mitsuyoshi Tamura, Yohei Yagi, Satoki Hanayama, Satoko Yoshizaki, Kazumoto Shibuya, Hiroki Masuda, Masahiro Mori
118 [GO] 2025―Dec―09 Modulation of TLR7, TYK2 and OAS1 expression during SARS-CoV-2 infection Estíbaliz Alegría-Carrasco, Marta Jaén-Castaño, Pablo Delgado-Wicke, Nelly D. Zurita-Cruz, Nuria Montes, Emilia Roy-Vallejo, et al. (+7)
119 [GO] 2025―Dec―04 CXCL9 and CXCL10 support the exacerbated humoral response in recovered COVID-19 patients who developed acute respiratory distress syndrome by promoting plasma cell differentiation, whereas CXCL9 also induces CD40L and CXCR3 upregulation on T helper cells Romina Quiroga, Sergio Sanhueza, Catalina Sepúlveda, Bárbara Antilef, Camila Muñoz, Camilo Cabrera, et al. (+9)
120 [GO] 2025―Dec―03 COVID-19 vaccine-induced autoimmune hyperthyroidism: Graves’ disease Avaniyapuram Kannan Murugan, Ali S. Alzahrani
121 [GO] 2025―Dec―03 Variant-adapted COVID-19 vaccine boosters enhance humoral immunity and limit IgG4 accumulation in solid cancer patients Chiara Piubelli, Matteo Valerio, Donato Zipeto, Elisa Orlandi, Sara Caldrer, Francesco Rizzolo, et al. (+10)
122 [GO] 2025―Nov―28 Hidden players of COVID-19: the evolving roles of SARS-CoV-2 accessory proteins Miguel Padilla-Blanco, Tránsito García-García, Juozas Grigas, Blanca D. López-Ayllón, Juan J. Garrido, María A. Oliva, María Montoya
123 [GO] 2025―Nov―28 Convalescent plasma therapy for COVID-19 prophylaxis in adults early post-hematopoietic stem cell transplantation: one-year outcomes from a randomized controlled trial Yigeng Cao, Qiang Li, Wenwen Guo, Mingyue Xu, Kuo Fang, Fengjiao Wang, et al. (+16)
124 [GO] 2025―Nov―28 Dysregulated TFEB-autophagy-lysosome pathway links acute COVID-19 immunopathology to Long COVID sequelae Magdalena Gabig-Cimińska
125 [GO] 2025―Nov―25 A comprehensive longitudinal analysis of the cellular immune response specific to the spike protein in healthcare workers vaccinated against SARS-CoV-2- ORCHESTRA Project Stefano Ugel, Akshita Gupta, Gianluca Spiteri, Pierpaolo Marchetti, Francesco De Sanctis, Shari Wouters, et al. (+15)
126 [GO] 2025―Nov―25 Immune responses in pulmonary sarcoidosis following COVID-19 Anna Starshinova, Igor Kudryavtsev, Artem Rubinstein, Tatiana Akisheva, Alexey Golovkin, Zoia Korobova, et al. (+2)
127 [GO] 2025―Nov―21 SARS-CoV-2 spike protein induces salivary gland dysfunction and immune infiltration in C57BL/6 mice Fernanda Aragão Felix, Yuqiao Jiang, Jing Zhou, Dongfang Li, Victoria Zhou, Sílvia Ferreira de Sousa, et al. (+2)
128 [GO] 2025―Nov―21 Coordinated kinetics of humoral, T-cell, and cytokine responses to SARS-COV-2 in West African healthcare workers: a multicenter longitudinal study in university hospitals of Abidjan, Côte d’Ivoire Amah Patricia Victorine Goran-Kouacou, Oppong Richard Yéboah, Yida Jocelyne Séri, Aya Ursule Aniela Assi, Adjoumanvoulé Honoré Adou, Salimata Moussa, et al. (+4)
129 [GO] 2025―Nov―19 Vaccination and COVID-19: impact on long-COVID Gustavo N. Guimarães, Natália S. Brunetti, Dieila G. De Lima, José Luiz Proenca-Modena, Alessandro S. Farias
130 [GO] 2025―Nov―19 Natalizumab and fumarate treatment differentially modulate CD4+ T cell and B cell subtypes in multiple sclerosis patients without impacting durable COVID-19 vaccine responses Ryan Curtin, Yogambigai Velmurugu, Fatoumatta Dibba, Yuan Hao, Samantha Nyovanie, Andrea Lopez, et al. (+11)
131 [GO] 2025―Nov―19 Transplacental transferred anti-SARS-CoV-2 neutralizing antibodies in unvaccinated pregnant women in Cameroon occurred during the COVID-19 pandemic, but not in the pre-pandemic period Reine Medouen Ndeumou Seumko’o, Thandeka Moyo-Gwete, Tandile Hermanus, Sosthene Hillary Matabou Tene, Romeo Brice Dieffouo Djounda, Chris Marco Mbianda Nana, et al. (+9)
132 [GO] 2025―Nov―18 Heterologous ORFV-Ad26 vaccination broadens antibody breadth and amplifies cellular immunity against SARS-CoV-2 spike Alena Reguzova, Verena Haug, Melanie Müller, Madeleine Fandrich, Alex Dulovic, Ralf Amann
133 [GO] 2025―Nov―17 Utilisation of monoclonal antibodies in the single radial immunodiffusion assay to determine potency and stability for seasonal and pandemic influenza vaccines Jesse Bodle, David Burge, Gopal Gounder, Kirsten Vandenberg, Karen Laurie, Steven Rockman
134 [GO] 2025―Nov―17 Immunogenicity and safety to SARS-Cov-2 vaccination in patients with systemic vasculitis Erika Biegelmeyer, Mariana de Freitas Aguiar, Priscila Dias Cardoso Ribeiro, Ketty Lysie Libardi Lira Machado, Camila Maria Paiva França Telles, Sandra Lúcia Euzébio Ribeiro, et al. (+43)
135 [GO] 2025―Nov―14 Correction: Maternal and neonatal immune response to SARS-CoV-2, IgG transplacental transfer and cytokine profile Rocío Rubio, Ruth Aguilar, Mariona Bustamante, Erica Muñoz, Miquel Vázquez-Santiago, Rebeca Santano, et al. (+11)
136 [GO] 2025―Nov―14 Safety, tolerability, and immunogenicity of a DNA-based vaccine (INO-4700) against Middle East respiratory syndrome coronavirus: phase 2a study in healthy volunteers Joseph T. Agnes, Sarah A. Marcus, Sahem S. Al-Ghraibeh, Suleimman Ahmad Al-Sweedan, Josphat Kosgei, Bernhards Ogutu, et al. (+12)
137 [GO] 2025―Nov―13 Correction: Immune cell communication networks and memory CD8+ T cell signatures sustaining chronic inflammation in COVID-19 and Long COVID Hengrui Liu, Zewen Xu, Ilayda Karsidag, Panpan Wang, Jieling Weng
138 [GO] 2025―Nov―11 Multi-antigen MVA-vectored SARS-CoV-2 vaccine, GEO-CM04S1, induces cross-protective immune responses to ancestral and Omicron variants Amany Elsharkawy, Shannon Stone, Anchala Guglani, Felix Wussow, JD Burleson, Mary Hauser, et al. (+8)
139 [GO] 2025―Nov―11 Promiscuous class II-binding SARS-CoV-2-nuc derived vaccine-peptide induced extensive conventional, innate and unconventional T cell responses Naomi Krickeberg, Hans-Georg Rammensee, Karin Schilbach
140 [GO] 2025―Nov―07 Transcriptome analysis of classical blood cells reveals downregulation of pro-inflammatory genes in the classical monocytes of long COVID patients Florian Fricke, Franz Mai, Christine Wossidlo, Felix Steinbeck, Wendy Bergmann-Ewert, Marcel Kordt, et al. (+4)
141 [GO] 2025―Nov―07 Impact of immunodeficiencies on immunity induced by SARS-CoV-2 infection, mRNA BNT162b2 vaccination, and their combination in children and young adults Lubica Fialova, Birivan Macek-Nabova, Monika Zilkova, Natalia Turic-Csokova, Denisa Palova, Stanislav Katina, et al. (+7)
142 [GO] 2025―Nov―06 Neutrophil gene expression in COVID-19 patients with acute respiratory distress syndrome Hiroshi Ito, Masakazu Ishikawa, Jumpei Yoshimura, Yuchen Liu, Shuhei Sakakibara, Fuminori Sugihara, et al. (+5)
143 [GO] 2025―Nov―05 Hookworm infection modulates lung and intestinal transcriptomic responses to SARS-CoV-2 in Syrian hamsters Bruce A. Rosa, Mahdiyeh Bigham, Tamarand L. Darling, Ashutosh Arun, Kumar Sachin Singh, John Martin, et al. (+2)
144 [GO] 2025―Oct―30 Minimal association between Th1-specific responses to COVID-19 vaccines and SARS-CoV-2 breakthrough infections in multiple sclerosis patients receiving disease-modifying therapies Alessandra Aiello, Assunta Navarra, Shalom Haggiag, Serena Ruggieri, Gilda Cuzzi, Valentina Vanini, et al. (+17)
145 [GO] 2025―Oct―29 T-cell exhaustion in COVID-19: what do we know? Roderick Chen-Camaño, Rodrigo DeAntonio, Sandra López-Vergès
146 [GO] 2025―Oct―29 CKD-related impairment in humoral and cellular immune response and potential correlation with long COVID-19: a systematic review Dali Wang, Fenghua Zhang
147 [GO] 2025―Oct―23 Distinct characteristics of T cell receptor repertoire associated with the SARS-CoV-2 reinfection Liling Zeng, Li Liu, Baolin Ren, Bing Feng, Xudong Lai, Xunxi Lai, et al. (+3)
148 [GO] 2025―Oct―22 Exploring ceRNA mechanisms in COVID-19 mRNA vaccine-induced myocarditis: implications for future vaccine design Jing Wang, Xin-Yi Sun, Qian Gao, Min Fu, Mian Xiao, Ning Du, Xi-Yuan Ge
149 [GO] 2025―Oct―22 Immune cell communication networks and memory CD8+ T cell signatures sustaining chronic inflammation in COVID-19 and Long COVID Hengrui Liu, Zewen Xu, Ilayda Karsidag, Panpan Wang, Jieling Weng
150 [GO] 2025―Oct―16 Immune dysregulation and endothelial dysfunction associate with a pro-thrombotic profile in Long COVID Alicia Simón-Rueda, Clara Sánchez-Menéndez, Guiomar Casado, Daniel Fuertes, María Aránzazu Murciano-Antón, Elena Mateos, et al. (+9)
151 [GO] 2025―Oct―15 Post-pandemic upsurge of group A streptococcus infections: potential link to impaired herd trained immunity following COVID-19 lockdowns Janusz Marcinkiewicz
152 [GO] 2025―Oct―13 SARS-CoV-2 vaccines induce a diverse spike-specific CD4+ T cell receptor repertoire in people living with HIV with low CD4 nadirs Alicia Mercado, Joel Sop, Steven Amanat, Li Zhang, Natasha M. Chida, Christie R. Basseth, et al. (+5)
153 [GO] 2025―Oct―07 The innate immune response in SARS-CoV2 infection: focus on toll-like receptor 4 in severe disease outcomes Enrico Maggi, Nadine Landolina, Francesca Romana Mariotti, Enrico Munari, Nicola Tumino, Paola Vacca, et al. (+2)
154 [GO] 2025―Oct―02 Patterns of restricted TCR usage following SARS-CoV-2 vaccination and severe disease Emily Parsons, Zhongyan Lu, Stephanie A. Richard, Amanda Zelkoski, Janifer Le, Naraen Palanikumar, et al. (+16)
155 [GO] 2025―Oct―02 Multi-omics and machine learning identify novel biomarkers and therapeutic targets of COVID-19 Yumei Zhou, Pengbei Fan, Haiyun Zhang, Shuai Han, Minghua Bai, Ji Wang, Qi Wang
156 [GO] 2025―Oct―01 Humoral immune response to COVID-19 vaccines in onchocerciasis-infected individuals: a field study from Ghana Julia Meyer, Ute Klarmann-Schulz, Jennifer Nadal, Marijo Parcina, Linda Batsa Debrah, Jubin Osei-Mensah, et al. (+9)
157 [GO] 2025―Oct―01 Impact of an aerosolized or intramuscular adenovirus type 5-vectored COVID-19 vaccine on Fc-mediated immune effector functions in a hybrid immunity population Mingzhi Gan, Weiwei Han, Chuang Li, Simin Li, Zhuangzhuang Huang, Lingjie Xu, et al. (+4)
158 [GO] 2025―Oct―01 Severe COVID-19 induces prolonged elevation of the acute-phase protein pentraxin 3 Bernhard Kratzer, Robert B. Stieger, Seyma Durmus, Doris Trapin, Pia Gattinger, Paul Ettel, et al. (+15)
159 [GO] 2025―Sep―30 Personalized prediction of SARS-CoV-2 vaccine-induced immunity after boost: a longitudinal analysis using joint modeling Iraklis Papadopoulos, Anh Nguyet Diep, Joey Schyns, Claire Gourzones, Frédéric Minner, Germain Bonhomme, et al. (+10)
160 [GO] 2025―Sep―30 Editorial: Advances in understanding mucosal immunity in coronaviruses: from mechanisms to vaccines Farhat Afrin, Qibo Zhang, Wael Alturaiki, Waleed Mahallawi
161 [GO] 2025―Sep―30 Impact of CMV latency on T-cell responses to COVID-19 vaccination among predominantly antibody-deficient patients Trinidad Alba-Cano, Roberto Alonso, Héctor Balastegui-Martín, Luz Yadira Bravo-Gallego, Paloma Sánchez-Mateos, Mónica Martín-López, Juana Gil-Herrera
162 [GO] 2025―Sep―29 Identification of novel genetic biomarkers for ChAdOx1 nCoV-19 mediated immunogenicity Wan-Hsuan Chou, Che-Mai Chang, Jafit Ting, Min-Rou Lin, Hsin-Ni Liao, Yi-Chien Chou, et al. (+16)
163 [GO] 2025―Sep―29 Impact of recent COVID-19 infection on liver and kidney transplantation - a worldwide meta-analysis and systematic review Nicola Sariye Pollmann, Felix Dondorf, Falk Rauchfuß, Utz Settmacher, Lukas Pollmann, Markus Selzner
164 [GO] 2025―Sep―26 The landscape of neutralizing antibodies against SARS-CoV-2 variants: Insights from a stratified vaccination cohort Maria Julia Fialho, Carlos José Ferreira da Silva, Gabriel Brendo Alves Miranda, Izadora Sthephanie da Silva Assis, Adalgiza Mafra Moreno, Paulo Henrique Moura, et al. (+3)
165 [GO] 2025―Sep―25 Impact of chemotherapy on humoral and cellular immune responses to COVID-19 vaccination in patients with solid tumors Andrea Favalli, Giorgio Patelli, Paola Gruarin, Andrea Gobbini, Elisa Pesce, Sara Mariano, et al. (+16)
166 [GO] 2025―Sep―25 Patient and donor antibody profiles in early COVID-19 convalescent plasma therapy in the COnV-ert trial Andrea Alemany, Dan Ouchi, Edwards Pradenas, Ruth Aguilar, Marta Vidal, Alfons Jimenez, et al. (+9)
167 [GO] 2025―Sep―25 Autoantibody production in pregnancy: relationship with mRNA BNT162b2 immunization, active COVID-19, and pre-eclampsia Mauro César da Silva, George Tadeu Nunes Diniz, Maria Júlia da Silva Correia, Neila Caroline Henrique da Silva, Camila Rodrigues de Melo Barbosa, Ana Laura Carneiro Gomes Ferreira, et al. (+5)
168 [GO] 2025―Sep―23 Comparative analysis of neutralization assays performed using live SARS-CoV-2 virus and pseudovirus to assess immunogenicity of a bivalent SARS-CoV-2 protein vaccine in humans Cuige Gao, Jiang Yi, Adam Baidoo, Dongfang Liu, Jing Li, Dongyang Li, et al. (+3)
169 [GO] 2025―Sep―23 Chemokines as potential biomarkers for predicting the course of COVID-19 - a review of the literature Blanka Wolszczak-Biedrzycka, Beata Cieślikiewicz, Filip Studniarz, Łukasz Dąbrowski, Mateusz Fąs, Krystyna Matyszkiewicz-Suchodolska, et al. (+2)
170 [GO] 2025―Sep―22 Identification of blood immunological biomarkers of SARS-CoV-2 infection during pandemic in Poland Monika Leśniak, Agata Borkowska, Krzysztof Kłos, Karolina Aleksandrowicz, Klaudia Porębska, Dagmara Kobza, et al. (+7)
171 [GO] 2025―Sep―22 Antiviral and immunomodulatory effect of zapnometinib in animal models and hospitalized COVID-19 patients Yvonne Füll, Lara M. Schüssele, Hazem Hamza, Helen Hoffmann, Martin Bauer, Stephan Stenglein, et al. (+10)
172 [GO] 2025―Sep―19 Correction: Immune response dynamics of SARS-CoV-2 vaccination in chronic lymphocytic leukemia individuals: a descriptive analysis Clara Sánchez-Menéndez, Alejandro Zurdo, Magdalena Corona, Elena Mateos de la Morenas, Sara Rodríguez-Mora, Guiomar Casado, et al. (+8)
173 [GO] 2025―Sep―19 Heterologous prime-pull mucosal vaccination with an adjuvanted RBD vaccine elicits robust IgA production and protects against SARS-CoV-2 Allyson H. Hirsch, Calder R. Ellsworth, William A. Lewis, Ryan Craig, Amy E. Meyer, Jonatan Maldonado, et al. (+10)
174 [GO] 2025―Sep―19 Impact of pregnant mothers’ previous COVID-19 infection and vaccination on newborns’ serological profiling Alaa Masry, Mohammad A. A. Bayoumi, Prem Chandra, Hana J. Abukhadijah, Tawa Olukade, Ismail Abdelhady, et al. (+14)
175 [GO] 2025―Sep―17 Immunogenicity and safety of the booster COVID-19 vaccine among people with HIV: a systematic review and meta-analysis Zhenzhen Chen, Chunping Wan, Bing Chen, Qingyan Mo, Mingqian Ju, Kunlong Deng, et al. (+2)
176 [GO] 2025―Sep―15 Comparative single-cell immune responses in peripheral blood and lymph node of immunized SARS-CoV-2 challenged infant rhesus macaques Sasha Anronikov, Cameron Meikle, Emma C. Milligan, Han Chen, Nilanjan Mukherjee, Zach Bjornson, et al. (+7)
177 [GO] 2025―Sep―15 Case Report: An unexpected case of tumor regression in blue nevus melanoma following COVID-19 infection Yadriel Bracero, Emily Nghiem, Ajay K. Singh, Divya B. Kenchappa, Rachel Berglas, Shabnam Fidvi, et al. (+5)
178 [GO] 2025―Sep―12 Commentary: Long COVID in pediatric age: an observational, prospective, longitudinal, multicenter study in Italy Cristiana Indolfi, Angela Klain, Giulio Dinardo, Carolina Grella, Maria Maddalena Marrapodi, Michele Miraglia del Giudice
179 [GO] 2025―Sep―12 Longitudinal evaluation of T-cell responses to Pfizer-BioNTech and Janssen SARS-CoV-2 vaccines as boosters in Ghanaian adults Frank Osei, Kekeli Korshi Tudzi, Isaac Otieno Othol, Selorm Philip Segbefia, Diana Ahu Prah, Evans Nii Armah-Vedjesu, et al. (+12)
180 [GO] 2025―Sep―12 Immunization route-mediated differences in long-term maturation of humoral immune response induced by adenovirus vector-based COVID-19 vaccine Sputnik V in nonhuman primates Amir I. Tukhvatulin, Ilya V. Gordeychuk, Alina S. Dzharullaeva, Inna V. Dolzhikova, Ekaterina O. Bayurova, Fatima M. Izhaeva, et al. (+16)
181 [GO] 2025―Sep―05 Reduced spike specific T-cell responses in COVID-19 vaccinated subjects undergoing SARS-CoV-2 breakthrough infection Stefania Varchetta, Federica Sole Golfetto, Patrizia Bono, Annapaola Callegaro, Tanya Fabbris, Andrea Favalli, et al. (+11)
182 [GO] 2025―Sep―03 The impact of mycobacteria-induced trained immunity on SARS-CoV-2 vaccine responses Lidia Sánchez-Morales, Néstor Porras, Andrea Pérez-Domingo, Marta Pérez-Sancho, Teresa García-Seco, Marta Diaz-Frutos, et al. (+9)
183 [GO] 2025―Sep―03 Immuno-epigenetic paradigms in coronavirus infection Swati Gupta, Hassan A. Hemeg, Farhat Afrin
184 [GO] 2025―Sep―03 Severity-dependent IgG epitope profiling in COVID-19 reveals differential recognition of pathogen-derived antigens Lais Alves do Nascimento, NicolleRakanidis Machado, João Vitor da Silva Borges, Beatriz Oliveira Fagundes, Isabella Siuffi Bergamasco, Fabio da Ressureição Sgnotto, et al. (+3)
185 [GO] 2025―Sep―02 Anti-MDA5+ dermatomyositis following SARS-COV-2 infections: a systematic review Simone Lattarulo, Francesca Centrone, Maria Chironna
186 [GO] 2025―Sep―02 Upper respiratory tract immunization with Pam2Cys-adjuvanted spike protein vaccine achieves sterilizing protection against SARS-CoV-2 Erica L. Stewart, Skye Stockdale, Matt D. Johansen, Lachlan Smith, Sibel Alca, Joshua W. C. Maxwell, et al. (+11)
187 [GO] 2025―Aug―18 A genome-wide association study identifies new loci associated with response to SARS-CoV-2 mRNA-1273 vaccine in a cohort of healthy healthcare workers Antonio José Cabrera-Serrano, Lucía Ruiz-Durán, Juan Francisco Gutiérrez-Bautista, María Carretero-Fernández, Rob ter Horst, Yang Li, et al. (+7)
188 [GO] 2025―Aug―15 A fusion ORF3a-E subgenomic RNA involved in SARS-CoV-2 infection efficacy by influencing cellular protein synthesis Yifan Zhang, Jing Li, Xinglong Zhang, Xin Zhang, Jiali Li, Heng Li, et al. (+7)
189 [GO] 2025―Aug―15 Differential modulation of SARS-CoV-2 infection by complement factor H and properdin Uday Kishore, Praveen M. Varghese, Chandan Kumar, Susan Idicula-Thomas, Martin Mayora Neto, Anthony G. Tsolaki, et al. (+7)
190 [GO] 2025―Aug―14 From immune evasion to broad in silico binding: computational optimization of SARS-CoV-2 RBD-targeting nanobody Shuyuan Cao, Bo Sun, Feng Gao
191 [GO] 2025―Aug―13 Association of pro-inflammatory and anti-inflammatory cytokine polymorphisms with COVID-19 severity in unvaccinated patients Laura E. Martínez-Gómez, Carla I. Oropeza-Vélez, Maylin Almonte-Becerril, Leslie Chavez-Galan, Carlos Martinez-Armenta, Rosa P. Vidal-Vázquez, et al. (+23)
192 [GO] 2025―Aug―12 Circulating SARS-CoV-2 spike IgG antibody responses in cancer patients following multiple COVID-19 vaccination boosters Huijing Xue, Troy J. Kemp, Hayley North, Nancy V. Roche, Thomas E. Hickey, Ligia A. Pinto
193 [GO] 2025―Aug―06 Antiphospholipid antibodies during acute COVID-19 are not associated with long COVID: findings from a retrospective cohort study Robin Arcani, Alexandre Brodovitch, Xavier Heim, Jean-Louis Mège, Nathalie Bardin
194 [GO] 2025―Aug―04 Neutralizing antibody response to different COVID-19 vaccines in Brazil: the impact of previous infection and booster doses Beatriz L. L. Caetano, Paolla B. A. Pinto, Agatha R. Pacheco, Agnes R. Lage, Aline S. G. Pereira, Amanda V. P. Nascimento, et al. (+9)
195 [GO] 2025―Aug―01 COVID-19: a vascular nightmare unfolding Qinan Yin, Youjin Huang, Hulin Wang, Yin Wang, Xuefei Huang, Yujie Song, et al. (+3)
196 [GO] 2025―Jul―31 Correlation between SARS-CoV-2-specific antibody titers and the hormones DHEA, cortisol, testosterone, and progesterone Tanja Karl, Anja Schuster, Janne Cadamuro, Gertie Janneke Oostingh
197 [GO] 2025―Jul―31 The dialog between mother and newborn: insights from immune mediator crosstalk elicited by antenatal SARS-COV-2 exposure Maria Eduarda Canellas-de-Castro, Lizandra Moura Paravidine Sasaki, Geraldo Magela Fernandes, Felipe Motta, David Alves de Araújo Júnior, Heidi Luise Schulte, et al. (+21)
198 [GO] 2025―Jul―31 Treatment with intravenous immunoglobulin modulates coagulation- and complement-related pathways in COVID-19 patients Dominic McGrosso, Jessica Raygoza, Avnee J. Kumar, Michael T. Y. Lam, Laura A. Barnes, Sophia Karandashova, et al. (+9)
199 [GO] 2025―Jul―31 Previous COVID-19 infection significantly reduces elastase levels in newly diagnosed pulmonary tuberculosis patients Nancy Hilda Joseph, Alangudi Palaniappan Natarajan, Saravanan Natarajan, Chinnaiyan Ponnuraja, Madeshwaran A, Gunaparvathy I, et al. (+6)
200 [GO] 2025―Jul―30 Risk factor analysis and outcomes of heart transplant recipients infected by COVID-19 Lin Zhang, Sipeng Chen, Shanshan Zheng, Sheng Liu, Chenfei Rao, Zhongkai Liao, et al. (+4)
201 [GO] 2025―Jul―28 Vaccination, infection, and hybrid immunity: determinants of SARS-CoV-2 IgG antibody levels and protection in Quzhou, China Zhiying Yin, Mengcheng Yin, Fei Zhao, Canya Fu, Wenjie Xu, Quanjun Fang, et al. (+3)
202 [GO] 2025―Jul―28 Mixed lipopeptide-based mucosal vaccine elicits a long-term bone marrow memory response that is potentially cross-reactive against a broad-spectrum of coronaviruses in mice Raj S. Patel, Babita Agrawal
203 [GO] 2025―Jul―28 Hypertension attenuates COVID-19 vaccine protection in elderly patients: a retrospective cohort study Zhen Yuan, Iong Fong Wong, Ren-He Xu, Xiao Zhan Zhang, Chon Lok Lei
204 [GO] 2025―Jul―18 Comprehensive N-glycosylation profiling of recombinant spike S1 protein from the wild-type SARS-CoV-2 and its variants Yao Peng, Tian-Tian Tong, Qiu-Yu Deng, Lee-Fong Yau, Jia-Qi Qiu, Qing Zhao, et al. (+8)
205 [GO] 2025―Jul―17 Adjuvant combination and antigen multimerization shape neutralizing antibody and T cell responses to a SARS-CoV-2 RBD subunit vaccine João Pedro da Silva Nunes, Mariângela de Oliveira Silva, Juliana de Souza Apostolico, Isabela Pazotti Daher, Rodolfo Ferreira Marques, Marcio Massao Yamamoto, et al. (+12)
206 [GO] 2025―Jul―17 Comparison of SARS-CoV-2 immune responses following vaccination with Comirnaty (Pfizer) and Vaxzevria (AstraZeneca) in healthy individuals with or without prior SARS-CoV-2 infection Zdzisława Kondera-Anasz, Emilia Justyna Morawiec, Roksana Duszkiewicz, Filip Hajdrowski, Andrzej Wiczkowski
207 [GO] 2025―Jul―15 Comparison of SARS-CoV-2 IgG responses in hemodialysis patients and healthcare workers after COVID-19 vaccination Hakkı Öztürk, Metin Özsoy, Ayşegül Tuna, Artuner Varlibas, Salih Cesur, Altan Aksoy, et al. (+2)
208 [GO] 2025―Jul―10 Temporal TCR dynamics and epitope diversity mark recovery in severe COVID-19 patients Kriti Khare, Sunita Yadav, Sayanti Halder, Yogiraj Ray, Dipyaman Ganguly, Rajesh Pandey
209 [GO] 2025―Jul―04 The salvage therapy utilizing human umbilical cord-derived mesenchymal stem cells for the treatment of critically ill patients with COVID-19 Weiqi Yao, Boran Li, Yingan Jiang, Qiaoyu Yuan, Wenjie Wu, Ruizhen Hou, et al. (+4)
210 [GO] 2025―Jul―02 The quantity and quality of B-cell immunity against SARS-CoV-2 in children with cancer and hematological diseases Eva Tiselius, Emil Sundberg, Amanda Ramilo Amor, Hanna Andersson, Renate Varnaite, Linda Kolstad, et al. (+6)
211 [GO] 2025―Jun―30 Single-cell RNA-sequencing highlights a curtailed NK cell function in convalescent COVID-19 pregnant women Madhuri S. Salker, Nor Haslinda Abd Aziz, Natalia Carman Prodan, Zhiqi Yang, Aditya Kumar Lankapalli, Katrin Lazar, et al. (+17)
212 [GO] 2025―Jun―26 Amplification of select autonomous HERV loci and surrounding host gene transcription in monocytes from patients with post-acute sequelae of COVID-19 Hyunmin Koo, Casey D. Morrow
213 [GO] 2025―Jun―25 Progress in combination vaccines and the co-administration of influenza virus and SARS-CoV-2 vaccines Chengyu Hu, Chenguang Niu, Xiaohui Li, Ke He, Mengyu Li, Xiaonan Gao, et al. (+8)
214 [GO] 2025―Jun―24 RhCMV reactivation in SARS-CoV-2 infected aged rhesus macaques Jamin W. Roh, Peter A. Barry, Peter W. Hunt, Smita S. Iyer, Barbara L. Shacklett
215 [GO] 2025―Jun―19 The fibrin-derived peptide FX06 protects human pulmonary endothelial cells against the COVID-19-triggered cytokine storm Zhiran Wang, Dmitrii Lebedev, Simeng Li, Sudharshan Rao, Kevin Wu, Lorcan Doyle, et al. (+10)
216 [GO] 2025―Jun―19 Thromboinflammation vs. immunothrombosis: strategies for overcoming anticoagulant resistance in COVID-19 and other hyperinflammatory diseases. Is ROTEM helpful or not? Lou M. Almskog, Anna Ågren
217 [GO] 2025―Jun―18 Wuhan strain of SARS-CoV-2 triggers activation of immune evasion machinery similar to the one operated by cancer cells Maryam Abooali, Inna M. Yasinska, Gauri Thapa, Xi Lei, Kelly A. S. da Costa, Stephanie Schlichtner, et al. (+5)
218 [GO] 2025―Jun―18 Evolving fitness and immune escape: a retrospective analysis of SARS-CoV-2 spike protein (2020-2024) using protein language model Sihua Peng, Leke Lyu, Ludy Registre Carmola, Sachin Subedi, M. H. M. Mubassir, Mohamed A. Bakheet, Justin Bahl
219 [GO] 2025―Jun―16 A novel and safe SmartCap® SC101 to develop the COVID-19 mRNA vaccine STP2104 inducing potent immune responses in humans Rachel Kim, Tae-Gi Uhm, Jisu Kim, Dayeon Woo, Uk-Il Kim, Xue Meng, et al. (+18)
220 [GO] 2025―Jun―12 The DEAD-box RNA helicase 27 negatively regulates the replication of porcine reproductive and respiratory syndrome virus by mediating GP2a autophagy degradation and inducing interferon-β production Binghua Chen, Yunyan Luo, Yongjie Chen, Jingxing Wang, Jiecong Yan, Zhan He, et al. (+2)
221 [GO] 2025―Jun―11 Plasma proteomic profiling of hospitalized patients co-infected with HIV and SARS-CoV-2 Xinyu Zhang, Xuan Yan, Jinfeng Sun, Yueming Shao, Wei Song, Tangkai Qi, et al. (+12)
222 [GO] 2025―Jun―11 Proteomic and metabolomic analysis of serum in women infected with COVID-19 during late pregnancy Yi Zheng, Jinyu Ning, Jiang Zhu, Honglin Zhu, Zhihua She, Pei Cai
223 [GO] 2025―Jun―10 Understanding the long-term interplay of SARS-CoV-2 immune and inflammatory responses with proteases in COVID-19 recovery: a longitudinal study Natalia Ćwilichowska-Puślecka, Aleksandra Makowiecka, Małgorzata Kalinka, Katarzyna Groborz, Tobiasz Puślecki, Marcin Drąg, et al. (+4)
224 [GO] 2025―Jun―09 Discovery and development of a safe and efficient COVID-19 mRNA vaccine, STP2104, using a novel capping library screening method Kanghyun Choi, Joo-Young Lee, Uk-Il Kim, So-Hyun Park, So-Hee Hong, Yoo-Jin Bang, et al. (+31)
225 [GO] 2025―Jun―06 Immune response dynamics of SARS-CoV-2 vaccination in chronic lymphocytic leukemia individuals: a descriptive analysis Clara Sánchez-Menéndez, Alejandro Zurdo, Magdalena Corona, Elena Mateos de la Morenas, Sara Rodríguez-Mora, Guiomar Casado, et al. (+8)
226 [GO] 2025―Jun―06 Intramuscular DNA vaccine provides protection in non-human primate and mouse models of SARS-CoV-2 Subeena Sood, Ebony N. Gary, Majed Matar, Jessica Kim, Casey E. Hojecki, Bryce Warner, et al. (+15)
227 [GO] 2025―Jun―06 Whole-cell response of coronavirus-infected BMDCs through proteomic and transcriptomic analyses Yanxi Ji, Yuzhen Zhang, Yongjia Tong, Liu Cao, Lanyi Zeng, Yiran Xu, et al. (+9)
228 [GO] 2025―Jun―05 Impact of vitamin D supplementation in the prognosis of patients with SARS-CoV2 pneumonia admitted to the intensive care unit - a randomized controlled trial Ana Moura Gonçalves, Bárbara Sucena Rodrigues, Maria Lobo Antunes, João Gonçalves, António Marinho
229 [GO] 2025―Jun―04 Soluble SARS-CoV-2 Spike glycoprotein: considering some potential pathogenic effects Bruno Azzarone, Nadine Landolina, Francesca Romana Mariotti, Lorenzo Moretta, Enrico Maggi
230 [GO] 2025―Jun―04 Novel NUDCD1 gene variant predisposes to severe COVID-19 disease in Asians through modulation of antiviral DHX15- and MAVS-mediated signalling Aseervatham Anusha Amali, Douglas Jie Wen Tay, Yiqi Seow, Marie Loh, Sharada Ravikumar, Jocelyn Jin Yu, et al. (+23)
231 [GO] 2025―May―30 IgA autoimmunity and coagulation among post-acute sequelae of SARS-CoV-2 infection (PASC) patients with persistent respiratory symptoms: a case-control study Claudia Gomes, Jonathan H. Whiteson, Fabio Ponzo, Rany Condos, Mila B. Ortigoza, Marisol Zuniga, et al. (+2)
232 [GO] 2025―May―30 Markers of T cell activation and exhaustion in plasma are associated with persistent symptoms up to 18 months following mild SARS-CoV-2 infection Thor Ueland, Rebecca Jane Cox, Annika E. Michelsen, Elisabeth Berg Fjelltveit, Kari Otterdal, Tuva Dahl, et al. (+6)
233 [GO] 2025―May―30 Negative associations of age and lifestyle factors with the antibody response to the COVID-19 vaccine BNT162b2 in health workers from Spain Luis Sarabia de Ardanaz, Esther Serrano-Conde, Ana Fuentes, Alba Leyva, Federico García, Pilar Requena
234 [GO] 2025―May―28 Heterologous prime-boost vaccination drives stromal activation and adaptive immunity against SARS-CoV-2 variants Ji Hyang Jeon, Seongryong Kim, Seo-Yeon Kim, Kwang-Soo Shin, Bongju Park, Soojeong Chang, et al. (+6)
235 [GO] 2025―May―27 Long COVID-19 autoantibodies and their potential effect on fertility Laura Talamini, Dennyson Leandro M. Fonseca, Darja Kanduc, Olivier Chaloin, Cindy Verdot, Christian Galmiche, et al. (+19)
236 [GO] 2025―May―22 Comparative analysis of neutrophil dynamics and disease in SARS-CoV-2 Delta and Omicron variants utilizing an in vivo feline model for COVID-19 Sachithra Gunasekara, Shoroq Shatnawi, Sunil More, Breya Ludwig, Sai Narayanan, Miruthula Tamil Selvan, et al. (+2)
237 [GO] 2025―May―22 Distinct proteomic signatures in Ethiopians predict acute and long-term sequelae of COVID-19 Dawit Wolday, Abrha G. Gebrehiwot, An Nguyen Le Minh, Muhammed Ahmed Rameto, Saro Abdella, Atsbeha Gebreegziabxier, et al. (+11)
238 [GO] 2025―May―21 Predominant T-cell epitopes of SARS-CoV-2 restricted by multiple prevalent HLA-B and HLA-C allotypes in Northeast Asia Yu Zhao, Min Peng, Chengtao He, Min Li, Xuelian Han, Qiang Fu, et al. (+5)
239 [GO] 2025―May―20 Fc-effector functional antibody assays for SARS-CoV-2 variants of concern Xuemin Chen, Grace Li, Caroline Ciric, Theda Gibson, Larry J. Anderson, Christina A. Rostad
240 [GO] 2025―May―20 Exploring the standardized detection and sampling methods of human nasal SARS-CoV-2 RBD IgA Xuanxuan Zhang, Jizong Jia, Chaoying Hu, Yulong Fu, Guanxing Liu, Yajing Li, et al. (+12)
241 [GO] 2025―May―19 Addressing SARS-CoV-2 evolution: neutralization of emerging variants of concern by the AVX/COVID-12 ‘Patria’ vaccine based on HexaPro-S ancestral Wuhan spike or its updated BA.2.75.2 version Gregorio Carballo-Uicab, Gabriela Mellado-Sánchez, Edith González-González, Juana Salinas-Trujano, Ivette Mendoza-Salazar, Karina López-Olvera, et al. (+19)
242 [GO] 2025―May―19 Latent tuberculosis coinfection in mild COVID-19 is associated with a distinct immune cell phenotype marked by enhanced cytotoxic degranulation and mitochondrial alterations Carlos Peña-Bates, Lucero A. Ramón-Luing, Julio Flores-Gonzalez, Enrique Espinosa, María F. Martinez-Moreno, Karen Medina-Quero, et al. (+6)
243 [GO] 2025―May―16 Correlation between severe acute respiratory syndrome coronavirus 2 infection and serum anti-neutrophil cytoplasmic antibody formation Hao Huang, Yu-Jie Zang, Zheng-Guo Li, Qian Li, Chun-Yan Ma, Hai-Yuan Zhao, Hang Li
244 [GO] 2025―May―16 The protein interaction of mitochondrial transcription factors A and B2 is associated with 30-day survival in critical COVID-19 Britta Westhus, Patrick Thon, Lars Palmowski, Katharina Rump, Björn Koos, Frederik Wiebel, et al. (+19)
245 [GO] 2025―May―14 Immune modulation: the key to combat SARS-CoV-2 induced myocardial injury Zhaoqing Li, Luning Qin, Xiaojian Xu, Ruolan Chen, Guoliang Zhang, Banghui Wang, et al. (+2)
246 [GO] 2025―May―12 Effective cellular and neutralizing immunity against SARS-CoV-2 after mRNA booster vaccination is associated with pDC and B cell activation Dorit Fabricius, Carolin Ludwig, Matthias Proffen, Janina Hägele, Judith Scholz, Christiane Vieweg, et al. (+5)
247 [GO] 2025―May―12 Distinct immunity dynamics of natural killer cells in mild and moderate COVID-19 cases during the Omicron variant phase Yukari Nishikawa, Kosuke Yamaguchi, Ma’arif Athok Shofiudin, Momone Mimura, Miyako Takata, Shu Mihara, et al. (+14)
248 [GO] 2025―May―09 Virus-specific host responses and gene signatures following infection with major SARS-CoV-2 variants of concern: role of ZBP1 in viral clearance and lung inflammation Amany Elsharkawy, Hamid Reza Jahantigh, Anchala Guglani, Shannon Stone, Komal Arora, Mukesh Kumar
249 [GO] 2025―May―09 Reduced immune response to SARS-CoV-2 infection in the elderly after 6 months Qin Luo, Qinqin Song, Yan Li, Kexin Zong, Ti Liu, Junming He, et al. (+13)
250 [GO] 2025―May―09 Simultaneously ultrasensitive and differential detection of SARS-CoV-2, adenovirus and influenza a virus using multiplex fluorescence lateral flow immunoassay Xiaoyan Li, Changxu Zhao, Guangzheng Hou, Zhihua Sun, Xiaomei Liu, Yanlei Ding, et al. (+2)
251 [GO] 2025―May―09 The subsets of blood circulating T-cells associated with the development and prognosis of coinfection in patients with critical COVID-19 Xingming Li, Hongqiong Peng, Yunchuan Wang, Shiying He, Xueting Yang, Jiayue Chen
252 [GO] 2025―May―08 Ten years after introduction of NADC30-like strain in China: a novel chimeric porcine reproductive and respiratory syndrome vaccine candidate Weixin Wu, Xinyu Fang, Yiyao Jiang, Jiameng Hu, Qiongqiong Zhou, Peng Gao, et al. (+6)
253 [GO] 2025―May―08 Evaluation of humoral and cellular immune responses in healthcare workers with varying levels of SARS-CoV-2 exposure: effects of CoronaVac vaccination followed by heterologous booster Shayane Martins Rodrigues Gomes, Marcelo Ribeiro-Alves, Roberto Stefan de Almeida Ribeiro, Andréia Carolinne de Souza Brito, Vinicius da Cunha Lisboa, Samara Galdino de Azevedo, et al. (+7)
254 [GO] 2025―May―08 Immunological response and implications of Ad26.COV2. S (Janssen COVID-19 vaccine) vaccine in diabetic patients: a prospective cohort study in Ethiopia Chala Kenenisa Edae, Abdisa Tufa Bedada, Maria Degef Teklemariam, Abera Botore Gudisa, Abdurahman Adamu, Solomon Genet Gebre
255 [GO] 2025―May―05 Corrigendum: Pharmacological potential of Withania somnifera (L.) Dunal and Tinospora cordifolia (Willd.) Miers on the experimental models of COVID-19, T cell differentiation, and neutrophil functions Zaigham Abbas Rizvi, Prabhakar Babele, Upasna Madan, Srikanth Sadhu, Manas Ranjan Tripathy, Sandeep Goswami, et al. (+3)
256 [GO] 2025―May―02 Analysis of humoral and cellular immune activation up to 21 months after heterologous and homologous COVID-19 vaccination Davide Torre, Chiara Orlandi, Ilaria Conti, Simone Barocci, Eugenio Carlotti, Mauro Magnani, et al. (+2)
257 [GO] 2025―Apr―30 Transcriptomic analysis after SARS-CoV-2 mRNA vaccination reveals a specific gene signature in low-responder hemodialysis patients Simone Lucchesi, Giorgio Montesi, Jacopo Polvere, Fabio Fiorino, Gabiria Pastore, Margherita Sambo, et al. (+6)
258 [GO] 2025―Apr―30 The CD38+HLA-DR+ T cells with activation and exhaustion characteristics as predictors of severity and mortality in COVID-19 patients Qiuyue Long, Shixu Song, Jianbo Xue, Wenyi Yu, Yaolin Zheng, Jiwei Li, et al. (+10)
259 [GO] 2025―Apr―30 The underlying mechanism behind the different outcomes of COVID-19 in children and adults Zifang Shang, Ling Huang, Shijie Qin
260 [GO] 2025―Apr―29 Long donor leukocyte telomeres raise risk of severe COVID-19 in recipients of allogeneic hematopoietic cell transplant Kyra J. W. Mendez, Tsung-Po Lai, Stephen R. Spellman, Simon Verhulst, James Anderson, Wael Saber, et al. (+2)
261 [GO] 2025―Apr―25 Outcomes and risk factors of COVID-19 in patients with bullous pemphigoid: a cross-sectional study Yuexin Zhang, Dawei Huang, Yuling Shi, Yangfeng Ding, Yunlu Gao
262 [GO] 2025―Apr―24 Regulatory cytokines modulate early isotype-specific response associated with COVID-19 survival Sebastián Castro-Trujillo, Juanita Castro-Meneses, María Clemencia Rojas, Marcela Castro-Amaya, Giovani Lastra, Carlos F. Narváez
263 [GO] 2025―Apr―22 Associations between type III interferons, obesity and clinical severity of COVID-19 Dana Alalwan, Alejandro Abner Garcia Leon, Gurvin Saini, Colette Gaillard, Riya Negi, Camille Heckmann, et al. (+12)
264 [GO] 2025―Apr―17 Acute COVID-19 and LongCOVID syndrome - molecular implications for therapeutic strategies - review Krzysztof Piotr Michalak, Amelia Zofia Michalak, Alicja Brenk-Krakowska
265 [GO] 2025―Apr―16 SARS-CoV-2 post-acute sequelae linked to inflammation via extracellular vesicles Sara Bachiller, Joana Vitallé, Lluís Camprubí-Ferrer, Manuel García, Isabel Gallego, Marina López-García, et al. (+13)
266 [GO] 2025―Apr―15 Optimisation of the cultured ELISpot/Fluorospot technique for the selective investigation of SARS-CoV-2 reactive central memory T cells Jack R. Jerome, Kirsty L. Wilson, Joshuah Fialho, Georgia Goodchild, Monica D. Prakash, Charlie McLeod, et al. (+4)
267 [GO] 2025―Apr―15 Complex evaluation of coagulation, fibrinolysis, and inflammatory cytokines in SARS-CoV-2 infected pregnant women: a prospective, case-control study Zsuzsa Bagoly, Eszter Lilla Tóth, Rita Orbán-Kálmándi, Linda Lóczi, Tamás Deli, Olga Török, et al. (+8)
268 [GO] 2025―Apr―11 Corrigendum: Anti-RBD IgG antibodies from endemic coronaviruses do not protect against the acquisition of SARS-CoV-2 infection among exposed uninfected individuals Flávia Lopes Adami, Mateus Vidigal de Castro, Bianca da Silva Almeida, Isabela Pazotti Daher, Márcio Massao Yamamoto, Keity Souza Santos, et al. (+7)
269 [GO] 2025―Apr―11 Hematological and biochemical markers and cytokine levels in hospitalized psychiatric patients with COVID-19 Huirong Dai, Chih-Jung Chang, Zishun Li, Farong Liu, Qiao Zhang, Yixuan Bai, Pan You
270 [GO] 2025―Apr―09 Long COVID in pediatric age: an observational, prospective, longitudinal, multicenter study in Italy Susanna Esposito, Matteo Puntoni, Michela Deolmi, Greta Ramundo, Giuseppe Maglietta, Marco Poeta, et al. (+17)
271 [GO] 2025―Apr―04 A selective C5a-derived peptidomimetic enhances IgG response following inactivated SARS-CoV-2 immunization and confers rapid disease resolution following murine coronavirus infection Andrew J. Neville, Mackenzie E. Conrin, Thomas T. Schulze, Paul H. Davis
272 [GO] 2025―Apr―04 mRNA-1273 COVID-19 vaccine induces CD4+ T-cell responses among solid organ transplant recipients Bethany Girard, Amparo L. Figueroa, Stephen C. De Rosa, M. Juliana McElrath, Jamil R. Azzi, Dina Stolman, et al. (+5)
273 [GO] 2025―Apr―03 Monitoring immunological COVID-19 vaccine clinical testing across the CEPI Centralized Laboratory Network Lauren M. Schwartz, Jose Vila-Belda, Jerome Carless, Sadish Dhakal, Koen Hostyn, Trina Gorman, et al. (+5)
274 [GO] 2025―Apr―03 Case Report: Decentralized trial of tolerability-adapted exercise therapy after severe Covid-19 Jessica M. Scott, Zhuyu Qiu, Jahan Rahman, Chaya S. Moskowitz, Meghan G. Michalski, Sarah Lehman, et al. (+7)
275 [GO] 2025―Apr―02 Differential immunoregulation by human surfactant protein A variants determines severity of SARS-CoV-2-induced lung disease Ikechukwu B. Jacob, Akinkunmi O. Lawal, Salma S. Mahmoud, Emerson M. Kopsack, Erin S. Reynolds, Qinghe Meng, et al. (+5)
276 [GO] 2025―Apr―02 Distinct immune memory induced by SARS-CoV-2 in convalescent liver transplant recipients Mengcheng Liu, Feng Wu, Binwei Duan, Yuxuan Zhang, Wenjing Wang, Zhuangzhuang Chen, et al. (+6)
277 [GO] 2025―Apr―02 Nasal delivery of killed Bacillus subtilis spores protects against influenza, RSV and SARS-CoV-2 Rong Xu, Huynh A. Hong, Shadia Khandaker, Murielle Baltazar, Noor Allehyani, Daan Beentjes, et al. (+7)
278 [GO] 2025―Apr―02 Corrigendum: Global transmission of monkeypox virus-a potential threat under the COVID-19 pandemic Yang Wang, Ping Leng, Hao Zhou
279 [GO] 2025―Apr―02 Distinct Omicron longitudinal memory T cell profile and T cell receptor repertoire associated with COVID-19 hospitalisation Gavin Markey, Joseph McLaughlin, Darren McDaid, Seodhna M. Lynch, Andrew English, H. Denis Alexander, et al. (+10)
280 [GO] 2025―Apr―01 Clara cell 16 kDa protein: an important marker for COVID-19 severity Tineke Kardol-Hoefnagel, Bart Luijk, Leon Reteig, Saskia Haitjema, Helen L. Leavis, Henny G. Otten
281 [GO] 2025―Mar―28 Effectiveness of early intervention and combination treatment with monoclonal antibodies and antivirals in oncohematological patients with SARS-CoV-2: a retrospective experience Silvia Di Bari, Francesco Izzo, Livia Bresciani, Giulia Mancarella, Silvia Garattini, Andrea Gasperin, et al. (+14)
282 [GO] 2025―Mar―28 Anti-S2 antibodies responsible for the SARS-CoV-2 infection-induced serological cross-reactivity against MERS-CoV and MERS-related coronaviruses Siyuan Sun, Jiaying He, Luotian Liu, Yuzhen Zhu, Qingsong Zhang, Yinong Qiu, et al. (+14)
283 [GO] 2025―Mar―28 Beyond interferon gamma - decreased cellular response to COVID-19 vaccination booster in patients with autoimmune inflammatory rheumatic diseases Jakub Wroński, Magdalena Massalska, Bożena Jaszczyk, Anna Felis-Giemza, Anna Kornatka, Magdalena Plebańczyk, et al. (+4)
284 [GO] 2025―Mar―28 Differences in the inflammatory response and outcome among hospitalized patients during different waves of the COVID-19 pandemic Violeta Briciu, Daniel-Corneliu Leucuta, Monica Muntean, Amanda Radulescu, Cristina Cismaru, Adriana Topan, et al. (+6)
285 [GO] 2025―Mar―28 Longitudinal cellular and humoral immune responses following COVID-19 BNT162b2-mRNA-based booster vaccination of craft and manual workers in Qatar Remy Thomas, Ahmed Zaqout, Bakhita Meqbel, Umar Jafar, Nishant N. Vaikath, Abdullah Aldushain, et al. (+16)
286 [GO] 2025―Mar―28 Chimeric receptor-binding domain vaccine design and sequential immunization enhanced broadly neutralizing antibody responses against COVID-19 Xiao Yang, Xin Tang, Ying Sun, Hualong Xi, Wei Peng, Lu Yan, et al. (+3)
287 [GO] 2025―Mar―27 Spike specific IgG3 and nucleocapsid IgG response in serum serve as distinguishing immunological markers between SARS-CoV-2 infection and vaccination Marjahan Akhtar, Md. Rashedul Islam, Fatema Khaton, Fatima Rahman, Tausif Adnan Sami, Imam Tauheed, et al. (+12)
288 [GO] 2025―Mar―27 Improved antibody breadth with an extended primary dose interval of COVID-19 vaccine is overcome by boosters Jessica I. Ahmed, Samantha J. Krosta, Mandy N. Reimer, Winnie Cheung, Christine Mesa, Carmen Lopez, et al. (+21)
289 [GO] 2025―Mar―24 Memory B cell proliferation drives differences in neutralising responses between ChAdOx1 and BNT162b2 SARS-CoV-2 vaccines David Hodgson, Yi Liu, Louise Carolan, Siddhartha Mahanty, Kanta Subbarao, Sheena G. Sullivan, et al. (+2)
290 [GO] 2025―Mar―24 Mutations in ace2 gene modulate cytokine levels and alter immune responses in Mycobacterium tuberculosis and SARS-CoV-2 co-infection: a Cameroonian cohort Mary Ngongang Kameni, Eric Berenger Tchoupe, Severin Donald Kamdem, Nikhil Bhalla, Jean Paul Assam Assam, Arnaud Njuiget Tepa, et al. (+5)
291 [GO] 2025―Mar―21 Enhanced and long-lasting SARS-CoV-2 immune memory in individuals with common cold coronavirus cross-reactive T cell immunity David M. Florian, Michael Bauer, Amelie Popovitsch, Ingrid Fae, David N. Springer, Marianne Graninger, et al. (+9)
292 [GO] 2025―Mar―18 T and B cell responses in different immunization scenarios for COVID-19: a narrative review Eva Piano Mortari, Francesca Ferrucci, Irini Zografaki, Rita Carsetti, Luciano Pacelli
293 [GO] 2025―Mar―18 Characterizing HLA-A2-restricted CD8+ T-cell epitopes and immune responses to Omicron variants in SARS-CoV-2-inactivated vaccine recipients Chanchan Xiao, Jian Xiang, Haoyun Wang, Wen Gao, Tianchan Peng, Shumin Li, et al. (+7)
294 [GO] 2025―Mar―17 Mucosal multivalent NDV-based vaccine provides cross-reactive immune responses against SARS-CoV-2 variants in animal models Irene González-Domínguez, Adam Abdeljawad, Tsoi Ying Lai, Marta Boza, Stephen McCroskery, Nicholas Lemus, et al. (+15)
295 [GO] 2025―Mar―17 Non-neutralizing anti-type I interferon autoantibodies could increase thrombotic risk in critical COVID-19 patients Mario Framil, Lydia García-Serrano, Francisco Morandeira, Juan Francisco Luchoro, Arnau Antolí, Jose Luis Gomez-Vazquez, et al. (+2)
296 [GO] 2025―Mar―17 Editorial: Long COVID and brain inflammation: unravelling mechanisms and potential therapies Fatemeh Saheb Sharif-Askari, Jacob Raber, Karem H. Alzoubi
297 [GO] 2025―Mar―14 The impact of the mRNA COVID-19 vaccine on the Th-like cytokine profile in individuals with no history of COVID-19: insights into autoimmunity targeting heat shock proteins Stefan Tukaj, Magdalena Sitna, Krzysztof Sitko
298 [GO] 2025―Mar―14 Increased circulating levels of SP-D and IL-10 are associated with the development of disease severity and pulmonary fibrosis in patients with COVID-19 Xin Pan, Zhisheng Huang, Ningning Tao, Chuanjun Huang, Shanshan Wang, Zuowang Cheng, et al. (+2)
299 [GO] 2025―Mar―13 Harnessing immunotherapeutic molecules and diagnostic biomarkers as human-derived adjuvants for MERS-CoV vaccine development Abdullah R. Alrasheed, Maaweya Awadalla, Hadeel Alnajran, Mohammed H. Alammash, Adil M. Almaqati, Ishtiaq Qadri, Bandar Alosaimi
300 [GO] 2025―Mar―12 Pulmonary lymphoid tissue induced after SARS-CoV-2 infection in rhesus macaques Zhong-Min Ma, Katherine J. Olstad, Koen K. A. Van Rompay, Smita S. Iyer, Christopher J. Miller, J. Rachel Reader
301 [GO] 2025―Mar―07 Corrigendum: Differential co-expression network analysis reveals key hub-high traffic genes as potential therapeutic targets for COVID-19 pandemic Aliakbar Hasankhani, Abolfazl Bahrami, Negin Sheybani, Behzad Aria, Behzad Hemati, Farhang Fatehi, et al. (+5)
302 [GO] 2025―Mar―07 Intersecting SARS-CoV-2 spike mutations and global vaccine efficacy against COVID-19 Samaneh Tokhanbigli, Samira Salami Ghaleh, Karim Rahimian, Mohammadamin Mahmanzar, Saleha Bayat, Shahrzad Ahangarzadeh, et al. (+5)
303 [GO] 2025―Mar―06 Enhanced T-cell immunity and lower humoral responses following 5-dose SARS-CoV-2 vaccination in patients with inborn errors of immunity compared with healthy controls Vitor Gabriel Lopes da Silva, Gabriela Justamante Händel Schmitz, Kathleen E. Sullivan, Júlia Barbate, Maria Izabel de Haro Azinar, Carolina Sanchez Aranda, Maria Isabel de Moraes-Pinto
304 [GO] 2025―Mar―06 Heterogeneity and longitudinal transcriptomic characteristics of Tregs in COVID-19 patients Yanling Wen, Juanjuan Zhao, Zheng Zhang
305 [GO] 2025―Mar―05 Longitudinal analysis of immune responses to SARS-CoV-2 recombinant vaccine S-268019-b in phase 1/2 prime-boost study Masaya Fujitani, Xiuyuan Lu, Ryo Shinnakasu, Takeshi Inoue, Yujiro Kidani, Naomi M. Seki, et al. (+19)
306 [GO] 2025―Feb―28 T cell receptor usage and epitope specificity amongst CD8+ and CD4+ SARS-CoV-2-specific T cells Ulrik Fahnøe, Shan Feng, Alexander P. Underwood, Kivin Jacobsen, Amir Ameri, Thomas H. Blicher, et al. (+5)
307 [GO] 2025―Feb―27 Corrigendum: SARS-CoV2 infection during pregnancy causes persistent immune abnormalities in women without affecting the newborns Elena Vazquez-Alejo, Laura Tarancon-Diez, Itzíar Carrasco, Sara Vigil-Vázquez, Mar Muñoz-Chapuli, Elena Rincón-López, et al. (+10)
308 [GO] 2025―Feb―26 Association between SARS-CoV-2 infection and anti-apolipoprotein A-1 antibody in children Nicolas Vuilleumier, Sabrina Pagano, Elsa Lorthe, Julien Lamour, Mayssam Nehme, Catherine Juillard, et al. (+5)
309 [GO] 2025―Feb―26 Development of a multi-epitope vaccine candidate to combat SARS-CoV-2 and dengue virus co-infection through an immunoinformatic approach Saurav Mandal, Waribam Pratibha Chanu, Kalimuthusamy Natarajaseenivasan
310 [GO] 2025―Feb―26 Animal models of post-acute COVID-19 syndrome: a call for longitudinal animal studies Jingyi Dai, Fanyi He, Qian Chen, Qiujing Li, Liping Zhao, Yingrong Du
311 [GO] 2025―Feb―25 Dynamic SARS-CoV-2-specific B-cell and T-cell responses induced in people living with HIV after a full course of inactivated SARS-CoV-2 vaccine Xiuwen Wang, Xiaodong Yang, Xin Zhang, Hongxia Yan, Junyan Jin, Zhenglai Ma, et al. (+10)
312 [GO] 2025―Feb―25 Serum proteomics reveals high-affinity and convergent antibodies by tracking SARS-CoV-2 hybrid immunity to emerging variants of concern Anand Patel, Thiago Lima, Richard Carson, Qiulong Huang, Stefano R. Bonissone, Natalie Castellana
313 [GO] 2025―Feb―25 SARS-CoV-2 spike peptide analysis reveals a highly conserved region that elicits potentially pathogenic autoantibodies: implications to pan-coronavirus vaccine development Marilyn Diaz, Zbignew Mikulski, Dan Leaman, Angel Gandarilla, Nathalia Da Silva, Annie Verkoczy, et al. (+2)
314 [GO] 2025―Feb―24 Neutrophil extracellular traps and macrophage activation contibute to thrombosis and post-covid syndrome in SARS-CoV-2 infection Irene Serrano-Gonzalo, Bárbara Menéndez-Jandula, Esther Franco-García, Isidro Arévalo-Vargas, Calos Lahoz-Gil, Paz Latre, et al. (+4)
315 [GO] 2025―Feb―20 Programmed cell death markers in COVID-19 survivors with and without sepsis Chandra Shekar Mallarpu, Srinivasa Ikswaja Chelluri, Tapaswi Krishna Katragadda, Maneendra Singarapu, Lakshmi Kiran Chelluri, Charitha Madiraju
316 [GO] 2025―Feb―19 Co-infections exacerbate inflammatory responses in COVID-19 patients, promoting coagulopathy and myocardial injury, leading to increased disease severity Xiaoxia Chang, Yanjun Lai, Yingying Zhao, Jing Zhao, Yunchao Zhang, Xiaotao Qian, Guochao Zhang
317 [GO] 2025―Feb―18 Follow-up of humoral and cellular immune responses after the third SARS-CoV-2 vaccine dose in multiple myeloma patients Vincenzo Raimondi, Paola Storti, Rosanna Vescovini, Valentina Franceschi, Denise Toscani, Laura Notarfranchi, et al. (+8)
318 [GO] 2025―Feb―18 Dynamics of spike-specific neutralizing antibodies across five-year emerging SARS-CoV-2 variants of concern reveal conserved epitopes that protect against severe COVID-19 Latifa Zayou, Swayam Prakash, Hawa Vahed, Nisha Rajeswari Dhanushkodi, Afshana Quadiri, Ahmed Belmouden, et al. (+5)
319 [GO] 2025―Feb―17 Intradermal delivery of SARS-CoV-2 RBD3-Fc mRNA vaccines via a needle-free injection system induces robust immune responses in rats Cenrong Wang, Xin Tang, Chenghan Jiang, Yu Zhang, Bo Han, Yi Sun, et al. (+7)
320 [GO] 2025―Feb―17 A large-scale database of T-cell receptor beta sequences and binding associations from natural and synthetic exposure to SARS-CoV-2 Sean Nolan, Marissa Vignali, Mark Klinger, Jennifer N. Dines, Ian M. Kaplan, Emily Svejnoha, et al. (+23)
321 [GO] 2025―Feb―17 XBB.1.5 mRNA COVID-19 vaccine protection against inpatient or emergency department visits among adults infected with SARS-CoV-2 JN.1 and XBB-lineage variants Matthew E. Levy, Vanessa Chilunda, Phillip R. Heaton, Deran McKeen, Jason D. Goldman, Richard E. Davis, et al. (+17)
322 [GO] 2025―Feb―14 Report on adverse events of COVID-19 vaccines in Iran: a comprehensive national prospective longitudinal analysis Hamidreza Jamaati, Saeed Karimi, Shahnam Arshi, Seyed Mohsen Zahraei, Yunes Panahi, Fatemeh Nouri, et al. (+18)
323 [GO] 2025―Feb―12 Immunologic and inflammatory consequences of SARS-CoV-2 infection and its implications in renal disease Hiam Naiditch, Michael R. Betts, H. Benjamin Larman, Moshe Levi, Avi Z. Rosenberg
324 [GO] 2025―Feb―07 Adjuvanted subunit intranasal vaccine reduces SARS-CoV-2 onward transmission in hamsters Yongjun Sui, Swagata Kar, Bhavna Chawla, Tanya Hoang, YuanKai Yu, Shannon M. Wallace, et al. (+2)
325 [GO] 2025―Feb―04 Ocular neuroinflammatory response secondary to SARS-CoV-2 infection-a review Yun Zhao, Ying Tang, Qi Yao Wang, Jia Li
326 [GO] 2025―Feb―04 Challenging the notion of endothelial infection by SARS-CoV-2: insights from the current scientific evidence Saravanan Subramaniam, Asha Jose, Devin Kenney, Aoife K. O’Connell, Markus Bosmann, Florian Douam, Nicholas Crossland
327 [GO] 2025―Feb―03 Cyclophilin-CD147 interaction enables SARS-CoV-2 infection of human monocytes and their activation via Toll-like receptors 7 and 8 Gabor Tajti, Laura Gebetsberger, Gregor Pamlitschka, Katharina Aigner-Radakovics, Judith Leitner, Peter Steinberger, et al. (+2)
328 [GO] 2025―Jan―31 Autoimmune hepatitis under the COVID-19 veil: an analysis of the nature of potential associations Chaojie Yu, Wenrui Wang, Qian Zhang, Zhenjing Jin
329 [GO] 2025―Jan―28 Fusion protein-based COVID-19 vaccines exemplified by a chimeric vaccine based on a single fusion protein (W-PreS-O) Pia Gattinger, Luibov I. Kozlovskaya, Alexander S. Lunin, Olga S. Gancharova, Dina I. Sirazova, Vasiliy D. Apolokhov, et al. (+5)
330 [GO] 2025―Jan―24 Corrigendum: Identifying risk factors for secondary infection post-SARS-COV-2 infection in patients with severe and critical COVID-19 Mingquan Guo, Menglu Gao, Jing Gao, Tengfei Zhang, Xin Jin, Jian Fan, et al. (+4)
331 [GO] 2025―Jan―23 Lipoxin A4 levels correlate with severity in a Spanish COVID-19 cohort: potential use of endogenous pro-resolving mediators as biomarkers Sergio Sánchez-García, Rafael I. Jaén, Roberto Lozano-Rodríguez, José Avendaño-Ortiz, Alejandro Pascual-Iglesias, Laura Hurtado-Navarro, et al. (+3)
332 [GO] 2025―Jan―22 Humoral and cellular immune durability of different COVID-19 vaccine platforms following homologous/heterologous boosters: one-year post vaccination Maaweya Awadalla, Halah Z. AlRawi, Rahaf A. Henawi, Fawziya Barnawi, Haitham Alkadi, Ahmed Alyami, et al. (+5)
333 [GO] 2025―Jan―21 Humoral and cell-mediated immune responses to COVID-19 vaccines up to 6 months post three-dose primary series in adults with inborn errors of immunity and their breakthrough infections Dana Unninayar, Emilia L. Falcone, Hugo Chapdelaine, Donald C. Vinh, Karina A. Top, Beata Derfalvi, et al. (+19)
334 [GO] 2025―Jan―21 A randomized, placebo-controlled trial of the BTK inhibitor zanubrutinib in hospitalized patients with COVID-19 respiratory distress: immune biomarker and clinical findings Steven P. Treon, Camille N. Kotton, David J. Park, Giorgia Moranzoni, Camilla K. Lemvigh, Joseph C. Gathe, et al. (+29)
335 [GO] 2025―Jan―20 Lymphoma patients treated with anti-CD20 and chemotherapy display disconnected T and B cell responses to COVID-19 vaccine Sylvain Lamure, Houria Hendel Chavez, Marie-Ghislaine de Goër de Herve, Luc-Matthieu Fornecker, Bernard Drenou, Caroline Jacquet, et al. (+8)
336 [GO] 2025―Jan―20 TLR10 overexpression modulates immune response in A549 lung epithelial cells challenged with SARS-CoV-2 S and N proteins Špela Knez, Mojca Narat, Jernej Ogorevc
337 [GO] 2025―Jan―17 Therapeutic plasma exchange accelerates immune cell recovery in severe COVID-19 Aurelie Guironnet-Paquet, Hind Hamzeh-Cognasse, Frederic Berard, Fabrice Cognasse, Jean Christophe Richard, Hodane Yonis, et al. (+19)
338 [GO] 2025―Jan―16 Editorial: Immune studies of SARS-CoV2 and vaccines using preclinical modeling Cordelia Dunai, Smita S. Iyer, William J. Murphy
339 [GO] 2025―Jan―15 Caspase-1 activation, IL-1/IL-6 signature and IFNγ-induced chemokines in lungs of COVID-19 patients Audrey Cambon, Christophe Guervilly, Clémence Delteil, Nicola Potere, Richard Bachelier, Edwige Tellier, et al. (+17)
340 [GO] 2025―Jan―14 Comparison of immune responses to SARS-CoV-2 spike following Omicron infection or Omicron BA.4/5 vaccination in kidney transplant recipients Inga Tometten, Tobias Brandt, Maike Schlotz, Ricarda Stumpf, Sinje Landmann, Marta Kantauskaite, et al. (+14)
341 [GO] 2025―Jan―14 Impact of SARS-CoV-2 vaccination and of seasonal variations on the innate immune inflammatory response Hend Jarras, Isalie Blais, Benjamin Goyer, Wilfried W. Bazié, Henintsoa Rabezanahary, Mathieu Thériault, et al. (+9)
342 [GO] 2025―Jan―13 Unravelling the impact of SARS-CoV-2 on hemostatic and complement systems: a systems immunology perspective Didar Murad, Rehan Zafar Paracha, Maryum Nisar
343 [GO] 2025―Jan―13 Analysis of whole transcriptome reveals the immune response to porcine reproductive and respiratory syndrome virus infection and tylvalosin tartrate treatment in the porcine alveolar macrophages Kun Du, Yu Xia, Qian Wu, Miao Yin, Hong Zhao, Xi-wen Chen
344 [GO] 2025―Jan―08 Maternal-fetal cytokine profiles in acute SARS-CoV-2 “breakthrough” infection after COVID-19 vaccination Claire H. Packer, Olyvia Jasset, Nikolina Hanniford, Sara Brigida, Stepan Demidkin, Roy H. Perlis, et al. (+2)
345 [GO] 2025―Jan―08 Investigating the relationship between the immune response and the severity of COVID-19: a large-cohort retrospective study Riccardo Giuseppe Margiotta, Emanuela Sozio, Fabio Del Ben, Antonio Paolo Beltrami, Daniela Cesselli, Marco Comar, et al. (+5)
346 [GO] 2025―Jan―08 Identification of an immunological signature of long COVID syndrome Gisella Guerrera, Manolo Sambucci, Eleonora Timperi, Mario Picozza, Andrea Misiti, Roberta Placido, et al. (+13)
347 [GO] 2025―Jan―08 Comprehensive analyses of immune activity in COVID-19-vaccinated idiopathic pulmonary fibrosis patients Agata Maciejewska, Piotr Czernia, Magdalena Piotrowska-Mieczkowska, Beata Wajda, Bartosz Słomiński, Jan Romantowski, et al. (+8)
348 [GO] 2025―Jan―07 Characteristics of humoral responses to the first coronavirus disease booster vaccine and breakthrough infection in central China: a multicentre, prospective, longitudinal cohort study Junhong Xu, Youhua Yuan, Guohua Chen, Bing Ma, Yin Long Zou, Baoya Wang, et al. (+7)
349 [GO] 2025―Jan―07 Magnitude and dynamics of the T-cell response to SARS-CoV-2 infection at both individual and population levels Thomas M. Snyder, Rachel M. Gittelman, Mark Klinger, Damon H. May, Edward J. Osborne, Ruth Taniguchi, et al. (+52)
350 [GO] 2025―Jan―07 An allelic atlas of immunoglobulin heavy chain variable regions reveals antibody binding epitope preference resilient to SARS-CoV-2 mutation escape Weiqi Deng, Xuefeng Niu, Ping He, Qihong Yan, Huan Liang, Yongping Wang, et al. (+7)
351 [GO] 2025―Jan―06 Long-term increase in soluble interleukin-6 receptor levels in convalescents after mild COVID-19 infection Juliane Lokau, Yvonne Garbers, Manuel M. Vicente, Anna Dittrich, Stefan Meltendorf, Holger Lingel, et al. (+3)
352 [GO] 2025―Jan―06 Extracellular acyl-CoA-binding protein as an independent biomarker of COVID-19 disease severity Stephane Isnard, Tsoarello Mabanga, Léna Royston, Carolina A. Berini, Simeng Bu, Orthy Aiyana, et al. (+7)
353 [GO] 2025―Jan―06 Distinct response patterns of endothelial markers to the BNT162b2 mRNA COVID-19 booster vaccine are associated with the spike-specific IgG antibody production Beatriz Castro-Robles, Francisco J. Cimas, Lourdes Arias-Salazar, Jesús Ontañón, Julia Lozano, Susana López-López, et al. (+6)
354 [GO] 2025―Jan―06 Autoantibodies in COVID-19: implications for disease severity and clinical outcomes Yannick Galipeau, Curtis Cooper, Marc-André Langlois
355 [GO] 2025―Jan―03 S6P mutation in Delta and Omicron variant spike protein significantly enhances the efficacy of mRNA COVID-19 vaccines Yong-Sik Bong, David Brown, Ezra Chung, Neeti Ananthaswamy, Renxiang Chen, Evan Lewoczko, et al. (+9)
356 [GO] 2024―Dec―23 Inflammatory discoveries two years after acute severe COVID-19: a longitudinal biomarker profile assessment in long COVID individuals in the Brazilian Amazon Alex Bezerra Silva Maciel, Arlene Santos Pinto, Bernardo Maia Silva, Cassia Luz Goulart, Luis Felipe Alho Silva, Amanda Silva Chaves, et al. (+11)
357 [GO] 2024―Dec―20 Evaluation of link between COVID-19 adjacent spike in hydroxychloroquine use and increased reports of pemphigus: a disproportionality analysis of the FDA Adverse Event Reporting System Justin Baroukhian, Kristina Seiffert-Sinha, Kristopher Attwood, Animesh A. Sinha
358 [GO] 2024―Dec―20 Development of a two-component recombinant vaccine for COVID-19 Yi-Sheng Sun, Fang Xu, Han-Ping Zhu, Yong Xia, Qiao-Min Li, Yuan-Yuan Luo, et al. (+5)
359 [GO] 2024―Dec―20 Association of the immunogenicity of intramuscular SARS-CoV-2 mRNA vaccination with computed tomography muscle images in patients with muscular disorders Tomoaki Naka, Michinori Funato, Kunihiko Yasuda, Takahiro Nakayama, Satoshi Kuru
360 [GO] 2024―Dec―19 MVA-based SARS-CoV-2 vaccine candidates encoding different spike protein conformations induce distinct early transcriptional responses which may impact subsequent adaptive immunity Ilka Grewe, Monika Friedrich, Marie-Louise Dieck, Michael Spohn, My Linh Ly, Verena Krähling, et al. (+10)
361 [GO] 2024―Dec―18 SARS-CoV-2 strains and clinical profiles of COVID-19 patients in a Southern Brazil hospital Bibiana S. de Oliveira Fam, Nathan Araujo Cadore, Renan Sbruzzi, Marilea Furtado Feira, Giovanna Câmara Giudicelli, Luiz G. P. de Almeida, et al. (+8)
362 [GO] 2024―Dec―18 Impact of COVID-19, lockdowns and vaccination on immune responses in a HIV cohort in the Netherlands Twan Otten, Xun Jiang, Manoj Kumar Gupta, Nadira Vadaq, Maartje Cleophas-Jacobs, Jéssica C. dos Santos, et al. (+13)
363 [GO] 2024―Dec―18 Clinical and immunological features in patients with neuroimmune complications of COVID-19 during Omicron wave in China: a case series Siyin Gong, Bo Deng, Hai Yu, Xiang Zhang, Wenbo Yang, Xiangjun Chen
364 [GO] 2024―Dec―18 SARS-CoV-2 immune responses in patients with multiple myeloma and lenalidomide maintenance therapy Ioana Martac, Sina A. Beer, Aileen Schenk, Osama Ahmad, Claus-Philipp Maier, Gülay Demirel, et al. (+6)
365 [GO] 2024―Dec―17 Reduced durability of hybrid immunity to SARS-CoV-2 in immunocompromised children Youjia Zhong, Amuthavalli Kottaiswamy, Chen Xiang Ang, Hui’ En Li, Gaik Chin Yap, Carina J. X. Tay, et al. (+15)
366 [GO] 2024―Dec―17 A comprehensive immune repertoire signature distinguishes pulmonary infiltration in SARS-CoV-2 Omicron variant infection Xuechuan Li, Hongyi Zhu, Peipei Xu, Jie Zhang, Zhe Wang, Hui He, et al. (+19)
367 [GO] 2024―Dec―16 Clinical characteristics and prognostic factors of COVID-19 in rheumatic patients and their family members: a retrospective study Yihua Fan, Yiwen Wang, Juanli Du, Rui Wu, Jianbin Li, Changhong Xiao, et al. (+20)
368 [GO] 2024―Dec―16 Proteomic profiling of peripheral blood mononuclear cells reveals immune dysregulation and metabolic alterations in kidney transplant recipients with COVID-19 Giuseppe G. F. Leite, Mônica Bragança Sousa, Larissa de Oliveira C. P. Rodrigues, Milena Karina Colo Brunialti, José Medina-Pestana, Joe M. Butler, et al. (+3)
369 [GO] 2024―Dec―16 Optimizing immunogenicity and product presentation of a SARS-CoV-2 subunit vaccine composition: effects of delivery route, heterologous regimens with self-amplifying RNA vaccines, and lyophilization William R. Lykins, Jeroen Pollet, Jessica A. White, Brian Keegan, Leroy Versteeg, Ulrich Strych, et al. (+15)
370 [GO] 2024―Dec―11 Unraveling metabolic signatures in SARS-CoV-2 variant infections using multiomics analysis Sunho Lee, Jueun Lee, Kwang-Soo Lyoo, Yourim Shin, Dong-Min Shin, Jun-Won Kim, et al. (+4)
371 [GO] 2024―Dec―10 Biochemical profiles of patients with COVID-19 during the first and second waves in Ethiopia Habtamu Abebe Getahun, Assefa Legesse, Diliab Desta, Ahmed Johar, Israel Bekele, Kebenesa Angasu, et al. (+3)
372 [GO] 2024―Dec―10 Unraveling the impact of SARS-CoV-2 mutations on immunity: insights from innate immune recognition to antibody and T cell responses Rafael Bayarri-Olmos, Adrian Sutta, Anne Rosbjerg, Mie Mandal Mortensen, Charlotte Helgstrand, Per Franklin Nielsen, et al. (+10)
373 [GO] 2024―Dec―09 Booster COVID-19 mRNA vaccination ameliorates impaired B-cell but not T-cell responses in older adults Kohei Kometani, Takaaki Yorimitsu, Norihide Jo, Erina Yamaguchi, Osamu Kikuchi, Masaru Fukahori, et al. (+19)
374 [GO] 2024―Dec―09 Editorial: Cross-reactive immunity and COVID-19 Aristo Vojdani, Ahmed Yaqinuddin, Alberto Beretta, Pedro A. Reche
375 [GO] 2024―Dec―09 Generation of a SARS-CoV-2-susceptible mouse model using adenovirus vector expressing human angiotensin-converting enzyme 2 driven by an elongation factor 1α promoter with leftward orientation Yusuke Matsumoto, Tomoko Honda, Fumihiko Yasui, Akinori Endo, Takahiro Sanada, Sakiko Toyama, et al. (+7)
376 [GO] 2024―Dec―06 Remodeling of the chromatin landscape in peripheral blood cells in patients with severe Delta COVID-19 Vasiliy E. Akimov, Dmitriy I. Tychinin, Olga A. Antonova, Abusaid M. Shaymardanov, Maria D. Voronina, Kseniia A. Deinichenko, et al. (+15)
377 [GO] 2024―Dec―05 Developing a universal multi-epitope protein vaccine candidate for enhanced borna virus pandemic preparedness Jingjing Zhang, Youfang Yang, Binyu Wang, Wanting Qiu, Helin Zhang, Yuyang Qiu, et al. (+3)
378 [GO] 2024―Dec―04 Developing a digital phenotype to subdivide adult immunosuppressed COVID-19 outcomes within the English Primary Care Sentinel Network Meredith Leston, Debasish Kar, Anna Forbes, Gavin Jamie, Rashmi Wimalaratna, Gunjan Jiwani, et al. (+7)
379 [GO] 2024―Dec―03 A blood-based mRNA signature distinguishes people with Long COVID from recovered individuals Daniel Missailidis, Esmaeil Ebrahimie, Manijeh Mohammadi Dehcheshmeh, Claire Allan, Oana Sanislav, Paul Fisher, et al. (+2)
380 [GO] 2024―Dec―03 Exploring lymphocyte subsets in COVID-19 patients: insights from a tertiary academic medical center with a high proportion of patients on immunosuppression Katrijn Daenen, Samantha van Hooijdonk, Kirby Tong-Minh, Willem A. Dik, Petrus M. van Hagen, Jilske A. Huijben, et al. (+4)
381 [GO] 2024―Nov―29 Serum transgelin is a novel prognostic biomarker for COVID-19 patients Lei Gao, Ying Liu, Qi-Yuan He, Yu Wang, Ya-Lin Jiang, Jin Yang, et al. (+2)
382 [GO] 2024―Nov―28 A multi-antigen vaccinia vaccine broadly protected mice against SARS-CoV-2 and influenza A virus while also targeting SARS-CoV-1 and MERS-CoV Nan Gao, Tianhan Yang, Lanlan Dong, Wanda Tang, Kangli Cao, Longfei Ding, et al. (+8)
383 [GO] 2024―Nov―28 Long COVID symptoms 6 months after acute infection among people living with HIV and people not living with HIV Qin Li, Yijie Ma, Peng He, Dongqiong Chen, Tingrui Zhang, Xiaoying Wang, et al. (+4)
384 [GO] 2024―Nov―27 Prognostic performance of early immune and endothelial activation markers in mild-to-moderate COVID-19 outpatients: a nested case-control study Andrea Alemany, Núria Balanza, Pere Millat-Martinez, Dan Ouchi, Marc Corbacho-Monné, Cristian Morales-Indiano, et al. (+8)
385 [GO] 2024―Nov―27 Single spike mutation differentiating XBB.1 and XBB.1.5 enhances SARS-CoV-2 cell-to-cell transmission and facilitates serum-mediated enhancement Elena Criscuolo, Benedetta Giuliani, Matteo Castelli, Mattia Cavallaro, Sofia Sisti, Roberto Burioni, et al. (+4)
386 [GO] 2024―Nov―26 Exosomes and SARS-CoV-2 infection Liuying Li, Zixuan Yang, Jia Li
387 [GO] 2024―Nov―26 Effects of COVID-19 virus-like particles on the behavioral and cognitive performance of human apolipoprotein E targeted replacement mice Abigail O’Niel, Alexandra Pederson, Elizabeth Saltontall, Kayla Nguyen, Monzerrat Pantoja, Mitali Chaudhari, et al. (+6)
388 [GO] 2024―Nov―25 Characteristics of cytokines/chemokines associated with disease severity and adverse prognosis in COVID-19 patients Jianghao Cheng, Haozhen Wang, Chaodan Li, Jianhua Yu, Mingli Zhu
389 [GO] 2024―Nov―25 Immunophenotyping characteristics and clinical outcome of COVID-19 patients treated with azvudine during the Omicron surge Meihua Qiu, Xiaogang Song, Qianqian Zhang, Shenchun Zou, Lingling Pang, Xueyuan Nian
390 [GO] 2024―Nov―22 Dynamics of cytokine and antibody responses in community versus hospital SARS-CoV-2 infections Tulika Singh, Andrew N. Macintyre, Thomas W. Burke, Jack Anderson, Elizabeth Petzold, Erica L. Stover, et al. (+9)
391 [GO] 2024―Nov―22 Immunosuppressants in dermatology on vaccine immunogenicity: a prospective cohort study of pemphigus patients in the pandemic Kun-Lin Lu, Hua-En Lee, Chun-Bing Chen, Rosaline Chung-Yee Hui, Ya-Ching Chang, Chun-Wei Lu, et al. (+2)
392 [GO] 2024―Nov―21 Long-term COVID-19 vaccine- and Omicron infection-induced humoral and cell-mediated immunity Milja Belik, Arttu Reinholm, Pekka Kolehmainen, Jemna Heroum, Sari Maljanen, Eda Altan, et al. (+14)
393 [GO] 2024―Nov―20 COVID-19 mitigates the response to TKIs in patients with CML via the inhibition of T-cell immunity Na He, Guosheng Li, Jinting Liu, Wancheng Liu, Ruifeng Tian, Daoxin Ma
394 [GO] 2024―Nov―18 Early immune profiling reveals distinct inflammatory responses between children and adults few days after primary SARS-CoV-2 infection Martijn D. B. Van de Garde, Alberto Miranda-Bedate, Nening M. Nanlohy, Ronald H. J. Jacobi, Adam Meijer, Daphne F. M. Reukers, et al. (+6)
395 [GO] 2024―Nov―18 Research progress of spike protein mutation of SARS-CoV-2 mutant strain and antibody development Xinkang Huan, Jiuyu Zhan, Hongwei Gao
396 [GO] 2024―Nov―15 Shared genetic architecture between COVID-19 and irritable bowel syndrome: a large-scale genome-wide cross-trait analysis Xianqiang Liu, Dingchang Li, Wenxing Gao, Hao Liu, Peng Chen, Yingjie Zhao, et al. (+2)
397 [GO] 2024―Nov―14 Case report: Intravascular large B cell lymphoma mimicking acute demyelinating encephalomyelitis after SARS-CoV-2 reinfection: diagnostic value of advanced MRI techniques and the literature review with the assistance of ChatGPT Sujuan Chen, Mingchen Cai, Guirong Tan, Ruomi Guo, Qiong Liang, Hainan Li, Xiang Liu
398 [GO] 2024―Nov―14 Unbiased immunome characterisation correlates with COVID-19 mRNA vaccine failure in immunocompromised adults Juan H-Vázquez, Paloma Cal-Sabater, Elisa Arribas-Rodríguez, Aida Fiz-López, Candido Perez-Segurado, Álvaro Martín-Muñoz, et al. (+40)
399 [GO] 2024―Nov―13 Comparison of antibody responses of heterologous and homologous Covid-19 booster vaccination: an observational study Nayab Batool Rizvi, Maryam Bibi, Muhmmad Zeeshan Rana, Sehrish Zaffar, Hassam Farooq
400 [GO] 2024―Nov―13 Case report: A novel JAK3 homozygous variant in a patient with severe combined immunodeficiency and persistent COVID-19 Renan Cesar Sbruzzi, Mayara Jorgens Prado, Bibiana Fam, Helena Ashton Prolla, Alessandra Hellwig, Grazielle Motta Rodrigues, et al. (+7)
401 [GO] 2024―Nov―07 Effects of COVID-19 on bone fragility: a new perspective from osteoimmunological biomarkers Emanuela Galliera, Luca Massaccesi, Laura Mangiavini, Elena De Vecchi, Francesca Villa, Massimiliano Marco Corsi Romanelli, Giuseppe Peretti
402 [GO] 2024―Nov―07 Risk factors for COVID-19 pneumonia in patients with hematological malignancies: a multi-center, prospective study in China Jun Li, Ran Chen, Lin Cao, Yi Liu, Yong Zhang, Xia Wei, et al. (+22)
403 [GO] 2024―Nov―07 Ensemble modeling of SARS-CoV-2 immune dynamics in immunologically naïve rhesus macaques predicts that potent, early innate immune responses drive viral elimination Catherine Byrne, Joshua T. Schiffer
404 [GO] 2024―Nov―06 Clinical characteristics and antibody response to Omicron variants among solid carcinoma patients in China on the 2022.12-2023.4 wave of the COVID-19 pandemic Rongrong Dai, Weiyu Peng, Nani Xu, Pan Qin, Linling Ding, Qianhui Hua, et al. (+3)
405 [GO] 2024―Nov―01 COVID-19 vaccine and the risk of flares in inflammatory arthritis: a systematic literature review and meta-analysis Ariela Hoxha, Giovanni Striani, Marco Lovisotto, Paolo Simioni, Andrea Doria, Roberta Ramonda
406 [GO] 2024―Nov―01 Prediction of the risk of mortality in older patients with coronavirus disease 2019 using blood markers and machine learning Linchao Zhu, Yimin Yao
407 [GO] 2024―Oct―28 BCR, not TCR, repertoire diversity is associated with favorable COVID-19 prognosis Faith Jessica Paran, Rieko Oyama, Abdullah Khasawneh, Tomohiko Ai, Hendra Saputra Ismanto, Aalaa Alrahman Sherif, et al. (+12)
408 [GO] 2024―Oct―24 Glycosylation signature of plasma IgA of critically ill COVID-19 patients Daniel P. Potaczek, Bianca D. M. van Tol, David Falck, Christina Krolczik, Kristina Zlatina, Wilhelm Bertrams, et al. (+11)
409 [GO] 2024―Oct―21 Cytokine production in an ex vivo model of SARS-CoV-2 lung infection Daria A. Vorobyeva, Daria M. Potashnikova, Elena V. Maryukhnich, George I. Rusakovich, Anna V. Tvorogova, Anna I. Kalinskaya, et al. (+11)
410 [GO] 2024―Oct―18 Circulating IL-17F, but not IL-17A, is elevated in severe COVID-19 and leads to an ERK1/2 and p38 MAPK-dependent increase in ICAM-1 cell surface expression and neutrophil adhesion on endothelial cells Jérôme Bédard-Matteau, Antoine Soulé, Katelyn Yixiu Liu, Lyvia Fourcade, Douglas D. Fraser, Amin Emad, Simon Rousseau
411 [GO] 2024―Oct―18 Multiple sclerosis and COVID-19: a bidirectional Mendelian randomization study Shitong Liu, Yixin Liang, Binbin Sheng, Rongxin Zhang
412 [GO] 2024―Oct―17 Immunomodulatory effect of bovine lactoferrin during SARS-CoV-2 infection Andrea Marques Vieira da Silva, Thiago Lazari Machado, Ryann de Souza Nascimento, Miguel Pires Medeiros Diniz Rodrigues, Felipe Soares Coelho, Luciana Neves Tubarão, et al. (+18)
413 [GO] 2024―Oct―14 Pulmonary SARS-CoV-2 infection leads to para-infectious immune activation in the brain Cordelia Dunai, Claire Hetherington, Sarah A. Boardman, Jordan J. Clark, Parul Sharma, Krishanthi Subramaniam, et al. (+22)
414 [GO] 2024―Oct―10 The molecular mechanisms of CD8+ T cell responses to SARS-CoV-2 infection mediated by TCR-pMHC interactions Shasha Deng, Zhihao Xu, Jing Hu, Yunru Yang, Fang Zhu, Zhuan Liu, et al. (+3)
415 [GO] 2024―Oct―10 High prevalence of long COVID in anti-TPO positive euthyroid individuals with strongly elevated SARS-CoV-2-specific T cell responses and moderately raised anti-spike IgG levels 23 months post-infection Zsolt Matula, Viktória Király, Gabriella Bekő, Márton Gönczi, András Zóka, Róbert Steinhauser, et al. (+2)
416 [GO] 2024―Oct―09 Increased plasma imatinib exposure and toxicity in chronically treated GIST patients with SARS-CoV-2 infection: a case series Sara Gagno, Bianca Posocco, Marco Orleni, Eleonora Cecchin, Arianna Fumagalli, Michela Guardascione, et al. (+5)
417 [GO] 2024―Oct―08 Genetic signatures of AKT1 variants associated with worse COVID-19 outcomes - a multicentric observational study Ingrid Marins de Almeida, Bruna Ramos Tosta, Laiane da Cruz Pena, Hatilla dos Santos Silva, Fabiane S. Reis-Goes, Nívia N. Silva, et al. (+19)
418 [GO] 2024―Oct―08 Role of SARS-CoV-2-specific memory B cells promoting immune protection after booster vaccination in solid organ transplantation Laura Donadeu, Susana Gomez-Olles, Franc Casanova, Alba Torija, Manuel Lopez-Meseguer, Meritxell Boada-Pérez, et al. (+35)
419 [GO] 2024―Oct―07 Analysis of B-cell receptor repertoire to evaluate the immunogenicity of SARS-CoV-2 RBD mRNA vaccine: MAFB-7256a (DS-5670d) Goh Ohji, Yohei Funakoshi, Kimikazu Yakushijin, Takaji Matsutani, Tomoki Sasaki, Takahiro Kusakabe, et al. (+7)
420 [GO] 2024―Oct―04 Systemic increase in IL-26 is associated with severe COVID-19 and comorbid obstructive lung disease Eduardo I. Cardenas, Josefina Robertson, Salvia Misaghian, Jermaine Brown, Mingyue Wang, Martin Stengelin, et al. (+4)
421 [GO] 2024―Oct―04 Case report: Rare Guillain-Barré syndrome variants and mild encephalitis/encephalopathy with a reversible splenial lesion as the para-infectious manifestations of SARS-CoV-2 infection Wei Si, Yuanrui Li, Ganqin Du
422 [GO] 2024―Oct―02 SARS-CoV-2 induced vitamin D deficiency and psychological stress: a manifestation of autoimmune disease onset Meshal A. Alobaid, Bshaier S. Alqabandi
423 [GO] 2024―Oct―02 M protein ectodomain-specific immunity restrains SARS-CoV-2 variants replication Yibo Tang, Kaiming Tang, Yunqi Hu, Zi-Wei Ye, Wanyu Luo, Cuiting Luo, et al. (+10)
424 [GO] 2024―Oct―01 Virological characteristics of SARS-CoV-2 Omicron BA.5.2.48 Wenqi Wang, Qiushi Jin, Ruixue Liu, Wentao Zeng, Pengfei Zhu, Tingting Li, et al. (+11)
425 [GO] 2024―Sep―30 Development of a COVID-19 early risk assessment system based on multiple machine learning algorithms and routine blood tests: a real-world study Qiangqiang Qin, Qingxuan Li, Guiyin Zhu, Haiyang Yu, Mingyan Peng, Shuang Wu, et al. (+3)
426 [GO] 2024―Sep―25 Corrigendum: Six-month humoral immune response to inactivated COVID-19 vaccine among people living with HIV Shi Zou, Wei Guo, Songjie Wu, Fangzhao Ming, Yuting Tan, Mengmeng Wu, et al. (+2)
427 [GO] 2024―Sep―25 Exploring the role of galectin-9 and artemin as biomarkers in long COVID with chronic fatigue syndrome: links to inflammation and cognitive function Shokrollah Elahi, Maryam Rezaeifar, Mohammed Osman, Shima Shahbaz
428 [GO] 2024―Sep―23 Distinct soluble immune checkpoint profiles characterize COVID-19 severity, mortality and SARS-CoV-2 variant infections Tudorita Gabriela Paranga, Mariana Pavel-Tanasa, Daniela Constantinescu, Elena Iftimi, Claudia Elena Plesca, Ionela-Larisa Miftode, et al. (+2)
429 [GO] 2024―Sep―19 Robust and persistent B-cell responses following SARS-CoV-2 vaccine determine protection from SARS-CoV-2 infection Joanne Byrne, Lili Gu, Alejandro Garcia-Leon, Colette Marie Gaillard, Gurvin Saini, Dana Alalwan, et al. (+24)
430 [GO] 2024―Sep―18 Identifying immune checkpoints on dysregulated T-cells as prognostic biomarkers for multiple myeloma patients with COVID-19 Ziping Li, Huiwen He, Fujing Zhang, Haolong Li, Xianghong Jin, Yuhang Song, et al. (+3)
431 [GO] 2024―Sep―18 SARS-CoV-2 spike protein induces the cytokine release syndrome by stimulating T cells to produce more IL-2 Chao Niu, Tingting Liang, Yongchong Chen, Shan Zhu, Lei Zhou, Naifei Chen, et al. (+5)
432 [GO] 2024―Sep―16 Association of IFNAR2 and TYK2 with COVID-19 pathology: current and future Alireza Razavi, Maedeh Raei, Ken Shirato
433 [GO] 2024―Sep―12 Immune responses and transcription landscape of adults with the third dose of homologous and heterologous booster vaccines of COVID-19 Hui Zheng, Cuidan Li, Xiuyu Zheng, Hu-Dachuan Jiang, Yuqing Li, Aihua Yao, et al. (+10)
434 [GO] 2024―Sep―11 Alterations in the plasma proteome persist ten months after recovery from mild to moderate SARS-CoV-2 infection Julio A. Huapaya, Salina Gairhe, Shreya Kanth, Xin Tian, Cumhur Y. Demirkale, David Regenold, et al. (+18)
435 [GO] 2024―Sep―11 Strategies for developing self-assembled nanoparticle vaccines against SARS-CoV-2 infection Kaiwen Yang, Youqin Zeng, Xinyu Wu, Jia Li, Jinlin Guo
436 [GO] 2024―Sep―11 Increased incidence of seronegative autoimmune hepatitis in children during SARS-CoV-2 pandemia period Muriel Schmutz, Suzanne Chartier, Thierry Leblanc, Charlotte Mussini, Antoine Gardin, Emmanuel Gonzales, et al. (+9)
437 [GO] 2024―Sep―09 The role of convalescent plasma and hyperimmune immunoglobulins in the COVID-19 pandemic, including implications for future preparedness Cynthia So-Osman, Thierry Burnouf, Arwa Z. Al-Riyami, Evan M. Bloch, Lise Estcourt, Ruchika Goel, et al. (+4)
438 [GO] 2024―Sep―06 Photonanozyme-Kras-ribosome combination treatment of non-small cell lung cancer after COVID-19 Qiaoyan Si, Mingjian Bai, Xiaolong Wang, Tianyu Wang, Yan Qin
439 [GO] 2024―Sep―06 RNA editing in response to COVID-19 vaccines: unveiling dynamic epigenetic regulation of host immunity Yun-Yun Jin, Ya-Ping Liang, Jia-Qi Pan, Wen-Hao Huang, Yan-Meng Feng, Wei-Jia Sui, et al. (+4)
440 [GO] 2024―Sep―06 Effect of pioglitazone on inflammatory response and clinical outcome in T2DM patients with COVID-19: a randomized multicenter double-blind clinical trial Khaled Baagar, Thamer Alessa, Mohamed Abu-Farha, Jehad Abubaker, Heba Alhumaidi, Jose Antonio Franco Ceruto, et al. (+26)
441 [GO] 2024―Sep―05 Humoral and cellular immune response from first to fourth SARS-CoV-2 mRNA vaccination in anti-CD20-treated multiple sclerosis patients-a longitudinal cohort study Frederik Novak, Anna Christine Nilsson, Emil Birch Christensen, Caroline Louise Stougaard, Mike Bogetofte Barnkob, Dorte K. Holm, et al. (+5)
442 [GO] 2024―Sep―04 Immunomics in one health: understanding the human, animal, and environmental aspects of COVID-19 Jing Gao, Chutian Zhang, Åsa M. Wheelock, Siming Xin, Hui Cai, Lei Xu, Xiao-jun Wang
443 [GO] 2024―Sep―04 The immune response to Covid-19 mRNA vaccination among Lymphoma patients receiving anti-CD20 treatment Edina Komlodi-Pasztor, Marta Escarra-Senmarti, Danielle A. Bazer, Aastha Bhatnagar, Carlos A. Perez Heydrich, Marcus Messmer, et al. (+10)
444 [GO] 2024―Sep―03 Evaluating TRAIL and IP-10 alterations in vaccinated pregnant women after COVID-19 diagnosis and their correlation with neutralizing antibodies Wei-Chun Chen, Shu-Yu Hu, Chao-Min Cheng, Ching-Fen Shen, Hui-Yu Chuang, Chin-Ru Ker, et al. (+2)
445 [GO] 2024―Sep―02 Booster vaccination using bivalent DS-5670a/b is safe and immunogenic against SARS-CoV-2 variants in children aged 5-11 years: a phase 2/3, randomized, active-controlled study Rino Suzuki, Miharu Suda, Katsuyasu Ishida, Kei Furihata, Aisaku Ota, Kaori Takahashi, et al. (+3)
446 [GO] 2024―Aug―30 Predictive biomarkers of mortality in patients with severe COVID-19 hospitalized in intensive care unit Sandrelli Meridiana de Fátima Ramos dos Santos Medeiros, Bruna Maria Nepomuceno Sousa Lino, Vinícius Pietta Perez, Eduardo Sérgio Soares Sousa, Eloiza Helena Campana, Fábio Miyajima, et al. (+8)
447 [GO] 2024―Aug―30 The influence of 4G/5G polymorphism in the plasminogen-activator-inhibitor-1 promoter on COVID-19 severity and endothelial dysfunction Tetiana Yatsenko, Ricardo Rios, Tatiane Nogueira, Yousef Salama, Satoshi Takahashi, Eisuke Adachi, et al. (+7)
448 [GO] 2024―Aug―30 TGF-β1 overexpression in severe COVID-19 survivors and its implications for early-phase fibrotic abnormalities and long-term functional impairment Enrique Alfaro, Raquel Casitas, Elena Díaz-García, Sara García-Tovar, Raúl Galera, María Torres-Vargas, et al. (+6)
449 [GO] 2024―Aug―30 Intranasal HD-Ad-FS vaccine induces systemic and airway mucosal immunities against SARS-CoV-2 and systemic immunity against SARS-CoV-2 variants in mice and hamsters Peter Zhou, Jacqueline Watt, Juntao Mai, Huibi Cao, Zhijie Li, Ziyan Chen, et al. (+6)
450 [GO] 2024―Aug―30 Mucosal immunity in upper and lower respiratory tract to MERS-CoV Khalid J. Shrwani, Waleed H. Mahallawi, Abdulrhman I. Mohana, Abdullah Algaissi, Nabil Dhayhi, Nouf J. Sharwani, et al. (+9)
451 [GO] 2024―Aug―29 Commentary: Effect of high-dose Spirulina supplementation on hospitalized adults with COVID-19: a randomized controlled trial Elias E. Mazokopakis, Maria G. Papadomanolaki
452 [GO] 2024―Aug―29 Antigen-specific T helper cells and cytokine profiles predict intensity and longevity of cellular and humoral responses to SARS-CoV-2 booster vaccination Lukas Page, Kevin Dennehy, Katharina Mueller, Philipp Girl, Eva Loell, Hellen Buijze, et al. (+6)
453 [GO] 2024―Aug―29 MVA-based vaccine candidates expressing SARS-CoV-2 prefusion-stabilized spike proteins of the Wuhan, Beta or Omicron BA.1 variants protect transgenic K18-hACE2 mice against Omicron infection and elicit robust and broad specific humoral and cellular immune responses Patricia Pérez, David Astorgano, Guillermo Albericio, Sara Flores, Cristina Sánchez-Corzo, María A. Noriega, et al. (+6)
454 [GO] 2024―Aug―29 Bacterial pneumonia patients with elevated globulin levels did not get infected with SARS-CoV-2: two case reports Qi Zhong, Qiu-mei Lin, Hong-bin Long, Cai-xia Liao, Xiao-xiao Sun, Miao-du Yang, et al. (+4)
455 [GO] 2024―Aug―27 Individuals carrying the HLA-B*15 allele exhibit favorable responses to COVID-19 vaccines but are more susceptible to Omicron BA.5.2 and XBB.1.16 infection Lingxin Meng, Yue Pan, Yueping Liu, Rui He, Yuting Sun, Chenhui Wang, et al. (+7)
456 [GO] 2024―Aug―27 Variant-specific antibody profiling for tracking SARS-CoV-2 variant infections in children and adolescents Daniela Kuthning, Dina Raafat, Silva Holtfreter, Jana Gramenz, Nico Wittmann, Barbara M. Bröker, Almut Meyer-Bahlburg
457 [GO] 2024―Aug―22 COVID-19 vaccines are not associated with axonal injury in patients with multiple sclerosis Susana Sainz de la Maza, Alexander Rodero-Romero, Enric Monreal, Juan Luis Chico-García, Noelia Villarrubia, Fernando Rodríguez-Jorge, et al. (+5)
458 [GO] 2024―Aug―22 A head-to-head comparison of humoral and cellular immune responses of five COVID-19 vaccines in adults in China Xu Han, Hongxing Pan, Pengfei Jin, Mingwei Wei, Siyue Jia, Wenjuan Wang, et al. (+5)
459 [GO] 2024―Aug―22 SARS-CoV-2 spike protein antibody titers after the fourth dose of BNT162b2 vaccine among Japanese patients undergoing hemodialysis: a single-center study Shun Watanabe, Toyoaki Sawano, Hiroaki Saito, Akihiko Ozaki, Masatoshi Wakui, Tianchen Zhao, et al. (+8)
460 [GO] 2024―Aug―20 Immunogenicity and safety of different combinations involving a third booster dose of SARS-CoV-2 inactivated vaccine, inactivated quadrivalent influenza vaccine, and 23-valent pneumococcal polysaccharide vaccine in adults aged ≥60 years: a phase 4, randomized, open-label study Shuang Bai, Shanshan Zhou, Junnan Zhang, Weixin Chen, Min Lv, Jian Wang, et al. (+3)
461 [GO] 2024―Aug―20 Evaluation of the COVID-19 vaccine effectiveness on the outcomes of COVID 19 disease in Iran: a test-negative case-control study Fatemeh Khosravi Shadmani, Ghobad Moradi, Mohammadreza Naghipour, Fatemeh Torkaman Asadi, Ali Ahmadi, Alireza Mirahmadizadeh, et al. (+9)
462 [GO] 2024―Aug―19 Do immunosuppressive treatments influence immune responses against adenovirus-based COVID-19 vaccines in patients with multiple sclerosis? An Argentine multicenter study Berenice Anabel Silva, Esteban Miglietta, Juan Cruz Casabona, Shirley Wenker, María Bárbara Eizaguirre, Ricardo Alonso, et al. (+31)
463 [GO] 2024―Aug―17 A single domain antibody-based Luminex assay for the detection of SARS-CoV-2 in clinical samples Ellen R. Goldman, Victor A. Sugiharto, Lisa C. Shriver-Lake, Andrew M. Garcia, Shuenn-Jue Wu, Sarah A. Jenkins, Hua-Wei Chen
464 [GO] 2024―Aug―14 Mucosal immunity in COVID-19: a comprehensive review Saeed Awad M. Alqahtani
465 [GO] 2024―Aug―09 Vaccine and antiviral drug promise for preventing post-acute sequelae of COVID-19, and their combination for its treatment Tomonari Sumi, Kouji Harada
466 [GO] 2024―Aug―07 Hub genes identification and validation of ferroptosis in SARS-CoV-2 induced ARDS: perspective from transcriptome analysis Yutang Li, Li Tang, Fang Wang, Chencheng Gao, Qi Yang, Liyu Luo, et al. (+3)
467 [GO] 2024―Aug―05 Longitudinal transcriptomic analysis reveals persistent enrichment of iron homeostasis and erythrocyte function pathways in severe COVID-19 ARDS Moemen Eltobgy, Finny Johns, Daniela Farkas, Laura Leuenberger, Sarah P. Cohen, Kevin Ho, et al. (+7)
468 [GO] 2024―Aug―01 Immunological characterization and comparison of children with COVID-19 from their adult counterparts at single-cell resolution Ran Jia, Zifeng Li, Shiwen Hu, Hailing Chang, Mei Zeng, Pengcheng Liu, et al. (+5)
469 [GO] 2024―Jul―29 The longitudinal characterization of immune responses in COVID-19 patients reveals novel prognostic signatures for disease severity, patients’ survival and long COVID Maddalena Noviello, Rebecca De Lorenzo, Raniero Chimienti, Norma Maugeri, Claudia De Lalla, Gabriel Siracusano, et al. (+30)
470 [GO] 2024―Jul―26 Immunogenicity and protective efficacy of the HC009 mRNA vaccine against SARS-CoV-2 Juan Liu, Huafeng Han, Binbin Yang, Naifang Zhang, Jing Li, Xicheng Chen, et al. (+3)
471 [GO] 2024―Jul―26 4th booster-dose SARS-CoV-2 heterologous and homologous vaccination in rheumatological patients Maria Jose Gallardo-Nelson, Marcos Cruces, Yolanda M. Gómez, Constanza Fuenzalida, Javiera Silva, Laura Aravena-Traipi, et al. (+6)
472 [GO] 2024―Jul―25 Corrigendum: Protecting the vulnerable: addressing the COVID-19 care needs of people with compromised immunity Raymund R. Razonable
473 [GO] 2024―Jul―25 A single-dose MCMV-based vaccine elicits long-lasting immune protection in mice against distinct SARS-CoV-2 variants Kristin Metzdorf, Henning Jacobsen, Yeonsu Kim, Luiz Gustavo Teixeira Alves, Upasana Kulkarni, Maja Cokarić Brdovčak, et al. (+15)
474 [GO] 2024―Jul―19 A potent, broadly neutralizing human monoclonal antibody that efficiently protects hACE2-transgenic mice from infection with the Wuhan, BA.5, and XBB.1.5 SARS-CoV-2 variants Sergey V. Guselnikov, Konstantin O. Baranov, Sergey V. Kulemzin, Tatyana N. Belovezhets, Anton N. Chikaev, Svetlana V. Murasheva, et al. (+17)
475 [GO] 2024―Jul―18 Tetanus-diphtheria vaccine can prime SARS-CoV-2 cross-reactive T cells Sara Alonso Fernandez, Hector F. Pelaez-Prestel, Tara Fiyouzi, Marta Gomez-Perosanz, Jesús Reiné, Pedro A. Reche
476 [GO] 2024―Jul―16 Editorial: Therapeutic management of COVID-19 in immunocompromised patients and interaction with the immune response: from preventive to curative strategies Ilies Benotmane, Morgane Solis
477 [GO] 2024―Jul―16 Causal effect of COVID-19 on optic nerve and visual pathway disorders: genetic evidence of lung-brain axis Chunge Cao, Qiong Li, Dajun Cai, Chaoyan Yue, Hu Zhao
478 [GO] 2024―Jul―16 The seroconversion history to SARS-CoV-2 in Indigenous people from Brazil - the interplay between exposure, vaccination, and tuberculosis Alice Nagai, Renan Barbosa Lemes, José Geraldo Mill, Alexandre Costa Pereira, Rafael Elias Marques, Tábita Hünemeier
479 [GO] 2024―Jul―15 Implications of disease-modifying therapies for multiple sclerosis on immune cells and response to COVID-19 vaccination Valeria Orré, Valentina Serra, Michele Marongiu, Sandra Lai, Valeria Lodde, Magdalena Zoledziewska, et al. (+29)
480 [GO] 2024―Jul―10 Establishment and characterization of an hACE2/hTMPRSS2 knock-in mouse model to study SARS-CoV-2 Hongwei Liu, Terza Brostoff, Ana Ramirez, Talia Wong, Douglas J. Rowland, Mollie Heffner, et al. (+6)
481 [GO] 2024―Jul―10 Editorial: Deciphering the T cell response in SARS-CoV-2 infection Laura Maggi, Alessio Mazzoni, Sara De Biasi
482 [GO] 2024―Jul―09 Hypocortisolemic ASIA: a vaccine- and chronic infection-induced syndrome behind the origin of long COVID and myalgic encephalomyelitis Manuel Ruiz-Pablos, Bruno Paiva, Aintzane Zabaleta
483 [GO] 2024―Jul―08 Timing of maternal vaccination against COVID-19 for effective protection of neonates: cohort study Aleksandra Nowakowska, Seung Mi Lee, Minjee Kim, Jungmin Chun, Sehyun Kim, Byung Chul Kim, et al. (+12)
484 [GO] 2024―Jul―05 Autoantibodies in COVID-19 survivors with post-COVID symptoms: a systematic review Kin Israel Notarte, Timothy Hudson David Culasino Carandang, Jacqueline Veronica Velasco, Adriel Pastrana, Abbygail Therese Ver, Gerald Neil Manalo, et al. (+5)
485 [GO] 2024―Jul―05 Suppression of interferon α and γ response by Huwe1-mediated Miz1 degradation promotes SARS-CoV-2 replication Vinothini Arunagiri, Laura Cooper, Huali Dong, Jake Class, Indrani Biswas, Sujan Vahora, et al. (+6)
486 [GO] 2024―Jul―04 Network-based pharmacology and UHPLC-Q-Exactive-Orbitrap-MS reveal Jinhua Qinggan granule's mechanism in reducing cellular inflammation in COVID-19 Liping Qian, Zehua Zeng
487 [GO] 2024―Jul―04 Single cell multi-omic analysis identifies key genes differentially expressed in innate lymphoid cells from COVID-19 patients Abhinav Kaushik, Iris Chang, Xiaorui Han, Ziyuan He, Zsolt I. Komlosi, Xuhuai Ji, et al. (+9)
488 [GO] 2024―Jul―03 SARS-CoV-2 anti-RBD and anti-N protein responses are differentially regulated between mother-child pairs: insight from a national study cohort at the Faroe Islands Ida Jarlhelt, Cecilie Bo Hansen, Laura Pérez-Alós, Pál Weihe, Maria Skaalum Petersen, Peter Garred
489 [GO] 2024―Jun―27 Corrigendum: Epigenetic immune monitoring for COVID-19 disease course prognosis Björn Samans, Marta Rosselló Chornet, Araceli Rosselló Chornet, Janine Jung, Konstantin Schildknecht, Laura Lozza, et al. (+4)
490 [GO] 2024―Jun―27 The effect of previous SARS-CoV-2 infection on systemic immune responses in individuals with tuberculosis Mariana S. Xavier, Mariana Araujo-Pereira, Quezia M. de Oliveira, Flavia M. Sant’Anna, Felipe M. Ridolfi, Alice M. S. de Andrade, et al. (+7)
491 [GO] 2024―Jun―21 Corrigendum: C-reactive protein isoforms as prognostic markers of COVID-19 severity Blanca Molins, Marc Figueras-Roca, Oliver Valero, Victor Llorens, Sara Romero-Vázquez, Oriol Sibila, et al. (+3)
492 [GO] 2024―Jun―21 Heterologous booster vaccination enhances antibody responses to SARS-CoV-2 by improving Tfh function and increasing B-cell clonotype SHM frequency Yanli Song, Jiaolei Wang, Zhihui Yang, Qian He, Chunting Bao, Ying Xie, et al. (+5)
493 [GO] 2024―Jun―20 Protective interplay: Mycobacterium tuberculosis diminishes SARS-CoV-2 severity through innate immune priming Brittany D. Williams, Debora Ferede, Hazem F. M. Abdelaal, Bryan J. Berube, Brendan K. Podell, Sasha E. Larsen, et al. (+2)
494 [GO] 2024―Jun―18 Extracellular matrix remodelling pathway in peripheral blood mononuclear cells from severe COVID-19 patients: an explorative study Sarah Louise Murphy, Nora Reka Balzer, Trine Ranheim, Ellen Lund Sagen, Camilla Huse, Vigdis Bjerkeli, et al. (+13)
495 [GO] 2024―Jun―14 Molecular mimicry of SARS-COV-2 antigens as a possible natural anti-cancer preventive immunization Concetta Ragone, Angela Mauriello, Beatrice Cavalluzzo, Ernesta Cavalcanti, Luigi Russo, Carmen Manolio, et al. (+4)
496 [GO] 2024―Jun―12 The impact of COVID-19 on “biological aging” Fathima Humaira Amanullah, Tanvir Alam, Nady El Hajj, Yosra Bejaoui
497 [GO] 2024―Jun―11 Exploring the protective association between COVID-19 infection and laryngeal cancer: insights from a Mendelian randomization study Heng Wang, Ning Fang, Prithweeraj Mozumder, Richeng Jiang, Xin Wang
498 [GO] 2024―Jun―11 New insights into the pathogenesis of SARS-CoV-2 during and after the COVID-19 pandemic Jonatan J. Carvajal, Valeria García-Castillo, Shelsy V. Cuellar, Claudia P. Campillay-Véliz, Camila Salazar-Ardiles, Andrea M. Avellaneda, et al. (+6)
499 [GO] 2024―Jun―11 Aging is associated with an insufficient early inflammatory response of lung endothelial cells in SARS-CoV-2 infection Saravanan Subramaniam, Devin Kenney, Archana Jayaraman, Aoife Kateri O’Connell, Sarah Walachowski, Paige Montanaro, et al. (+5)
500 [GO] 2024―Jun―11 Efficacy, safety, and immunogenicity of SARS-CoV-2 mRNA vaccine (Omicron BA.5) LVRNA012: a randomized, double-blind, placebo-controlled phase 3 trial Huan Zhou, Hui Zheng, Yucai Peng, Yue Su, Xuya Yu, Weixiao Wang, et al. (+12)
501 [GO] 2024―Jun―11 Revisiting the interaction between complement lectin pathway protease MASP-2 and SARS-CoV-2 nucleoprotein Isabelle Bally, Guillaume Drumont, Véronique Rossi, Serafima Guseva, Maiia Botova, Jean-Baptiste Reiser, et al. (+8)
502 [GO] 2024―Jun―11 Escalating SARS-CoV-2 specific humoral immune response in rheumatoid arthritis patients and healthy controls Dora Nemeth, Hajnalka Vago, Laszlo Tothfalusi, Zsuzsanna Ulakcsai, David Becker, Zsofia Szabo, et al. (+4)
503 [GO] 2024―Jun―05 Immune cell populations and induced immune responses at admission in patients hospitalized with vaccine breakthrough SARS-CoV-2 infections Adin Sejdic, Hans Jakob Hartling, Jon Gitz Holler, Lars Klingen Gjærde, Birgitte Lindegaard, Arnold Matovu Dungu, et al. (+11)
504 [GO] 2024―Jun―03 Association of immune checkpoint inhibitors with SARS-CoV-2 infection rate and prognosis in patients with solid tumors: a systematic review and meta-analysis Lin Sun, Fangmin Zhao, Yuying Xiang, Shuyi Chen, Qijin Shu
505 [GO] 2024―May―31 TLR2/4 are novel activating receptors for SARS-CoV-2 spike protein on NK cells Nadine Landolina, Biancamaria Ricci, Irene Veneziani, Claudia Alicata, Francesca Romana Mariotti, Andrea Pelosi, et al. (+8)
506 [GO] 2024―May―31 The effectiveness of booster vaccination of inactivated COVID-19 vaccines against susceptibility, infectiousness, and transmission of omicron BA.2 variant: a retrospective cohort study in Shenzhen, China Yuxue Liao, Jiao Su, Jieru Zhao, Zhen Qin, Zhuo’Ao Zhang, Wei Gao, et al. (+4)
507 [GO] 2024―May―30 Newcastle disease virus vector-based SARS-CoV-2 vaccine candidate AVX/COVID-12 activates T cells and is recognized by antibodies from COVID-19 patients and vaccinated individuals Alejandro Torres-Flores, Luis Alberto Ontiveros-Padilla, Ruth Lizzeth Madera-Sandoval, Araceli Tepale-Segura, Julián Gajón-Martínez, Tania Rivera-Hernández, et al. (+16)
508 [GO] 2024―May―29 TIGIT+Tfh show poor B-helper function and negatively correlate with SARS-CoV-2 antibody titre Natalie M. Edner, Luke P. Houghton, Elisavet Ntavli, Chloe Rees-Spear, Lina Petersone, Chunjing Wang, et al. (+8)
509 [GO] 2024―May―24 Association of specific ACE2 and TMPRSS2 variants with circulatory cytokines of COVID-19 Emirati patients Noha M. Elemam, Amal Bouzid, Habiba Alsafar, Samrein BM Ahmed, Shirin Hafezi, Thenmozhi Venkatachalam, et al. (+12)
510 [GO] 2024―May―24 Normalization of eosinophil count is predictive of oxygen weaning over the course of COVID-19 infection among hospitalized adults during the first wave of 2020 pandemic Benjamin Davido, Karim Jaffal, Azzam Saleh-Mghir, Isabelle Vaugier, Stephane Bourlet, Pierre De Truchis, Djillali Annane
511 [GO] 2024―May―23 Editorial: Neuroimmune cell signaling in COVID-19 Kiarash Saleki, Zahra Mojtahedi, Timo Ulrichs, Mehdi Mahdavi, Abbas Azadmehr
512 [GO] 2024―May―23 Anti-RBD IgG antibodies from endemic coronaviruses do not protect against the acquisition of SARS-CoV-2 infection among exposed uninfected individuals Flávia Lopes Adami, Mateus Vidigal de Castro, Bianca da Silva Almeida, Isabela Pazotti Daher, Márcio Massao Yamamoto, Keity Souza Santos, et al. (+7)
513 [GO] 2024―May―22 Development and application of EpitopeScan, a Python3 toolset for mutation tracking in SARS-CoV-2 immunogenic epitopes Alexander Kovalenko, Sebastien Viatte
514 [GO] 2024―May―21 New findings on retinal microvascular changes in patients with primary COVID-19 infection: a longitudinal study Chenxi Zhang, Shiyu Cheng, Huan Chen, Jingyuan Yang, Youxin Chen
515 [GO] 2024―May―21 COVID-19 PBMCs are doubly harmful, through LDN-mediated lung epithelial damage and monocytic impaired responsiveness to live Pseudomonas aeruginosa exposure Clémence Gaudin, Maëlys Born-Bony, Bérengère Villeret, Madeleine Jaillet, Dorothée Faille, Jean-François Timsit, et al. (+5)
516 [GO] 2024―May―21 Sex-biased immunogenicity of a mucosal subunit vaccine against SARS-CoV-2 in mice Jianping Li, Kevin S. Hsu, Savannah E. Howe, Tanya Hoang, Zheng Xia, Jay A. Berzofsky, Yongjun Sui
517 [GO] 2024―May―17 Seasonal human coronavirus humoral responses in AZD1222 (ChaAdOx1 nCoV-19) COVID-19 vaccinated adults reveal limited cross-immunity Ann Marie Stanley, Anastasia A. Aksyuk, Deidre Wilkins, Justin A. Green, Dongmei Lan, Kathryn Shoemaker, et al. (+4)
518 [GO] 2024―May―15 Antibody responses in blood and saliva post COVID-19 bivalent booster do not reveal an Omicron BA.4/BA.5- specific response Ryan Baker, Rebecca Lawlor, Maeve Smith, Jessica Price, Ashley Eaton, Andrew Lover, et al. (+4)
519 [GO] 2024―May―15 Immune responses during COVID-19 breakthrough cases in vaccinated children and adolescents Daniela Rivera-Pérez, Constanza Méndez, Benjamín Diethelm-Varela, Felipe Melo-González, Yaneisi Vázquez, Xing Meng, et al. (+19)
520 [GO] 2024―May―15 Pre-existing cell populations with cytotoxic activity against SARS-CoV-2 in people with HIV and normal CD4/CD8 ratio previously unexposed to the virus Guiomar Casado-Fernández, Juan Cantón, Laura Nasarre, Fernando Ramos-Martín, Mario Manzanares, Clara Sánchez-Menéndez, et al. (+8)
521 [GO] 2024―May―14 Two new and effective food-extracted immunomodulatory agents exhibit anti-inflammatory response activity in the hACE2 acute lung injury murine model of COVID-19 Shasha Liu, Baiqiao Wang, Tianran Chen, Hui Wang, Jinbo Liu, Xuan Zhao, Yi Zhang
522 [GO] 2024―May―14 Non-cross-reactive epitopes dominate the humoral immune response to COVID-19 vaccination - kinetics of plasma antibodies, plasmablasts and memory B cells Kilian A. Wietschel, Kevin Fechtner, Elmer Antileo, Goran Abdurrahman, Chiara A. Drechsler, Michelle Kudzayi Makuvise, et al. (+11)
523 [GO] 2024―May―14 Effectiveness of different booster vaccine combinations against SARS-CoV-2 during a six-month follow-up in Mexico and Argentina Arnulfo Garza-Silva, Diego Rivera-Salinas, Andrea Rivera-Cavazos, Iván Francisco Fernández-Chau, Andrea Belinda Cepeda-Medina, Devany Paola Morales-Rodríguez, et al. (+9)
524 [GO] 2024―May―13 Effectiveness of COVID-19 XBB.1.5 monovalent mRNA vaccine in Korea: interim analysis Eliel Nham, Jang Wook Sohn, Won Suk Choi, Seong-Heon Wie, Jacob Lee, Jin-Soo Lee, et al. (+9)
525 [GO] 2024―May―13 Gut microbiota, inflammatory proteins and COVID-19: a Mendelian randomisation study Yuling Chen, Chang Chen
526 [GO] 2024―May―13 Microplastics dysregulate innate immunity in the SARS-CoV-2 infected lung Cameron R. Bishop, Kexin Yan, Wilson Nguyen, Daniel J. Rawle, Bing Tang, Thibaut Larcher, Andreas Suhrbier
527 [GO] 2024―May―10 Efficacy and safety of Chinese herbal medicine to prevent and treat COVID-19 household close contacts in Hong Kong: an open-label, randomized controlled trial Peipei Du, Wai Ching Lam, Choryin Leung, Huijuan Li, Zipan Lyu, Chun Sum Yuen, et al. (+4)
528 [GO] 2024―May―10 Metabolic predictors of COVID-19 mortality and severity: a survival analysis Abdallah Musa Abdallah, Asmma Doudin, Theeb Osama Sulaiman, Omar Jamil, Rida Arif, Fatima Al Sada, et al. (+6)
529 [GO] 2024―May―10 Serum AXL is a potential molecular marker for predicting COVID-19 progression Jianbin You, Rong Huang, Ruifang Zhong, Jing Shen, Shuhang Huang, Jinhua Chen, et al. (+3)
530 [GO] 2024―May―10 Lipidome is a valuable tool for the severity prediction of coronavirus disease 2019 Shan-Shan Zhang, Zhiling Zhao, Wan-Xue Zhang, Rui Wu, Fei Li, Han Yang, et al. (+9)
531 [GO] 2024―May―09 A bioinformatic analysis of T-cell epitope diversity in SARS-CoV-2 variants: association with COVID-19 clinical severity in the United States population Grace J. Kim, Jacob H. Elnaggar, Mallory Varnado, Amy K. Feehan, Darlene Tauzier, Rebecca Rose, et al. (+7)
532 [GO] 2024―May―08 Exploring the relationship between HCMV serostatus and outcomes in COVID-19 sepsis Dominik Ziehe, Alexander Wolf, Tim Rahmel, Hartmuth Nowak, Helge Haberl, Lars Bergmann, et al. (+21)
533 [GO] 2024―May―08 Corrigendum: The role of peroxisome proliferator-activated receptors in the modulation of hyperinflammation induced by SARS-CoV-2 infection: A perspective for COVID-19 therapy Aliakbar Hasankhani, Abolfazl Bahrami, Bahareh Tavakoli-Far, Setare Iranshahi, Farnaz Ghaemi, Majid Reza Akbarizadeh, et al. (+3)
534 [GO] 2024―May―08 The single-dose Janssen Ad26.COV2.S COVID-19 vaccine elicited robust and persistent anti-spike IgG antibody responses in a 12-month Ugandan cohort Jennifer Serwanga, Laban Kato, Gerald Kevin Oluka, Violet Ankunda, Jackson Sembera, Claire Baine, et al. (+6)
535 [GO] 2024―May―08 Heterologous Ad26/Ad5 adenovirus-vectored vaccines elicited SARS-CoV-2-specific antibody responses with potent Fc activities Jéromine Klingler, Shreyas Kowdle, Juan C. Bandres, Rozita Emami-Gorizi, Raymond A. Alvarez, Priyanka G. Rao, et al. (+9)
536 [GO] 2024―May―07 Distinct T cell responsiveness to different COVID-19 vaccines and cross-reactivity to SARS-CoV-2 variants with age and CMV status Jolanda Brummelman, Sara Suárez-Hernández, Lia de Rond, Marjan Bogaard-van Maurik, Petra Molenaar, Emma van Wijlen, et al. (+10)
537 [GO] 2024―May―03 A murine model of post-acute neurological sequelae following SARS-CoV-2 variant infection Ankita Singh, Awadalkareem Adam, Bi-Hung Peng, Xiaoying Yu, Jing Zou, Vikram V. Kulkarni, et al. (+6)
538 [GO] 2024―May―02 Protecting the vulnerable: addressing the COVID-19 care needs of people with compromised immunity Raymund R. Razonable
539 [GO] 2024―May―02 Long-term humoral and cellular immunity against vaccine strains and Omicron subvariants (BQ.1.1, BN.1, XBB.1, and EG.5) after bivalent COVID-19 vaccination Hakjun Hyun, Eliel Nham, Hye Seong, Jin Gu Yoon, Ji Yun Noh, Hee Jin Cheong, et al. (+7)
540 [GO] 2024―Apr―30 A universal recombinant adenovirus type 5 vector-based COVID-19 vaccine Xingxing Li, Qinhua Peng, Xinyu Liu, Hongshan Xu, Jingjing Liu, Xiaohong Wu, et al. (+3)
541 [GO] 2024―Apr―29 Venous thromboembolism and severe COVID-19: a Mendelian randomization trial and transcriptomic analysis Liang Chen, Xiaoting Dai
542 [GO] 2024―Apr―29 SARS-CoV-2 strains bearing Omicron BA.1 spike replicate in C57BL/6 mice Patricia P. Ogger, Minerva Garcia Martín, Soyeon Jang, Jie Zhou, Jonathan Brown, Ksenia Sukhova, et al. (+6)
543 [GO] 2024―Apr―26 Corrigendum: Genetic overlap and causality between COVID-19 and multi-site chronic pain: the importance of immunity Yanjing Chen, Ping Liu, Zhiyi Zhang, Yingling Ye, Sijie Yi, Chunhua Fan, et al. (+2)
544 [GO] 2024―Apr―23 Circulating mortalin in blood and activation of the alternative complement pathway as risk indicators in COVID-19 infection Maya Avraham, György Sinkovits, Lisa Hurler, Zoltán Prohászka, Zvi Fishelson
545 [GO] 2024―Apr―23 Does SARS-CoV-2 infect platelets? Saravanan Subramaniam, Naila Mohiuddin, Asha Jose
546 [GO] 2024―Apr―23 RNA m5C methylation modification: a potential therapeutic target for SARS-CoV-2-associated myocarditis Yan Xiong, Yanan Li, Weiwei Qian, Qing Zhang
547 [GO] 2024―Apr―22 Case report: Experience and insights on the treatment of two cases of cryptococcal meningitis during the later stages of the COVID-19 pandemic Yuli Zhou, Bingfeng Qiu, Jun Jiang, Tianwen Chen, Liqian Wang, Yunxing Yang, et al. (+5)
548 [GO] 2024―Apr―19 Intravenous immunoglobulins for the treatment of prolonged COVID-19 in immunocompromised patients: a brief report Bénédicte Billi, Paul Cholley, Vincent Grobost, Mélissa Clément, Virginie Rieu, Guillaume Le Guenno, Hervé Lobbes
549 [GO] 2024―Apr―19 Antiphospholipid antibody-related hepatic vasculitis in a juvenile after non-severe COVID-19: a case report and literature review Qingyu Li, Jingya Li, Menglan Zhou, Ying Ge, Zhengyin Liu, Taisheng Li, Li Zhang
550 [GO] 2024―Apr―18 Immunogenicity of COVID-19 booster vaccination in IEI patients and their one year clinical follow-up after start of the COVID-19 vaccination program Leanne P. M. van Leeuwen, Marloes Grobben, Corine H. GeurtsvanKessel, Pauline M. Ellerbroek, Godelieve J. de Bree, Judith Potjewijd, et al. (+6)
551 [GO] 2024―Apr―17 Anti-SARS-CoV-2 glyco-humanized polyclonal antibody XAV-19: phase II/III randomized placebo-controlled trial shows acceleration to recovery for mild to moderate patients with COVID-19 Garyfallia Poulakou, Pierre-Joseph Royer, Nikolay Evgeniev, Gwénaëlle Evanno, Françoise Shneiker, Anne-Geneviève Marcelin, et al. (+4)
552 [GO] 2024―Apr―17 Prevalence of anti-lymphocyte IgM autoantibodies driving complement activation in COVID-19 patients Ainhoa Pérez-Díez, Xiangdong Liu, Stephanie Calderon, Ashlynn Bennett, Andrea Lisco, Anela Kellog, et al. (+11)
553 [GO] 2024―Apr―17 High interleukin-6 levels induced by COVID-19 pneumonia correlate with increased circulating follicular helper T cell frequency and strong neutralization antibody response in the acute phase of Omicron breakthrough infection Hitoshi Kawasuji, Yoshitomo Morinaga, Kentaro Nagaoka, Hideki Tani, Yoshihiro Yoshida, Hiroshi Yamada, et al. (+6)
554 [GO] 2024―Apr―16 Clinical and immunological comparison of COVID-19 disease between critical and non-critical courses: a systematic review and meta-analysis Mojtaba Hedayati-Ch, Hadi Sedigh Ebrahim-Saraie, Arash Bakhshi
555 [GO] 2024―Apr―15 Sulfasalazine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) coinfected with COVID-19 complicated by hemophagocytic lymphohistiocytosis: a case report Mengmeng Li, Furong li, Yang Dai, Yunou Zhang Zeng, Xiaomei Chen
556 [GO] 2024―Apr―15 Proteomics validate circulating GDF-15 as an independent biomarker for COVID-19 severity Simeng Bu, Léna Royston, Tsoarello Mabanga, Carolina A. Berini, Cécile Tremblay, Bertrand Lebouché, et al. (+5)
557 [GO] 2024―Apr―15 The glycosaminoglycan-binding chemokine fragment CXCL9(74-103) reduces inflammation and tissue damage in mouse models of coronavirus infection Vivian Louise Soares Oliveira, Celso Martins Queiroz-Junior, Delphine Hoorelbeke, Felipe Rocha da Silva Santos, Ian de Meira Chaves, Mauro Martins Teixeira, et al. (+5)
558 [GO] 2024―Apr―15 SARS-Cov-2 spike induces intestinal barrier dysfunction through the interaction between CEACAM5 and Galectin-9 Yingshu Luo, Zhenling Zhang, Jiangnan Ren, Chunxu Dou, Jiancheng Wen, Yang Yang, et al. (+3)
559 [GO] 2024―Apr―11 Case report: Atypical case of autoimmune glial fibrillary acidic protein astrocytopathy following COVID-19 vaccination refractory to immunosuppressive treatments Yuto Morishima, Takanori Hata, Sho Nakajima, Kazumasa Shindo, Mai Tsuchiya, Tsubasa Watanabe, et al. (+5)
560 [GO] 2024―Apr―08 Effect of high-dose Spirulina supplementation on hospitalized adults with COVID-19: a randomized controlled trial Mohammad Reza Aghasadeghi, Mohammad Ali Zaheri Birgani, Saeedreza Jamalimoghadamsiyahkali, Hadiseh Hosamirudsari, Ali Moradi, Majid Jafari-Sabet, et al. (+20)
561 [GO] 2024―Apr―05 Utilizing noncatalytic ACE2 protein mutant as a competitive inhibitor to treat SARS-CoV-2 infection Shengjiang Liu, Haifeng Chen, Xiangqun Chen, Ningguang Luo, Sameera Peraramelli, Xiaoming Gong, et al. (+2)
562 [GO] 2024―Apr―05 Identification and characterization of endogenous retroviruses upon SARS-CoV-2 infection Xuefei Guo, Yang Zhao, Fuping You
563 [GO] 2024―Apr―03 Boosting the immunogenicity of the CoronaVac SARS-CoV-2 inactivated vaccine with Huoxiang Suling Shuanghua Decoction: a randomized, double-blind, placebo-controlled study Ruying Tang, Linyuan Wang, Jianjun Zhang, Wenting Fei, Rui Zhang, Jinlian Liu, et al. (+9)
564 [GO] 2024―Apr―02 Clonal structure and the specificity of vaccine-induced T cell response to SARS-CoV-2 Spike protein Saveliy A. Sheetikov, Alexandra A. Khmelevskaya, Ksenia V. Zornikova, Ivan V. Zvyagin, Alina S. Shomuradova, Yana V. Serdyuk, et al. (+13)
565 [GO] 2024―Mar―28 High frequencies of alpha common cold coronavirus/SARS-CoV-2 cross-reactive functional CD4+ and CD8+ memory T cells are associated with protection from symptomatic and fatal SARS-CoV-2 infections in unvaccinated COVID-19 patients Pierre-Gregoire Coulon, Swayam Prakash, Nisha R. Dhanushkodi, Ruchi Srivastava, Latifa Zayou, Delia F. Tifrea, et al. (+12)
566 [GO] 2024―Mar―27 Bioinformatics and system biology approach to identify the influences among COVID-19, influenza, and HIV on the regulation of gene expression Zhen Zhang, Hao Jin, Xu Zhang, Mei Bai, Kexin Zheng, Jing Tian, et al. (+4)
567 [GO] 2024―Mar―27 The fatal contribution of serine protease-related genetic variants to COVID-19 outcomes Laura Edith Martínez-Gómez, Carlos Martinez-Armenta, Teresa Tusie-Luna, Paola Vázquez-Cárdenas, Rosa P. Vidal-Vázquez, Juan P. Ramírez-Hinojosa, et al. (+22)
568 [GO] 2024―Mar―27 A generalizable and easy-to-use COVID-19 stratification model for the next pandemic via immune-phenotyping and machine learning Xinlei He, Xiao Cui, Zhiling Zhao, Rui Wu, Qiang Zhang, Lei Xue, et al. (+3)
569 [GO] 2024―Mar―26 Seroprevalence of antibodies against SARS-CoV-2 in the school community in Campo Grande, state of Mato Grosso do Sul, Brazil, October 2021-November 2022 Claudia Stutz, Daniel Maximo Correa Alcantara, Camila Maria dos Santos, Jaire Marinho Torres, Rudielle Rodrigues, Glaucia Elisete Barbosa Marcon, et al. (+12)
570 [GO] 2024―Mar―26 Human surfactant protein A inhibits SARS-CoV-2 infectivity and alleviates lung injury in a mouse infection model Ikechukwu B. Jacob, Amanda Gemmiti, Weichuan Xiong, Erin Reynolds, Brian Nicholas, Saravanan Thangamani, et al. (+2)
571 [GO] 2024―Mar―26 Computational identification and experimental verification of a novel signature based on SARS-CoV-2-related genes for predicting prognosis, immune microenvironment and therapeutic strategies in lung adenocarcinoma patients Yuzhi Wang, Yunfei Xu, Yuqin Deng, Liqiong Yang, Dengchao Wang, Zhizhen Yang, Yi Zhang
572 [GO] 2024―Mar―25 Case report: unprecedented case of infantile cerebral infarction following COVID-19 and favorable outcome Shuhong Zheng, Hairui Chen, Weiwei Xu, Haifeng Li, Zhongyu Chen, Jianhua Li, Enfu Tao
573 [GO] 2024―Mar―25 Role of microRNAs in host defense against porcine reproductive and respiratory syndrome virus infection: a hidden front line Xuewei Huang, Weiye Liu
574 [GO] 2024―Mar―21 Prevalence and duration of SARS-CoV-2 fecal shedding in breastfeeding dyads following maternal COVID-19 diagnosis Ryan M. Pace, Elana A. King-Nakaoka, Andrew G. Morse, Kelsey J. Pascoe, Anna Winquist, Beatrice Caffé, et al. (+12)
575 [GO] 2024―Mar―21 Clinical and immunologic features of co-infection in COVID-19 patients, along with potential traditional Chinese medicine treatments Guochao Zhang, Junjun Zhang, Qi Gao, Yingying Zhao, Yanjun Lai
576 [GO] 2024―Mar―20 Alveolar cytokines and interferon autoantibodies in COVID-19 ARDS Trine B. Jonassen, Sofie E. Jørgensen, Nikki H. Mitchell, Trine H. Mogensen, Ronan M. G. Berg, Andreas Ronit, Ronni R. Plovsing
577 [GO] 2024―Mar―20 Neutralizing antibody and CD8+ T cell responses following BA.4/5 bivalent COVID-19 booster vaccination in adults with and without prior exposure to SARS-CoV-2 Alexander P. Underwood, Christina Sølund, Kivin Jacobsen, Alekxander Binderup, Carlota Fernandez-Antunez, Lotte S. Mikkelsen, et al. (+9)
578 [GO] 2024―Mar―19 Immune and behavioral correlates of protection against symptomatic post-vaccination SARS-CoV-2 infection Emilie Goguet, Cara H. Olsen, William A. Meyer, Sara Ansari, John H. Powers, Tonia L. Conner, et al. (+42)
579 [GO] 2024―Mar―18 Diminished neutralizing activity against the XBB1.5 strain in 55.9% of individuals post 6 months COVID-19 mRNA booster vaccination: insights from a pseudovirus assay on 1,353 participants in the Fukushima vaccination community survey, Japan Tianchen Zhao, Yuta Tani, Chieko Makino-Okamura, Morihito Takita, Chika Yamamoto, Eiki Kawahara, et al. (+11)
580 [GO] 2024―Mar―18 Genetic overlap and causality between COVID-19 and multi-site chronic pain: the importance of immunity Yanjing Chen, Ping Liu, Zhiyi Zhang, Yingling Ye, Sijie Yi, Chunhua Fan, et al. (+2)
581 [GO] 2024―Mar―15 Comparison of SARS-CoV-2 spike-specific IgA and IgG in nasal secretions, saliva and serum Oscar Bladh, Katherina Aguilera, Ulrika Marking, Martha Kihlgren, Nina Greilert Norin, Anna Smed-Sörensen, et al. (+7)
582 [GO] 2024―Mar―14 T-cell count and T-cell telomere length in patients with severe COVID-19 Bryan D. Kraft, Simon Verhulst, Tsung-Po Lai, Bruce A. Sullenger, Yunfei Wang, Wes Rountree, et al. (+4)
583 [GO] 2024―Mar―13 Corrigendum: Urokinase-type plasminogen activator and plasminogen activator inhibitor-1 complex as a serum biomarker for COVID-19 Tetiana Yatsenko, Ricardo Rios, Tatiane Nogueira, Yousef Salama, Satoshi Takahashi, Yoko Tabe, et al. (+4)
584 [GO] 2024―Mar―12 Long-term analysis of humoral responses and spike-specific T cell memory to Omicron variants after different COVID-19 vaccine regimens Chia-Lo Ho, Li-Chen Yen, Hong-Wei Huang, Chun-Chi Lu, Yi-Jen Hung, Ching-Len Liao, et al. (+2)
585 [GO] 2024―Mar―11 Association between loss of hypercoagulable phenotype, clinical features and complement pathway consumption in COVID-19 Daisuke Kasugai, Taku Tanaka, Takako Suzuki, Yoshinori Ito, Kazuki Nishida, Masayuki Ozaki, et al. (+16)
586 [GO] 2024―Mar―11 Identification of mouse CD4+ T cell epitopes in SARS-CoV-2 BA.1 spike and nucleocapsid for use in peptide:MHCII tetramers Laura Bricio-Moreno, Juliana Barreto de Albuquerque, Jake M. Neary, Thao Nguyen, Lucy F. Kuhn, YeePui Yeung, et al. (+12)
587 [GO] 2024―Mar―06 Coagulation profile in hospitalized children with COVID-19: pediatric age dependency and its impact on long COVID development Oksana Boyarchuk, Vita Perestiuk, Tetyana Kosovska, Liubov Volianska
588 [GO] 2024―Mar―06 Rapid isolation of pan-neutralizing antibodies against Omicron variants from convalescent individuals infected with SARS-CoV-2 Peng Yu, Jingping Ran, Ruiqi Yang, Hang Zhu, Song Lu, Yuzhang Wu, et al. (+2)
589 [GO] 2024―Mar―05 The effect of SARS-CoV-2 infection and vaccination on Th17 and regulatory T cells in a pregnancy cohort in NYC Frederieke A. J. Gigase, Mara Graziani, Juliana Castro, Corina Lesseur, Anna-Sophie Rommel, Tammy Flores, et al. (+7)
590 [GO] 2024―Mar―04 Anti-synthetase syndrome is associated with a higher risk of hospitalization among patients with idiopathic inflammatory myopathy and COVID-19 Wanlong Wu, Runci Wang, Cuiying Xie, Yi Chen, Xiangyu Teng, Shuhui Sun, et al. (+12)
591 [GO] 2024―Mar―04 The knowns and unknowns of long COVID-19: from mechanisms to therapeutical approaches Roxana Gheorghita, Iuliana Soldanescu, Andrei Lobiuc, Olga Adriana Caliman Sturdza, Roxana Filip, Adela Constantinescu - Bercu, et al. (+3)
592 [GO] 2024―Feb―29 Understanding COVID-19-associated endothelial dysfunction: role of PIEZO1 as a potential therapeutic target Xiaoting Zhang, Jinhai Liu, Xiaoming Deng, Lulong Bo
593 [GO] 2024―Feb―29 Longitudinal rheumatoid factor autoantibody responses after SARS-CoV-2 vaccination or infection Sofie Keijzer, Nienke Oskam, Pleuni Ooijevaar-de Heer, Maurice Steenhuis, Jim B.D. Keijser, Luuk Wieske, et al. (+11)
594 [GO] 2024―Feb―28 Corrigendum: Brief research report: impact of vaccination on antibody responses and mortality from severe COVID-19 Bindu Adhikari, Joseph S. Bednash, Jeffrey C. Horowitz, Mark P. Rubinstein, Anastasia N. Vlasova
595 [GO] 2024―Feb―28 Pathophysiological, immunological, and inflammatory features of long COVID Karen Bohmwald, Benjamín Diethelm-Varela, Linmar Rodríguez-Guilarte, Thomas Rivera, Claudia A. Riedel, Pablo A. González, Alexis M. Kalergis
596 [GO] 2024―Feb―27 Serum antibody fingerprinting of SARS-CoV-2 variants in infected and vaccinated subjects by label-free microarray biosensor Thomas Carzaniga, Luca Casiraghi, Giovanni Nava, Giuliano Zanchetta, Tommaso Inzani, Marcella Chiari, et al. (+7)
597 [GO] 2024―Feb―26 The immunobiology of SARS-CoV-2 infection and vaccine responses: potential influences of cross-reactive memory responses and aging on efficacy and off-target effects Craig P. Collins, Dan L. Longo, William J. Murphy
598 [GO] 2024―Feb―26 Comprehensive evaluation of inactivated SARS-CoV-2 vaccination on sperm parameters and sex hormones Yehao Dong, Zaihua Ba, Yining Qin, Jiao Ma, Yuqi Li, Yingze Zhang, et al. (+2)
599 [GO] 2024―Feb―23 Potential immune evasion of the severe acute respiratory syndrome coronavirus 2 Omicron variants Luyi Chen, Ying He, Hongye Liu, Yongjun Shang, Guoning Guo
600 [GO] 2024―Feb―22 Evaluating the effects of circulating inflammatory proteins as drivers and therapeutic targets for severe COVID-19 Ancha Baranova, Jing Luo, Li Fu, Guanqun Yao, Fuquan Zhang
601 [GO] 2024―Feb―22 Dynamics of SARS-CoV-2 immunity after vaccination and breakthrough infection in rituximab-treated rheumatoid arthritis patients: a prospective cohort study Hassen Kared, Ingrid Jyssum, Amin Alirezaylavasani, Ingrid M. Egner, Trung The Tran, Lisa Tietze, et al. (+11)
602 [GO] 2024―Feb―22 Comprehensive bioinformatics analysis and systems biology approaches to identify the interplay between COVID-19 and pericarditis Daisong Li, Ruolan Chen, Chao Huang, Guoliang Zhang, Zhaoqing Li, Xiaojian Xu, et al. (+3)
603 [GO] 2024―Feb―22 Superoxide dismutase alterations in COVID-19: implications for disease severity and mortality prediction in the context of omicron variant infection Jinshen Chu, Lin Hua, Xiaofeng Liu, Huomei Xiong, Fangtinghui Jiang, Wei Zhou, et al. (+2)
604 [GO] 2024―Feb―22 A case of IgG4-related ophthalmic disease after SARS-CoV-2 vaccination: case report and literature review Peixuan Zhang, Qian Wu, Xiao Xu, Minliang Chen
605 [GO] 2024―Feb―21 Case report: Complex evaluation of coagulation, fibrinolysis and inflammatory cytokines in a SARS-CoV-2 infected pregnant woman with fetal loss Eszter Lilla Tóth, Rita Orbán-Kálmándi, Zsuzsa Bagoly, Linda Lóczi, Tamás Deli, Olga Török, et al. (+9)
606 [GO] 2024―Feb―21 Corrigendum: Experimental validation of immunogenic SARS-CoV-2 T cell epitopes identified by artificial intelligence Lorenzo Federico, Brandon Malone, Simen Tennøe, Viktoriia Chaban, Julie Røkke Osen, Murat Gainullin, et al. (+7)
607 [GO] 2024―Feb―19 Self-DNA driven inflammation in COVID-19 and after mRNA-based vaccination: lessons for non-COVID-19 pathologies Martin Heil
608 [GO] 2024―Feb―16 The single nucleotide polymorphism rs4986790 (c.896A>G) in the gene TLR4 as a protective factor in corona virus disease 2019 (COVID-19) Christoph Zacher, Kristina Schönfelder, Hana Rohn, Winfried Siffert, Birte Möhlendick
609 [GO] 2024―Feb―16 The effect of dose-interval on antibody response to mRNA COVID-19 vaccines: a prospective cohort study Nisha D. Almeida, Ian Schiller, Danbing Ke, Elsa Sakr, Maria Plesa, Sandeep Vanamala, et al. (+13)
610 [GO] 2024―Feb―15 Global research on RNA vaccines for COVID-19 from 2019 to 2023: a bibliometric analysis Ziyi Chen, Zhiliang Liu, Yali Feng, Aochen Shi, Liqing Wu, Yi Sang, Chenxi Li
611 [GO] 2024―Feb―14 Boosting NAD+ levels through fasting to aid in COVID-19 recovery Rachmad Anres Dongoran, Meity Mardiana, Chih-Yang Huang, Jiro Hasegawa Situmorang
612 [GO] 2024―Feb―14 SARS-CoV-2 spike-reactive naïve B cells and pre-existing memory B cells contribute to antibody responses in unexposed individuals after vaccination Shishan Teng, Yabin Hu, You Wang, Yinggen Tang, Qian Wu, Xingyu Zheng, et al. (+8)
613 [GO] 2024―Feb―13 Drug-target identification in COVID-19 disease mechanisms using computational systems biology approaches Anna Niarakis, Marek Ostaszewski, Alexander Mazein, Inna Kuperstein, Martina Kutmon, Marc E. Gillespie, et al. (+71)
614 [GO] 2024―Feb―13 Allograft function predicts mortality in kidney transplant recipients with severe COVID-19: a paradoxical risk factor Han Luo, Jingyu Wen, Hongji Yang, Qing Ran, Yifu Hou
615 [GO] 2024―Feb―12 Cognition-associated long noncoding RNAs are dysregulated upon severe COVID-19 Jonathan D. Lee, Isaac H. Solomon, Frank J. Slack, Maria Mavrikaki
616 [GO] 2024―Feb―12 Elevated levels of cell-free NKG2D-ligands modulate NKG2D surface expression and compromise NK cell function in severe COVID-19 disease Daniel Fernández-Soto, Álvaro F. García-Jiménez, José M. Casasnovas, Mar Valés-Gómez, Hugh T. Reyburn
617 [GO] 2024―Feb―09 Neutralizing antibody levels detected early after mRNA-based vaccination do not predict by themselves subsequent breakthrough infections of SARS-CoV-2 Roberto Alonso, Sergio Gil-Manso, Pilar Catalán, Ignacio Sánchez-Arcilla, Marco Marzola, Rafael Correa-Rocha, et al. (+2)
618 [GO] 2024―Feb―08 New-onset autoimmune disease after COVID-19 Corrilynn O. Hileman, Shahdi K. Malakooti, Nirav Patil, Nora G. Singer, Grace A. McComsey
619 [GO] 2024―Feb―07 Brief research report: impact of vaccination on antibody responses and mortality from severe COVID-19 Bindu Adhikari, Joseph S. Bednash, Jeffrey C. Horowitz, Mark P. Rubinstein, Anastasia N. Vlasova
620 [GO] 2024―Feb―06 Successful salvage of a severe COVID-19 patient previously with lung cancer and radiation pneumonitis by mesenchymal stem cells: a case report and literature review Xiaohua Huang, Xin Tan, Xiuwen Xie, Tingshu Jiang, Yang Xiao, Zenghui Liu
621 [GO] 2024―Feb―06 Corrigendum: Heterologous vaccination with inactivated vaccine and mRNA vaccine augments antibodies against both spike and nucleocapsid proteins of SARS-CoV-2: a local study in Macao Hoi Man Ng, Chon Lok Lei, Siyi Fu, Enqin Li, Sek In Leong, Chu Iong Nip, et al. (+5)
622 [GO] 2024―Feb―05 Multifaceted role of SARS-CoV-2 structural proteins in lung injury Guoping Zheng, Guanguan Qiu, Huifeng Qian, Qiang Shu, Jianguo Xu
623 [GO] 2024―Feb―05 Central nervous system immune-related disorders after SARS-CoV-2 vaccination: a multicenter study Alberto Vogrig, Sara Tartaglia, Marta Dentoni, Martina Fabris, Francesco Bax, Marco Belluzzo, et al. (+13)
624 [GO] 2024―Feb―05 Intramuscular vaccination against SARS-CoV-2 transiently induces neutralizing IgG rather than IgA in the saliva Stephan Winklmeier, Heike Rübsamen, Ceren Özdemir, Paul R. Wratil, Gaia Lupoli, Marcel Stern, et al. (+13)
625 [GO] 2024―Feb―02 A SARS-CoV-2 RBD vaccine fused to the chemokine MIP-3α elicits sustained murine antibody responses over 12 months and enhanced lung T-cell responses James Tristan Gordy, Yinan Hui, Courtney Schill, Tianyin Wang, Fengyixin Chen, Kaitlyn Fessler, et al. (+10)
626 [GO] 2024―Jan―30 Psoriasis and biological drugs at the time of SARS-CoV-2 infection: a mini review outlining risk of infection, seroprevalence, and safety and efficacy of the BNT162b2 vaccine Janosch Railton, Martina Volonté, Eugenio Isoletta, Alice Bonelli, Stefania Barruscotti, Valeria Brazzelli
627 [GO] 2024―Jan―30 Efficacy of sotrovimab on omicron BA.2, BA.4 and BA.5 subvariants of sars-cov-2 vs. other early therapies: a systematic review and meta-analysis of literature data Antonio Russo, Pierantonio Grimaldi, Mariantonietta Pisaturo, Lorenzo Onorato, Nicola Coppola
628 [GO] 2024―Jan―29 An early warning indicator of mortality risk in patients with COVID-19: the neutrophil extracellular traps/neutrophilic segmented granulocyte ratio Qiong Wang, Yu Qin, Jingyun Ma, Kehao Zhou, Guiping Xia, Ya Li, et al. (+6)
629 [GO] 2024―Jan―29 Bioinformatic analysis of defective viral genomes in SARS-CoV-2 and its impact on population infection characteristics Zhaobin Xu, Qingzhi Peng, Jian Song, Hongmei Zhang, Dongqing Wei, Jacques Demongeot, Qiangcheng Zeng
630 [GO] 2024―Jan―26 Low pre-existing endemic human coronavirus (HCoV-NL63)-specific T cell frequencies are associated with impaired SARS-CoV-2-specific T cell responses in people living with HIV Tiza L. Ng’uni, Vernon Musale, Thandeka Nkosi, Jonathan Mandolo, Memory Mvula, Clive Michelo, et al. (+8)
631 [GO] 2024―Jan―26 Corrigendum: Antimicrobial resistance in the COVID-19 landscape: is there an opportunity for anti-infective antibodies and antimicrobial peptides? José M. Pérez de la Lastra, Uttpal Anand, Sergio González-Acosta, Manuel R. López, Abhijit Dey, Elza Bontempi, Antonio Morales delaNuez
632 [GO] 2024―Jan―25 Case report: Ensitrelvir for treatment of persistent COVID-19 in lymphoma patients: a report of two cases Chiho Furuya, Hajime Yasuda, Makoto Hiki, Shuichi Shirane, Tomohito Yamana, Ayana Uchimura, et al. (+4)
633 [GO] 2024―Jan―23 Persistent CD8+ T cell proliferation and activation in COVID-19 adult survivors with post-acute sequelae: a longitudinal, observational cohort study of persistent symptoms and T cell markers Stephanie M. LaVergne, Taru S. Dutt, Kim McFann, Bridget A. Baxter, Tracy L. Webb, Kailey Berry, et al. (+6)
634 [GO] 2024―Jan―23 Immunological insights into COVID-19 in Southern Nigeria Chinedu A. Ugwu, Oluwasina Alao, Oluwagboadurami G. John, Blossom Akinnawo, Israel Ajayi, Ooreofe Odebode, et al. (+45)
635 [GO] 2024―Jan―22 Associations between post-acute sequelae of SARS-CoV-2, COVID-19 vaccination and HIV infection: a United States cohort study George A. Yendewa, Jaime Abraham Perez, Nirav Patil, Grace A. McComsey
636 [GO] 2024―Jan―22 Early immune factors associated with the development of post-acute sequelae of SARS-CoV-2 infection in hospitalized and non-hospitalized individuals Jacqueline M. Leung, Michelle J. Wu, Pouya Kheradpour, Chen Chen, Katherine A. Drake, Gary Tong, et al. (+18)
637 [GO] 2024―Jan―22 Cross-protection induced by highly conserved human B, CD4+, and CD8+ T-cell epitopes-based vaccine against severe infection, disease, and death caused by multiple SARS-CoV-2 variants of concern Swayam Prakash, Nisha R. Dhanushkodi, Latifa Zayou, Izabela Coimbra Ibraim, Afshana Quadiri, Pierre Gregoire Coulon, et al. (+13)
638 [GO] 2024―Jan―18 Nucleated red blood cells are a late biomarker in predicting intensive care unit mortality in patients with COVID-19 acute respiratory distress syndrome: an observational cohort study Götz Schmidt, Arnd Martens, Christian Koch, Melanie Markmann, Emmanuel Schneck, Ulrich Matt, et al. (+5)
639 [GO] 2024―Jan―18 Metabolomic and immune alterations in long COVID patients with chronic fatigue syndrome Suguru Saito, Shima Shahbaz, Xian Luo, Mohammed Osman, Desiree Redmond, Jan Willem Cohen Tervaert, et al. (+2)
640 [GO] 2024―Jan―17 People who use drugs show no increase in pre-existing T-cell cross-reactivity toward SARS-CoV-2 but develop a normal polyfunctional T-cell response after standard mRNA vaccination Murat Gainullin, Lorenzo Federico, Julie Røkke Osen, Viktoriia Chaban, Hassen Kared, Amin Alirezaylavasani, et al. (+12)
641 [GO] 2024―Jan―16 Safety and efficacy of COVID-19 vaccine immunization during pregnancy in 1024 pregnant women infected with the SARS-CoV-2 Omicron virus in Shanghai, China Hongmei Deng, Yinpeng Jin, Minmin Sheng, Min Liu, Jie Shen, Wei Qian, et al. (+5)
642 [GO] 2024―Jan―15 Role of interferons in the antiviral battle: from virus-host crosstalk to prophylactic and therapeutic potential in SARS-CoV-2 infection Grigore Mihaescu, Mariana Carmen Chifiriuc, Roxana Filip, Coralia Bleotu, Lia Mara Ditu, Marian Constantin, et al. (+5)
643 [GO] 2024―Jan―15 Case report: A case of Acute Macular Neuroretinopathy secondary to Influenza A virus during Long COVID Jiaqi Zhang, Yihao Xia, Xiaodong Li, Runxi He, Xuejun Xie
644 [GO] 2024―Jan―12 Nebulized glycyrrhizin/enoxolone drug modulates IL-17A in COVID-19 patients: a randomized clinical trial Ulises Zendejas-Hernandez, Nemi Alcántara-Martínez, Diana Tovar Vivar, Fermín Valenzuela, Alejandro Sosa Espinoza, Eduardo Emir Cervera Ceballos
645 [GO] 2024―Jan―12 Mutational analysis of SARS-CoV-2 ORF6-KPNA2 binding interface and identification of potent small molecule inhibitors to recuse the host immune system Muhammad Suleman, Afsheen Said, Haji Khan, Shoaib Ur Rehman, Abdulrahman Alshammari, Sergio Crovella, Hadi M. Yassine
646 [GO] 2024―Jan―12 Modified live vaccine strains of porcine reproductive and respiratory syndrome virus cause immune system dysregulation similar to wild strains Katerina Stepanova, Miroslav Toman, Jana Sinkorova, Simon Sinkora, Sarka Pfeiferova, Helena Kupcova Skalnikova, et al. (+14)
647 [GO] 2024―Jan―11 Urokinase-type plasminogen activator and plasminogen activator inhibitor-1 complex as a serum biomarker for COVID-19 Tetiana Yatsenko, Ricardo Rios, Tetiana Noguiera, Satoshi Takahashi, Yoko Tabe, Toshio Naito, et al. (+3)
648 [GO] 2024―Jan―11 Immunogenicity and reactogenicity of repeated intradermal mRNA COVID-19 vaccines administered as a second booster dose in a Thai geriatric population Prasert Assantachai, Suvimol Niyomnaitham, Zheng Quan Toh, Monthira Thammasalee, Napaporn Pengsorn, Wiyachatr Monklang, et al. (+2)
649 [GO] 2024―Jan―10 Interferon response and profiling of interferon response genes in peripheral blood of vaccine-naive COVID-19 patients Baozhen Huang, Jinghan Huang, Nim Hang Chiang, Zigui Chen, Grace Lui, Lowell Ling, et al. (+12)
650 [GO] 2024―Jan―08 COVID-19 infection characteristics, risk factors and its potential impacts on Takayasu arteritis: a web-based survey in a large cohort Xiufang Kong, Jinghua Wang, Guihua Fan, Huijing Huang, Ying Sun, Huiyong Chen, et al. (+3)
651 [GO] 2024―Jan―08 Microfluidic antibody profiling after repeated SARS-CoV-2 vaccination links antibody affinity and concentration to impaired immunity and variant escape in patients on anti-CD20 therapy Ashley Priddey, Michael Xin Hua Chen-Xu, Daniel James Cooper, Serena MacMillan, Georg Meisl, Catherine K. Xu, et al. (+10)
652 [GO] 2024―Jan―08 Gene crosstalk between COVID-19 and preeclampsia revealed by blood transcriptome analysis Yijing Chu, Min Li, Mingze Sun, Jing Wang, Wan Xin, Lin Xu
653 [GO] 2024―Jan―08 ANCA-associated glomerulonephritis and lupus nephritis following COVID-19 vaccination: a case report and literature review Marcos Adriano Garcia Campos, Tiago de Oliveira Valois, Luís Eduardo Magalhães, Lucas Fernandes Vasques, Rafael Goulart de Medeiros, Denise Maria do Nascimento Costa, et al. (+4)
654 [GO] 2024―Jan―08 Transmission characteristics and inactivated vaccine effectiveness against transmission of the SARS-CoV-2 Omicron BA.2 variant in Shenzhen, China Xiaofeng He, Yuxue Liao, Yuanhao Liang, Jiexin Yu, Wei Gao, Jia Wan, et al. (+4)
655 [GO] 2024―Jan―08 Single-cell RNA sequencing reveals characteristics of myeloid cells in post-acute sequelae of SARS-CoV-2 patients with persistent respiratory symptoms Hyundong Yoon, Logan S. Dean, Boonyanudh Jiyarom, Vedbar S. Khadka, Youping Deng, Vivek R. Nerurkar, et al. (+5)
656 [GO] 2024―Jan―05 Immunogenicity, safety and consistency of seven lots of an inactivated COVID-19 vaccine in healthy children and adolescents: a randomized, double-blind, controlled, phase IV clinical trial Weijun Hu, Xiaoyu Liu, Xi Lu, Dan Zhang, Shuo Liu, Xianjin Gu, et al. (+8)
657 [GO] 2024―Jan―04 Reduced monocyte proportions and responsiveness in convalescent COVID-19 patients Eugene V. Ravkov, Elizabeth S. C. P. Williams, Marc Elgort, Adam P. Barker, Vicente Planelles, Adam M. Spivak, et al. (+3)
658 [GO] 2024―Jan―04 Changes in chemokine and growth factor levels may be useful biomarkers for monitoring disease severity in COVID-19 patients; a pilot study Blanka Wolszczak-Biedrzycka, Justyna Dorf, Marzena Wojewódzka-Żelezniakowicz, Małgorzata Żendzian-Piotrowska, Violetta Dymicka-Piekarska, Joanna Matowicka-Karna, Mateusz Maciejczyk
659 [GO] 2024―Jan―04 Humoral and cellular immune responses after COVID-19 vaccination of lung transplant recipients and patients on the waiting list: a 6-month follow-up Rogier A. S. Hoek, Siqi Liu, Corine H. GeurtsvanKessel, Erik A. M. Verschuuren, Judith M. Vonk, Merel E. Hellemons, et al. (+11)
660 [GO] 2024―Jan―04 Corrigendum: Efficacy of umbilical cord mesenchymal stromal cells for COVID-19: a systematic review and meta-analysis Cong-wen Yang, Ru-dong Chen, Qing-run Zhu, Shi-jie Han, Ming-jie Kuang
661 [GO] 2024―Jan―04 Humoral and cell-mediated immune responses in HIV-vertically infected young patients after three doses of the BNT162b2 mRNA SARS-CoV-2 vaccine Claudia Vanetti, Marta Stracuzzi, Elisa Crivellaro, Federica Ciciliano, Micaela Garziano, Claudio Fenizia, et al. (+8)
662 [GO] 2024―Jan―03 Novel antioxidant protein target therapy to counter the prevalence and severity of SARS-CoV-2 Priyajit Kaur, Akash Dey, Kartik Rawat, Sharmistha Dey
663 [GO] 2024―Jan―03 T4 apoptosis in the acute phase of SARS-CoV-2 infection predicts long COVID Renaud Cezar, Lucy Kundura, Sonia André, Claire Lozano, Thierry Vincent, Laurent Muller, et al. (+9)
664 [GO] 2023―Dec―22 Allergic diseases aggravate the symptoms of SARS-CoV-2 infection in China Huishan Zhang, Jilei Lin, Jinhong Wu, Jing Zhang, Lei Zhang, Shuhua Yuan, et al. (+12)
665 [GO] 2023―Dec―22 Mitochondrial oxidative stress, mitochondrial ROS storms in long COVID pathogenesis Kunwadee Noonong, Moragot Chatatikun, Sirirat Surinkaew, Manas Kotepui, Rahni Hossain, Kingkan Bunluepuech, et al. (+17)
666 [GO] 2023―Dec―21 Signaling network analysis reveals fostamatinib as a potential drug to control platelet hyperactivation during SARS-CoV-2 infection Özge Osmanoglu, Shishir K. Gupta, Anna Almasi, Seray Yagci, Mugdha Srivastava, Gabriel H. M. Araujo, et al. (+3)
667 [GO] 2023―Dec―21 The impact of prior SARS-CoV-2 infection on host inflammatory cytokine profiles in patients with TB or other respiratory diseases Annabelle Cottam, Ismaila L. Manneh, Awa Gindeh, Abdou K. Sillah, Ousainou Cham, Joseph Mendy, et al. (+9)
668 [GO] 2023―Dec―20 Appearance of tolerance-induction and non-inflammatory SARS-CoV-2 spike-specific IgG4 antibodies after COVID-19 booster vaccinations Marjahan Akhtar, Md. Rashedul Islam, Fatema Khaton, Umma Hany Soltana, Syeda Anoushka Jafrin, Sadia Isfat Ara Rahman, et al. (+25)
669 [GO] 2023―Dec―20 Evaluation of the humoral and mucosal immune response of a multiepitope vaccine against COVID-19 in pigs Juan Mosqueda, Diego Josimar Hernández-Silva, Marco Antonio Vega-López, Lineth J. Vega-Rojas, Rolando Beltrán, Andrés Velasco-Elizondo, et al. (+10)
670 [GO] 2023―Dec―20 Contribution of SARS-CoV-2 infection preceding COVID-19 mRNA vaccination to generation of cellular and humoral immune responses in children Marije K. Verheul, Martijn Vos, Lia de Rond, Mary-Lène De Zeeuw-Brouwer, Kim H. Nijhof, Debbie Smit, et al. (+12)
671 [GO] 2023―Dec―20 Pediatric humoral immune responses and infection risk after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and two-dose vaccination during SARS-CoV-2 omicron BA.5 and BN.1 variants predominance in South Korea Hyun-Woo Choi, Chiara Achangwa, Joonhong Park, Sun Min Lee, Nan Young Lee, Chae-Hyeon Jeon, et al. (+7)
672 [GO] 2023―Dec―15 Association of eosinopenia with worsening prognosis in hospitalized Azvudine-treated COVID-19 patients: a retrospective cohort study Xiaomin Wang, Yating Dian, Qian Zhou, Guangtong Deng, Rui Wei, Furong Zeng
673 [GO] 2023―Dec―15 IFN-γ-mediated control of SARS-CoV-2 infection through nitric oxide Bruno J. de Andrade Silva, Paul A. Krogstad, Rosane M. B. Teles, Priscila R. Andrade, Jacob Rajfer, Monica G. Ferrini, et al. (+3)
674 [GO] 2023―Dec―15 Characterization of young and aged ferrets as animal models for SARS-CoV-2 infection with focus on neutrophil extracellular traps Veronika Pilchová, Ingo Gerhauser, Federico Armando, Katrin Wirz, Tom Schreiner, Nicole de Buhr, et al. (+7)
675 [GO] 2023―Dec―13 Taming the SARS-CoV-2-mediated proinflammatory response with BromAc® Geovane Marques Ferreira, Felipe Alves Clarindo, Ágata Lopes Ribeiro, Letícia Gomes-de-Pontes, Luciana Debortoli de Carvalho, Olindo Assis Martins-Filho, et al. (+7)
676 [GO] 2023―Dec―12 Immunoinformatics lessons on the current COVID-19 pandemic and future coronavirus zoonoses Daniel López, Marina García-Peydró
677 [GO] 2023―Dec―12 Preclinical immune efficacy against SARS-CoV-2 beta B.1.351 variant by MVA-based vaccine candidates Patricia Pérez, Guillermo Albericio, David Astorgano, Sara Flores, Cristina Sánchez-Corzo, Pedro J. Sánchez-Cordón, et al. (+5)
678 [GO] 2023―Dec―11 The causal association between COVID-19 and herpes simplex virus: a Mendelian randomization study Ming Yan, Li-yuan Xiao, Martin Gosau, Reinhard E. Friedrich, Ralf Smeets, Ling-ling Fu, et al. (+2)
679 [GO] 2023―Dec―11 Association between sleep duration and antibody acquisition after mRNA vaccination against SARS-CoV-2 Muneto Izuhara, Kentaro Matsui, Takuya Yoshiike, Aoi Kawamura, Tomohiro Utsumi, Kentaro Nagao, et al. (+4)
680 [GO] 2023―Dec―11 Robust memory humoral immune response to SARS-CoV-2 in the tonsils of adults and children Tarfa A. Altorki, Rwaa H. Abdulal, Bandar A. Suliman, Talal M. Aljeraisi, Asem Alsharef, Wesam H. Abdulaal, et al. (+12)
681 [GO] 2023―Dec―11 Inducing enhanced neutralizing antibodies against broad SARS-CoV-2 variants through glycan-shielding multiple non-neutralizing epitopes of RBD Qingyun Zhang, Yi Yang, Jun Lan, Ziyi Wang, Yan Gao, Xiao Li, et al. (+7)
682 [GO] 2023―Dec―08 Novel S2 subunit-specific antibody with broad neutralizing activity against SARS-CoV-2 variants of concern Chang-Kyu Heo, Won-Hee Lim, Jihyun Yang, Sumin Son, Sang Jick Kim, Doo-Jin Kim, et al. (+2)
683 [GO] 2023―Dec―08 Approaches to pandemic prevention - the chromatin vaccine Jielin Zhang, Philip Askenase, Rudolf Jaenisch, Clyde S. Crumpacker
684 [GO] 2023―Dec―07 A community study of neutralizing antibodies against SARS-CoV-2 in China Yitong Lv, Lei Huang, Junhu Wang, Hui He, Libo Song, Jia He, et al. (+4)
685 [GO] 2023―Dec―05 Biological analysis of the potential pathogenic mechanisms of Infectious COVID-19 and Guillain-Barré syndrome Hongyu Gao, Shuning Wang, Hanying Duan, Yushi Wang, Hui Zhu
686 [GO] 2023―Dec―04 Causal relationships between susceptibility and severity of COVID-19 and neuromyelitis optica spectrum disorder (NMOSD) in European population: a bidirectional Mendelian randomized study Shengnan Wang, Lijuan Wang, Jianglong Wang, Mingqin Zhu
687 [GO] 2023―Dec―04 Novel Spike-stabilized trimers with improved production protect K18-hACE2 mice and golden Syrian hamsters from the highly pathogenic SARS-CoV-2 Beta variant Carlos Ávila-Nieto, Júlia Vergara-Alert, Pep Amengual-Rigo, Erola Ainsua-Enrich, Marco Brustolin, María Luisa Rodríguez de la Concepción, et al. (+28)
688 [GO] 2023―Dec―01 Lipid compartments and lipid metabolism as therapeutic targets against coronavirus Daniella Cesar-Silva, Filipe S. Pereira-Dutra, Ana Lucia Moraes Giannini, Clarissa M. Maya-Monteiro, Cecília Jacques G. de Almeida
689 [GO] 2023―Dec―01 Bendamustine impairs humoral but not cellular immunity to SARS-CoV-2 vaccination in rituximab-treated B-cell lymphoma-affected patients Anna Vanni, Lorenzo Salvati, Alessio Mazzoni, Giulia Lamacchia, Manuela Capone, Stefania Francalanci, et al. (+9)
690 [GO] 2023―Dec―01 Disparate viral pandemics from COVID19 to monkeypox and beyond: a simple, effective and universal therapeutic approach hiding in plain sight Howard M. Johnson, Chulbul M. Ahmed
691 [GO] 2023―Nov―30 A predictive model for disease severity among COVID-19 elderly patients based on IgG subtypes and machine learning Zhenchao Zhuang, Yuxiang Qi, Yimin Yao, Ying Yu
692 [GO] 2023―Nov―29 Editorial: The Covid-19 and TB syndemic: differences and similarities Stefan H. E. Kaufmann, Alex Sigal, Birgit Sawitzki, Alan Sher
693 [GO] 2023―Nov―28 COVID-19 and trained immunity: the inflammatory burden of long covid Jienan Gu, Qianhui Liu, Jiale Zhang, Shijie Xu
694 [GO] 2023―Nov―28 Neutrophil heterogeneity and aging: implications for COVID-19 and wound healing Yi Liu, Changlan Xiang, Zhenni Que, Chenglong Li, Wen Wang, Lijuan Yin, et al. (+2)
695 [GO] 2023―Nov―27 Analysis of the protective efficacy of approved COVID-19 vaccines against Omicron variants and the prospects for universal vaccines Keda Chen, Ling Zhang, Zhongbiao Fang, Jiaxuan Li, Chaonan Li, Wancheng Song, et al. (+4)
696 [GO] 2023―Nov―27 Rapid transient and longer-lasting innate cytokine changes associated with adaptive immunity after repeated SARS-CoV-2 BNT162b2 mRNA vaccinations Margherita Rosati, Evangelos Terpos, Philip Homan, Cristina Bergamaschi, Sevasti Karaliota, Ioannis Ntanasis-Stathopoulos, et al. (+8)
697 [GO] 2023―Nov―27 Humoral antibody response following mRNA vaccines against SARS-CoV-2 in solid organ transplant recipients; a status after a fifth and bivalent vaccine dose Emma Christophorou, Anna Christine Nilsson, Inge Petersen, Susan O. Lindvig, Jesper R. Davidsen, Rozeta Abazi, et al. (+7)
698 [GO] 2023―Nov―24 A SARS-CoV-2 NSP7 homolog of a Treg epitope suppresses CD4+ and CD8+ T cell memory responses S. M. Shahjahan Miah, Sandra Lelias, Andres H. Gutierrez, Mitchell McAllister, Christine M. Boyle, Lenny Moise, Anne S. De Groot
699 [GO] 2023―Nov―23 Serum CRP interacts with SPARC and regulate immune response in severe cases of COVID-19 infection Chengyang Liu, Chenyang Zheng, Xipeng Shen, Ling Liang, Qiuyu Li
700 [GO] 2023―Nov―23 More rapid blood interferon α2 decline in fatal versus surviving COVID-19 patients Candie Joly, Delphine Desjardins, Raphael Porcher, Hélène Péré, Thomas Bruneau, Qian Zhang, et al. (+17)
701 [GO] 2023―Nov―23 Antibodies to S2 domain of SARS-CoV-2 spike protein in Moderna mRNA vaccinated subjects sustain antibody-dependent NK cell-mediated cell cytotoxicity against Omicron BA.1 Corey A. Balinsky, Le Jiang, Vihasi Jani, Ying Cheng, Zhiwen Zhang, Tatyana Belinskaya, et al. (+9)
702 [GO] 2023―Nov―22 The two-stage molecular scenery of SARS-CoV-2 infection with implications to disease severity: An in-silico quest George Potamias, Polymnia Gkoublia, Alexandros Kanterakis
703 [GO] 2023―Nov―20 Prevalence of serum MOG antibody and AQP4 antibody in optic neuritis after SARS-CoV-2 infection Chuan-bin Sun
704 [GO] 2023―Nov―20 A 12-month follow-up of the immune response to SARS-CoV-2 primary vaccination: evidence from a real-world study Giorgio Fedele, Ilaria Schiavoni, Filippo Trentini, Pasqualina Leone, Eleonora Olivetta, Alessandra Fallucca, et al. (+24)
705 [GO] 2023―Nov―18 Experimental validation of immunogenic SARS-CoV-2 T cell epitopes identified by artificial intelligence Lorenzo Federico, Brandon Malone, Simen Tennøe, Viktoriia Chaban, Julie Røkke Osen, Murat Gainullin, et al. (+7)
706 [GO] 2023―Nov―18 Impact of SARS-CoV-2 vaccination on FcγRIIIA/CD16 dynamics in Natural Killer cells: relevance for antibody-dependent functions Cristina Capuano, Davide De Federicis, Daniel Ciuti, Ombretta Turriziani, Antonio Angeloni, Emanuela Anastasi, et al. (+6)
707 [GO] 2023―Nov―17 A third (booster) dose of the inactivated SARS-CoV-2 vaccine elicits immunogenicity and T follicular helper cell responses in people living with HIV Zhengchao Lv, Songqin Lv, Qin Li, Yafei Xia, Zaineng Feng, Haohong Zhang, et al. (+9)
708 [GO] 2023―Nov―15 Vaccine development against tuberculosis before and after Covid-19 Stefan H. E. Kaufmann
709 [GO] 2023―Nov―15 The role of post-transcriptional regulation in SARS-CoV-2 infection and pathogenicity Xuan Wang, Zecheng Chang, Tingting Zhao, Weiyao Zhong, Jingwei Shi, Guoqing Wang, Xuesong Xu
710 [GO] 2023―Nov―14 Neurological risks of COVID-19 in women: the complex immunology underpinning sex differences Jienan Gu, Jiale Zhang, Qianhui Liu, Shijie Xu
711 [GO] 2023―Nov―14 Circulating myeloid-derived suppressor cells may be a useful biomarker in the follow-up of unvaccinated COVID-19 patients after hospitalization Carlos Jiménez-Cortegana, Elena Salamanca, Natalia Palazón-Carrión, Flora Sánchez-Jiménez, Antonio Pérez-Pérez, Teresa Vilariño-García, et al. (+14)
712 [GO] 2023―Nov―14 Case Report: Gene expression profiling of COVID-19 vaccination-related lymphadenopathies reveals evidence of a dominantly extrafollicular immune response Thomas Menter, Carl P. Zinner, Christoph T. Berger, Philip Went, Alexandar Tzankov
713 [GO] 2023―Nov―13 Niacinamide enhances cathelicidin mediated SARS-CoV-2 membrane disruption Tanay Bhatt, Binita Dam, Sneha Uday Khedkar, Sahil Lall, Subhashini Pandey, Sunny Kataria, et al. (+10)
714 [GO] 2023―Nov―13 Systematical assessment of the impact of single spike mutations of SARS-CoV-2 Omicron sub-variants on the neutralization capacity of post-vaccination sera Maeva Katzmarzyk, Denise Christine Clesle, Joop van den Heuvel, Markus Hoffmann, Henk Garritsen, Stefan Pöhlmann, et al. (+2)
715 [GO] 2023―Nov―07 Corrigendum: Predictors of high SARS-CoV-2 immunoglobulin G titers in COVID-19 convalescent whole-blood donors: a cross-sectional study in China Jingyun Tang, Humin Liu, Qing Wang, Xiaobo Gu, Jia Wang, Wenjun Li, et al. (+8)
716 [GO] 2023―Nov―06 Genetic and immunological insights into COVID-19 with acute myocardial infarction: integrated analysis of mendelian randomization, transcriptomics, and clinical samples Zequn Zheng, Yueran Zhou, Yongfei Song, Pengxiang Ying, Xuerui Tan
717 [GO] 2023―Nov―03 SARS-CoV-2 specific immune responses in overweight and obese COVID-19 patients Therese Bredholt Onyango, Fan Zhou, Geir Bredholt, Karl A. Brokstad, Sarah Lartey, Kristin G.-I. Mohn, et al. (+8)
718 [GO] 2023―Nov―03 Side effects of COVID-19 vaccines in the middle eastern population Ghida M. Murished, Iman Dandachi, Waleed Aljabr
719 [GO] 2023―Nov―03 Surveillance of SARS-CoV-2 immunogenicity: loss of immunodominant HLA-A*02-restricted epitopes that activate CD8+ T cells Ágata Lopes-Ribeiro, Patrícia de Melo Oliveira, Henrique Morais Retes, Edel Figueiredo Barbosa-Stancioli, Flávio Guimarães da Fonseca, Moriya Tsuji, Jordana Grazziela Alves Coelho-dos-Reis
720 [GO] 2023―Nov―03 SARS-CoV-2 N protein induced acute kidney injury in diabetic db/db mice is associated with a Mincle-dependent M1 macrophage activation Wenjing Wu, Wenbiao Wang, Liying Liang, Junzhe Chen, Sifan Sun, Biao Wei, et al. (+6)
721 [GO] 2023―Nov―02 Effectiveness and waning of protection with the BNT162b2 vaccine against the SARS-CoV-2 Delta variant in immunocompromised individuals Zoltán Szekanecz, Zoltán Vokó, Orsolya Surján, Éva Rákóczi, Szilvia Szamosi, Gabriella Szűcs, et al. (+3)
722 [GO] 2023―Oct―31 Bioinformatics analyses of gene expression profile to identify pathogenic mechanisms for COVID-19 infection and cutaneous lupus erythematosus Zhenyu Gao, Xinchao Zhai, Guoqing Yan, Yao Tian, Xia Huang, Qingchao Wu, et al. (+2)
723 [GO] 2023―Oct―28 Recombinant C1 inhibitor in the prevention of severe COVID-19: a randomized, open-label, multi-center phase IIa trial Pascal Urwyler, Marina Leimbacher, Panteleimon Charitos, Stephan Moser, Ingmar A. F. M. Heijnen, Marten Trendelenburg, et al. (+9)
724 [GO] 2023―Oct―27 Vaccine-induced SARS-CoV-2 antibody response: the comparability of S1-specific binding assays depends on epitope and isotype discrimination Silvia Schest, Claus Langer, Yuriko Stiegler, Bianca Karnuth, Jan Arends, Hugo Stiegler, et al. (+3)
725 [GO] 2023―Oct―26 SARS-CoV-2 pre-exposure prophylaxis with tixagevimab/cilgavimab (AZD7442) provides protection in inborn errors of immunity with antibody defects: a real-world experience Federica Pulvirenti, Giulia Garzi, Cinzia Milito, Eleonora Sculco, Maddalena Sciannamea, Anna Napoli, et al. (+8)
726 [GO] 2023―Oct―25 Three doses of COVID-19 mRNA vaccine induce class-switched antibody responses in inflammatory arthritis patients on immunomodulatory therapies Jenny M. Lee, Alexis Figueroa, Jaiprasath Sachithanandham, Maggie Li, Caoilfhionn M. Connolly, Janna R. Shapiro, et al. (+17)
727 [GO] 2023―Oct―25 Macrophage migration inhibitory factor receptor CD74 expression is associated with expansion and differentiation of effector T cells in COVID-19 patients Jaana Westmeier, Annika Brochtrup, Krystallenia Paniskaki, Zehra Karakoese, Tanja Werner, Kathrin Sutter, et al. (+18)
728 [GO] 2023―Oct―25 Impact of a booster dose on SARS-CoV2 mRNA vaccine-specific humoral-, B- and T cell immunity in pediatric stem cell transplant recipients Linda Marie Laura Thole, Laura Tóth, Vanessa Proß, Janine Siegle, Carolin Stahl, Georg Hermsdorf, et al. (+10)
729 [GO] 2023―Oct―24 Low switched memory B cells are associated with no humoral response after SARS-CoV-2 vaccine boosters in kidney transplant recipients Mariana Seija, Joaquin García-Luna, Florencia Rammauro, Andreína Brugnini, Natalia Trías, Rossana Astesiano, et al. (+16)
730 [GO] 2023―Oct―24 From aging to long COVID: exploring the convergence of immunosenescence, inflammaging, and autoimmunity Ludmila Müller, Svetlana Di Benedetto
731 [GO] 2023―Oct―23 Single-cell RNA-seq public data reveal the gene regulatory network landscape of respiratory epithelial and peripheral immune cells in COVID-19 patients Lin Zhang, Hafumi Nishi, Kengo Kinoshita
732 [GO] 2023―Oct―23 How immune breakthroughs could slow disease progression and improve prognosis in COVID-19 patients: a retrospective study Yiting Wang, Bennan Zhao, Xinyi Zhang, Xia Zhang, Fengjiao Gao, Xiaoyan Yuan, et al. (+3)
733 [GO] 2023―Oct―20 Integrated Immunopeptidomic and Proteomic Analysis of COVID-19 lung biopsies Shanye Yin, Susan Klaeger, Vipheaviny A. Chea, Isabel P. Carulli, Suzanna Rachimi, Katherine E. Black, et al. (+10)
734 [GO] 2023―Oct―20 Real-world clinical effectiveness of Tixagevimab/Cilgavimab and Regdanvimab monoclonal antibodies for COVID-19 treatment in Omicron variant-dominant period Daria S. Fomina, Marina S. Lebedkina, Anna A. Iliukhina, Anna V. Kovyrshina, Artem Y. Shelkov, Sergey S. Andreev, et al. (+10)
735 [GO] 2023―Oct―20 Presence of MDSC associates with impaired antigen-specific T cell reactivity following COVID-19 vaccination in cirrhotic patients Andreas Törnell, Elin Blick, Samer Al-Dury, Hanna Grauers Wiktorin, Johan Waern, Johan Ringlander, et al. (+5)
736 [GO] 2023―Oct―19 Oral mucosa immunity: ultimate strategy to stop spreading of pandemic viruses Hyesun Jang, Michele Matsuoka, Marcelo Freire
737 [GO] 2023―Oct―18 The purinergic receptor P2X7 and the NLRP3 inflammasome are druggable host factors required for SARS-CoV-2 infection Déborah Lécuyer, Roberta Nardacci, Désirée Tannous, Emie Gutierrez-Mateyron, Aurélia Deva Nathan, Frédéric Subra, et al. (+25)
738 [GO] 2023―Oct―18 Optimized vaccine candidate MVA-S(3P) fully protects against SARS-CoV-2 infection in hamsters Rana Abdelnabi, Patricia Pérez, David Astorgano, Guillermo Albericio, Winnie Kerstens, Hendrik Jan Thibaut, et al. (+11)
739 [GO] 2023―Oct―17 Specific immune responses after BNT162b2 mRNA vaccination and COVID-19 infection Simona Arientová, Kateřina Matúšková, Oldřich Bartoš, Michal Holub, Ondřej Beran
740 [GO] 2023―Oct―17 Effectiveness of booster vaccination with inactivated COVID-19 vaccines against SARS-CoV-2 Omicron BA.2 infection in Guangdong, China: a cohort study Xiaofeng He, Biao Zeng, Ye Wang, Yulian Pang, Meng Zhang, Ting Hu, et al. (+3)
741 [GO] 2023―Oct―16 Bovine colostrum and its potential contributions for treatment and prevention of COVID-19 Hatice Duman, Sercan Karav
742 [GO] 2023―Oct―16 Prolonged mask wearing changed nasal microbial characterization of young adults during the COVID-19 pandemic in Shanghai, China Guoxiu Xiang, Kai Xu, Ying Jian, Lei He, Zhen Shen, Min Li, Qian Liu
743 [GO] 2023―Oct―16 Thrombosis and antiphospholipid antibodies in Japanese COVID-19: based on propensity score matching Seiya Oba, Tadashi Hosoya, Risa Kaneshige, Daisuke Kawata, Taiki Yamaguchi, Takahiro Mitsumura, et al. (+11)
744 [GO] 2023―Oct―16 Differences in the inflammatory response among hospitalized patients with distinct variants of SARS-CoV-2 Jose-Reynaldo Homen-Fernandez, Adrián Valls, Ana García, Noemí Cabello, Isabel Ortega, Eva Orviz, et al. (+3)
745 [GO] 2023―Oct―16 Variant-dependent oxidative and cytokine responses of human neutrophils to SARS-CoV-2 spike protein and anti-spike IgG1 antibodies Nathalie Bonatti Franco Almeida, Kayla Marie Fantone, Demba Sarr, Nuha Milad Ashtiwi, Sarah Channell, Rafaella Fortini Queiroz Grenfell, et al. (+2)
746 [GO] 2023―Oct―10 Possible contribution of rare alleles of human ACE2 in the emergence of SARS-CoV-2 variants escaping the immune response Christian A. Devaux, Jacques Fantini
747 [GO] 2023―Oct―10 Immunological profiling in long COVID: overall low grade inflammation and T-lymphocyte senescence and increased monocyte activation correlating with increasing fatigue severity Julia C. Berentschot, Hemmo A. Drexhage, Daniel G. Aynekulu Mersha, Annemarie J. M. Wijkhuijs, Corine H. GeurtsvanKessel, Marion P. G. Koopmans, et al. (+11)
748 [GO] 2023―Oct―09 Distinct anti-NP, anti-RBD and anti-Spike antibody profiles discriminate death from survival in COVID-19 Carolina do Prado Servian, Mônica Spadafora-Ferreira, Déborah Carolina Carvalho dos Anjos, Adriana Oliveira Guilarde, Antonio Roberto Gomes-Junior, Moara Alves Santa Bárbara Borges, et al. (+22)
749 [GO] 2023―Oct―09 No causal association between COVID-19 and sepsis: a bidirectional two-sample Mendelian randomization study Hao Lu, Yu Cao, Ming Zhong
750 [GO] 2023―Oct―06 Age- and sex-specific differences in immune responses to BNT162b2 COVID-19 and live-attenuated influenza vaccines in UK adolescents Cecilia Jay, Emily Adland, Anna Csala, Nicholas Lim, Stephanie Longet, Ane Ogbe, et al. (+9)
751 [GO] 2023―Oct―05 Role of NLRP3 inflammasome in diabetes and COVID-19 role of NLRP3 inflammasome in the pathogenesis and treatment of COVID-19 and diabetes NLRP3 inflammasome in diabetes and COVID-19 intervention Jiayu Zhang, Xuejing Ma, Fuwei Liu, Deju Zhang, Jitao Ling, Zicheng Zhu, et al. (+7)
752 [GO] 2023―Oct―05 Tuberculosis and COVID-19 in the elderly: factors driving a higher burden of disease Anna Allué-Guardia, Jordi B. Torrelles, Alex Sigal
753 [GO] 2023―Oct―05 Altered sphingolipid pathway in SARS-CoV-2 infected human lung tissue Rabisa J. Khan, Sierra L. Single, Christopher S. Simmons, Mohammad Athar, Yuelong Liu, Sandeep Bodduluri, et al. (+3)
754 [GO] 2023―Oct―05 Population-based study of the durability of humoral immunity after SARS-CoV-2 infection David Peterhoff, Simon Wiegrebe, Sebastian Einhauser, Arisha J. Patt, Stephanie Beileke, Felix Günther, et al. (+8)
755 [GO] 2023―Oct―05 Biomarkers of sustained systemic inflammation and microvascular dysfunction associated with post-COVID-19 condition symptoms at 24 months after SARS-CoV-2-infection Lotte M. C. Jacobs, Marieke S. J. N. Wintjens, Magdolna Nagy, Loes Willems, Hugo ten Cate, Henri M. H. Spronk, et al. (+6)
756 [GO] 2023―Oct―04 Boosting with an aerosolized Ad5-nCoV elicited robust immune responses in inactivated COVID-19 vaccines recipients Zhe Zhang, Shipo Wu, Yawei Liu, Kailiang Li, Pengfei Fan, Xiaohong Song, et al. (+25)
757 [GO] 2023―Oct―03 Current knowledge of thrombocytopenia in sepsis and COVID-19 Junjie Cheng, Hanhai Zeng, Huaijun Chen, Linfeng Fan, Chaoran Xu, Huaping Huang, et al. (+2)
758 [GO] 2023―Oct―02 A phosphodiesterase-4 inhibitor reduces lung inflammation and fibrosis in a hamster model of SARS-CoV-2 infection Afsal Kolloli, Santhamani Ramasamy, Ranjeet Kumar, Annuurun Nisa, Gilla Kaplan, Selvakumar Subbian
759 [GO] 2023―Oct―02 Genome sequencing of SARS-CoV-2 omicron variants in Delhi reveals alterations in immunogenic regions in spike glycoprotein Sristy Shikha, Mukesh Kumar Jogi, Ruchika Jha, Rana Amit Kumar, Tathagat Sah, Pushpendra Singh, et al. (+10)
760 [GO] 2023―Oct―02 SARS-COV-2 protein NSP9 promotes cytokine production by targeting TBK1 Yihua Zhang, Bowen Xin, Yinan Liu, Wenyi Jiang, Wendong Han, Jian Deng, et al. (+3)
761 [GO] 2023―Sep―29 Immune interaction between SARS-CoV-2 and Mycobacterium tuberculosis Petro Booysen, Katalin A. Wilkinson, Dylan Sheerin, Robyn Waters, Anna K. Coussens, Robert J. Wilkinson
762 [GO] 2023―Sep―28 SARS-CoV-2 Omicron variant infection affects blood platelets, a comparative analysis with Delta variant Cédric Garcia, Baptiste Compagnon, Agnès Ribes, Sophie Voisin, Fanny Vardon-Bounes, Bernard Payrastre
763 [GO] 2023―Sep―28 Pediatric population (aged 3-11 years) received primary inactivated SARS-CoV-2 vaccination prior to infection exhibiting robust humoral immune response following infected with Omicron variant: a study conducted in Beijing Jing Li, Jingjing Li, Shuzhi Dai, Li Dang, Lin Wang, Ling Cao, et al. (+7)
764 [GO] 2023―Sep―28 Neutrophil extracellular traps and long COVID Areez Shafqat, Mohamed H. Omer, Ibrahem Albalkhi, Ghazi Alabdul Razzak, Humzah Abdulkader, Saleha Abdul Rab, et al. (+3)
765 [GO] 2023―Sep―27 Persistence is key: unresolved immune dysfunction is lethal in both COVID-19 and non-COVID-19 sepsis Andy Y. An, Arjun Baghela, Peter Zhang, Reza Falsafi, Amy H. Lee, Uriel Trahtemberg, et al. (+3)
766 [GO] 2023―Sep―27 A hub gene signature as a therapeutic target and biomarker for sepsis and geriatric sepsis-induced ARDS concomitant with COVID-19 infection Guojun Qian, Hongwei Fang, Anning Chen, Zhun Sun, Meiying Huang, Mengyuan Luo, et al. (+4)
767 [GO] 2023―Sep―27 A novel bispecific antibody dual-targeting approach for enhanced neutralization against fast-evolving SARS-CoV-2 variants Ji Woong Kim, Hyun Jung Kim, Kyun Heo, Yoonwoo Lee, Hui Jeong Jang, Ho-Young Lee, et al. (+8)
768 [GO] 2023―Sep―26 Editorial: The immunological role of platelet activation in the pathophysiology of COVID-19 Theresa Marie Rossouw, Etheresia Pretorius, Geoffrey D. Wool
769 [GO] 2023―Sep―26 Differential expression patterns of purinergic ectoenzymes and the antioxidative role of IL-6 in hospitalized COVID-19 patient recovery Yanina Luciana Mazzocco, Gastón Bergero, Sebastian Del Rosso, Natalia Eberhardt, Claudia Sola, Héctor Alex Saka, et al. (+3)
770 [GO] 2023―Sep―22 Case Report: High-dose steroid and IVIG successful treatment in a case of COVID-19-associated autoimmune encephalitis: a literature review Chi-Hung Liu, Li-Chung Chiu, Chih-Chun Lee, Tien-Ming Chan
771 [GO] 2023―Sep―21 Corrigendum: Complement activation via the lectin and alternative pathway in patients with severe COVID-19 Janina Niederreiter, Christine Eck, Tajana Ries, Arndt Hartmann, Bruno Märkl, Maike Buettner-Herold, et al. (+2)
772 [GO] 2023―Sep―21 SARS-CoV-2 spike antigen-specific B cell and antibody responses in pre-vaccination period COVID-19 convalescent males and females with or without post-covid condition Marc-André Limoges, Akouavi Julite Irmine Quenum, Mohammad Mobarak Hussain Chowdhury, Fjolla Rexhepi, Mozhdeh Namvarpour, Sara Ali Akbari, et al. (+14)
773 [GO] 2023―Sep―21 COVID-19 patients display changes in lymphocyte subsets with a higher frequency of dysfunctional CD8lo T cells associated with disease severity Luisina Ines Onofrio, Constanza Marin, Jeremías Dutto, María Belén Brugo, Ruth Eliana Baigorri, Sabrina Noemi Bossio, et al. (+29)
774 [GO] 2023―Sep―21 Immunophenotyping characteristics and outcome of COVID-19 patients: peripheral blood CD8+T cell as a prognostic biomarker for patients with Nirmatrelvir Yuming Sun, Yating Dian, Qian Gao, Guangtong Deng
775 [GO] 2023―Sep―21 Immune monitoring of SARS-CoV-2-specific T cell and B cell responses in patients with multiple sclerosis treated with ocrelizumab Elina Groß-Albenhausen, Alicia Weier, Markus Velten, Thorsten Heider, Rittika Chunder, Stefanie Kuerten
776 [GO] 2023―Sep―19 Distinct SARS-CoV-2 specific NLRP3 and IL-1β responses in T cells of aging patients during acute COVID-19 infection Shanmuga Sundaram Mahalingam, Sangeetha Jayaraman, Adhvika Arunkumar, Holly M. Dudley, Donald D. Anthony, Carey L. Shive, et al. (+2)
777 [GO] 2023―Sep―19 What do we know about the function of SARS-CoV-2 proteins? Santiago Justo Arevalo, Adriana Castillo-Chávez, Carmen Sofia Uribe Calampa, Daniela Zapata Sifuentes, César J. Huallpa, Gianfranco Landa Bianchi, et al. (+3)
778 [GO] 2023―Sep―18 Expression of concern on: A SARS-CoV-2 spike receptor binding motif peptide induces anti-spike antibodies in mice andIs recognized by COVID-19 patients
779 [GO] 2023―Sep―14 Disseminated tuberculosis in a child during the COVID-19 pandemic: a case report and literature review Taoping Weng, Yaqiong Dong, Niwen Huang, Chenqu Zhao, Lei Zhang, Shan Cao, et al. (+3)
780 [GO] 2023―Sep―13 Changes of gut microbiota under different nutritional methods in elderly patients with severe COVID-19 and their relationship with prognosis Jiawei Zhang, Jiaxin Deng, Juan Li, Yuping Su, Jiancong Hu, Dezheng Lin, et al. (+8)
781 [GO] 2023―Sep―13 Comparative effectiveness of mRNA-1273 and BNT162b2 COVID-19 vaccines in immunocompromised individuals: a systematic review and meta-analysis using the GRADE framework Xuan Wang, Katrin Haeussler, Anne Spellman, Leslie E. Phillips, Allison Ramiller, Mary T. Bausch-Jurken, et al. (+4)
782 [GO] 2023―Sep―12 COVID-19 outcomes in patients with a history of immune-mediated glomerular diseases Philipp Gauckler, Jana S. Kesenheimer, Duvuru Geetha, Balazs Odler, Kathrin Eller, Timothee Laboux, et al. (+15)
783 [GO] 2023―Sep―11 Reduced maternal immunity and vertical transfer of immunity against SARS-CoV-2 variants of concern with COVID-19 exposure or initial vaccination in pregnancy Rupsa C. Boelig, Sidhartha Chaudhury, Gregory D. Gromowski, Sandra Mayer, Jocelyn King, Zubair H. Aghai, Elke Bergmann-Leitner
784 [GO] 2023―Sep―11 Rationale for combined therapies in severe-to-critical COVID-19 patients Aitor Gonzaga, Etelvina Andreu, Luis M. Hernández-Blasco, Rut Meseguer, Karima Al-Akioui-Sanz, Bárbara Soria-Juan, et al. (+30)
785 [GO] 2023―Sep―11 Unleashing the power of shark variable single domains (VNARs): broadly neutralizing tools for combating SARS-CoV-2 Olivia Cabanillas-Bernal, Blanca J. Valdovinos-Navarro, Karla E. Cervantes-Luevano, Noemi Sanchez-Campos, Alexei F. Licea-Navarro
786 [GO] 2023―Sep―11 Heterologous DNA-prime/protein-boost immunization with a monomeric SARS-CoV-2 spike antigen redundantizes the trimeric receptor-binding domain structure to induce neutralizing antibodies in old mice Dominik Pflumm, Alina Seidel, Fabrice Klein, Rüdiger Groß, Lea Krutzke, Stefan Kochanek, et al. (+4)
787 [GO] 2023―Sep―08 BCG mediated protection of the lung against experimental SARS-CoV-2 infection Kerry L. Hilligan, Sivaranjani Namasivayam, Alan Sher
788 [GO] 2023―Sep―06 Study of efficacy and antibody duration to fourth-dose booster of Ad5-nCoV or inactivated SARS-CoV-2 vaccine in Chinese adults: a prospective cohort study Nani Xu, Yu Xu, Rongrong Dai, Lin Zheng, Pan Qin, Peng Wan, et al. (+5)
789 [GO] 2023―Sep―05 Clinical severity classes in COVID-19 pneumonia have distinct immunological profiles, facilitating risk stratification by machine learning Laura Wiffen, Leon Gerard D’Cruz, Thomas Brown, Tim W. Higenbottam, Jonathan A. Bernstein, Courtney Campbell, et al. (+5)
790 [GO] 2023―Sep―05 Factors influencing immunogenicity and safety of SARS-CoV-2 vaccine in liver transplantation recipients: a systematic review and meta-analysis Xinyi Luo, Fabrice Yves Ndjana Lessomo, Zhimin Yu, Yong Xie
791 [GO] 2023―Sep―04 Predictive values of immune indicators on respiratory failure in the early phase of COVID-19 due to Delta and precedent variants K. Nagaoka, H. Kawasuji, Y. Takegoshi, Y. Murai, M. Kaneda, K. Kimoto, et al. (+5)
792 [GO] 2023―Sep―04 Relatively preserved functional immune capacity with standard COVID-19 vaccine regimen in people living with HIV Chen-Yiu Hung, Sung-Han Hsiao, Chung-Guei Huang, Chia-Shiang Chang, Guan-Yan Chen, Yu-Lin Huang, et al. (+2)
793 [GO] 2023―Sep―01 Association of serum vitamin D concentration with the final course of hospitalization in patients with COVID-19 Klaudia Konikowska, Katarzyna Kiliś-Pstrusińska, Agnieszka Matera-Witkiewicz, Krzysztof Kujawa, Barbara Adamik, Adrian Doroszko, et al. (+6)
794 [GO] 2023―Sep―01 Pentameric C-reactive protein is a better prognostic biomarker and remains elevated for longer than monomeric CRP in hospitalized patients with COVID-19 Francis R. Hopkins, Johan Nordgren, Rafael Fernandez-Botran, Helena Enocsson, Melissa Govender, Cecilia Svanberg, et al. (+7)
795 [GO] 2023―Sep―01 Causal effects of the gut microbiome on COVID-19 susceptibility and severity: a two-sample Mendelian randomization study Meng-Mei Zhong, Jia-Hao Xie, Yao Feng, Shao-Hui Zhang, Jiang-Nan Xia, Li Tan, et al. (+5)
796 [GO] 2023―Sep―01 Co-infection of mice with SARS-CoV-2 and Mycobacterium tuberculosis limits early viral replication but does not affect mycobacterial loads Paul J. Baker, Eduardo P. Amaral, Ehydel Castro, Andrea C. Bohrer, Flor Torres-Juárez, Cassandra M. Jordan, et al. (+5)
797 [GO] 2023―Sep―01 Natural infection versus hybrid (natural and vaccination) humoral immune response to SARS-CoV-2: a comparative paired analysis Laila AbdelWareth, Farida Alhousani, Rowan Abuyadek, James Donnelly, Andrea Leinberger-Jabari, Shereen Atef, Rami H. Al-Rifai
798 [GO] 2023―Aug―31 A nasal vaccine with inactivated whole-virion elicits protective mucosal immunity against SARS-CoV-2 in mice Nagisa Tokunoh, Shigeyuki Tamiya, Masato Watanabe, Toru Okamoto, Jessica Anindita, Hiroki Tanaka, et al. (+5)
799 [GO] 2023―Aug―30 The impact of the COVID-19 pandemic on the global tuberculosis epidemic Dennis Falzon, Matteo Zignol, Mathieu Bastard, Katherine Floyd, Tereza Kasaeva
800 [GO] 2023―Aug―30 Cellular immunity to SARS-CoV-2 following intrafamilial exposure in seronegative family members Cecilia Jay, Emily Adland, Anna Csala, Christina Dold, Matthew Edmans, Carl-Philipp Hackstein, et al. (+17)
801 [GO] 2023―Aug―29 Lipid alternations in the plasma of COVID-19 patients with various clinical presentations Xiao Liang, Xin Qi, Jin Yang, Xiaorui Wang, Hongyu Qin, Fang Hu, et al. (+4)
802 [GO] 2023―Aug―29 Immunocytometric analysis of patients with thymic epithelial tumors revealed that COVID-19 vaccine booster strongly enhanced the immune response Gustavo Cernera, Monica Gelzo, Pietro De Placido, Margaret Ottaviano, Erica Pietroluongo, Maddalena Raia, et al. (+6)
803 [GO] 2023―Aug―28 The risk of COVID-19 in IBD patients is increased by urban living and is not influenced by disease activity or intravenous biologics Margaux Lelong, Régis Josien, Marianne Coste-Burel, Marie Rimbert, Céline Bressollette-Bodin, Stéphane Nancey, et al. (+20)
804 [GO] 2023―Aug―28 SARS-CoV-2 neutralizing antibody bebtelovimab - a systematic scoping review and meta-analysis Mabel Nyit Yi Liew, Kok Pim Kua, Shaun Wen Huey Lee, Kon Ken Wong
805 [GO] 2023―Aug―28 Case Report: Four cases of SARS-CoV-2-associated Guillain-Barré Syndrome with SARS-CoV-2-positive cerebrospinal fluid detected by metagenomic next-generation sequencing: a retrospective case series from China Yalin Guan, Changshen Yu, Yunhan Fei, Qiushi Wang, Pan Wang, Wenchao Zuo, et al. (+3)
806 [GO] 2023―Aug―25 BNT162b2 COVID-19 vaccination in children alters cytokine responses to heterologous pathogens and Toll-like receptor agonists Andrés Noé, Thanh D. Dang, Christine Axelrad, Emma Burrell, Susie Germano, Sonja Elia, et al. (+4)
807 [GO] 2023―Aug―25 Impact of SARS-CoV-2 mRNA vaccine on arthritis condition in rheumatoid arthritis Ayuko Takatani, Naoki Iwamoto, Serina Koto, Toshiyuki Aramaki, Kaoru Terada, Yukitaka Ueki, et al. (+2)
808 [GO] 2023―Aug―25 Editorial: New therapeutic approaches for SARS-CoV-2/COVID-19 Alfonso J. Rodriguez-Morales, Alexandre Naime Barbosa, Sergio Cimerman
809 [GO] 2023―Aug―25 Vaccine-induced neutralizing antibody responses to seasonal influenza virus H1N1 strains are not enhanced during subsequent pandemic H1N1 infection Petra Mooij, Daniella Mortier, Aafke Aartse, Alexandre B. Murad, Ricardo Correia, António Roldão, et al. (+11)
810 [GO] 2023―Aug―25 The impact of immunocompromise on outcomes of COVID-19 in children and young people-a systematic review and meta-analysis James Greenan-Barrett, Samuel Aston, Claire T. Deakin, Coziana Ciurtin
811 [GO] 2023―Aug―18 The impact of immunoglobulin G N-glycosylation level on COVID-19 outcome: evidence from a Mendelian randomization study Feiwu Long, Chenghan Xiao, Huijie Cui, Wei Wang, Zongze Jiang, Mingshuang Tang, et al. (+16)
812 [GO] 2023―Aug―18 Initial immune response after exposure to Mycobacterium tuberculosis or to SARS-COV-2: similarities and differences Alessandra Aiello, Saeid Najafi-Fard, Delia Goletti
813 [GO] 2023―Aug―17 Administration of BNT162b2 mRNA COVID-19 vaccine to subjects with various allergic backgrounds Yaarit Ribak, Limor Rubin, Aviv Talmon, Zvi Dranitzki, Oded Shamriz, Isca Hershkowitz, et al. (+2)
814 [GO] 2023―Aug―17 Systematic Mendelian randomization study of the effect of gut microbiome and plasma metabolome on severe COVID-19 Han Yan, Si Zhao, Han-Xue Huang, Pan Xie, Xin-He Cai, Yun-Dan Qu, et al. (+4)
815 [GO] 2023―Aug―17 Temporal patterns of cytokine and injury biomarkers in hospitalized COVID-19 patients treated with methylprednisolone Victor Irungu Mwangi, Rebeca Linhares Abreu Netto, Carlos Eduardo Padron de Morais, Arineia Soares Silva, Bernardo Maia Silva, Amanda Barros Lima, et al. (+10)
816 [GO] 2023―Aug―17 Effect of seasonal coronavirus immune imprinting on the immunogenicity of inactivated COVID-19 vaccination Di Yin, Zirong Han, Bing Lang, Yanjun Li, Guoqin Mai, Hongbiao Chen, et al. (+8)
817 [GO] 2023―Aug―17 Upregulated CD8+ MAIT cell differentiation and KLRD1 gene expression after inactivated SARS-CoV-2 vaccination identified by single-cell sequencing Xiaowen Dou, Mian Peng, Ruiwei Jiang, Weiqin Li, Xiuming Zhang
818 [GO] 2023―Aug―17 Corrigendum: Cross-reactive humoral and CD4+ T cell responses to Mu and Gamma SARS-CoV-2 variants in a Colombian population Fabiola Martel, Juliana Cuervo-Rojas, Juana Ángel, Beatriz Ariza, John Mario González, Carolina Ramírez-Santana, et al. (+17)
819 [GO] 2023―Aug―17 The role of vaccination route with an adenovirus-vectored vaccine in protection, viral control, and transmission in the SARS-CoV-2/K18-hACE2 mouse infection model Alexandria Dickson, Elizabeth Geerling, E. Taylor Stone, Mariah Hassert, Tara L. Steffen, Taneesh Makkena, et al. (+8)
820 [GO] 2023―Aug―17 Five doses of the mRNA vaccination potentially suppress ancestral-strain stimulated SARS-CoV2-specific cellular immunity: a cohort study from the Fukushima vaccination community survey, Japan Yuta Tani, Morihito Takita, Masatoshi Wakui, Hiroaki Saito, Takamitsu Nishiuchi, Tianchen Zhao, et al. (+8)
821 [GO] 2023―Aug―16 Growth hormone-releasing hormone antagonist MIA-602 inhibits inflammation induced by SARS-CoV-2 spike protein and bacterial lipopolysaccharide synergism in macrophages and human peripheral blood mononuclear cells Giuseppina Granato, Iacopo Gesmundo, Francesca Pedrolli, Ramesh Kasarla, Laura Begani, Dana Banfi, et al. (+8)
822 [GO] 2023―Aug―14 Mechanisms of redox balance and inflammatory response after the use of methylprednisolone in children with multisystem inflammatory syndrome associated with COVID-19 Stasa Krasic, Vladislav Vukomanovic, Sanja Ninic, Srdjan Pasic, Gordana Samardzija, Nemanja Mitrovic, et al. (+3)
823 [GO] 2023―Aug―14 Pathophysiology and clinical management of coronavirus disease (COVID-19): a mini-review Ying Zhu, Lokesh Sharma, De Chang
824 [GO] 2023―Aug―14 Comparison of platelet-and endothelial-associated biomarkers of disease activity in people hospitalized with Covid-19 with and without HIV co-infection Mieke A. van der Mescht, Helen C. Steel, Zelda de Beer, Fareed Abdullah, Veronica Ueckermann, Ronald Anderson, Theresa M. Rossouw
825 [GO] 2023―Aug―11 Activation and pro-inflammatory cytokine production by unswitched memory B cells during SARS-CoV-2 infection Moriah J. Castleman, Adriana Luna Santos, Kelsey E. Lesteberg, James P. Maloney, William J. Janssen, Kara J. Mould, et al. (+3)
826 [GO] 2023―Aug―11 Animal models for COVID-19 and tuberculosis Björn Corleis, Max Bastian, Donata Hoffmann, Martin Beer, Anca Dorhoi
827 [GO] 2023―Aug―11 The Janus face of proliferating plasmablasts in dengue and COVID-19 infections Priya Nayak, Kavitha Mukund, Shankar Subramaniam
828 [GO] 2023―Aug―11 Impact of inactivated COVID-19 vaccination on female ovarian reserve: a propensity score-matched retrospective cohort study Jialyu Huang, Tianshu Guan, Lifeng Tian, Leizhen Xia, Dingfei Xu, Xingwu Wu, et al. (+9)
829 [GO] 2023―Aug―10 Deciphering the crosstalk of immune dysregulation between COVID-19 and idiopathic inflammatory myopathy Zhao Zhang, Weidong Tao, Debin Cheng, Marong Qin, Jun Fu, Dong Liu
830 [GO] 2023―Aug―10 Customizably designed multibodies neutralize SARS-CoV-2 in a variant-insensitive manner Cecilia Abreu, Claudia Ortega, Natalia Olivero-Deibe, Federico Carrión, Aracelly Gaete-Argel, Fernando Valiente-Echeverría, et al. (+4)
831 [GO] 2023―Aug―10 Direct endothelial ENaC activation mitigates vasculopathy induced by SARS-CoV2 spike protein Maritza J. Romero, Qian Yue, Bhupesh Singla, Jürg Hamacher, Supriya Sridhar, Auriel S. Moseley, et al. (+11)
832 [GO] 2023―Aug―09 Antibodies against angiotensin II receptor type 1 and endothelin A receptor are increased in COVID-19 patients Jelle R. Miedema, Matthijs L. Janssen, Jan von der Thüsen, Henrik Endeman, Anton W. Langerak, Merel E. Hellemons, et al. (+4)
833 [GO] 2023―Aug―09 Negative association between ascaris lumbricoides seropositivity and Covid-19 severity: insights from a study in Benin Tomabu Adjobimey, Julia Meyer, Anneka Hennenfent, Anick J. Bara, Latifou Lagnika, Bienvenu Kocou, et al. (+4)
834 [GO] 2023―Aug―08 Dexamethasone attenuates interferon-related cytokine hyperresponsiveness in COVID-19 patients Job J. Engel, Caspar I. van der Made, Nick Keur, Todia Setiabudiawan, Rutger J. Röring, Georgia Damoraki, et al. (+10)
835 [GO] 2023―Aug―04 An attenuated herpesvirus vectored vaccine candidate induces T-cell responses against highly conserved porcine reproductive and respiratory syndrome virus M and NSP5 proteins that are unable to control infection Rory C. F. de Brito, Kerry Holtham, Jessica Roser, Jack E. Saunders, Yvonne Wezel, Summer Henderson, et al. (+16)
836 [GO] 2023―Aug―04 Proinflammatory role of monocytes in SARS-CoV-2 infection in chronic hemodialysis patients Viorica Bumbea, Luminita Ardelean, Luminita Radulescu, Luminita Damian, Horia Bumbea, Ion Dumitru, et al. (+2)
837 [GO] 2023―Aug―03 Despite delayed kinetics, people living with HIV achieve equivalent antibody function after SARS-CoV-2 infection or vaccination Boitumelo M. Motsoeneng, Nelia P. Manamela, Haajira Kaldine, Prudence Kgagudi, Tandile Hermanus, Frances Ayres, et al. (+10)
838 [GO] 2023―Aug―02 Apoptotic cells for treatment of acute respiratory distress syndrome associated with COVID-19 Peter Vernon van Heerden, Avraham Abutbul, Ahmad Naama, Shlomo Maayan, Nassar Makram, Akiva Nachshon, et al. (+6)
839 [GO] 2023―Aug―01 T cell immune response predicts survival in severely ill COVID-19 patients requiring venovenous extracorporeal membrane oxygenation support Zsuzsanna Ulakcsai, Liliana Szabo, Zsofia Szabo, Eva Karaszi, Tamas Szabo, Levente Fazekas, et al. (+8)
840 [GO] 2023―Aug―01 Homologous versus Heterologous prime-boost COVID-19 Vaccination in autologous hematopoietic stem cell transplantation recipients: a blinded randomized controlled trial Leyla Sharifi Aliabadi, Manoochehr Karami, Maryam Barkhordar, Seyed Saeed Hashemi Nazari, Amir Kavousi, Mohammad Ahmadvand, Mohammad Vaezi
841 [GO] 2023―Aug―01 Safety and immunogenicity of rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine against SARS-CoV-2 in healthy adolescents: an open-label, non-randomized, multicenter, phase 1/2, dose-escalation study Amir I. Tukhvatulin, Inna V. Dolzhikova, Alina S. Dzharullaeva, Daria M. Grousova, Anna V. Kovyrshina, Olga V. Zubkova, et al. (+22)
842 [GO] 2023―Aug―01 Impact of mAb-induced A475V substitution on viral fitness and antibody neutralization of SARS-CoV-2 omicron variants in the presence of monoclonal antibodies and human convalescent sera Ratchanont Viriyakitkosol, Asawin Wanitchang, Kanjana Srisutthisamphan, Janya Saenboonreung, Chatikorn Boonkrai, Trairak Pisitkun, Anan Jongkaewwattana
843 [GO] 2023―Jul―31 Immune responses and disease biomarker long-term changes following COVID-19 mRNA vaccination in a cohort of rheumatic disease patients Zesheng An, Gabriel Figueroa-Parra, Xian Zhou, Yanfeng Li, Jane Jaquith, Kathleen McCarthy-Fruin, et al. (+10)
844 [GO] 2023―Jul―31 Antibody responses to an inactivated SARS-CoV-2 vaccine in individuals aged from 50 to 102 years Hong-Hong Zhu, Guo-Qing Sun, Ji-Yu Wu, Su-Qing Fan, Ying-Ying Zhu, Zhi-Cheng Wang, Xiao-Fang Liao
845 [GO] 2023―Jul―27 COVID-19 and the risk of neuromyelitis optica spectrum disorder: a Mendelian randomization study Dongren Sun, Qin Du, Rui Wang, Ziyan Shi, Hongxi Chen, Hongyu Zhou
846 [GO] 2023―Jul―27 Response to SARS-CoV-2 initial series and additional dose vaccine in pediatric patients with predominantly antibody deficiency Megha Tandon, Daniel V. DiGiacomo, Baijun Zhou, Paul Hesterberg, Chen E. Rosenberg, Sara Barmettler, Jocelyn R. Farmer
847 [GO] 2023―Jul―27 Immune response to SARS-CoV-2 mRNA vaccination in multiple sclerosis patients after rituximab treatment interruption Remigius Gröning, Andy Dernstedt, Clas Ahlm, Johan Normark, Peter Sundström, Mattias N. E. Forsell
848 [GO] 2023―Jul―27 Cross-reactive humoral and CD4+ T cell responses to Mu and Gamma SARS-CoV-2 variants in a Colombian population Fabiola Martel, Juliana Cuervo-Rojas, Juana Ángel, Beatriz Ariza, John Mario González, Carolina Ramírez-Santana, et al. (+17)
849 [GO] 2023―Jul―26 High expression of IL6 and decrease in immune cells in COVID-19 patients combined with myocardial injury Tingting Chen, Haixin Chen, Ping Chen, Linchao Zhu, Wei Mao, Yimin Yao
850 [GO] 2023―Jul―26 Multi-phasic gene profiling using candidate gene approach predict the capacity of specific antibody production and maintenance following COVID-19 vaccination in Japanese population Yuki Takemoto, Naoki Tanimine, Hisaaki Yoshinaka, Yuka Tanaka, Toshiro Takafuta, Aya Sugiyama, et al. (+2)
851 [GO] 2023―Jul―26 The impact of SARS-CoV-2 infection and vaccination on inflammatory arthritis: a cohort study Giovanni Striani, Ariela Hoxha, Mariagrazia Lorenzin, Giacomo Cozzi, Laura Scagnellato, Tatiana Vangelista, et al. (+5)
852 [GO] 2023―Jul―26 Transcriptomic profile of TNFhigh MAIT cells is linked to B cell response following SARS-CoV-2 vaccination Paolo Marzano, Simone Balin, Sara Terzoli, Silvia Della Bella, Valentina Cazzetta, Rocco Piazza, et al. (+15)
853 [GO] 2023―Jul―26 Cellular immune response of SARS-CoV-2 vaccination in kidney transplant recipients: a systematic review and meta-analysis Suwasin Udomkarnjananun, Sivaporn Gatechompol, Asada Leelahavanichkul, Stephen J. Kerr
854 [GO] 2023―Jul―25 Immunogenicity and reactogenicity of inactivated SARS-CoV-2 vaccines in healthy adults Yufei Wu, Ping Huang, Mingjie Xu, Qianqian Zhao, Yihui Xu, Shuyi Han, et al. (+2)
855 [GO] 2023―Jul―21 Evaluation of humoral immune response in relation to COVID-19 severity over 1 year post-infection: critical cases higher humoral immune response than mild cases Mi-Seon Bang, Choon-Mee Kim, Nam-Hyuk Cho, Jun-Won Seo, Da Young Kim, Na Ra Yun, Dong-Min Kim
856 [GO] 2023―Jul―21 Suppressive myeloid cells in SARS-CoV-2 and Mycobacterium tuberculosis co-infection Jane Alexandra Shaw, Stephanus T. Malherbe, Gerhard Walzl, Nelita du Plessis
857 [GO] 2023―Jul―21 NVX-CoV2373-induced T- and B-cellular immunity in immunosuppressed people with multiple sclerosis that failed to respond to mRNA and viral vector SARS-CoV-2 vaccines Magdalena Mueller-Enz, Christina Woopen, Georges Katoul Al Rahbani, Rocco Haase, Marie Dunsche, Tjalf Ziemssen, Katja Akgün
858 [GO] 2023―Jul―21 Retained avidity despite reduced cross-binding and cross-neutralizing antibody levels to Omicron after SARS-COV-2 wild-type infection or mRNA double vaccination Teresa Harthaller, Barbara Falkensammer, David Bante, Maria Huber, Melanie Schmitt, Habib Benainouna, et al. (+6)
859 [GO] 2023―Jul―20 SARS-CoV-2 accessory proteins involvement in inflammatory and profibrotic processes through IL11 signaling Blanca D. López-Ayllón, Ana de Lucas-Rius, Laura Mendoza-García, Tránsito García-García, Raúl Fernández-Rodríguez, José M. Suárez-Cárdenas, et al. (+8)
860 [GO] 2023―Jul―20 SARS-CoV-2 infection risk is higher in vaccinated patients with inflammatory autoimmune diseases or liver transplantation treated with mycophenolate due to an impaired antiviral immune response: results of the extended follow up of the RIVALSA prospective cohort Manuela Rizzi, Stelvio Tonello, Cristiana Brinno, Erika Zecca, Erica Matino, Micol Cittone, et al. (+15)
861 [GO] 2023―Jul―20 Divergent adaptive immune responses define two types of long COVID Jérôme Kervevan, Isabelle Staropoli, Dorsaf Slama, Raphaël Jeger-Madiot, Françoise Donnadieu, Delphine Planas, et al. (+8)
862 [GO] 2023―Jul―18 Identification of cuproptosis-related molecular subtypes and a novel predictive model of COVID-19 based on machine learning Hong Luo, Jisong Yan, Dingyu Zhang, Xia Zhou
863 [GO] 2023―Jul―17 The immune mechanism of the nasal epithelium in COVID-19-related olfactory dysfunction Shunmei Chen, Shufen Wang
864 [GO] 2023―Jul―15 Persistent and transient olfactory deficits in COVID-19 are associated to inflammation and zinc homeostasis Lorenzo Lupi, Anna Bordin, Gabriele Sales, Davide Colaianni, Adriana Vitiello, Alberto Biscontin, et al. (+8)
865 [GO] 2023―Jul―15 Longitudinal study of humoral immunity against SARS-CoV-2 of health professionals in Brazil: the impact of booster dose and reinfection on antibody dynamics Ana Paula Moreira Franco-Luiz, Nubia Monteiro Gonçalves Soares Fernandes, Thais Bárbara de Souza Silva, Wilma Patrícia de Oliveira Santos Bernardes, Mateus Rodrigues Westin, Thais Garcia Santos, et al. (+9)
866 [GO] 2023―Jul―15 Cytokine response and damages in the lungs of aging Syrian hamsters on a high-fat diet infected with the SARS-CoV-2 virus Gleb Fomin, Kairat Tabynov, Rinat Islamov, Nurkeldi Turebekov, Duman Yessimseit, Toktasyn Yerubaev
867 [GO] 2023―Jul―13 Erratum: Breakthrough infections with the omicron and delta variants of SARS-CoV-2 result in similar re-activation of vaccine-induced immunity
868 [GO] 2023―Jul―13 Immune responses in COVID-19 patients during breakthrough infection with SARS-CoV-2 variants Delta, Omicron-BA.1 and Omicron-BA.5 Maren Bormann, Leonie Brochhagen, Mira Alt, Mona Otte, Laura Thümmler, Lukas van de Sand, et al. (+14)
869 [GO] 2023―Jul―13 Early protective effect of a (“pan”) coronavirus vaccine (PanCoVac) in Roborovski dwarf hamsters after single-low dose intranasal administration Mohammed O. Abdelaziz, Martin J. Raftery, Julian Weihs, Olivia Bielawski, Richard Edel, Julia Köppke, et al. (+12)
870 [GO] 2023―Jul―13 Intravesical BCG in bladder cancer induces innate immune responses against SARS-CoV-2 Renate Pichler, Gabriel Diem, Hubert Hackl, Jiří Koutník, Laura S. Mertens, David D`Andrea, et al. (+10)
871 [GO] 2023―Jul―12 Case Report: Resolution of Lichen Planus Pemphigoides as an unexpected outcome of SARS-CoV-2 infection Valentina Ruffo di Calabria, Alice Verdelli, Lavinia Quintarelli, Alberto Corrà, Elena Biancamaria Mariotti, Cristina Aimo, et al. (+5)
872 [GO] 2023―Jul―10 Are the integrin binding motifs within SARS CoV-2 spike protein and MHC class II alleles playing the key role in COVID-19? Marijan Gerencer, Liam J. McGuffin
873 [GO] 2023―Jul―10 Editorial: Immune response to SARS-CoV-2 and implications for clinical outcome Edwin Bölke, Martijn van Griensven, E. Marion Schneider, Johannes C. Fischer, Torsten Feldt, Verena Keitel, et al. (+4)
874 [GO] 2023―Jul―07 Genetic support of the causal association between gut microbiome and COVID-19: a bidirectional Mendelian randomization study Zengbin Li, Guixian Zhu, Xiangye Lei, Liqiong Tang, Guangyao Kong, Mingwang Shen, et al. (+2)
875 [GO] 2023―Jul―07 NK cells from COVID-19 positive patients exhibit enhanced cytotoxic activity upon NKG2A and KIR2DL1 blockade Grace Lee, Robert Schauner, Juanita Burke, Jade Borocz, Smitha Vasana, Lukasz Sobieraj, et al. (+6)
876 [GO] 2023―Jul―07 Robust spike-specific CD4+ and CD8+ T cell responses in SARS-CoV-2 vaccinated hematopoietic cell transplantation recipients: a prospective, cohort study Lorenzo Federico, Tor Henrik Anderson Tvedt, Murat Gainullin, Julie Røkke Osen, Viktoriia Chaban, Katrine Persgård Lund, et al. (+13)
877 [GO] 2023―Jul―06 Effect of antiviral and immunomodulatory treatment on a cytokine profile in patients with COVID-19 Diana Martonik, Anna Parfieniuk-Kowerda, Aleksandra Starosz, Kamil Grubczak, Marcin Moniuszko, Robert Flisiak
878 [GO] 2023―Jul―06 Advances in attractive therapeutic approach for macrophage activation syndrome in COVID-19 Shunyao Chen, Cong Zhang, Deng Chen, Liming Dong, Teding Chang, Zhao-Hui Tang
879 [GO] 2023―Jul―06 Comparison of vaccination and booster rates and their impact on excess mortality during the COVID-19 pandemic in European countries Olga Matveeva, Svetlana A. Shabalina
880 [GO] 2023―Jul―05 T cell receptor β repertoires in patients with COVID-19 reveal disease severity signatures Jing Xu, Xiao-xiao Li, Na Yuan, Chao Li, Jin-gang Yang, Li-ming Cheng, et al. (+13)
881 [GO] 2023―Jul―05 Potential value of neuroimmunotherapy for COVID-19: efficacies and mechanisms of vagus nerve stimulation, electroacupuncture, and cholinergic drugs Xianqiang Yu, Qingming Kong
882 [GO] 2023―Jul―05 A unique maternal and placental galectin signature upon SARS-CoV-2 infection suggests galectin-1 as a key alarmin at the maternal-fetal interface Fangqi Zhao, Ann-Christin Tallarek, Yiru Wang, Yiran Xie, Anke Diemert, Alice Lu-Culligan, et al. (+9)
883 [GO] 2023―Jul―04 The Italian data on SARS-CoV-2 infection in transplanted patients support an organ specific immune response in liver recipients Maria Rendina, Michele Barone, Chiara Lillo, Silvia Trapani, Lucia Masiero, Paolo Trerotoli, et al. (+54)
884 [GO] 2023―Jul―03 Impact of vaccine platform and BCG vaccination on antibody responses to COVID-19 vaccination Nicole L. Messina, Mariana G. Sperotto, Marco A. M. Puga, Patricia V. da Silva, Roberto D. de Oliveira, Cecilia L. Moore, et al. (+8)
885 [GO] 2023―Jul―03 Immunologic and vascular biomarkers of mortality in critical COVID-19 in a South African cohort Jane Alexandra Shaw, Maynard Meiring, Candice Snyders, Frans Everson, Lovemore Nyasha Sigwadhi, Veranyay Ngah, et al. (+17)
886 [GO] 2023―Jul―03 COVID-19 vaccine induced poor neutralization titers for SARS-CoV-2 omicron variants in maternal and cord blood Sakthivel Govindaraj, Narayanaiah Cheedarla, Suneethamma Cheedarla, LesShon S. Irby, Andrew S. Neish, John D. Roback, et al. (+2)
887 [GO] 2023―Jul―03 Case Report: Kinetics and durability of humoral and cellular response of SARS-CoV-2 messenger RNA vaccine in a lung and kidney transplant recipient James Long, Mithil Soni, Pawel Muranski, Maureen J. Miller, Cathleen Conry-Cantilena, Valeria De Giorgi
888 [GO] 2023―Jun―30 SARS-CoV-2 infection dysregulates NAD metabolism Amin Izadpanah, Joseph C. Mudd, Joe G. N. Garcia, Sudesh Srivastav, Mohamed Abdel-Mohsen, Clovis Palmer, et al. (+4)
889 [GO] 2023―Jun―30 Breakthrough infection evokes the nasopharyngeal innate immune responses established by SARS-CoV-2-inactivated vaccine Xiaomeng He, Yingyin Cao, Yanmei Lu, Furong Qi, Haiyan Wang, Xuejiao Liao, et al. (+6)
890 [GO] 2023―Jun―29 mRNA-based SARS-CoV-2 Comirnaty vaccine elicits weak and short specific memory B cell response in individuals with no previous infection José L. Casado, Pilar Vizcarra, Adrián Martín-Hondarza, Sandra Gómez-Maldonado, Magdalena Muedra-Sánchez, Judith del Pino, et al. (+5)
891 [GO] 2023―Jun―28 Durability and extent of protection of SARS-CoV-2 antibodies among patients with COVID-19 in Metro Manila, Philippines Ma. Liza Antoinette M. Gonzales, Leonila F. Dans, Carol Stephanie C. Tan-Lim, Elenore Uy, Eva Cutiongco-dela Paz, Maria Vanessa V. Sulit, et al. (+6)
892 [GO] 2023―Jun―28 Humoral and cellular responses to repeated COVID-19 exposure in multiple sclerosis patients receiving B-cell depleting therapies: a single-center, one-year, prospective study Roberto Alfonso-Dunn, Jerry Lin, Joyce Lei, Jiayuan Liu, Morgan Roche, Antonia De Oliveira, et al. (+6)
893 [GO] 2023―Jun―27 Circulating Reelin promotes inflammation and modulates disease activity in acute and long COVID-19 cases Laurent Calvier, Aleksandra Drelich, Jason Hsu, Chien-Te Tseng, Yair Mina, Avindra Nath, et al. (+2)
894 [GO] 2023―Jun―24 Deficiency in the production of antibodies to lipids correlates with increased lipid metabolism in severe COVID-19 patients Ignacio Piédrola, Sara Martínez, Ana Gradillas, Alma Villaseñor, Vanesa Alonso-Herranz, Isabel Sánchez-Vera, et al. (+7)
895 [GO] 2023―Jun―24 Identifying hub genes and common biological pathways between COVID-19 and benign prostatic hyperplasia by machine learning algorithms Hang Zhou, Mingming Xu, Ping Hu, Yuezheng Li, Congzhe Ren, Muwei Li, et al. (+3)
896 [GO] 2023―Jun―24 Exploring the potential common denominator pathogenesis of system lupus erythematosus with COVID-19 based on comprehensive bioinformatics analysis Huiqiong Zeng, Yu Zhuang, Xiaojuan Li, Zhihua Yin, Xia Huang, Haiyan Peng
897 [GO] 2023―Jun―21 Systematic review and meta-analysis of cell therapy for COVID-19: global clinical trial landscape, published safety/efficacy outcomes, cell product manufacturing and clinical delivery Pedro S. Couto, Nada Al-Arawe, Igor S. Filgueiras, Dennyson L. M. Fonseca, Irene Hinterseher, Rusan A. Catar, et al. (+5)
898 [GO] 2023―Jun―21 Systemic inflammation index, disease severity, and mortality in patients with COVID-19: a systematic review and meta-analysis Arduino A. Mangoni, Angelo Zinellu
899 [GO] 2023―Jun―21 The genetic associations of COVID-19 on genitourinary symptoms Zhenglin Chang, Lingyue An, Min Lei, Zhenfeng Song, Jian Deng, Ruizheng Tang, et al. (+3)
900 [GO] 2023―Jun―20 Corrigendum: Bioinformatics and system biology approach to identify the influences among COVID-19, ARDS and sepsis Peiyu Li, Tao Li, Zhiming Zhang, Xingui Dai, Bin Zeng, Zhen Li, Zhiwang Li
901 [GO] 2023―Jun―20 OVX033, a nucleocapsid-based vaccine candidate, provides broad-spectrum protection against SARS-CoV-2 variants in a hamster challenge model Charlotte Primard, Elodie Monchâtre-Leroy, Judith Del Campo, Séverine Valsesia, Elsa Nikly, Marion Chevandier, et al. (+10)
902 [GO] 2023―Jun―19 Safety and efficacy of dendritic cell vaccine for COVID-19 prevention after 1-Year follow-up: phase I and II clinical trial final result Jonny Jonny, Terawan Agus Putranto, Martina Lily Yana, Enda Cindylosa Sitepu, Raoulian Irfon, Bunga Pinandhita Ramadhani, et al. (+6)
903 [GO] 2023―Jun―19 A tale of two conditions: when people living with HIV meet three doses of inactivated COVID-19 vaccines Yuting Tan, Shi Zou, Fangzhao Ming, Songjie Wu, Wei Guo, Mengmeng Wu, et al. (+2)
904 [GO] 2023―Jun―19 SARS-CoV-2 and the host-immune response David P. Maison, Youping Deng, Mariana Gerschenson
905 [GO] 2023―Jun―19 Immunogenicity and efficacy of a novel multi-patch SARS-CoV-2/COVID-19 vaccine candidate Beatriz Perdiguero, Laura Marcos-Villar, María López-Bravo, Pedro J. Sánchez-Cordón, Carmen Zamora, José Ramón Valverde, et al. (+7)
906 [GO] 2023―Jun―16 A shared genetic contribution to osteoarthritis and COVID-19 outcomes: a large-scale genome-wide cross-trait analysis Yi-Xuan Huang, Tian Tian, Ji-Xiang Huang, Jing Wang, Cong Sui, Jing Ni
907 [GO] 2023―Jun―16 Immunity following SARS-CoV-2 vaccination in autoimmune neurological disorders treated with rituximab or ocrelizumab Petra Nytrova, Dominika Stastna, Adam Tesar, Ingrid Menkyova, Helena Posova, Helena Koprivova, et al. (+7)
908 [GO] 2023―Jun―16 A likely association between low mannan-binding lectin level and brain fog onset in long COVID patients Roberta Bulla, Lucrezia Rossi, Giovanni Furlanis, Chiara Agostinis, Miriam Toffoli, Andrea Balduit, et al. (+5)
909 [GO] 2023―Jun―15 Vascular and Non-HLA autoantibody profiles in hospitalized patients with COVID-19 Brian Lichtenstein, Ying Zheng, David Gjertson, Kathie G. Ferbas, Anne W. Rimoin, Otto O. Yang, et al. (+4)
910 [GO] 2023―Jun―15 SARS-CoV-2 Infection-and mRNA Vaccine-induced Humoral Immunity among Schoolchildren in Hawassa, Ethiopia Yared Merid, Wondwosen Tekleselasie, Emnet Tesfaye, Anteneh Gadisa, Dessalegn Fentahun, Alegntaw Abate, et al. (+4)
911 [GO] 2023―Jun―15 Durability of immune response after SARS-CoV-2 vaccination in patients with chronic liver disease Ruixin Song, Chao Yang, Qianqian Li, Jiayin Wang, Jing Chen, Kai Sun, et al. (+15)
912 [GO] 2023―Jun―14 Comparison of C-reactive protein with distinct hyperinflammatory biomarkers in association with COVID-19 severity, mortality and SARS-CoV-2 variants Tudorita Gabriela Paranga, Mariana Pavel-Tanasa, Daniela Constantinescu, Claudia Elena Plesca, Cristina Petrovici, Ionela-Larisa Miftode, et al. (+3)
913 [GO] 2023―Jun―14 Predictors of high SARS-CoV-2 immunoglobulin G titers in COVID-19 convalescent whole-blood donors: a cross-sectional study in China Jingyun Tang, Humin Liu, Qing Wang, Xiaobo Gu, Jia Wang, Wenjun Li, et al. (+8)
914 [GO] 2023―Jun―14 T-cell immunity to SARS-CoV-2: what if the known best is not the optimal course for the long run? Adapting to evolving targets Alexandre E. Nowill, Manuel Caruso, Pedro O. de Campos-Lima
915 [GO] 2023―Jun―14 Enhanced antiviral immunity and dampened inflammation in llama lymph nodes upon MERS-CoV sensing: bridging innate and adaptive cellular immune responses in camelid reservoirs Jordi Rodon, Nigeer Te, Joaquim Segalés, Júlia Vergara-Alert, Albert Bensaid
916 [GO] 2023―Jun―13 Case report: Anti-IgLON5 disease and anti-LGI1 encephalitis following COVID-19 Yanfei Li, Yanjie Jia
917 [GO] 2023―Jun―13 A novel ACE2 decoy for both neutralization of SARS-CoV-2 variants and killing of infected cells Alexandra Kegler, Laura Drewitz, Claudia Arndt, Cansu Daglar, Liliana Rodrigues Loureiro, Nicola Mitwasi, et al. (+21)
918 [GO] 2023―Jun―12 Immune response of heterologous versus homologous prime-boost regimens with adenoviral vectored and mRNA COVID-19 vaccines in immunocompromised patients Chang Chu, Anne Schönbrunn, Dorothea Fischer, Yvonne Liu, Johann-Georg Hocher, Jutta Weinerth, et al. (+5)
919 [GO] 2023―Jun―12 Hypoxia-altered cholesterol homeostasis enhances the expression of interferon-stimulated genes upon SARS-CoV-2 infections in monocytes Rebekka Bauer, Sofie Patrizia Meyer, Rebecca Raue, Megan A. Palmer, Vanesa Maria Guerrero Ruiz, Giulia Cardamone, et al. (+10)
920 [GO] 2023―Jun―12 Corrigendum: SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines Shanti Pather, Shabir A. Madhi, Benjamin J. Cowling, Paul Moss, Jeremy P. Kamil, Sandra Ciesek, et al. (+2)
921 [GO] 2023―Jun―09 Preclinical immunogenicity and protective efficacy of a SARS-CoV-2 RBD-based vaccine produced with the thermophilic filamentous fungal expression system Thermothelomyces heterothallica C1 Mariana Gonzalez-Hernandez, Franziska Karola Kaiser, Imke Steffen, Malgorzata Ciurkiewicz, Geert van Amerongen, Ronen Tchelet, et al. (+9)
922 [GO] 2023―Jun―08 The multifaceted nature of IL-10: regulation, role in immunological homeostasis and its relevance to cancer, COVID-19 and post-COVID conditions Valentina Carlini, Douglas M. Noonan, Eslam Abdalalem, Delia Goletti, Clementina Sansone, Luana Calabrone, Adriana Albini
923 [GO] 2023―Jun―08 Case Report: Intercurrent infections in COVID-19-induced sustained immunodepression: is interferon gamma a suitable drug? Aurianne De Waard, Laurent Lefebvre, Julien Textoris, Didier Payen
924 [GO] 2023―Jun―08 Glyco engineered pentameric SARS-CoV-2 IgMs show superior activities compared to IgG1 orthologues Somanath Kallolimath, Roman Palt, Esther Föderl-Höbenreich, Lin Sun, Qiang Chen, Florian Pruckner, et al. (+4)
925 [GO] 2023―Jun―07 Central role of lung macrophages in SARS-CoV-2 physiopathology: a cross-model single-cell RNA-seq perspective Thibaut Olivier, Joël Blomet, Daniel Desmecht
926 [GO] 2023―Jun―05 Fucosylated N-glycans as early biomarkers of COVID-19 severity Beatrix Paton, Pol Herrero, Joaquim Peraire, Antoni del Pino, Silvia Chafino, Javier Martinez-Picado, et al. (+4)
927 [GO] 2023―Jun―05 Analyzing the effect of the COVID-19 vaccine on Parkinson’s disease symptoms Revati Sabat, Orrin L. Dayton, Amit Agarwal, Vinata Vedam-Mai
928 [GO] 2023―Jun―05 A review of the main genetic factors influencing the course of COVID-19 in Sardinia: the role of human leukocyte antigen-G Stefano Mocci, Roberto Littera, Luchino Chessa, Marcello Campagna, Maurizio Melis, Carla Maria Ottelio, et al. (+18)
929 [GO] 2023―Jun―05 Variable neutralizing antibody responses to 10 SARS-CoV-2 variants in natural infection with wild- type (B.1) virus, Kappa (B.1.617.1), and Delta (B.1.617.2) variants and COVISHIELD vaccine immunization in India: utility of the MSD platform Rajashree Patil, Sonali Palkar, Akhileshchandra Mishra, Rahul Patil, Vidya Arankalle
930 [GO] 2023―Jun―02 The presence of senescent peripheral T-cells is negatively correlated to COVID-19 vaccine-induced immunity in cancer patients under 70 years of age E. Orillard, L. Spehner, L. Mansi, A. Bouard, A. Falcoz, Q. Lepiller, et al. (+5)
931 [GO] 2023―Jun―02 Mucosal immunization with lipopeptides derived from conserved regions of SARS-CoV-2 antigens induce robust cellular and cross-variant humoral immune responses in mice Raj S. Patel, Babita Agrawal
932 [GO] 2023―Jun―01 Corrigendum: Definition of the immune parameters related to COVID-19 severity Sarah Birindelli, Maciej S. Tarkowski, Marcello Gallucci, Marco Schiuma, Alice Covizzi, Przemysław Lewkowicz, et al. (+6)
933 [GO] 2023―Jun―01 Editorial: Community series in immunometabolic mechanisms underlying the severity of COVID-19, volume II Julia Kzhyshkowska, Vishwanath Venketaraman, Galileo Escobedo
934 [GO] 2023―Jun―01 Editorial: Mucosal immunity to HIV and SARS-CoV-2 infection and vaccination Morgane Bomsel, Lucia Lopalco
935 [GO] 2023―May―31 Effect of an inactivated coronavirus disease 2019 vaccine, CoronaVac, on blood coagulation and glucose: a randomized, controlled, open-label phase IV clinical trial Qing Xu, Xi Lu, Xiaodong Liu, Yanwei Zhao, Dapeng Sun, Qingfan Cao, et al. (+10)
936 [GO] 2023―May―29 Machine learning analysis of humoral and cellular responses to SARS-CoV-2 infection in young adults Ricards Marcinkevics, Pamuditha N. Silva, Anna-Katharina Hankele, Charlyn Dörnte, Sarah Kadelka, Katharina Csik, et al. (+43)
937 [GO] 2023―May―29 Neuro-PASC is characterized by enhanced CD4+ and diminished CD8+ T cell responses to SARS-CoV-2 Nucleocapsid protein Lavanya Visvabharathy, Barbara A. Hanson, Zachary S. Orban, Patrick H. Lim, Nicole M. Palacio, Millenia Jimenez, et al. (+6)
938 [GO] 2023―May―26 Tocilizumab versus anakinra in COVID-19: results from propensity score matching Robin Arcani, Florian Correard, Pierre Suchon, Gilles Kaplanski, Rodolphe Jean, Raphael Cauchois, et al. (+15)
939 [GO] 2023―May―25 Controlled human infection models in COVID-19 and tuberculosis: current progress and future challenges Hazel Morrison, Susan Jackson, Helen McShane
940 [GO] 2023―May―25 Reducedhumoral response against variants of concern in childhood solid cancer patients compared to adult patients and healthy children after SARS-CoV-2 vaccination Yifei Ma, Bocen Chen, Yanqi Wang, Pengfei Zhu, Nianqi Liu, Zhiying Zhang, et al. (+11)
941 [GO] 2023―May―25 Defining the pediatric response to SARS-CoV-2 variants Reanne M. Ho, Asha C. Bowen, Christopher C. Blyth, Allison Imrie, Tobias R. Kollmann, Stephen M. Stick, Anthony Kicic
942 [GO] 2023―May―24 Impact of aging on immunity in the context of COVID-19, HIV, and tuberculosis Alba Grifoni, Tonino Alonzi, Galit Alter, Douglas McClain Noonan, Alan L. Landay, Adriana Albini, Delia Goletti
943 [GO] 2023―May―24 SARS-CoV-2 bivalent mRNA vaccine with broad protection against variants of concern Qinhai Ma, Man Li, Lin Ma, Caroline Zhang, Hong Zhang, Huiling Zhong, et al. (+9)
944 [GO] 2023―May―24 Corrigendum: The impact of circadian rhythm on Bacillus Calmette-Guérin vaccination effects on SARS-CoV-2 infections Konstantin Föhse, Esther J. M. Taks, Simone J. C. F. M. Moorlag, Marc J. M. Bonten, Reinout van Crevel, Jaap ten Oever, et al. (+4)
945 [GO] 2023―May―23 Two issues should be noted when designing a clinical trial to evaluate BCG effects on COVID-19 Wenping Gong, Yinping Liu, Yong Xue, Li Zhuang
946 [GO] 2023―May―23 SARS-CoV-2 infection impairs NK cell functions via activation of the LLT1-CD161 axis Marzena Lenart, Magdalena Górecka, Michal Bochenek, Emilia Barreto-Duran, Artur Szczepański, Adrianna Gałuszka-Bulaga, et al. (+8)
947 [GO] 2023―May―23 SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines Shanti Pather, Shabir A. Madhi, Benjamin J. Cowling, Paul Moss, Jeremy P. Kamil, Sandra Ciesek, et al. (+2)
948 [GO] 2023―May―23 Simultaneous co-infection with swine influenza A and porcine reproductive and respiratory syndrome viruses potentiates adaptive immune responses Tiphany Chrun, Emmanuel A. Maze, Kelly J. Roper, Eleni Vatzia, Basudev Paudyal, Adam McNee, et al. (+15)
949 [GO] 2023―May―23 The analysis of cathepsin L that mediates cellular SARS-CoV-2 infection leading to COVID-19 in head and neck squamous cell carcinoma Feng Gao, Xia Wang, Nianhong Qin, Mingxia Zhang, Mingfeng Liao, Meiqi Zeng, et al. (+2)
950 [GO] 2023―May―22 Serum IL-23, IL-10, and TNF-α predict in-hospital mortality in COVID-19 patients Shukur Wasman Smail, Esmaeil Babaei, Kawa Amin, Wayel H. Abdulahad
951 [GO] 2023―May―22 Basement membrane product, endostatin, as a link between inflammation, coagulation and vascular permeability in COVID-19 and non-COVID-19 acute respiratory distress syndrome Katharina Jandl, Johannes Lorenz Berg, Anna Birnhuber, Elisabeth Fliesser, Izabela Borek, Benjamin Seeliger, et al. (+9)
952 [GO] 2023―May―22 Machine learning and integrative analysis identify the common pathogenesis of azoospermia complicated with COVID-19 Jiarong He, Yuanqiao Zhao, Zhixian Zhou, Mingming Zhang
953 [GO] 2023―May―22 Identification of 3 key genes as novel diagnostic and therapeutic targets for OA and COVID-19 Yiwei Zhang, Zhengwei Duan, Yonghao Guan, Tianyang Xu, Yuesong Fu, Guodong Li
954 [GO] 2023―May―22 Swine acute diarrhoea syndrome coronavirus (SADS-CoV) Nsp5 antagonizes type I interferon signaling by cleaving DCP1A Hai-xin Huang, Chen-chen Zhao, Xiao-xiao Lei, Xin-yu Zhang, Yu-ying Li, Tian Lan, et al. (+5)
955 [GO] 2023―May―19 Platelet-neutrophil interaction in COVID-19 and vaccine-induced thrombotic thrombocytopenia Johannes Hirsch, Günalp Uzun, Jan Zlamal, Anurag Singh, Tamam Bakchoul
956 [GO] 2023―May―19 Enhancing immune protection against MERS-CoV: the synergistic effect of proteolytic cleavage sites and the fusion peptide and RBD domain targeting VLP immunization Jeein Oh, Uni Park, Juhyung Kim, Kyeongseok Jeon, Chulwoo Kim, Nam-Hyuk Cho, Youn Soo Choi
957 [GO] 2023―May―18 New progresses on cell surface protein HSPA5/BiP/GRP78 in cancers and COVID-19 Ting Li, Jiewen Fu, Jingliang Cheng, Abdo A. Elfiky, Chunli Wei, Junjiang Fu
958 [GO] 2023―May―18 No genetic causal association between systemic lupus erythematosus and COVID-19 Shu-Zhen Xu, Zhi-Xin Wang, Xi Fang, Cong Chen, Xiao-Ke Yang, Zong-Wen Shuai, Sha-Sha Tao
959 [GO] 2023―May―18 Impact of peptide:HLA complex stability for the identification of SARS-CoV-2-specific CD8+T cells Olivia Lie-Andersen, Mie Linder Hübbe, Krishanthi Subramaniam, Daniel Steen-Jensen, Ann Christina Bergmann, Daniel Justesen, et al. (+5)
960 [GO] 2023―May―17 Antibody response and safety of inactivated SARS-CoV-2 vaccines in chronic hepatitis B patients with and without cirrhosis Huanhuan Cao, Yufei Huang, Chunxiu Zhong, Xingmei Liao, Wenjuan Tan, Siru Zhao, et al. (+2)
961 [GO] 2023―May―17 Analysis and comparison of SARS-CoV-2 variant antibodies and neutralizing activity for 6 months after a booster mRNA vaccine in a healthcare worker population Sina Hosseinian, Rafael de Assis, Ghali Khalil, Madeleine K. Luu, Aarti Jain, Peter Horvath, et al. (+13)
962 [GO] 2023―May―16 Bioinformatics and system biology approach to identify the influences among COVID-19, ARDS and sepsis Peiyu Li, Tao Li, Zhiming Zhang, Xingui Dai, Bin Zeng, Zhen Li, Zhiwang Li
963 [GO] 2023―May―16 Dysregulated early transcriptional signatures linked to mast cell and interferon responses are implicated in COVID-19 severity Rachel MacCann, Alejandro Abner Garcia Leon, Gabriel Gonzalez, Michael J. Carr, Eoin R. Feeney, Obada Yousif, et al. (+5)
964 [GO] 2023―May―15 Monoclonal antibodies for prophylaxis and therapy of respiratory syncytial virus, SARS-CoV-2, human immunodeficiency virus, rabies and bacterial infections: an update from the World Association of Infectious Diseases and Immunological Disorders and the Italian Society of Antinfective Therapy Susanna Esposito, Gayatri Amirthalingam, Matteo Bassetti, Francesco Blasi, Francesco Giuseppe De Rosa, Natasha B. Halasa, et al. (+6)
965 [GO] 2023―May―12 Proteomic profiling of single extracellular vesicles reveals colocalization of SARS-CoV-2 with a CD81/integrin-rich EV subpopulation in sputum from COVID-19 severe patients Ruiting Sun, Yanling Cai, Yumin Zhou, Ge Bai, Airu Zhu, Panyue Kong, et al. (+11)
966 [GO] 2023―May―12 Inflammasomes: a rising star on the horizon of COVID-19 pathophysiology Man Wang, Fei Yu, Wenguang Chang, Yuan Zhang, Lei Zhang, Peifeng Li
967 [GO] 2023―May―12 Increase in gut permeability and oxidized ldl is associated with post-acute sequelae of SARS-CoV-2 Christian Mouchati, Jared C. Durieux, Sokratis N. Zisis, Danielle Labbato, Michael A. Rodgers, Kate Ailstock, et al. (+3)
968 [GO] 2023―May―12 A novel precision-serology assay for SARS-CoV-2 infection based on linear B-cell epitopes of Spike protein Samuel B. Lundin, Hanna Kann, Alma Fulurija, Björn Andersson, Sravya S. Nakka, Lars-Magnus Andersson, et al. (+2)
969 [GO] 2023―May―12 Heterologous vaccination with inactivated vaccine and mRNA vaccine augments antibodies against both spike and nucleocapsid proteins of SARS-CoV-2: a local study in Macao Hoi Man Ng, Chon Lok Lei, Siyi Fu, Enqin Li, Sek In Leong, Chu Iong Nip, et al. (+5)
970 [GO] 2023―May―10 Characterization of RBD-specific cross-neutralizing antibodies responses against SARS-CoV-2 variants from COVID-19 convalescents Zheng Wang, Dan Li, Yulu Chen, Yeping Sun, Changzhong Jin, Caiqin Hu, et al. (+10)
971 [GO] 2023―May―10 T cell immunity following COVID-19 vaccination in adult patients with primary antibody deficiency - a 22-month follow-up Antti Hurme, Pinja Jalkanen, Minna Marttila-Vaara, Jemna Heroum, Heidi Jokinen, Saimi Vara, et al. (+5)
972 [GO] 2023―May―10 Current hotspot and study trend of innate immunity in COVID-19: a bibliometric analysis from 2020 to 2022 Ping Lai, Shuquan Xu, Jin-hua Xue, Hong-zhou Zhang, Yi-ming Zhong, Yong-ling Liao
973 [GO] 2023―May―10 Impact of SARS-CoV2 infection on anti-apolipoprotein A-1 IgG response in inflammatory rheumatic diseases Celine Lamacchia, Denis Mongin, Catherine Juillard, Paola Antinori-Malaspina, Cem Gabay, Axel Finckh, et al. (+2)
974 [GO] 2023―May―09 Seroprevalence and durability of antibody responses to AstraZeneca vaccination in Ugandans with prior mild or asymptomatic COVID-19: implications for vaccine policy Jennifer Serwanga, Claire Baine, Susan Mugaba, Violet Ankunda, Betty Oliver Auma, Gerald Kevin Oluka, et al. (+9)
975 [GO] 2023―May―09 Maintained imbalance of triglycerides, apolipoproteins, energy metabolites and cytokines in long-term COVID-19 syndrome patients Georgy Berezhnoy, Rosi Bissinger, Anna Liu, Claire Cannet, Hartmut Schäfer, Katharina Kienzle, et al. (+5)
976 [GO] 2023―May―09 Innate and adaptive immunity to SARS-CoV-2 and predisposing factors Jiaying Shen, Junyan Fan, Yue Zhao, Doming Jiang, Zheyun Niu, Zihan Zhang, Guangwen Cao
977 [GO] 2023―May―08 Safety of COVID-19 vaccine in patients with myasthenia gravis: a self-controlled case series study Zhe Ruan, Xiao Huan, Yue Su, Yong-Lan Tang, Dong-Dong Meng, Da-Lin Ren, et al. (+6)
978 [GO] 2023―May―05 Prognostic immune markers identifying patients with severe COVID-19 who respond to tocilizumab Sara De Biasi, Marco Mattioli, Marianna Meschiari, Domenico Lo Tartaro, Annamaria Paolini, Rebecca Borella, et al. (+10)
979 [GO] 2023―May―05 The shed P2X7 receptor is an index of adverse clinical outcome in COVID-19 patients Valentina Vultaggio-Poma, Juana Maria Sanz, Andrea Amico, Alessandra Violi, Sara Ghisellini, Stefano Pizzicotti, et al. (+5)
980 [GO] 2023―May―05 Global transmission of monkeypox virus-a potential threat under the COVID-19 pandemic Yang Wang, Ping Leng, Hao Zhou
981 [GO] 2023―May―05 Evidence for broad cross-reactivity of the SARS-CoV-2 NSP12-directed CD4+ T-cell response with pre-primed responses directed against common cold coronaviruses Tim Westphal, Maria Mader, Hendrik Karsten, Leon Cords, Maximilian Knapp, Sophia Schulte, et al. (+12)
982 [GO] 2023―May―05 A linear B-cell epitope close to the furin cleavage site within the S1 domain of SARS-CoV-2 Spike protein discriminates the humoral immune response of nucleic acid- and protein-based vaccine cohorts Peter Lorenz, Felix Steinbeck, Franz Mai, Emil C. Reisinger, Brigitte Müller-Hilke
983 [GO] 2023―May―04 Detection of specific RBD+ IgG+ memory B cells by flow cytometry in healthcare workers and patients with inborn errors of immunity after BNT162b2 m RNA COVID-19 vaccination Lucía del Pino Molina, Luz Yadira Bravo Gallego, Pilar Nozal, Yolanda Soto-Serrano, Ana Martínez-Feito, Keren Reche-Yebra, et al. (+8)
984 [GO] 2023―May―03 Risk factors and characteristics influencing humoral response to COVID-19 vaccination in patients after allogeneic stem cell transplantation Marie Luise Hütter-Krönke, Adela Neagoie, Igor Wolfgang Blau, Verena Wais, Lam Vuong, Andrea Gantner, et al. (+11)
985 [GO] 2023―May―03 Circulating extracellular particles from severe COVID-19 patients show altered profiling and innate lymphoid cell-modulating ability Dorian Forte, Roberto Maria Pellegrino, Sara Trabanelli, Tommaso Tonetti, Francesca Ricci, Mara Cenerenti, et al. (+15)
986 [GO] 2023―May―03 Corrigendum: Can vitamin D status influence seroconversion to SARS-COV2 vaccines? Endrit Shahini, Francesco Pesce, Antonella Argentiero, Antonio Giovanni Solimando
987 [GO] 2023―May―02 The relationship between gut microbiota and COVID-19 progression: new insights into immunopathogenesis and treatment Man Wang, Yuan Zhang, Chunmei Li, Wenguang Chang, Lei Zhang
988 [GO] 2023―May―01 Interferon regulatory factor 3 mediates effective antiviral responses to human coronavirus 229E and OC43 infection Joseph K. Sampson Duncan, Danyang Xu, Maria Licursi, Michael A. Joyce, Holly A. Saffran, Kaiwen Liu, et al. (+4)
989 [GO] 2023―Apr―28 Corrigendum: Phenotypic alteration of low-density granulocytes in people with pulmonary post-acute sequelae of SARS-CoV-2 infection Logan S. Dean, Gehan Devendra, Boonyanudh Jiyarom, Natalie Subia, Michelle D. Tallquist, Vivek R. Nerurkar, et al. (+4)
990 [GO] 2023―Apr―28 Long COVID brain fog and muscle pain are associated with longer time to clearance of SARS-CoV-2 RNA from the upper respiratory tract during acute infection Annukka A. R. Antar, Tong Yu, Zoe O Demko, Chen Hu, Jeffrey A. Tornheim, Paul W. Blair, et al. (+2)
991 [GO] 2023―Apr―28 Corrigendum: XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2 spike receptor-binding domain, targets multiple epitopes and broadly neutralizes variants Bernard Vanhove, Stéphane Marot, Ray T. So, Benjamin Gaborit, Gwénaëlle Evanno, Isabelle Malet, et al. (+11)
992 [GO] 2023―Apr―28 Characterization of post-vaccination SARS-CoV-2 T cell subtypes in patients with different hematologic malignancies and treatments Roald Pfannes, Arkadiusz Pierzchalski, Ambra Maddalon, Alexandra Simion, Christos C. Zouboulis, Gerhard Behre, et al. (+4)
993 [GO] 2023―Apr―28 Host immune responses in aged rhesus macaques against BBV152, an inactivated SARS-CoV-2 vaccine, and cross-neutralization with beta and delta variants Dilip R. Patil, Anita M. Shete, Pragya D. Yadav, Gajanan N. Sapkal, Gururaj R. Deshpande, Himanshu Kaushal, et al. (+5)
994 [GO] 2023―Apr―27 Editorial: Definition of the immune parameters related to COVID-19 severity Camilla Tincati, Rory de Vries, Milos Jesenak, Giulia Marchetti
995 [GO] 2023―Apr―27 Cellular and humoral responses after second and third SARS-CoV-2 vaccinations in patients with autoimmune diseases treated with rituximab: specific T cell immunity remains longer and plays a protective role against SARS-CoV-2 reinfections Natalia Egri, Hugo Calderón, Robert Martinez, Mario Vazquez, Verónica Gómez-Caverzaschi, Mariona Pascal, et al. (+4)
996 [GO] 2023―Apr―26 Guillain-Barré syndrome and COVID-19 vaccines: focus on adenoviral vectors Piotr Rzymski
997 [GO] 2023―Apr―26 Memory SARS-CoV-2 T-cell response in convalescent COVID-19 patients with undetectable specific IgG antibodies: a comparative study Raquel Fernández-Moreno, Jorge Valle-Arroyo, Aurora Páez-Vega, Ana Salinas, Angela Cano, Ana B. Pérez, et al. (+2)
998 [GO] 2023―Apr―26 Cellular immunity in COVID-19 and other infections in Common variable immunodeficiency Ragnhild Øye Løken, Børre Fevang
999 [GO] 2023―Apr―25 PM10 promotes an inflammatory cytokine response that may impact SARS-CoV-2 replication in vitro Damariz Marín-Palma, Jorge H. Tabares-Guevara, María I. Zapata-Cardona, Wildeman Zapata-Builes, Natalia Taborda, Maria T. Rugeles, Juan C. Hernandez
1000 [GO] 2023―Apr―25 SARS-CoV-2 vaccination of convalescents boosts neutralization capacity against Omicron subvariants BA.1, BA.2 and BA.5 and can be predicted by anti-S antibody concentrations in serological assays Alina Seidel, Simone Hoffmann, Bernd Jahrsdörfer, Sixten Körper, Carolin Ludwig, Christiane Vieweg, et al. (+10)
1001 [GO] 2023―Apr―24 Inflammasome signaling proteins as biomarkers of COVID-19 Roey Hadad, Robert W. Keane, Juan Pablo de Rivero Vaccari
1002 [GO] 2023―Apr―21 Blood filtering system for COVID-19 management: novel modality of the cytokine storm therapeutics Vivek P. Chavda, Nidhi Raval, Soham Sheta, Lalitkumar K. Vora, Fatma Elrashdy, Elrashdy M. Redwan, et al. (+2)
1003 [GO] 2023―Apr―21 mRNA-1273 boost after BNT162b2 vaccination generates comparable SARS-CoV-2-specific functional responses in naïve and COVID-19-recovered individuals Roberto Lozano-Rodríguez, José Avendaño-Ortíz, Verónica Terrón, Karla Montalbán-Hernández, José Casalvilla-Dueñas, Marta Bergón-Gutiérrez, et al. (+14)
1004 [GO] 2023―Apr―21 The specialized pro-resolving lipid mediator Protectin D1 affects macrophages differentiation and activity in Adult-onset Still’s disease and COVID-19, two hyperinflammatory diseases sharing similar transcriptomic profiles Luca Navarini, Marta Vomero, Damiano Currado, Onorina Berardicurti, Alice Biaggi, Annalisa Marino, et al. (+21)
1005 [GO] 2023―Apr―20 Editorial: Porcine reproductive and respiratory syndrome virus - animal virology, immunology, and pathogenesis Chunhe Guo, Xiaohong Liu
1006 [GO] 2023―Apr―20 Long COVID: a review and proposed visualization of the complexity of long COVID Rubeshan Perumal, Letitia Shunmugam, Kogieleum Naidoo, Salim S. Abdool Karim, Dave Wilkins, Alfredo Garzino-Demo, et al. (+4)
1007 [GO] 2023―Apr―19 Immune interference in effectiveness of influenza and COVID-19 vaccination Yiwen Xie, Xuebin Tian, Xiaodi Zhang, Hangping Yao, Nanping Wu
1008 [GO] 2023―Apr―19 Altered somatic hypermutation patterns in COVID-19 patients classifies disease severity Modi Safra, Zvi Tamari, Pazit Polak, Shachaf Shiber, Moshe Matan, Hani Karameh, et al. (+9)
1009 [GO] 2023―Apr―19 Longitudinal analysis of SARS-CoV-2 infection and vaccination in the LA-SPARTA cohort reveals increased risk of infection in vaccinated Hispanic participants Meagan M. Jenkins, Donna Phan Tran, Evelyn A. Flores, Deborah Kupferwasser, Harry Pickering, Ying Zheng, et al. (+6)
1010 [GO] 2023―Apr―19 Three doses of a recombinant conjugated SARS-CoV-2 vaccine early after allogeneic hematopoietic stem cell transplantation: predicting indicators of a high serologic response-a prospective, single-arm study Maryam Barkhordar, Bahram Chahardouli, Alireza Biglari, Mohammad Ahmadvand, Tanaz Bahri, Farshid Alaeddini, et al. (+7)
1011 [GO] 2023―Apr―19 Pre-pandemic SARS-CoV-2-specific IFN-γ and antibody responses were low in Ugandan samples and significantly reduced in HIV-positive specimens Hellen Nantambi, Jackson Sembera, Violet Ankunda, Ivan Ssali, Arthur Watelo Kalyebi, Gerald Kevin Oluka, et al. (+11)
1012 [GO] 2023―Apr―18 Editorial: Host-microbe interaction in SARS-CoV-2 infection: mechanism and intervention Arnaud John Kombe Kombe, Tengchuan Jin
1013 [GO] 2023―Apr―18 COVID-19 vaccination in patients with primary immunodeficiencies: an international survey on patient vaccine hesitancy and self-reported adverse events Martine Pergent, Filomeen Haerynck, Levi Hoste, Ann Gardulf
1014 [GO] 2023―Apr―18 Case Report: Molecular autopsy underlie COVID-19-associated sudden, unexplained child mortality Kana Unuma, Dan Tomomasa, Kosuke Noma, Kouhei Yamamoto, Taka-aki Matsuyama, Yohsuke Makino, et al. (+8)
1015 [GO] 2023―Apr―18 Identificationof a novel linear epitope on the porcine reproductive and respiratory syndrome virus nucleocapsid protein, as recognized by a specific monoclonal antibody Yuening Cheng, Miaoli Wu, Li Xiao, Mengdi Zhang, Bihong Huang, Feng Cong, Li Yi
1016 [GO] 2023―Apr―17 Immune correlates of protection for SARS-CoV-2, Ebola and Nipah virus infection Beatriz Escudero-Pérez, Philip Lawrence, Javier Castillo-Olivares
1017 [GO] 2023―Apr―17 Impaired SARS-CoV-2 specific T-cell response in patients with severe COVID-19 Lidewij W. Rümke, Wouter L. Smit, Ailko Bossink, Gijs J. M. Limonard, Danya Muilwijk, Lenneke E. M. Haas, et al. (+10)
1018 [GO] 2023―Apr―17 Polymorphisms in the MBL2 gene are associated with the plasma levels of MBL and the cytokines IL-6 and TNF-α in severe COVID-19 Maria Alice Freitas Queiroz, Angélica Menezes Santiago, Wandrey Roberto dos Santos Brito, Keise Adrielle Santos Pereira, William Botelho de Brito, Maria Karoliny da Silva Torres, et al. (+27)
1019 [GO] 2023―Apr―17 The long-term antibody response after SARS-CoV-2 prime-boost vaccination in healthy individuals. The positive influence of extended between-dose intervals and heterologous schedule Gretel Naidich, Natalia E. Santucci, Stella Maris Pezzotto, Eduardo A. Ceccarelli, Oscar A. Bottasso, A. Mario Perichón
1020 [GO] 2023―Apr―14 Corrigendum: Temporal trends of COVID-19 antibodies in vaccinated healthcare workers undergoing repeated serological sampling: an individual-level analysis within 13 months in the ORCHESTRA cohort Giulia Collatuzzo, Giuseppe De Palma, Francesco S. Violante, Stefano Porru, Francesca Larese Filon, Eleonora Fabianova, et al. (+18)
1021 [GO] 2023―Apr―14 Tuning the immune response: sulfated archaeal glycolipid archaeosomes as an effective vaccine adjuvant for induction of humoral and cell-mediated immunity towards the SARS-CoV-2 Omicron variant of concern Tyler M. Renner, Bassel Akache, Matthew Stuible, Nazanin Rohani, Yuneivy Cepero-Donates, Lise Deschatelets, et al. (+10)
1022 [GO] 2023―Apr―14 Hypothesis: inflammatory acid-base disruption underpins Long Covid Vicky van der Togt, Jeremy S. Rossman
1023 [GO] 2023―Apr―13 Editorial: Interactions between COVID-19 and malaria Stephanie K. Yanow, Maxine Anne Whittaker
1024 [GO] 2023―Apr―12 Panoramic snapshot of serum soluble mediator interplay in pregnant women with convalescent COVID-19: an exploratory study Geraldo Magela Fernandes, Lizandra Moura Paravidine Sasaki, Gabriela Profírio Jardim-Santos, Heidi Luise Schulte, Felipe Motta, Ângelo Pereira da Silva, et al. (+33)
1025 [GO] 2023―Apr―11 Non-spike and spike-specific memory T cell responses after the third dose of inactivated COVID-19 vaccine Ruoqiong Huang, Liyang Ying, Jiangmei Wang, Jie Xia, Yanjun Zhang, Haiyan Mao, et al. (+5)
1026 [GO] 2023―Apr―11 DNA immunization with in silico predicted T-cell epitopes protects against lethal SARS-CoV-2 infection in K18-hACE2 mice Gry Persson, Katherine H. Restori, Julie Hincheli Emdrup, Sophie Schussek, Michael Schantz Klausen, McKayla J. Nicol, et al. (+4)
1027 [GO] 2023―Apr―11 SARS-CoV-2 Spike protein alters microglial purinergic signaling Vinícius Santos Alves, Stephanie Alexia Cristina Silva Santos, Raíssa Leite-Aguiar, Elaine Paiva-Pereira, Renata Rodrigues dos Reis, Mariana L. Calazans, et al. (+10)
1028 [GO] 2023―Apr―06 Thyroid function and associated mood changes after COVID-19 vaccines in patients with Hashimoto thyroiditis Yifei Ma, Jiling Zeng, Yongluo Jiang, Yi-Wei Xu, Youlong Wang, Guanqing Zhong, et al. (+17)
1029 [GO] 2023―Apr―06 Severe COVID-19 and non-COVID-19 severe sepsis converge transcriptionally after a week in the intensive care unit, indicating common disease mechanisms Andy Y. An, Arjun Baghela, Peter Zhang, Reza Falsafi, Amy H. Lee, Uriel Trahtemberg, et al. (+3)
1030 [GO] 2023―Apr―05 Different degree of cytokinemia and T-cell activation according to serum IL-6 levels in critical COVID-19 Chan Mi Lee, Minji Kim, Chang Kyung Kang, Pyoeng Gyun Choe, Nam Joong Kim, Hyeeun Bang, et al. (+5)
1031 [GO] 2023―Apr―05 The retrospective study of the metabolic patterns of BCG-vaccination in type-2 diabetic individuals in COVID-19 infection Najeha R. Anwardeen, Farhan S. Cyprian, Hadi M. Yassine, Asmaa A. Al-Thani, Abdallah M. Abdallah, Mohamed M. Emara, Mohamed A. Elrayess
1032 [GO] 2023―Apr―05 Different configurations of SARS-CoV-2 spike protein delivered by integrase-defective lentiviral vectors induce persistent functional immune responses, characterized by distinct immunogenicity profiles Martina Borghi, Alessandra Gallinaro, Maria Franca Pirillo, Andrea Canitano, Zuleika Michelini, Maria Laura De Angelis, et al. (+14)
1033 [GO] 2023―Apr―04 Optimizing the use of nirmatrelvir/ritonavir in solid organ transplant recipients with COVID-19: A review of immunosuppressant adjustment strategies Yangming Tang, Yue Li, Turun Song
1034 [GO] 2023―Apr―04 Editorial: Beneficial and pathological roles of myeloid cells during COVID-19 Lokesh Sharma, Shaon Sengupta, Thierry Roger
1035 [GO] 2023―Apr―03 Elevated circulating monocytes and monocyte activation in COVID-19 convalescent individuals Juwon Park, Logan S. Dean, Boonyanudh Jiyarom, Louie Mar Gangcuangco, Parthav Shah, Thomas Awamura, et al. (+6)
1036 [GO] 2023―Apr―03 Decreased breadth of the antibody response to the spike protein of SARS-CoV-2 after repeated vaccination Lydia Horndler, Pilar Delgado, Salvador Romero-Pinedo, Marina Quesada, Ivaylo Balabanov, Rocío Laguna-Goya, et al. (+8)
1037 [GO] 2023―Mar―31 Application of weighted gene co-expression network and immune infiltration for explorations of key genes in the brain of elderly COVID-19 patients Lixia Huang, Wei Qin, Zirui Guo, Xiaoyu Li, Fajiu Li, Xiang Wang
1038 [GO] 2023―Mar―31 Comparable cellular and humoral immunity upon homologous and heterologous COVID-19 vaccination regimens in kidney transplant recipients Nina Körber, Christopher Holzmann-Littig, Gesa Wilkens, Bo-Hung Liao, Maia L. Werz, Louise Platen, et al. (+13)
1039 [GO] 2023―Mar―31 TNFα aggravates detrimental effects of SARS-CoV-2 infection in the liver Jöran Lücke, Mikolaj Nawrocki, Josa Schnell, Nicholas Meins, Fabian Heinrich, Tao Zhang, et al. (+16)
1040 [GO] 2023―Mar―31 Rational strategies for enhancing mAb binding to SARS-CoV-2 variants through CDR diversification and antibody-escape prediction Masaud Shah, Ji-Yon Shin, Hyun Goo Woo
1041 [GO] 2023―Mar―30 rAAV expressing recombinant antibody for emergency prevention and long-term prophylaxis of COVID-19 Ilias B. Esmagambetov, Ekaterina I. Ryabova, Artem A. Derkaev, Dmitry V. Shcheblyakov, Inna V. Dolzhikova, Irina A. Favorskaya, et al. (+12)
1042 [GO] 2023―Mar―30 mRNA melanoma vaccine revolution spurred by the COVID-19 pandemic Ziyang Xu, David E. Fisher
1043 [GO] 2023―Mar―30 Breakthrough infections due to SARS-CoV-2 Delta variant: relation to humoral and cellular vaccine responses Matthieu Buscot, Marion Cremoni, Daisy Graça, Vesna Brglez, Johan Courjon, Jonathan Allouche, et al. (+6)
1044 [GO] 2023―Mar―30 Characterisation of the pro-inflammatory cytokine signature in severe COVID-19 Heike C. Hawerkamp, Adam H. Dyer, Neha D. Patil, Matt McElheron, Niamh O’Dowd, Laura O’Doherty, et al. (+17)
1045 [GO] 2023―Mar―30 Pre-clinical models to define correlates of protection for SARS-CoV-2 Caolann Brady, Tom Tipton, Stephanie Longet, Miles W. Carroll
1046 [GO] 2023―Mar―29 The impact of chronic rhinosinusitis on COVID-19 risk and outcomes: A systematic review and meta-analysis Abdullah Reda, Basant Ismail Lashin, Mustafa Mohammad Alaaraj, Moustafa Abouelkheir, Mahmoud Ibrahim Ahmed, Jaffer Shah, Amr Ehab El-Qushayri
1047 [GO] 2023―Mar―29 Immunometabolic interference between cancer and COVID-19 Francesca Maria Consonni, Barbara Durante, Marcello Manfredi, Augusto Bleve, Chiara Pandolfo, Valentina Garlatti, et al. (+9)
1048 [GO] 2023―Mar―29 Non-coding RNAs derived from the foot-and-mouth disease virus genome trigger broad antiviral activity against coronaviruses Miguel Rodríguez-Pulido, Eva Calvo-Pinilla, Miryam Polo, Juan-Carlos Saiz, Raúl Fernández-González, Eva Pericuesta, et al. (+4)
1049 [GO] 2023―Mar―29 SARS-CoV-2 spike antibody concentration in gamma globulin products from high-prevalence COVID-19 countries are transmitted to X-linked agammaglobulinemia patients Allon Raphael, Oded Shamriz, Ariella Tvito, Sophie Magen, Shmuel Goldberg, Orli Megged, et al. (+6)
1050 [GO] 2023―Mar―28 Complement lectin pathway activation is associated with COVID-19 disease severity, independent of MBL2 genotype subgroups Lisa Hurler, Ágnes Szilágyi, Federica Mescia, Laura Bergamaschi, Blanka Mező, György Sinkovits, et al. (+22)
1051 [GO] 2023―Mar―28 Editorial: Immune determinants of COVID-19 protection and disease: A focus on asymptomatic COVID and long COVID Maria J. Polyak, Levon Abrahamyan, Mariana G. Bego
1052 [GO] 2023―Mar―28 Editorial: The relationship between COVID-19 severity and cancer immunity and immunotherapy Jacques A. Nunès, Trisha M. Wise-Draper, Claude Lambert
1053 [GO] 2023―Mar―27 Role of increased neutrophil extracellular trap formation on acute kidney injury in COVID-19 patients In Soo Kim, Do Hyun Kim, Hoi Woul Lee, Sung Gyun Kim, Yong Kyun Kim, Jwa-Kyung Kim
1054 [GO] 2023―Mar―27 Clinical implications of gut microbiota and cytokine responses in coronavirus disease prognosis Hye Seong, Jun Hyoung Kim, Young-Hee Han, Ho Seong Seo, Hak Jun Hyun, Jin Gu Yoon, et al. (+6)
1055 [GO] 2023―Mar―24 Immune and ionic mechanisms mediating the effect of dexamethasone in severe COVID-19 Ameet A. Chimote, Abdulaziz O. Alshwimi, Martina Chirra, Vaibhavkumar S. Gawali, Margaret V. Powers-Fletcher, Kristin M. Hudock, Laura Conforti
1056 [GO] 2023―Mar―24 Cellular and humoral immunogenicity of the COVID-19 vaccine and COVID-19 disease severity in individuals with immunodeficiency C. E. Murray, C. O’Brien, S. Alamin, S. H. Phelan, R. Argue, R. Kiersey, et al. (+11)
1057 [GO] 2023―Mar―23 Identification of berberine as a potential therapeutic strategy for kidney clear cell carcinoma and COVID-19 based on analysis of large-scale datasets Zhihua Zheng, Xiushen Li, Kechao Nie, Xiaoyu Wang, Wencong Liang, Fuxia Yang, et al. (+2)
1058 [GO] 2023―Mar―23 Add fuel to the fire: Inflammation and immune response in lung cancer combined with COVID-19 Yanling Ai, Hengyi Wang, Qiao Zheng, Songtao Li, Jingwen Liu, Ju Huang, et al. (+2)
1059 [GO] 2023―Mar―23 Design and preclinical evaluation of a universal SARS-CoV-2 mRNA vaccine Jane Qin, Ju Hyeong Jeon, Jiangsheng Xu, Laura Katherine Langston, Ramesh Marasini, Stephanie Mou, et al. (+7)
1060 [GO] 2023―Mar―22 Tocilizumab-coated solid lipid nanoparticles loaded with cannabidiol as a novel drug delivery strategy for treating COVID-19: A review Aleksandra Zielińska, Piotr Eder, Jacek Karczewski, Marlena Szalata, Szymon Hryhorowicz, Karolina Wielgus, et al. (+5)
1061 [GO] 2023―Mar―22 Low humoral and cellular immune responses early after breakthrough infection may contribute to severe COVID-19 Chan Mi Lee, Pyoeng Gyun Choe, Chang Kyung Kang, Eunyoung Lee, Kyoung-Ho Song, Ji Hwan Bang, et al. (+10)
1062 [GO] 2023―Mar―22 Third SARS-CoV-2 vaccination and breakthrough infections enhance humoral and cellular immunity against variants of concern Louisa Ruhl, Jenny F. Kühne, Kerstin Beushausen, Jana Keil, Stella Christoph, Jasper Sauer, Christine S. Falk
1063 [GO] 2023―Mar―21 Association of SARS-CoV-2 nucleocapsid viral antigen and the receptor for advanced glycation end products with development of severe disease in patients presenting to the emergency department with COVID-19 Zachary A. Matthay, Alexander T. Fields, Katherine D. Wick, Chayse Jones, H. Clifford Lane, Kimberly Herrera, et al. (+6)
1064 [GO] 2023―Mar―21 Active regression model for clinical grading of COVID-19 Yuan Sh, Jierong Dong, Zhongqing Chen, Meiqing Yuan, Lingna Lyu, Xiuli Zhang
1065 [GO] 2023―Mar―21 Abnormal thrombosis and neutrophil activation increase hospital-acquired sacral pressure injuries and morbidity in COVID-19 patients Jatin Narang, Samreen Jatana, András K. Ponti, Ryan Musich, Joshua Gallop, Angela H. Wei, et al. (+10)
1066 [GO] 2023―Mar―21 Convalescent human IgG, but not IgM, from COVID-19 survivors confers dose-dependent protection against SARS-CoV-2 replication and disease in hamsters Hannah A. D. King, Vincent Dussupt, Letzibeth Mendez-Rivera, Bonnie M. Slike, Ursula Tran, Nathan D. Jackson, et al. (+17)
1067 [GO] 2023―Mar―21 Identification of common molecular signatures of SARS-CoV-2 infection and its influence on acute kidney injury and chronic kidney disease Weiwei Zhang, Leping Liu, Xiangcheng Xiao, Hongshan Zhou, Zhangzhe Peng, Wei Wang, et al. (+8)
1068 [GO] 2023―Mar―20 Rapid, early, and potent Spike-directed IgG, IgM, and IgA distinguish asymptomatic from mildly symptomatic COVID-19 in Uganda, with IgG persisting for 28 months Jennifer Serwanga, Violet Ankunda, Jackson Sembera, Laban Kato, Gerald Kevin Oluka, Claire Baine, et al. (+12)
1069 [GO] 2023―Mar―20 Effects of the circulating environment of COVID-19 on platelet and neutrophil behavior Alexander T. Fields, Elizabeth A. Andraska, Christof Kaltenmeier, Zachary A. Matthay, Kimberly Herrera, Brenda Nuñez-Garcia, et al. (+12)
1070 [GO] 2023―Mar―20 Protection from COVID-19 disease in hamsters vaccinated with subunit SARS-CoV-2 S1 mucosal vaccines adjuvanted with different adjuvants Yongjun Sui, Hanne Andersen, Jianping Li, Tanya Hoang, Yonas Bekele, Swagata Kar, et al. (+2)
1071 [GO] 2023―Mar―20 Exploration of the common genetic landscape of COVID-19 and male infertility Yinwei Chen, Taotao Sun, Kang Liu, Penghui Yuan, Chang Liu
1072 [GO] 2023―Mar―20 Architecture of the SARS-CoV-2-specific T cell repertoire Ksenia V. Zornikova, Saveliy A. Sheetikov, Alexander Yu Rusinov, Rustam N. Iskhakov, Apollinariya V. Bogolyubova
1073 [GO] 2023―Mar―17 Antibodies to SARS-CoV-2 in follicular fluids and their association with assisted reproduction Thilo Samson Chillon, Gregor Weiss, Kamil Demircan, Waldemar B. Minich, Michael Schenk, Lutz Schomburg
1074 [GO] 2023―Mar―16 COVID-19 vaccination in psoriasis patients receiving systemic treatment: A prospective single-center study Georg Christian Lodde, Frederik Krefting, Jan-Malte Placke, Lea Schneider, Melanie Fiedler, Ulf Dittmer, et al. (+5)
1075 [GO] 2023―Mar―16 Neutrophilic inflammation promotes SARS-CoV-2 infectivity and augments the inflammatory responses in airway epithelial cells Ben A. Calvert, Erik J. Quiroz, Zareeb Lorenzana, Ngan Doan, Seongjae Kim, Christiana N. Senger, et al. (+5)
1076 [GO] 2023―Mar―15 Antibody response in children with multisystem inflammatory syndrome related to COVID-19 (MIS-C) compared to children with uncomplicated COVID-19 Anaïs Thiriard, Benjamin Meyer, Christiane S. Eberhardt, Natasha Loevy, Serge Grazioli, Wafae Adouan, et al. (+9)
1077 [GO] 2023―Mar―15 Optimal time for COVID-19 vaccination in rituximab-treated dermatologic patients Chutima Seree-aphinan, Yanisa Ratanapokasatit, Poonkiat Suchonwanit, Ploysyne Rattanakaemakorn, Pichaya O-Charoen, Prapaporn Pisitkun, et al. (+4)
1078 [GO] 2023―Mar―15 SARS-CoV-2 antibody responses associate with sex, age and disease severity in previously uninfected people admitted to hospital with COVID-19: An ISARIC4C prospective study Eleanor Parker, Jordan Thomas, Kelly J. Roper, Samreen Ijaz, Tansy Edwards, Federica Marchesin, et al. (+22)
1079 [GO] 2023―Mar―15 Heterologous prime-boost immunisation with mRNA- and AdC68-based 2019-nCoV variant vaccines induces broad-spectrum immune responses in mice Xingxing Li, Jingjing Liu, Wenjuan Li, Qinhua Peng, Miao Li, Zhifang Ying, et al. (+16)
1080 [GO] 2023―Mar―15 Humoral and cellular immunity to SARS-COV-2 after vaccination with mRNA vaccines in PLWH with discordant immune response. Influence of the vaccine administered Luis F. López-Cortés, Abraham Saborido-Alconchel, María Trujillo-Rodríguez, Ana Serna-Gallego, Silvia Llaves-Flores, Esperanza Muñoz-Muela, et al. (+6)
1081 [GO] 2023―Mar―15 Alterations in gut immunological barrier in SARS-CoV-2 infection and their prognostic potential Gerasimos Eleftheriotis, Efthymios P. Tsounis, Ioanna Aggeletopoulou, Periklis Dousdampanis, Christos Triantos, Athanasia Mouzaki, et al. (+2)
1082 [GO] 2023―Mar―14 Epigenetic immune monitoring for COVID-19 disease course prognosis Björn Samans, Marta Rosselló Chornet, Araceli Rosselló Chornet, Janine Jung, Konstantin Schildknecht, Laura Lozza, et al. (+4)
1083 [GO] 2023―Mar―14 Adenosine deaminase augments SARS-CoV-2 specific cellular and humoral responses in aged mouse models of immunization and challenge Ebony N. Gary, Nicholas J. Tursi, Bryce M. Warner, Gina Cuismano, Jennifer Connors, Elizabeth M. Parzych, et al. (+17)
1084 [GO] 2023―Mar―14 A longitudinal analysis of humoral, T cellular response and influencing factors in a cohort of healthcare workers: Implications for personalized SARS-CoV-2 vaccination strategies Eleonora Sabetta, Maddalena Noviello, Clara Sciorati, Marco Viganò, Rebecca De Lorenzo, Valeria Beretta, et al. (+9)
1085 [GO] 2023―Mar―13 A deep look into the storm: Israeli multi-center experience of coronavirus disease 2019 (COVID-19) in patients with autoimmune inflammatory rheumatic diseases before and after vaccinations Fadi Kharouf, Tali Eviatar, Maya Braun, Elisheva Pokroy-Shapira, Michal Brodavka, Yair Zloof, et al. (+27)
1086 [GO] 2023―Mar―13 Vitamin B12 attenuates leukocyte inflammatory signature in COVID-19 via methyl-dependent changes in epigenetic markings Larissa M. G. Cassiano, Vanessa Cavalcante-Silva, Marina S. Oliveira, Bárbara V. O. Prado, Cristianne G. Cardoso, Anna C. M. Salim, et al. (+4)
1087 [GO] 2023―Mar―13 Exploring SARS-CoV-2 and Plasmodium falciparum coinfection in human erythrocytes Diana López-Farfán, Nerea Irigoyen, Elena Gómez-Díaz
1088 [GO] 2023―Mar―13 Impact of homologous and heterologous boosters in neutralizing antibodies titers against SARS-CoV-2 Omicron in solid-organ transplant recipients Aracelly Gaete-Argel, Vicente Saavedra-Alarcón, Denis Sauré, Luis Alonso-Palomares, Mónica L. Acevedo, Marion Alarcón, et al. (+5)
1089 [GO] 2023―Mar―10 SARS-CoV-2 epitope-specific T cells: Immunity response feature, TCR repertoire characteristics and cross-reactivity Gang Yang, Junxiang Wang, Ping Sun, Jian Qin, Xiaoyun Yang, Daxiang Chen, et al. (+3)
1090 [GO] 2023―Mar―09 A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta Brandon Carter, Pinghan Huang, Ge Liu, Yuejin Liang, Paulo J. C. Lin, Bi-Hung Peng, et al. (+13)
1091 [GO] 2023―Mar―09 Antibody response to different COVID-19 vaccines among the migrant workers of Bangladesh Md. Imam Hossain, Protim Sarker, Rubhana Raqib, Md Ziaur Rahman, Rezaul Hasan, Chloe K. Svezia, et al. (+2)
1092 [GO] 2023―Mar―09 Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative Hector Bonilla, Michael J. Peluso, Kathleen Rodgers, Judith A. Aberg, Thomas F. Patterson, Robert Tamburro, et al. (+19)
1093 [GO] 2023―Mar―09 Editorial: SARS-COV-2 infections within inborn errors of immunity populations Leif Gunnar Hanitsch, Anete S. Grumach, Ankur Kumar Jindal
1094 [GO] 2023―Mar―08 Differential regulatory T cell signature after recovery from mild COVID-19 Pedro Henrique de Sousa Palmeira, Rephany Fonseca Peixoto, Bárbara Guimarães Csordas, Isac Almeida de Medeiros, Fátima de Lourdes Assunção Araújo de Azevedo, Robson Cavalcante Veras, et al. (+3)
1095 [GO] 2023―Mar―08 Relevance of TMPRSS2, CD163/CD206, and CD33 in clinical severity stratification of COVID-19 Silvia Martínez-Diz, Fernando Marín-Benesiu, Ginesa López-Torres, Olivia Santiago, José F. Díaz-Cuéllar, Sara Martín-Esteban, et al. (+9)
1096 [GO] 2023―Mar―08 Gut and airway microbiota dysbiosis and their role in COVID-19 and long-COVID Giuseppe Ancona, Laura Alagna, Claudia Alteri, Emanuele Palomba, Anna Tonizzo, Andrea Pastena, et al. (+3)
1097 [GO] 2023―Mar―08 Pre-existing immunity to SARS-CoV-2 before the COVID-19 pandemic era in Cameroon: A comparative analysis according to HIV-status Abba Aissatou, Joseph Fokam, Ezechiel Ngoufack Jagni Semengue, Désiré Takou, Aude Christelle Ka’e, Collins Chenwi Ambe, et al. (+18)
1098 [GO] 2023―Mar―08 Corrigendum: Elevated IFNA1 and suppressed IL12p40 associated with persistent hyperinflammation in COVID-19 pneumonia Kyeongseok Jeon, Yuri Kim, Shin Kwang Kang, Uni Park, Jayoun Kim, Nanhee Park, et al. (+24)
1099 [GO] 2023―Mar―08 Long-term systemic and mucosal SARS-CoV-2 IgA response and its association with persistent smell and taste disorders Jessica Denis, Annabelle Garnier, Laurence Cheutin, Audrey Ferrier, Hawa Timera, Fanny Jarjaval, et al. (+6)
1100 [GO] 2023―Mar―08 Novel ACE2 fusion protein with adapting activity against SARS-CoV-2 variants in vitro Latifa Zekri, Natalia Ruetalo, Mary Christie, Carolin Walker, Timo Manz, Hans-Georg Rammensee, et al. (+3)
1101 [GO] 2023―Mar―07 Corrigendum: SARS-CoV-2 antibody response after mRNA vaccination in healthcare workers with and without previous COVID-19, a follow-up study from the University Hospital in Krakow, Poland Izabella Owsianka, Agnieszka Pac, Estera Jachowicz, Karolina Gutkowska, Wiktor Szczuciński, Barbara Maziarz, et al. (+5)
1102 [GO] 2023―Mar―07 Immune damage mechanisms of COVID-19 and novel strategies in prevention and control of epidemic Yuting Sun, Bin Luo, Yueping Liu, Yuzhang Wu, Yongwen Chen
1103 [GO] 2023―Mar―07 Pharmacological potential of Withania somnifera (L.) Dunal and Tinospora cordifolia (Willd.) Miers on the experimental models of COVID-19, T cell differentiation, and neutrophil functions Zaigham Abbas Rizvi, Prabhakar Babele, Upasna Madan, Srikanth Sadhu, Manas Ranjan Tripathy, Sandeep Goswami, et al. (+3)
1104 [GO] 2023―Mar―07 Improved outcomes over time and higher mortality in CMV seropositive allogeneic stem cell transplantation patients with COVID-19; An infectious disease working party study from the European Society for Blood and Marrow Transplantation registry Per Ljungman, Gloria Tridello, Jose Luis Piñana, Fabio Ciceri, Henrik Sengeloev, Alexander Kulagin, et al. (+36)
1105 [GO] 2023―Mar―06 Immunogenicity against wild-type and Omicron SARS-CoV-2 after a third dose of inactivated COVID-19 vaccine in healthy adolescents Daniel Leung, Carolyn A. Cohen, Xiaofeng Mu, Jaime S. Rosa Duque, Samuel M. S. Cheng, Xiwei Wang, et al. (+20)
1106 [GO] 2023―Mar―06 Immune response to BNT162b2 SARS-CoV-2 vaccine in patients living with HIV: The COVIH-DAPT study Sabrina Manni, Caroline Ruetsch, Roxane Fabre, Michel Ticchioni, Daisy Graça, Christian Pradier, et al. (+4)
1107 [GO] 2023―Mar―06 Utility of laboratory and immune biomarkers in predicting disease progression and mortality among patients with moderate to severe COVID-19 disease at a Philippine tertiary hospital Felix Eduardo R. Punzalan, Jaime Alfonso M. Aherrera, Sheriah Laine M. de Paz-Silava, Alric V. Mondragon, Anna Flor G. Malundo, Joanne Jennifer E. Tan, et al. (+11)
1108 [GO] 2023―Mar―06 COVID-19 spike polypeptide vaccine reduces the pathogenesis and viral infection in a mouse model of SARS-CoV-2 Yasmin Hisham, Sun-Min Seo, Sinae Kim, Saerok Shim, Jihyeong Hwang, Eun-Seon Yoo, et al. (+10)
1109 [GO] 2023―Mar―06 Long-term adaptive response in COVID-19 vaccine recipients and the effect of a booster dose Luca Perico, Marta Todeschini, Federica Casiraghi, Marilena Mister, Anna Pezzotta, Tobia Peracchi, et al. (+4)
1110 [GO] 2023―Mar―03 Characteristics of humoral and cellular responses to coronavirus disease 2019 (COVID-19) inactivated vaccine in central China: A prospective, multicenter, longitudinal study Youhua Yuan, Junhong Xu, Bing Ma, Guohua Chen, Zhibin Wang, Shanmei Wang, et al. (+7)
1111 [GO] 2023―Mar―03 A systematic review and meta-analysis of the effectiveness and safety of COVID-19 vaccination in older adults Kun Xu, Zihan Wang, Maorong Qin, Yangyu Gao, Na Luo, Wanting Xie, et al. (+3)
1112 [GO] 2023―Mar―03 Case report: Clearance of longstanding, immune-deficiency-associated, vaccine-derived polio virus infection following remdesivir therapy for chronic SARS-CoV-2 infection William Hywel Bermingham, Benjamin Canning, Thomas Wilton, Michael Kidd, Dimitra Klapsa, Manasi Majumdar, et al. (+3)
1113 [GO] 2023―Mar―03 Functional SARS-CoV-2-specific T cells of donor origin in allogeneic stem cell transplant recipients of a T-cell-replete infusion: A prospective observational study Corinna La Rosa, Flavia Chiuppesi, Yoonsuh Park, Qiao Zhou, Dongyun Yang, Ketevan Gendzekhadze, et al. (+20)
1114 [GO] 2023―Mar―03 Diversity of immune responses in children highly exposed to SARS-CoV-2 María Úbeda, María del Carmen Maza, Pilar Delgado, Lydia Horndler, David Abia, Laura García-Bermejo, et al. (+5)
1115 [GO] 2023―Mar―03 Erratum: Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies Belén Aparicio, Marta Ruiz, Noelia Casares, Leyre Silva, Josune Egea, Patricia Pérez, et al. (+5)
1116 [GO] 2023―Mar―02 Extending the dosing interval of COVID-19 vaccination leads to higher rates of seroconversion in people living with HIV Yi Wang, Jianhua Li, Wenhui Zhang, Shourong Liu, Liangbin Miao, Zhaoyi Li, et al. (+7)
1117 [GO] 2023―Mar―02 Antiphospholipid antibodies in patients with stroke during COVID-19: A role in the signaling pathway leading to platelet activation Antonella Capozzi, Gloria Riitano, Serena Recalchi, Valeria Manganelli, Agostina Longo, Anne Falcou, et al. (+5)
1118 [GO] 2023―Mar―01 Development and validation of a prognostic model based on immune variables to early predict severe cases of SARS-CoV-2 Omicron variant infection Tianyu Lu, Qiuhong Man, Xueying Yu, Shuai Xia, Lu Lu, Shibo Jiang, Lize Xiong
1119 [GO] 2023―Mar―01 SARS-CoV-2 infection and COVID19 vaccination across eight immune-mediated inflammatory disorders: A prospective, real-life Belgian cohort study - the BELCOMID study Jeroen Geldof, Marie Truyens, João Sabino, Marc Ferrante, Jo Lambert, Hilde Lapeere, et al. (+7)
1120 [GO] 2023―Feb―28 Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry Alessandro Busca, Jon Salmanton-García, Francesco Marchesi, Francesca Farina, Guldane Cengiz Seval, Jaap Van Doesum, et al. (+50)
1121 [GO] 2023―Feb―23 B cell receptor repertoire analysis from autopsy samples of COVID-19 patients Sadahiro Iwabuchi, Tomohide Tsukahara, Toshitugu Okayama, Masahiro Kitabatake, Hideki Motobayashi, Shigeyuki Shichino, et al. (+15)
1122 [GO] 2023―Feb―23 Single-cell RNA-seq analysis identifies distinct myeloid cells in a case with encephalitis temporally associated with COVID-19 vaccination Masakazu Ishikawa, Yuki Shimada, Tatsuhiko Ozono, Hisatake Matsumoto, Hiroshi Ogura, Keigo Kihara, et al. (+5)
1123 [GO] 2023―Feb―23 Galectins can serve as biomarkers in COVID-19: A comprehensive systematic review and meta-analysis Amir Hossein Behnoush, Amirmohammad Khalaji, Seyedeh Yasaman Alemohammad, Amirali Kalantari, Alessandro Cannavo, Charles J. Dimitroff
1124 [GO] 2023―Feb―23 Glycan masking of a non-neutralising epitope enhances neutralising antibodies targeting the RBD of SARS-CoV-2 and its variants George W. Carnell, Martina Billmeier, Sneha Vishwanath, Maria Suau Sans, Hannah Wein, Charlotte L. George, et al. (+21)
1125 [GO] 2023―Feb―23 Development and validation of a rapid and easy-to-perform point-of-care lateral flow immunoassay (LFIA) for the detection of SARS-CoV-2 spike protein Shamim Mohammad, Yuxia Wang, John Cordero, Christopher Watson, Robert Molestina, Sujatha Rashid, Rebecca Bradford
1126 [GO] 2023―Feb―22 Allogeneic hematopoietic stem cell transplantation in the COVID-19 era Jonathan Bordat, Sébastien Maury, Mathieu Leclerc
1127 [GO] 2023―Feb―22 Mucosal immunization with Ad5-based vaccines protects Syrian hamsters from challenge with omicron and delta variants of SARS-CoV-2 Molly R. Braun, Clarissa I. Martinez, Emery G. Dora, Laura J. Showalter, Annette R. Mercedes, Sean N. Tucker
1128 [GO] 2023―Feb―22 The use of bioinformatics methods to identify the effects of SARS-CoV-2 and influenza viruses on the regulation of gene expression in patients Zhongyi Sun, Li Ke, Qiuyue Zhao, Jiachen Qu, Yanan Hu, Han Gao, Zhiyong Peng
1129 [GO] 2023―Feb―22 Evolution of antibody profiles against SARS-CoV-2 in experienced and naïve vaccinated elderly people Iván Sanz-Muñoz, Rosa López-Mongil, Javier Sánchez-Martínez, Laura Sánchez-de Prada, Marta Domínguez-Gil González, Diana Pérez-SanJose, et al. (+6)
1130 [GO] 2023―Feb―21 Delivery of spike-RBD by bacterial type three secretion system for SARS-CoV-2 vaccine development Yuchen Zhou, Jing Qu, Xiaomeng Sun, Zhuo Yue, Yingzi Liu, Keli Zhao, et al. (+10)
1131 [GO] 2023―Feb―21 Third COVID-19 vaccine dose for people with multiple sclerosis who did not seroconvert following two doses of BBIBP-CorV (Sinopharm) inactivated vaccine: A pilot study on safety and immunogenicity Nahad Sedaghat, Masoud Etemadifar, Noushin Lotfi, Farnaz Sayahi, Ahmad Chitsaz, Mehri Salari, Alireza Ghasemi Movaghar
1132 [GO] 2023―Feb―21 Complementarity determining regions in SARS-CoV-2 hybrid immunity Glynis Frans, Doreen Dillaerts, Tom Dehaemers, Jan Van Elslande, Jonas De Leeuw, Lise Boon, et al. (+11)
1133 [GO] 2023―Feb―21 Avidity engineering of human heavy-chain-only antibodies mitigates neutralization resistance of SARS-CoV-2 variants Wenjuan Du, Rick Janssens, Anna Z. Mykytyn, Wentao Li, Dubravka Drabek, Rien van Haperen, et al. (+10)
1134 [GO] 2023―Feb―20 Evaluating SARS-CoV-2 antibody reactivity to natural exposure and inactivated vaccination with peptide microarrays Peiyan Zheng, Jing Ma, Jiao Yang, Baolin Liao, Zhangkai J. Cheng, Mingshan Xue, et al. (+8)
1135 [GO] 2023―Feb―20 SARS-COV-2 viroporins activate the NLRP3-inflammasome by the mitochondrial permeability transition pore Joseph W. Guarnieri, Alessia Angelin, Deborah G. Murdock, Patrick Schaefer, Prasanth Portluri, Timothy Lie, et al. (+2)
1136 [GO] 2023―Feb―17 The role of peroxisome proliferator-activated receptors in the modulation of hyperinflammation induced by SARS-CoV-2 infection: A perspective for COVID-19 therapy Aliakbar Hasankhani, Abolfazl Bahrami, Bahareh Tavakoli-Far, Setare Iranshahi, Farnaz Ghaemi, Majid Reza Akbarizadeh, et al. (+3)
1137 [GO] 2023―Feb―17 Therapeutic equine hyperimmune antibodies with high and broad-spectrum neutralizing activity protect rodents against SARS-CoV-2 infection Entao Li, Qiuxue Han, Jinhao Bi, Shimeng Wei, Shen Wang, Ying Zhang, et al. (+9)
1138 [GO] 2023―Feb―17 Multi-omics analysis reveals genomic, clinical and immunological features of SARS-CoV-2 virus target genes in pan-cancer Yong Liao, Jiaojiao Wang, Jiami Zou, Yong Liu, Zhiping Liu, Zunnan Huang
1139 [GO] 2023―Feb―16 Lung T cell response in COVID-19 Mehrnoush Hadaddzadeh Shakiba, Ioanna Gemünd, Marc Beyer, Lorenzo Bonaguro
1140 [GO] 2023―Feb―16 Case report: Immunological characteristics of de novo ulcerative colitis in a child post COVID-19 Atsushi Morita, Kazuo Imagawa, Manabu Tagawa, Noriaki Sakamoto, Hidetoshi Takada
1141 [GO] 2023―Feb―16 Factors associated with the humoral response after three doses of COVID-19 vaccination in kidney transplant recipients Ángel Bulnes-Ramos, María Mar Pozo-Balado, Israel Olivas-Martínez, Vanesa Garrido-Rodríguez, Gabriel Bernal-Blanco, Alejandro Suárez-Benjumea, et al. (+10)
1142 [GO] 2023―Feb―16 Performance of an interferon-γ release assay-based test for cell-mediated immunity to SARS-CoV-2 Luís Fonseca Brito, Silvia Tödter, Julian Kottlau, Kathrin Cermann, Anthea Spier, Elina Petersen, et al. (+5)
1143 [GO] 2023―Feb―16 The impact of circadian rhythm on Bacillus Calmette-Guérin vaccination effects on SARS-CoV-2 infections Konstantin Föhse, Esther J.M. Taks, Simone J. C. F. M. Moorlag, Marc J. M. Bonten, Reinout van Crevel, Jaap ten Oever, et al. (+4)
1144 [GO] 2023―Feb―15 Guillain-Barre syndrome following COVID-19 vaccines: A review of literature Miao Yu, Shuang Nie, Yue Qiao, Ying Ma
1145 [GO] 2023―Feb―13 Alterations in the immune system persist after one year of convalescence in severe COVID-19 patients Judith Abarca-Zabalía, Adela González-Jiménez, Myriam Calle-Rubio, Andrea R. López-Pastor, Tomás Fariña, Carlos Ramos-Acosta, et al. (+3)
1146 [GO] 2023―Feb―13 Risk of hospitalization and vaccine effectiveness among COVID-19 patients in the UAE during the Delta and Omicron outbreaks Mohammed Albreiki, Mira Mousa, Syafiq Kamarul Azman, Hema Vurivi, Zainab Alhalwachi, Fatima Alshehhi, et al. (+7)
1147 [GO] 2023―Feb―13 Persistent memory despite rapid contraction of circulating T Cell responses to SARS-CoV-2 mRNA vaccination Ellie Taus, Christian Hofmann, F. Javier Ibarrondo, Laura S. Gong, Mary Ann Hausner, Jennifer A. Fulcher, et al. (+7)
1148 [GO] 2023―Feb―10 Mid-titer human convalescent plasma administration results in suboptimal prophylaxis against SARS-CoV-2 infection in rhesus macaques Brandon J. Beddingfield, Nicholas J. Maness, Skye Spencer, Jay Rappaport, Pyone Pyone Aye, Kasi Russell-Lodrigue, et al. (+5)
1149 [GO] 2023―Feb―10 Vaccination using mutated receptor binding domains of SARS-CoV-2: Evidence for partial immune escape but not serotype formation Xinyue Chang, Xuelan Liu, Byron Martina, Andris Zeltins, Gilles Augusto, Monique Vogel, et al. (+3)
1150 [GO] 2023―Feb―09 Editorial: Research advances of tuberculosis vaccine and its implication on COVID-19 Wenping Gong, Jianping Xie, Hao Li, Ashok Aspatwar
1151 [GO] 2023―Feb―09 COVID-19 vaccine uptake, hesitancy and clinical effects on patients with Takayasu’s arteritis: A web-based questionnaire survey from a large cohort Xiufang Kong, Xiaojuan Dai, Lingying Ma, Jinghua Wang, Ying Sun, Lindi Jiang
1152 [GO] 2023―Feb―09 Alzheimer’s disease and COVID-19: Interactions, intrinsic linkages, and the role of immunoinflammatory responses in this process Wei Li, Lin Sun, Ling Yue, Shifu Xiao
1153 [GO] 2023―Feb―09 Predictors for reactogenicity and humoral immunity to SARS-CoV-2 following infection and mRNA vaccination: A regularized, mixed-effects modelling approach Erin C. Williams, Alexander Kizhner, Valerie S. Stark, Aria Nawab, Daniel D. Muniz, Felipe Echeverri Tribin, et al. (+7)
1154 [GO] 2023―Feb―09 Detailed characterization of SARS-CoV-2-specific T and B cells after infection or heterologous vaccination Domenico Lo Tartaro, Annamaria Paolini, Marco Mattioli, Julian Swatler, Anita Neroni, Rebecca Borella, et al. (+14)
1155 [GO] 2023―Feb―08 A beacon in the dark: COVID-19 course in CVID patients from two European countries: Different approaches, similar outcomes Cinzia Milito, Davide Firinu, Patrick Bez, Annalisa Villa, Alessandra Punziano, Gianluca Lagnese, et al. (+12)
1156 [GO] 2023―Feb―08 Editorial: Innate immune responses to SARS-CoV-2 in infected and vaccinated individuals Nitin K. Saksena, Pedro A. Reche, Srinivasa Reddy Bonam, Nicasio Mancini
1157 [GO] 2023―Feb―08 Wild-type SARS-CoV-2 neutralizing immunity decreases across variants and over time but correlates well with diagnostic testing Kelly M. O’Shea, Charles F. Schuler, Jesse Chen, Jonathan P. Troost, Pamela T. Wong, Kelsea Chen, et al. (+7)
1158 [GO] 2023―Feb―07 Immunogenicity of SARS-CoV-2 mRNA intramuscular vaccination in patients with muscular disorders Ryousuke Kasai, Michinori Funato, Kanako Maruta, Kunihiko Yasuda, Hiroshi Minatsu, Junji Ito, Kazuhiro Takahashi
1159 [GO] 2023―Feb―06 Signaling Through FcγRIIA and the C5a-C5aR Pathway Mediate Platelet Hyperactivation in COVID-19 Sokratis A. Apostolidis, Amrita Sarkar, Heather M. Giannini, Rishi R. Goel, Divij Mathew, Aae Suzuki, et al. (+30)
1160 [GO] 2023―Feb―06 Humoral and Cellular Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients with Multiple Sclerosis: An Israeli Multi-Center Experience Following 3 Vaccine Doses Ron Milo, Elsebeth Staun-Ram, Dimitrios Karussis, Arnon Karni, Mark A. Hellmann, Erez Bar-Haim, Ariel Miller
1161 [GO] 2023―Feb―04 How COVID-19 and other pathological conditions and medical treatments activate our intravascular innate immune system Bo Nilsson, Oskar Eriksson, Karin Fromell, Barbro Persson, Kristina N. Ekdahl
1162 [GO] 2023―Feb―03 Effect of extracorporeal hemoadsorption in critically ill patients with COVID-19: A narrative review Kaixi Chang, Yupei Li, Zheng Qin, Zhuyun Zhang, Liya Wang, Qinbo Yang, et al. (+4)
1163 [GO] 2023―Feb―03 Comprehensive analysis to identify the influences of SARS-CoV-2 infections to inflammatory bowel disease Chengyan Zhang, Zeyu Ma, Xi Nan, Wenhui Wang, Xianchang Zeng, Jinming Chen, et al. (+2)
1164 [GO] 2023―Feb―02 Approaches to demonstrating the effectiveness of filovirus vaccines: Lessons from Ebola and COVID-19 Marion F. Gruber, Steven Rubin, Philip R. Krause
1165 [GO] 2023―Feb―02 Severely ill and high-risk COVID-19 patients exhibit increased peripheral circulation of CD62L+ and perforin+ T cells Kelsey E. Lesteberg, Paula Araya, Katherine A. Waugh, Lakshmi Chauhan, Joaquin M. Espinosa, J. David Beckham
1166 [GO] 2023―Feb―02 Identifying potential pharmacological targets and molecular pathways of Meliae cortex for COVID-19 therapy Shakeel Ahmad Khan, Terence Kin Wah Lee
1167 [GO] 2023―Feb―02 Role of mTOR inhibitor in the cellular and humoral immune response to a booster dose of SARS-CoV-2 mRNA-1273 vaccine in kidney transplant recipients Isabel Pérez-Flores, Ignacio Juarez, Arianne S. Aiffil Meneses, Ana Lopez-Gomez, Natividad Calvo Romero, Beatriz Rodriguez-Cubillo, et al. (+8)
1168 [GO] 2023―Feb―02 Long-term high-dose immunoglobulin successfully treats Long COVID patients with pulmonary, neurologic, and cardiologic symptoms John S. Thompson, Alice C. Thornton, Timothy Ainger, Beth A. Garvy
1169 [GO] 2023―Feb―01 Different cytokine and chemokine profiles in hospitalized patients with COVID-19 during the first and second outbreaks from Argentina show no association with clinical comorbidities Laura Almada, Sofía Carla Angiolini, Nicolás Daniel Dho, Jeremías Dutto, Yamila Gazzoni, Clarisa Manzone-Rodríguez, et al. (+28)
1170 [GO] 2023―Feb―01 Differential haplotype expression in class I MHC genes during SARS-CoV-2 infection of human lung cell lines Ronaldo da Silva Francisco Junior, Jairo R. Temerozo, Cristina dos Santos Ferreira, Yasmmin Martins, Thiago Moreno L. Souza, Enrique Medina-Acosta, Ana Tereza Ribeiro de Vasconcelos
1171 [GO] 2023―Jan―31 Research progress on specific and non-specific immune effects of BCG and the possibility of BCG protection against COVID-19 Jingli Du, Yue Su, Ruilan Wang, Enjun Dong, Yan Cao, Wenjuan Zhao, Wenping Gong
1172 [GO] 2023―Jan―31 CytoSorb in patients with coronavirus disease 2019: A rapid evidence review and meta-analysis Shilin Wei, Yanchun Zhang, Kerong Zhai, Jian Li, Mingming Li, Jianbao Yang, et al. (+3)
1173 [GO] 2023―Jan―31 Patient-derived monoclonal antibodies to SARS-CoV-2 nucleocapsid protein N-terminal and C-terminal domains cross-react with their counterparts of SARS-CoV, but not other human betacoronaviruses Yingfen Wen, Wenjing Guo, Yuyi Min, Kexin Zhong, Xulei Zhang, Xiaomin Xing, et al. (+5)
1174 [GO] 2023―Jan―31 Characterization of METRNβ as a novel biomarker of Coronavirus disease 2019 severity and prognosis Xun Gao, Paul Kay-Sheung Chan, Katie Ching-Yau Wong, Rita Wai-Yin Ng, Apple Chung-Man Yeung, Grace Chung-Yan Lui, et al. (+4)
1175 [GO] 2023―Jan―31 SARS-CoV-2 RBD protein enhances the oncolytic activity of the vesicular stomatitis virus Almohanad A. Alkayyal, Reham Ajina, Marco Cacciabue, Aaesha A. Alkayyal, Nizar H. Saeedi, Taofik Hussain Alshehry, et al. (+6)
1176 [GO] 2023―Jan―30 Sex-disaggregated outcomes of adverse events after COVID-19 vaccination: A Dutch cohort study and review of the literature Janneke W. Duijster, Thomas Lieber, Silvia Pacelli, Leontine Van Balveren, Loes S. Ruijs, Monika Raethke, et al. (+2)
1177 [GO] 2023―Jan―30 Immune responses in mildly versus critically ill COVID-19 patients Hamid Nasrollahi, Atefe Ghamar Talepoor, Zahra Saleh, Mahsa Eshkevar Vakili, Paria Heydarinezhad, Narges Karami, et al. (+3)
1178 [GO] 2023―Jan―30 Intramuscular mRNA BNT162b2 vaccine against SARS-CoV-2 induces neutralizing salivary IgA Miri Stolovich-Rain, Sujata Kumari, Ahuva Friedman, Saveliy Kirillov, Yakov Socol, Maria Billan, et al. (+23)
1179 [GO] 2023―Jan―30 Comparison of the mucosal and systemic antibody responses in Covid-19 recovered patients with one dose of mRNA vaccine and unexposed subjects with three doses of mRNA vaccines Shaojun Liu, Joseph G. S. Tsun, Genevieve P. G. Fung, Grace C. Y. Lui, Kathy Y. Y. Chan, Paul K. S. Chan, Renee W. Y. Chan
1180 [GO] 2023―Jan―27 The COVID-19, tuberculosis and HIV/AIDS: Ménage à Trois Aniefiok John Udoakang, Alexandra Lindsey Djomkam Zune, Kesego Tapela, Nora Nghochuzie Nganyewo, Frances Ngozi Olisaka, Claudia Adzo Anyigba, et al. (+5)
1181 [GO] 2023―Jan―27 Hepcidin and ferritin levels as markers of immune cell activation during septic shock, severe COVID-19 and sterile inflammation Marcela Hortová-Kohoutková, Monika Skotáková, Isaac G. Onyango, Miriam Slezáková, Roman Panovský, Lukáš Opatřil, et al. (+14)
1182 [GO] 2023―Jan―27 Elevated IFNA1 and suppressed IL12p40 associated with persistent hyperinflammation in COVID-19 pneumonia Kyeongseok Jeon, Yuri Kim, Shin Kwang Kang, Uni Park, Jayoun Kim, Nanhee Park, et al. (+24)
1183 [GO] 2023―Jan―27 Nanocell COVID-19 vaccine triggers a novel immune response pathway producing high-affinity antibodies which neutralize all variants of concern Steven Y. Gao, Nancy B. Amaro-Mugridge, Jocelyn Madrid-Weiss, Nikolina Petkovic, Natasha Vanegas, Kumar Visvanathan, et al. (+3)
1184 [GO] 2023―Jan―27 Increased Seroprevalence and Improved Antibody Responses Following Third Primary SARS-CoV-2 Immunisation: An Update From the COV-AD Study Adrian M. Shields, Sian E. Faustini, Harriet J. Hill, Saly Al-Taei, Chloe Tanner, Fiona Ashford, et al. (+21)
1185 [GO] 2023―Jan―27 Clinical Management of Patients With B-Cell Depletion Agents to Treat or Prevent Prolonged and Severe SARS-COV-2 Infection: Defining a Treatment Pathway Alessandra D’Abramo, Serena Vita, Gaetano Maffongelli, Alessia Beccacece, Chiara Agrati, Eleonora Cimini, et al. (+4)
1186 [GO] 2023―Jan―27 Neutralizing antibodies to Omicron after the fourth SARS-CoV-2 mRNA vaccine dose in immunocompromised patients highlight the need of additional boosters Maria Rescigno, Chiara Agrati, Carlo Salvarani, Diana Giannarelli, Massimo Costantini, Alberto Mantovani, et al. (+15)
1187 [GO] 2023―Jan―27 Defending against SARS-CoV-2: The T cell perspective Patricia Almendro-Vázquez, Rocío Laguna-Goya, Estela Paz-Artal
1188 [GO] 2023―Jan―26 Extensive blood transcriptome analysis reveals cellular signaling networks activated by circulating glycocalyx components reflecting vascular injury in COVID-19 Melanie Borrmann, Florian Brandes, Benedikt Kirchner, Matthias Klein, Jean-Noël Billaud, Marlene Reithmair, et al. (+4)
1189 [GO] 2023―Jan―26 Machine learning of flow cytometry data reveals the delayed innate immune responses correlate with the severity of COVID-19 Jing Zhu, Tunan Chen, Xueying Mao, Yitian Fang, Heqi Sun, Dong-Qing Wei, Guangfu Ji
1190 [GO] 2023―Jan―26 The development of COVID-19 treatment Yongliang Yuan, Baihai Jiao, Lili Qu, Duomeng Yang, Ruijuan Liu
1191 [GO] 2023―Jan―26 Efficacy of interferon alpha for the treatment of hospitalized patients with COVID-19: A meta-analysis Mykhailo Buchynskyi, Iryna Kamyshna, Katerina Lyubomirskaya, Olena Moshynets, Nazarii Kobyliak, Valentyn Oksenych, Aleksandr Kamyshnyi
1192 [GO] 2023―Jan―26 Mathematical modelling of the waning of anti-RBD IgG SARS-CoV-2 antibody titers after a two-dose BNT162b2 mRNA vaccination Francisco J. Cimas, Javier Torres, Jesús Ontañón, Carlos de Cabo, Julia Lozano, María Ángeles Requena, et al. (+4)
1193 [GO] 2023―Jan―26 Exposed seronegative: Cellular immune responses to SARS-CoV-2 in the absence of seroconversion Cecilia Jay, Jeremy Ratcliff, Lance Turtle, Philip Goulder, Paul Klenerman
1194 [GO] 2023―Jan―25 Safety of SARS-CoV2 vaccination and COVID-19 short-term outcome in pediatric acquired demyelinating disorders of central nervous system: A single center experience Gabriele Monte, Laura Papetti, Michela Ada Noris Ferilli, Fabiana Ursitti, Romina Moavero, Giorgia Sforza, et al. (+6)
1195 [GO] 2023―Jan―24 T cell immunity ameliorates COVID-19 disease severity and provides post-exposure prophylaxis after peptide-vaccination, in Syrian hamsters Eszter Somogyi, Mariann Kremlitzka, Zsolt Csiszovszki, Levente Molnár, Orsolya Lőrincz, József Tóth, et al. (+5)
1196 [GO] 2023―Jan―24 Kinetics of SARS-CoV-2 neutralizing antibodies in Omicron breakthrough cases with inactivated vaccination: Role in inferring the history and duration of infection Aidibai Simayi, Chuchu Li, Cong Chen, Yin Wang, Chen Dong, Hua Tian, et al. (+11)
1197 [GO] 2023―Jan―24 Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies Belén Aparicio, Marta Ruiz, Noelia Casares, Leyre Silva, Josune Egea, Patricia Pérez, et al. (+5)
1198 [GO] 2023―Jan―23 Blood transcriptome responses in patients correlate with severity of COVID-19 disease Ya Wang, Klaus Schughart, Tiana Maria Pelaia, Tracy Chew, Karan Kim, Thomas Karvunidis, et al. (+12)
1199 [GO] 2023―Jan―23 Persistent T cell-mediated immune responses against Omicron variants after the third COVID-19 mRNA vaccine dose Milja Belik, Oona Liedes, Saimi Vara, Anu Haveri, Sakari Pöysti, Pekka Kolehmainen, et al. (+15)
1200 [GO] 2023―Jan―23 Benefits of high-dose intravenous immunoglobulin on mortality in patients with severe COVID-19: An updated systematic review and meta-analysis Xiaosheng Liu, Yuelun Zhang, Lianfeng Lu, Xiaodi Li, Yuanni Wu, Yang Yang, et al. (+2)
1201 [GO] 2023―Jan―23 SARS-CoV-2 spike HexaPro formulated in aluminium hydroxide and administered in an accelerated vaccination schedule partially protects Syrian Hamsters against viral challenge despite low neutralizing antibody responses Dennis Christensen, Charlotta Polacek, Daniel J. Sheward, Leo Hanke, Gerald McInerney, Ben Murrell, et al. (+10)
1202 [GO] 2023―Jan―20 Acute and long-term immune responses to SARS-CoV-2 infection in unvaccinated children and young adults with inborn errors of immunity Ana García-García, Claudia Fortuny, Victoria Fumadó, Iolanda Jordan, Laura Ruiz-López, Europa Azucena González-Navarro, et al. (+12)
1203 [GO] 2023―Jan―20 Assessment of the longitudinal humoral response in non-hospitalized SARS-CoV-2-positive individuals at decentralized sites: Outcomes and concordance Abdelhadi Djaïleb, Étienne Lavallée, Megan-Faye Parker, Marie-Pierre Cayer, Florence Desautels, Marie Joëlle de Grandmont, et al. (+8)
1204 [GO] 2023―Jan―19 Age-adjusted impact of prior COVID-19 on SARS-CoV-2 mRNA vaccine response Sachie Nakagama, Yu Nakagama, Yuko Komase, Masaharu Kudo, Takumi Imai, Evariste Tshibangu-Kabamba, et al. (+3)
1205 [GO] 2023―Jan―19 C-reactive protein isoforms as prognostic markers of COVID-19 severity Blanca Molins, Marc Figueras-Roca, Oliver Valero, Víctor Llorenç, Sara Romero-Vázquez, Oriol Sibila, et al. (+3)
1206 [GO] 2023―Jan―19 Longitudinal monitoring of mRNA-vaccine-induced immunity against SARS-CoV-2 Werner O. Monzon-Posadas, Jasmin Zorn, Kathrin Peters, Maximilian Baum, Hannah Proksch, Celina Beta Schlüter, et al. (+3)
1207 [GO] 2023―Jan―19 Protective roles and protective mechanisms of neutralizing antibodies against SARS-CoV-2 infection and their potential clinical implications Endeshaw Chekol Abebe, Tadesse Asmamaw Dejenie
1208 [GO] 2023―Jan―18 Patients with IBD have a more cautious attitude towards COVID-19 vaccination Shurong Hu, Jingwen Liu, Shuyan Li, Qiangqiang Wu, Xiaoying Wang, Dingting Xu, Yan Chen
1209 [GO] 2023―Jan―18 Analysis of neutralizing antibodies to COVID-19 inactivated or subunit recombinant vaccines in hospitalized patients with liver dysfunction Hu Li, Shiyin Li, Pan Xu, Xiaohao Wang, Huan Deng, Yu Lei, Shan Zhong
1210 [GO] 2023―Jan―17 Immunogenicity and reactogenicity of accelerated regimens of fractional intradermal COVID-19 vaccinations Suvimol Niyomnaitham, Suparat Atakulreka, Patimaporn Wongprompitak, Katherine Kradangna Copeland, Zheng Quan Toh, Paul V. Licciardi, et al. (+3)
1211 [GO] 2023―Jan―16 Lack of seroresponse to SARS-CoV-2 booster vaccines given early post-transplant in patients primed pre-transplantation Sarah Gleeson, Paul Martin, Tina Thomson, Katrina J. Spensley, Dawn Goodall, Rachna Bedi, et al. (+8)
1212 [GO] 2023―Jan―13 Humoral and T-cell response 12 months after the first BNT162b2 vaccination in solid organ transplant recipients and controls: Kinetics, associated factors, and role of SARS-CoV-2 infection Omid Rezahosseini, Sebastian Rask Hamm, Line Dam Heftdal, Laura Pérez-Alós, Dina Leth Møller, Michael Perch, et al. (+18)
1213 [GO] 2023―Jan―13 Distinct SARS-CoV-2 RNA fragments activate Toll-like receptors 7 and 8 and induce cytokine release from human macrophages and microglia Thomas Wallach, Martin Raden, Lukas Hinkelmann, Mariam Brehm, Dominik Rabsch, Hannah Weidling, et al. (+4)
1214 [GO] 2023―Jan―13 Persistent humoral and CD4+ TH cell immunity after mild SARS-COV-2 infection-The CoNAN long-term study Clara Schnizer, Nico Andreas, Wolfgang Vivas, Thomas Kamradt, Michael Baier, Michael Kiehntopf, et al. (+7)
1215 [GO] 2023―Jan―13 Protein post-translational modification in SARS-CoV-2 and host interaction Nana Cheng, Mingzhu Liu, Wanting Li, BingYue Sun, Dandan Liu, Guoqing Wang, et al. (+2)
1216 [GO] 2023―Jan―13 Robust humoral and cellular recall responses to AZD1222 attenuate breakthrough SARS-CoV-2 infection compared to unvaccinated Jill Maaske, Stephanie Sproule, Ann R. Falsey, Magdalena E. Sobieszczyk, Anne F. Luetkemeyer, Grant C. Paulsen, et al. (+19)
1217 [GO] 2023―Jan―12 mRNA vaccines against SARS-CoV-2 induce comparably low long-term IgG Fc galactosylation and sialylation levels but increasing long-term IgG4 responses compared to an adenovirus-based vaccine Jana Sophia Buhre, Tamas Pongracz, Inga Künsting, Anne S. Lixenfeld, Wenjun Wang, Jan Nouta, et al. (+15)
1218 [GO] 2023―Jan―11 Temporal trends of COVID-19 antibodies in vaccinated healthcare workers undergoing repeated serological sampling: An individual-level analysis within 13 months in the ORCHESTRA cohort Giulia Collatuzzo, Giuseppe De Palma, Francesco S. Violante, Stefano Porru, Francesca Larese Filon, Eleonora Fabianova, et al. (+18)
1219 [GO] 2023―Jan―11 Safety of COVID-19 vaccination in women undergoing IVF/ICSI treatment - Clinical study and systematic review Huijun Chen, Xiaoli Zhang, Ge Lin, Fei Gong, Berthold Hocher
1220 [GO] 2023―Jan―11 Duration of immunity to SARS-CoV-2 in children after natural infection or vaccination in the omicron and pre-omicron era: A systematic review of clinical and immunological studies Danilo Buonsenso, Francesca Cusenza, Lucrezia Passadore, Francesca Bonanno, Claudia De Guido, Susanna Esposito
1221 [GO] 2023―Jan―11 The impact of cross-reactive immunity on the emergence of SARS-CoV-2 variants Robin N. Thompson, Emma Southall, Yair Daon, Francesca A. Lovell-Read, Shingo Iwami, Craig P. Thompson, Uri Obolski
1222 [GO] 2023―Jan―11 Corrigendum: Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2 Bruce D. Wines, Liriye Kurtovic, Halina M. Trist, Sandra Esparon, Ester Lopez, Klasina Chappin, et al. (+18)
1223 [GO] 2023―Jan―10 Three doses of BNT162b2 COVID-19 mRNA vaccine establish long-lasting CD8+ T cell immunity in CLL and MDS patients Susana Patricia Amaya Hernandez, Ditte Stampe Hersby, Kamilla Kjærgaard Munk, Tripti Tamhane, Darya Trubach, Maria Tagliamonte, et al. (+4)
1224 [GO] 2023―Jan―10 Persistence of salivary antibody responses after COVID-19 vaccination is associated with oral microbiome variation in both healthy and people living with HIV Mahin Ghorbani, Khaled Al-Manei, Sabrina Naud, Katie Healy, Giorgio Gabarrini, Michal Jacek Sobkowiak, et al. (+13)
1225 [GO] 2023―Jan―10 No difference in anti-spike antibody and surrogate viral neutralization following SARS-CoV-2 booster vaccination in persons with HIV compared to controls (CO-HIV Study) Kendall D. Kling, Patrick Janulis, Alexis R. Demonbreun, Amelia Sancilio, Baiba Berzins, Karen Krueger, et al. (+8)
1226 [GO] 2023―Jan―10 Editorial: SARS-CoV-2 variants, B lymphocytes, and autoreactivity Marko Z. Radic, Moncef Zouali
1227 [GO] 2023―Jan―09 Distinct systemic immune networks define severe vs. mild COVID-19 in hematologic and solid cancer patients Flávio Pignataro-Oshiro, Amanda B. Figueiredo, Nayane A. L. Galdino, Katia L. P. Morais, Walderez O. Dutra, Bianca Grassi de Miranda Silva, et al. (+9)
1228 [GO] 2023―Jan―06 Inflammatory markers and pulmonary function in adolescents and young adults 6 months after mild COVID-19 Silke Lauren Sommen, Lise Beier Havdal, Joel Selvakumar, Gunnar Einvik, Truls Michael Leegaard, Fridtjof Lund-Johansen, et al. (+6)
1229 [GO] 2023―Jan―05 SARS-CoV-2 antibody response after mRNA vaccination in healthcare workers with and without previous COVID-19, a follow-up study from a university hospital in Poland during 6 months 2021 Izabella Owsianka, Agnieszka Pac, Estera Jachowicz, Karolina Gutkowska, Wiktor Szczuciński, Barbara Maziarz, et al. (+5)
1230 [GO] 2023―Jan―05 IFI27 transcription is an early predictor for COVID-19 outcomes, a multi-cohort observational study Maryam Shojaei, Amir Shamshirian, James Monkman, Laura Grice, Minh Tran, Chin Wee Tan, et al. (+54)
1231 [GO] 2023―Jan―05 BNT162b2 COVID-19 vaccination elicited protective robust immune responses in pediatric patients with inborn errors of metabolism Tanyel Zubarioglu, Harika Oyku Dinc, Duhan Hopurcuoglu, Ruveyda Gulmez, Esma Uygur, Gizem Yilmaz, et al. (+6)
1232 [GO] 2023―Jan―05 A novel mRNA vaccine, SYS6006, against SARS-CoV-2 Ke Xu, Wenwen Lei, Bin Kang, Hanyu Yang, Yajuan Wang, Yanli Lu, et al. (+7)
1233 [GO] 2023―Jan―05 Immunodominant antibody responses directed to SARS-CoV-2 hotspot mutation sites and risk of immune escape Jamille Ramos Oliveira, Cesar Manuel Remuzgo Ruiz, Rafael Rahal Guaragna Machado, Jhosiene Yukari Magawa, Isabela Pazotti Daher, Alysson Henrique Urbanski, et al. (+16)
1234 [GO] 2023―Jan―04 Viral load and its relationship with the inflammatory response and clinical outcomes in hospitalization of patients with COVID-19 Mauricio Kuri-Ayache, Andrea Rivera-Cavazos, María Fátima Pérez-Castillo, Juan Enrique Santos-Macías, Arnulfo González-Cantú, José Antonio Luviano-García, et al. (+3)
1235 [GO] 2023―Jan―04 Major alterations to monocyte and dendritic cell subsets lasting more than 6 months after hospitalization for COVID-19 Francis R. Hopkins, Melissa Govender, Cecilia Svanberg, Johan Nordgren, Hjalmar Waller, Åsa Nilsdotter-Augustinsson, et al. (+5)
1236 [GO] 2023―Jan―04 The impact of supervised physical exercise on chemokines and cytokines in recovered COVID-19 patients Tayrine Ordonio Filgueira, Paulo Roberto Cavalcanti Carvalho, Matheus Santos de Sousa Fernandes, Angela Castoldi, Ana Maria Teixeira, Renata Bezerra de Albuquerque, et al. (+2)
1237 [GO] 2023―Jan―04 Functional changes in cytotoxic CD8+ T-cell cross-reactivity against the SARS-CoV-2 Omicron variant after mRNA vaccination Takuto Nogimori, Koichiro Suzuki, Yuji Masuta, Ayaka Washizaki, Mika Yagoto, Mami Ikeda, et al. (+8)
1238 [GO] 2023―Jan―04 Immunoinformatics design of B and T-cell epitope-based SARS-CoV-2 peptide vaccination Muhammad Shehzad Khan, Ibrar Muhammad Khan, Syed Umair Ahmad, Ishrat Rahman, Muhammad Zahoor Khan, Muhammad Shah Zeb Khan, et al. (+3)
1239 [GO] 2022―Dec―23 Computer-aided drug design combined network pharmacology to explore anti-SARS-CoV-2 or anti-inflammatory targets and mechanisms of Qingfei Paidu Decoction for COVID-19 Zixuan Wang, Jiuyu Zhan, Hongwei Gao
1240 [GO] 2022―Dec―23 Vaccine-based clinical protection against SARS-CoV-2 infection and the humoral immune response: A 1-year follow-up study of patients with multiple sclerosis receiving ocrelizumab Saskia Räuber, Alice Willison, Melanie Korsen, Tristan Kölsche, Kristin S. Golombeck, Benedikt Plaack, et al. (+16)
1241 [GO] 2022―Dec―23 Ferric carboxymaltose and SARS-CoV-2 vaccination-induced immunogenicity in kidney transplant recipients with iron deficiency: The COVAC-EFFECT randomized controlled trial Joanna Sophia J. Vinke, Dania H. A. Altulea, Michele F. Eisenga, Renate L. Jagersma, Tessa M. Niekolaas, Debbie van Baarle, et al. (+6)
1242 [GO] 2022―Dec―22 The safety of COVID-19 vaccines in patients with myasthenia gravis: A scoping review Siyang Peng, Yukun Tian, Linghao Meng, Ruiying Fang, Weiqian Chang, Yajing Yang, et al. (+4)
1243 [GO] 2022―Dec―22 Monoclonal antibodies constructed from COVID-19 convalescent memory B cells exhibit potent binding activity to MERS-CoV spike S2 subunit and other human coronaviruses Yuan Peng, Yongcheng Liu, Yabin Hu, Fangfang Chang, Qian Wu, Jing Yang, et al. (+10)
1244 [GO] 2022―Dec―22 SARS-CoV-2 booster vaccination rescues attenuated IgG1 memory B cell response in primary antibody deficiency patients Frank J. Lin, Alexa Michelle Altman Doss, Hannah G. Davis-Adams, Lucas J. Adams, Christopher H. Hanson, Laura A. VanBlargan, et al. (+24)
1245 [GO] 2022―Dec―22 Novel neutralizing chicken IgY antibodies targeting 17 potent conserved peptides identified by SARS-CoV-2 proteome microarray, and future prospects Jin Li, Te Liang, Ailian Hei, Xiangbin Wang, Huijun Li, Xiaobo Yu, et al. (+7)
1246 [GO] 2022―Dec―21 In-depth analysis of T cell immunity and antibody responses in heterologous prime-boost-boost vaccine regimens against SARS-CoV-2 and Omicron variant Natalie Heinen, Corinna Sophie Marheinecke, Clara Bessen, Arturo Blazquez-Navarro, Toralf Roch, Ulrik Stervbo, et al. (+20)
1247 [GO] 2022―Dec―21 Methotrexate inhibition of SARS-CoV-2 entry, infection and inflammation revealed by bioinformatics approach and a hamster model Yun-Ti Chen, Yu-Hsiu Chang, Nikhil Pathak, Shey-Cherng Tzou, Yong-Chun Luo, Yen-Chao Hsu, et al. (+26)
1248 [GO] 2022―Dec―21 Determinants of long COVID among adults hospitalized for SARS-CoV-2 infection: A prospective cohort study Mattia Bellan, Daria Apostolo, Alice Albè, Martina Crevola, Nicolò Errica, Giacomo Ratano, et al. (+21)
1249 [GO] 2022―Dec―19 Macrophages and γδ T cells interplay during SARS-CoV-2 variants infection Perla Abou Atmeh, Laetitia Gay, Anthony Levasseur, Bernard La Scola, Daniel Olive, Soraya Mezouar, et al. (+2)
1250 [GO] 2022―Dec―19 Can vitamin D status influence seroconversion to SARS-COV2 vaccines? Endrit Shahini, Francesco Pesce, Antonella Argentiero, Antonio Giovanni Solimando
1251 [GO] 2022―Dec―16 The relationship between chronic immune response and neurodegenerative damage in long COVID-19 José Pedro Elizalde-Díaz, Clara Leticia Miranda-Narváez, Juan Carlos Martínez-Lazcano, Eduardo Martínez-Martínez
1252 [GO] 2022―Dec―16 Dissecting CD8+ T cell pathology of severe SARS-CoV-2 infection by single-cell immunoprofiling Felix Schreibing, Monica T. Hannani, Hyojin Kim, James S. Nagai, Fabio Ticconi, Eleanor Fewings, et al. (+23)
1253 [GO] 2022―Dec―15 Targeting heat shock proteins 90 and 70: A promising remedy for both autoimmune bullous diseases and COVID-19 Michael Kasperkiewicz, Stefan Tukaj
1254 [GO] 2022―Dec―15 Markers of blood-brain barrier disruption increase early and persistently in COVID-19 patients with neurological manifestations Valentina Bonetto, Laura Pasetto, Ilaria Lisi, Marco Carbonara, Rosalia Zangari, Erica Ferrari, et al. (+23)
1255 [GO] 2022―Dec―15 Phenotypic alteration of low-density granulocytes in people with pulmonary post-acute sequalae of SARS-CoV-2 infection Logan S. Dean, Gehan Devendra, Boonyanudh Jiyarom, Natalie Subia, Michelle D. Tallquist, Vivek R. Nerurkar, et al. (+4)
1256 [GO] 2022―Dec―15 The impact on colostrum oxidative stress, cytokines, and immune cells composition after SARS-CoV-2 infection during pregnancy Nayara Gomes Graciliano, Micaely Cristinados Santos Tenório, Marilene Brandão Tenório Fragoso, Fabiana Andréa Moura, Rayane Martins Botelho, Eloiza Lopes Lira Tanabe, et al. (+4)
1257 [GO] 2022―Dec―15 The BNT162b2 vaccine induces humoral and cellular immune memory to SARS-CoV-2 Wuhan strain and the Omicron variant in children 5 to 11 years of age Bianca Laura Cinicola, E Piano Mortari, Anna Maria Zicari, Chiara Agrati, Veronica Bordoni, Christian Albano, et al. (+14)
1258 [GO] 2022―Dec―14 T cell repertoire profiling in allografts and native tissues in recipients with COVID-19 after solid organ transplantation: Insight into T cell-mediated allograft protection from viral infection Jianing Fu, Dylan Rust, Zhou Fang, Wenyu Jiao, Stephen Lagana, Ibrahim Batal, et al. (+5)
1259 [GO] 2022―Dec―14 COVID-19 and monkeypox co-infection: A rapid systematic review Amr Ehab El-Qushayri, Abdullah Reda, Jaffer Shah
1260 [GO] 2022―Dec―13 Immune responses to SARS-CoV-2 in vaccinated patients receiving checkpoint blockade immunotherapy for cancer Alexander Piening, Emily Ebert, Niloufar Khojandi, Elise Alspach, Ryan M. Teague
1261 [GO] 2022―Dec―13 Erratum: Assessment of plasma Catestatin in COVID-19 reveals a hitherto unknown inflammatory activity with impact on morbidity-mortality
1262 [GO] 2022―Dec―13 A scoping review of regulatory T cell dynamics in convalescent COVID-19 patients - indications for their potential involvement in the development of Long COVID? Simon Haunhorst, Wilhelm Bloch, Florian Javelle, Karsten Krüger, Sabine Baumgart, Sebastian Drube, et al. (+8)
1263 [GO] 2022―Dec―13 Enhanced Spike-specific, but attenuated Nucleocapsid-specific T cell responses upon SARS-CoV-2 breakthrough versus non-breakthrough infections Mohamed Ibraheem Mahmoud Ahmed, Paulina Diepers, Christian Janke, Michael Plank, Tabea M. Eser, Raquel Rubio-Acero, et al. (+15)
1264 [GO] 2022―Dec―12 Longevity of memory B cells and antibodies, as well as the polarization of effector memory helper T cells, are associated with disease severity in patients with COVID-19 in Bangladesh Marjahan Akhtar, Salima Raiyan Basher, Nuder Nower Nizam, Mohammad Kamruzzaman, Fatema Khaton, Hasan Al Banna, et al. (+23)
1265 [GO] 2022―Dec―12 Comprehensive assessment of SARS-CoV-2 antibodies against various antigenic epitopes after naive COVID-19 infection and vaccination (BNT162b2 or ChAdOx1 nCoV-19) Jihyun Lee, Dong-Gun Lee, Jin Jung, Ji Hyeong Ryu, Soyoung Shin, Sung-Yeon Cho, et al. (+2)
1266 [GO] 2022―Dec―09 Omicron variants of SARS-CoV-2 and long COVID Chengliang Yang, Hedi Zhao, Casey P. Shannon, Scott J. Tebbutt
1267 [GO] 2022―Dec―09 Humoral immune response following a third SARS-CoV-2 mRNA vaccine dose in solid organ transplant recipients compared with matched controls Daniel Balsby, Anna Christine Nilsson, Inge Petersen, Susan O. Lindvig, Jesper Rømhild Davidsen, Rozeta Abazi, et al. (+5)
1268 [GO] 2022―Dec―09 A bias of Asparagine to Lysine mutations in SARS-CoV-2 outside the receptor binding domain affects protein flexibility Jennifer C. Boer, Qisheng Pan, Jessica K. Holien, Thanh-Binh Nguyen, David B. Ascher, Magdalena Plebanski
1269 [GO] 2022―Dec―09 Pam2CSK4-adjuvanted SARS-CoV-2 RBD nanoparticle vaccine induces robust humoral and cellular immune responses Yidan Qiao, Yikang Zhan, Yongli Zhang, Jieyi Deng, Achun Chen, Bingfeng Liu, et al. (+5)
1270 [GO] 2022―Dec―09 HBD-2 variants and SARS-CoV-2: New insights into inter-individual susceptibility Mohammed Y. Behairy, Mohamed A. Soltan, Muhammad Alaa Eldeen, Jawaher A. Abdulhakim, Maryam M. Alnoman, Mohamed M. Abdel-Daim, et al. (+10)
1271 [GO] 2022―Dec―08 Involvement of the STING signaling in COVID-19 Ruoxuan Xiao, Ao Zhang
1272 [GO] 2022―Dec―08 Preclinical evaluation of safety and immunogenicity of a primary series intranasal COVID-19 vaccine candidate (BBV154) and humoral immunogenicity evaluation of a heterologous prime-boost strategy with COVAXIN (BBV152) Raju Sunagar, Sai D. Prasad, Raches Ella, Krishna Mohan Vadrevu
1273 [GO] 2022―Dec―08 Protective role of engineered extracellular vesicles loaded quercetin nanoparticles as anti-viral therapy against SARS-CoV-2 infection: A prospective review Alok Raghav, Richa Giri, Saurabh Agarwal, Sanjay Kala, Goo-Bo- Jeong
1274 [GO] 2022―Dec―07 Progress of cGAS-STING signaling in response to SARS-CoV-2 infection Yaru Wu, Min Zhang, Cui Yuan, Zhenling Ma, Wenqing Li, Yanyan Zhang, et al. (+3)
1275 [GO] 2022―Dec―07 Effect of inactivated COVID-19 vaccines on seizure frequency in patients with epilepsy: A multicenter, prospective study Xiqin Fang, Shimin Hu, Tao Han, Tingting Yang, Junji Hu, Yucheng Song, et al. (+31)
1276 [GO] 2022―Dec―06 Oral GS-441524 derivatives: Next-generation inhibitors of SARS-CoV-2 RNA-dependent RNA polymerase Zhonglei Wang, Liyan Yang, Xian-qing Song
1277 [GO] 2022―Dec―05 High titre neutralizing antibodies in response to SARS-CoV-2 infection require RBD-specific CD4 T cells that include proliferative memory cells Chansavath Phetsouphanh, Weng Hua Khoo, Katherine Jackson, Vera Klemm, Annett Howe, Anupriya Aggarwal, et al. (+22)
1278 [GO] 2022―Dec―05 COVID-19 vaccinology landscape in Africa Sara Baptista, Sanushka Naidoo, Sara Suliman, Emmanuel Nepolo, Bernard N. Kanoi, Jesse Gitaka, et al. (+2)
1279 [GO] 2022―Dec―02 Editorial: Dysregulation of immunity predisposing to severe COVID-19 infection Rabih Halwani, Federica Pulvirenti, Saleh Al-Muhsen
1280 [GO] 2022―Dec―02 COVID-19 vaccination and Atypical hemolytic uremic syndrome Romy N. Bouwmeester, Esther M.G. Bormans, Caroline Duineveld, Arjan D. van Zuilen, Anne-Els van de Logt, Jack F.M. Wetzels, Nicole C.A.J. van de Kar
1281 [GO] 2022―Dec―02 Corrigendum: Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits Sung-Hee Kim, Jiseon Kim, Ji Yun Jang, Hyuna Noh, Jisun Park, Haengdueng Jeong, et al. (+35)
1282 [GO] 2022―Dec―02 Single-cell multiomics revealed the dynamics of antigen presentation, immune response and T cell activation in the COVID-19 positive and recovered individuals Partha Chattopadhyay, Kriti Khare, Manish Kumar, Pallavi Mishra, Alok Anand, Ranjeet Maurya, et al. (+10)
1283 [GO] 2022―Dec―02 Impact of SARS-CoV-2 vaccination on systemic immune responses in people living with HIV Clara Bessen, Carlos Plaza-Sirvent, Agit Simsek, Jaydeep Bhat, Corinna Marheinecke, Doris Urlaub, et al. (+13)
1284 [GO] 2022―Dec―01 Defective antifungal immunity in patients with COVID-19 Charles Oliver Morton, James S. Griffiths, Juergen Loeffler, Selinda Orr, P. Lewis White
1285 [GO] 2022―Dec―01 Multiple sclerosis-disease modifying therapies affect humoral and T-cell response to mRNA COVID-19 vaccine Federica Dominelli, Maria Antonella Zingaropoli, Matteo Tartaglia, Eeva Tortellini, Mariasilvia Guardiani, Valentina Perri, et al. (+10)
1286 [GO] 2022―Dec―01 SARS-CoV-2 induces “cytokine storm” hyperinflammatory responses in RA patients through pyroptosis Qingcong Zheng, Rongjie Lin, Yuchao Chen, Qi Lv, Jin Zhang, Jingbo Zhai, et al. (+2)
1287 [GO] 2022―Dec―01 SARS-CoV-2 infection of phagocytic immune cells and COVID-19 pathology: Antibody-dependent as well as independent cell entry Olga Matveeva, Yury Nechipurenko, Denis Lagutkin, Yegor E. Yegorov, Julia Kzhyshkowska
1288 [GO] 2022―Dec―01 Integrated bioinformatics to identify potential key biomarkers for COVID-19-related chronic urticaria Teng Zhang, Hao Feng, Xiaoyan Zou, Shixiong Peng
1289 [GO] 2022―Nov―30 Humoral and cellular immune response and the safety of third SARS-CoV-2 mRNA vaccine with longer interval after the second vaccination in kidney transplant recipients Satoshi Takai, Hayato Nishida, Hiromi Ito, Hiroki Fukuhara, Takaaki Nawano, Takafumi Narisawa, et al. (+8)
1290 [GO] 2022―Nov―30 A highly sensitive bead-based flow cytometric competitive binding assay to detect SARS-CoV-2 neutralizing antibody activity Xiangyu Yao, Zhichao Zhang, Qingmin Mei, Shenwei Li, Li Xing, Yali Long, et al. (+8)
1291 [GO] 2022―Nov―29 Intranasal inoculation of IFN-λ resolves SARS-CoV-2 lung infection via the rapid reduction of viral burden and improvement of tissue damage Haeun Shin, Sujin Kim, Ara Jo, Jina Won, Chan Hee Gil, So Yeon Yoon, et al. (+2)
1292 [GO] 2022―Nov―28 An overview of viral mutagenesis and the impact on pathogenesis of SARS-CoV-2 variants Muhammad Zafar Irshad Khan, Adila Nazli, Hawaa Al-furas, Muhammad Imran Asad, Iqra Ajmal, Dildar Khan, et al. (+3)
1293 [GO] 2022―Nov―28 Association of COVID-19 mortality with serum selenium, zinc and copper: Six observational studies across Europe Kamil Demircan, Thilo Samson Chillon, Tommy Bracken, Ilaria Bulgarelli, Irene Campi, Gijs Du Laing, et al. (+18)
1294 [GO] 2022―Nov―25 Autoimmune hepatitis after COVID-19 vaccination Han Zheng, Ting Zhang, Yiyao Xu, Xin Lu, Xinting Sang
1295 [GO] 2022―Nov―25 SARS-CoV-2 epitopes inform future vaccination strategies Areez Shafqat, Mohamed H. Omer, Omar Ahmad, Mahnoor Niaz, Humzah S. Abdulkader, Shameel Shafqat, et al. (+6)
1296 [GO] 2022―Nov―25 Corrigendum: IgG anti-spike antibodies and surrogate neutralizing antibody levels decline faster 3 to 10 months after BNT162b2 vaccination than after SARS-CoV-2 infection in healthcare workers Bram Decru, Jan Van Elslande, Sophie Steels, Gijs Van Pottelbergh, Lode Godderis, Bram Van Holm, et al. (+4)
1297 [GO] 2022―Nov―25 Simultaneous measurement of multiple variant-specific SARS-CoV-2 neutralizing antibodies with a multiplexed flow cytometric assay Hong Liu, Stephen Varvel, Ge Chen, Joseph McConnell, Rebecca Caffrey, Marzena Galdzicka, Shahrokh Shabahang
1298 [GO] 2022―Nov―24 Profiling the B cell immune response elicited by vaccination against the respiratory virus SARS-CoV-2 Elena Pettini, Donata Medaglini, Annalisa Ciabattini
1299 [GO] 2022―Nov―24 Case report: Evolution of pulmonary manifestations and virological markers in critical COVID-19 infection in Bruton’s agammaglobulinemia Nina Rise, Toke Touborg, Ditte Helene Lundsted, Michael Dalager-Pedersen, Trine H. Mogensen
1300 [GO] 2022―Nov―24 A flow cytometry-based neutralization assay for simultaneous evaluation of blocking antibodies against SARS-CoV-2 variants Leire Egia-Mendikute, Alexandre Bosch, Endika Prieto-Fernández, Laura Vila-Vecilla, Samanta Romina Zanetti, So Young Lee, et al. (+16)
1301 [GO] 2022―Nov―23 Cellular immune states in SARS-CoV-2-induced disease Keywan Mortezaee, Jamal Majidpoor
1302 [GO] 2022―Nov―23 Humoral and cellular immune responses to Pfizer-BioNTech BNT162b2 SARS-CoV-2 vaccine in adolescents with liver transplantation: Single center experience Elena Sánchez-Zapardiel, María Alós, Pilar Nozal, Miguel González-Muñoz, Esteban Frauca-Remacha, Lucía Blanca Gavilán, et al. (+3)
1303 [GO] 2022―Nov―22 Corrigendum: A potential bioelectromagnetic method to slow down the progression and prevent the development of ultimate pulmonary fibrosis by COVID-19 Syed Muzzammil Masaud, Oliver Szasz, A. Marcell Szasz, Huma Ejaz, Rana Attique Anwar, Andras Szasz
1304 [GO] 2022―Nov―22 Innate and adaptive immune response in SARS-CoV-2 infection-Current perspectives Qiugang Zhu, Yan Xu, Ting Wang, Feiting Xie
1305 [GO] 2022―Nov―21 Platelets’ morphology, metabolic profile, exocytosis, and heterotypic aggregation with leukocytes in relation to severity and mortality of COVID-19-patients Basma A. Yasseen, Aya A. Elkhodiry, Riem M. El-Messiery, Hajar El-sayed, Malak W. Elbenhawi, Azza G. Kamel, et al. (+6)
1306 [GO] 2022―Nov―21 SARS-COV-2 infections in inborn errors of immunity: A single center study Kimberley Cousins, Nicholas DeFelice, Stephanie Jeong, Jin Feng, Ashley Sang Eun Lee, Karina Rotella, et al. (+5)
1307 [GO] 2022―Nov―21 Preparing for the next pandemic: Simulation-based deep reinforcement learning to discover and test multimodal control of systemic inflammation using repurposed immunomodulatory agents Chase Cockrell, Dale Larie, Gary An
1308 [GO] 2022―Nov―18 Transcriptomic study reveals lncRNA-mediated downregulation of innate immune and inflammatory response in the SARS-CoV-2 vaccination breakthrough infections Partha Chattopadhyay, Pallavi Mishra, Priyanka Mehta, Jyoti Soni, Rohit Gupta, Bansidhar Tarai, et al. (+2)
1309 [GO] 2022―Nov―17 Increased IL-26 associates with markers of hyperinflammation and tissue damage in patients with acute COVID-19 Eduardo I. Cardenas, Sandra Ekstedt, Krzysztof Piersiala, Marianne Petro, Agneta Karlsson, Åsa Kågedal, et al. (+3)
1310 [GO] 2022―Nov―17 Prospective longitudinal analysis of antibody response after standard and booster doses of SARS-COV2 vaccination in patients with early breast cancer Jinyong Kim, Jiyun Jeong, Chan Mi Lee, Dae-Won Lee, Chang Kyung Kang, Pyeong Gyun Choe, et al. (+6)
1311 [GO] 2022―Nov―17 Age-dependent NK cell dysfunctions in severe COVID-19 patients Cinzia Fionda, Silvia Ruggeri, Giuseppe Sciumè, Mattia Laffranchi, Isabella Quinti, Cinzia Milito, et al. (+7)
1312 [GO] 2022―Nov―17 Differentially induced immunity in buccal and nasal mucosae after vaccination for SARS-CoV-2: Prospects for mass scale immunity-screening in large populations Chrysanthi Tsamadou, Carolin Ludwig, Judith Scholz, Matthias Proffen, Janina Hägele, Immanuel Rode, et al. (+7)
1313 [GO] 2022―Nov―16 An intranasal vaccine targeting the receptor binding domain of SARS-CoV-2 elicits a protective immune response Li Chen, Haiwei Zhang, Moxuan Li, Bihao Wu, Zhe Zhang, Rui Gong
1314 [GO] 2022―Nov―16 Pathophysiological mechanisms of thrombosis in acute and long COVID-19 Haijiao Jing, Xiaoming Wu, Mengqi Xiang, Langjiao Liu, Valerie A. Novakovic, Jialan Shi
1315 [GO] 2022―Nov―16 The published trend of studies on COVID-19 and dietary supplements: Bibliometric analysis Wenzhong Hu, Yun Xu
1316 [GO] 2022―Nov―16 Heterogeneity of neutrophils and inflammatory responses in patients with COVID-19 and healthy controls Jintao Xu, Bing He, Kyle Carver, Debora Vanheyningen, Brian Parkin, Lana X. Garmire, et al. (+2)
1317 [GO] 2022―Nov―15 Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits Sung-Hee Kim, Jiseon Kim, Ji Yun Jang, Hyuna Noh, Jisun Park, Haengdueng Jeong, et al. (+35)
1318 [GO] 2022―Nov―15 Clinical characteristics of the host DNA-removed metagenomic next-generation sequencing technology for detecting SARS-CoV-2, revealing host local immune signaling and assisting genomic epidemiology Sun Zhaoyang, Song Guowei, Pan Jing, Zhou Yundong, Lu Xinhua, Wei Muyun, et al. (+3)
1319 [GO] 2022―Nov―15 Serological responses triggered by different SARS-CoV-2 vaccines against SARS-CoV-2 variants in Taiwan Chiao-Hsuan Chao, Dayna Cheng, Sheng-Wen Huang, Yung-Chun Chuang, Trai-Ming Yeh, Jen-Ren Wang
1320 [GO] 2022―Nov―14 Pilot genome-wide association study of antibody response to inactivated SARS-CoV-2 vaccines Ping Li, Dawei Shi, Wenlong Shen, Shu Shi, Xinjie Guo, Jia Li, et al. (+3)
1321 [GO] 2022―Nov―14 C-Reactive Protein (CRP): A poor prognostic biomarker in COVID-19 Mohamed Zakaria Bouayed, Ilyass Laaribi, Charaf Eddine Mohammed Chatar, Iliass Benaini, Mohammed Amine Bouazzaoui, Younes Oujidi, et al. (+5)
1322 [GO] 2022―Nov―14 Prognostic peripheral blood biomarkers at ICU admission predict COVID-19 clinical outcomes Melina Messing, Mypinder S. Sekhon, Michael R. Hughes, Sophie Stukas, Ryan L. Hoiland, Jennifer Cooper, et al. (+9)
1323 [GO] 2022―Nov―14 Dynamics of humoral immune response in SARS-CoV-2 infected individuals with different clinical stages Yorjagis Mendez-Cortina, Ana Lucía Rodriguez-Perea, Mateo Chvatal-Medina, Tulio Jose Lopera, Natalia Alvarez-Mesa, Jan Karlo Rodas-Marín, et al. (+3)
1324 [GO] 2022―Nov―14 A minimally-edited mouse model for infection with multiple SARS-CoV-2 strains Sandra Nakandakari-Higa, Roham Parsa, Bernardo S. Reis, Renan V. H. de Carvalho, Luka Mesin, Hans-Heinrich Hoffmann, et al. (+9)
1325 [GO] 2022―Nov―14 Waning of specific antibodies against Delta and Omicron variants five months after a third dose of BNT162b2 SARS-CoV-2 vaccine in elderly individuals Yun Shan Goh, Angeline Rouers, Siew-Wai Fong, Nicole Ziyi Zhuo, Pei Xiang Hor, Chiew Yee Loh, et al. (+20)
1326 [GO] 2022―Nov―14 Unbalanced networks and disturbed kinetics of serum soluble mediators associated with distinct disease outcomes in severe COVID-19 patients Gabriela Profírio Jardim-Santos, Heidi Luise Schulte, Patricia Shu Kurizky, Ciro Martins Gomes, Otávio Tolêdo Nóbrega, Eliana Teles de Gois, et al. (+19)
1327 [GO] 2022―Nov―09 Analysis of macular structure in age-related cataract patients with different antibody levels of severe acute respiratory syndrome coronavirus-2 vaccine Xiaochun Li, Xiaoguang Cao, Zhongting Pan, Xinping Sun, Yongzhen Bao
1328 [GO] 2022―Nov―09 Circular RNAs as emerging regulators in COVID-19 pathogenesis and progression Xiaojun Gao, Dan Fang, Yu Liang, Xin Deng, Ni Chen, Min Zeng, Mao Luo
1329 [GO] 2022―Nov―09 A pilot study for treatment of severe COVID-19 pneumonia by aerosolized formulation of convalescent human immune plasma exosomes (ChipEXO™) Fethi Gül, Zeynep Burcin Gonen, Olcay Y. Jones, Neslihan Pakize Taşlı, Gökmen Zararsız, Ekrem Ünal, et al. (+13)
1330 [GO] 2022―Nov―09 Development and evaluation of low-volume tests to detect and characterize antibodies to SARS-CoV-2 Alice Halliday, Anna E. Long, Holly E. Baum, Amy C. Thomas, Kathryn L. Shelley, Elizabeth Oliver, et al. (+41)
1331 [GO] 2022―Nov―09 Non-replicative antibiotic resistance-free DNA vaccine encoding S and N proteins induces full protection in mice against SARS-CoV-2 Pedro J. Alcolea, Jaime Larraga, Daniel Rodríguez-Martín, Ana Alonso, Francisco J. Loayza, José M. Rojas, et al. (+14)
1332 [GO] 2022―Nov―09 A vaccine based on the yeast-expressed receptor-binding domain (RBD) elicits broad immune responses against SARS-CoV-2 variants Yu Liu, Danhua Zhao, Yichang Wang, Zhian Chen, Li Yang, Wenjuan Li, et al. (+13)
1333 [GO] 2022―Nov―09 Immune-profiling of SARS-CoV-2 viremic patients reveals dysregulated innate immune responses Xiaoming Sun, Ce Gao, Ke Zhao, Yanhui Yang, Yelizaveta Rassadkina, Jesse Fajnzylber, et al. (+4)
1334 [GO] 2022―Nov―09 SARS-CoV-2-specific humoral and cellular immune responses to BNT162b2 vaccine in Fibrodysplasia ossificans progressiva patients Jitka Smetanova, Tomas Milota, Michal Rataj, Jana Hurnakova, Hana Zelena, Rudolf Horvath
1335 [GO] 2022―Nov―08 Safety and immunogenicity of heterologous recombinant protein subunit vaccine (ZF2001) booster against COVID-19 at 3-9-month intervals following two-dose inactivated vaccine (CoronaVac) Yuting Liao, Yingping Chen, Bo Chen, Zhenzhen Liang, Xiaosong Hu, Bo Xing, et al. (+5)
1336 [GO] 2022―Nov―07 Post-vaccination SARS-CoV-2 seroprevalence in children aged 3-11 years and the positivity in unvaccinated children: A retrospective, single-center study Jing Li, Menglei Ge, Shuzhi Dai, Qinwei Song, Weijie Liu, Ying Wang, et al. (+2)
1337 [GO] 2022―Nov―07 Bioinformatics and systems biology approaches to identify molecular targeting mechanism influenced by COVID-19 on heart failure Kezhen Yang, Jipeng Liu, Yu Gong, Yinyin Li, Qingguo Liu
1338 [GO] 2022―Nov―04 Pathophysiological conditions induced by SARS-CoV-2 infection reduce ACE2 expression in the lung Yoko Miura, Hirotsugu Ohkubo, Akiko Nakano, Jane E. Bourke, Satoshi Kanazawa
1339 [GO] 2022―Nov―03 Targeted proteomics identifies circulating biomarkers associated with active COVID-19 and post-COVID-19 Martijn Zoodsma, Aline H. de Nooijer, Inge Grondman, Manoj Kumar Gupta, Agnes Bonifacius, Valerie A. C. M. Koeken, et al. (+19)
1340 [GO] 2022―Nov―03 Exploration of blood-derived coding and non-coding RNA diagnostic immunological panels for COVID-19 through a co-expressed-based machine learning procedure Mohadeseh Zarei Ghobadi, Rahman Emamzadeh, Majid Teymoori-Rad, Elaheh Afsaneh
1341 [GO] 2022―Nov―03 Differential effects of age, sex and dexamethasone therapy on ACE2/TMPRSS2 expression and susceptibility to SARS-CoV-2 infection Shima Shahbaz, Olaide Oyegbami, Suguru Saito, Mohammed Osman, Wendy Sligl, Shokrollah Elahi
1342 [GO] 2022―Nov―02 The derived neutrophil to lymphocyte ratio can be the predictor of prognosis for COVID-19 Omicron BA.2 infected patients Weiji Qiu, Qiqing Shi, Fang Chen, Qian Wu, Xiya Yu, Lize Xiong
1343 [GO] 2022―Nov―02 SARS-CoV-2 infected children form early immune memory responses dominated by nucleocapsid-specific CD8+ T cells and antibodies Karina Lima, Julia C. Fontoura, Priscila Oliveira de Souza, Tiago Fazolo, Gabriel Hilario, Renata Zorzetto, et al. (+20)
1344 [GO] 2022―Nov―01 A 9-mRNA signature measured from whole blood by a prototype PCR panel predicts 28-day mortality upon admission of critically ill COVID-19 patients Claire Tardiveau, Guillaume Monneret, Anne-Claire Lukaszewicz, Valérie Cheynet, Elisabeth Cerrato, Katia Imhoff, et al. (+17)
1345 [GO] 2022―Nov―01 The duration and breadth of antibody responses to 3-dose of inactivated COVID-19 vaccinations in healthy blood donors: An observational study Shanhai Ou, Zehong Huang, Miaoling Lan, Jianghui Ye, Jijin Chen, Huilin Guo, et al. (+14)
1346 [GO] 2022―Oct―31 Humoral and cellular immunogenicity of COVID-19 booster dose vaccination in inflammatory arthritis patients Jakub Wroński, Bożena Jaszczyk, Leszek Roszkowski, Anna Felis-Giemza, Krzysztof Bonek, Anna Kornatka, et al. (+9)
1347 [GO] 2022―Oct―31 Evaluation of humoral and cellular response to four vaccines against COVID-19 in different age groups: A longitudinal study Giorgio Fedele, Filippo Trentini, Ilaria Schiavoni, Sergio Abrignani, Guido Antonelli, Vincenzo Baldo, et al. (+25)
1348 [GO] 2022―Oct―31 Effectiveness, safety, and immunogenicity of half dose ChAdOx1 nCoV-19 COVID-19 Vaccine: Viana project Valéria Valim, Olindo Assis Martins-Filho, Maria da Penha Gomes Gouvea, Luiz Antônio Bastos Camacho, Daniel Antunes Maciel Villela, Sheila Maria Barbosa de Lima, et al. (+9)
1349 [GO] 2022―Oct―31 Uncovering the information immunology journals transmitted for COVID-19: A bibliometric and visualization analysis Jiefeng Zhao, Jinfeng Zhu, Chao Huang, Xiaojian Zhu, Zhengming Zhu, Qinrong Wu, Rongfa Yuan
1350 [GO] 2022―Oct―31 Vitamin D supplementation for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials Lara S. Kümmel, Hanna Krumbein, Paraskevi C. Fragkou, Ben L. Hünerbein, Rieke Reiter, Konstantinos A. Papathanasiou, et al. (+4)
1351 [GO] 2022―Oct―31 Superior humoral immunity in vaccinated SARS-CoV-2 convalescence as compared to SARS-COV-2 infection or vaccination Krystallenia Paniskaki, Margarethe J. Konik, Moritz Anft, Toni L. Meister, Corinna Marheinecke, Stephanie Pfaender, et al. (+9)
1352 [GO] 2022―Oct―31 SARS-CoV-2 modulates inflammatory responses of alveolar epithelial type II cells via PI3K/AKT pathway Ahmed A. Al-Qahtani, Ioanna Pantazi, Fatimah S. Alhamlan, Hani Alothaid, Sabine Matou-Nasri, George Sourvinos, et al. (+2)
1353 [GO] 2022―Oct―31 SARS-CoV-2 tetrameric RBD protein blocks viral infection and induces potent neutralizing antibody response Zheng Liu, Chenglu Yang, Haokun Zhang, Guojie Cao, Senzhen Wang, Siwen Yin, Yanming Wang
1354 [GO] 2022―Oct―28 Long pentraxin 3 (PTX3) levels predict death, intubation and thrombotic events among hospitalized patients with COVID-19 Giuseppe Lapadula, Roberto Leone, Davide Paolo Bernasconi, Andrea Biondi, Emanuela Rossi, Mariella D’Angiò, et al. (+7)
1355 [GO] 2022―Oct―28 Blood transcriptome analysis revealed the crosstalk between COVID-19 and HIV Cheng Yan, Yandie Niu, Xuannian Wang
1356 [GO] 2022―Oct―28 SARS-CoV-2 RNAs are processed into 22-nt vsRNAs in Vero cells Yang Liu, Jian Rao, Yingjie Mi, Lan Chen, Lijuan Feng, Qi Li, et al. (+6)
1357 [GO] 2022―Oct―28 Pan-neutralizing, germline-encoded antibodies against SARS-CoV-2: Addressing the long-term problem of escape variants Justin Mark Lunderberg, Sanjucta Dutta, Ai-Ris Y. Collier, Jeng-Shin Lee, Yen-Ming Hsu, Qiao Wang, et al. (+7)
1358 [GO] 2022―Oct―27 Early pathogenesis profiles across SARS-CoV-2 variants in K18-hACE2 mice revealed differential triggers of lung damages Zhen Qin Aw, Chee Keng Mok, Yi Hao Wong, Huixin Chen, Tze Minn Mak, Raymond T. P. Lin, et al. (+3)
1359 [GO] 2022―Oct―27 CD8+ T-cell immune escape by SARS-CoV-2 variants of concern Arnaud John Kombe Kombe, Fleury Augustin Nsole Biteghe, Zélia Nelly Ndoutoume, Tengchuan Jin
1360 [GO] 2022―Oct―27 Differential activation of human neutrophils by SARS-CoV-2 variants of concern Samuel Lebourgeois, Ambroise David, Houssem Redha Chenane, Vanessa Granger, Reyene Menidjel, Nadhira Fidouh, et al. (+8)
1361 [GO] 2022―Oct―26 Translation suppression underlies the restrained COVID-19 mRNA vaccine response in the high-risk immunocompromised group Kangsan Kim, Madhusudhanan Narasimhan, Lenin Mahimainathan, Ray Zhang, Ellen Araj, Elizabeth Kim, et al. (+8)
1362 [GO] 2022―Oct―26 Association between the side effect induced by COVID-19 vaccines and the immune regulatory gene polymorphism Ding-Ping Chen, Ying-Hao Wen, Wei-Tzu Lin, Fang-Ping Hsu
1363 [GO] 2022―Oct―25 MUC22, HLA-A, and HLA-DOB variants and COVID-19 in resilient super-agers from Brazil Erick C. Castelli, Mateus V. de Castro, Michel S. Naslavsky, Marilia O. Scliar, Nayane S. B. Silva, Raphaela N. Pereira, et al. (+28)
1364 [GO] 2022―Oct―25 Fully understanding the efficacy profile of the COVID-19 vaccination and its associated factors in multiple real-world settings Yunes Panahi, Behzad Einollahi, Fatemeh Beiraghdar, Mohammad Darvishi, Saeid Fathi, Mohammad Javanbakht, et al. (+2)
1365 [GO] 2022―Oct―25 A GABA-receptor agonist reduces pneumonitis severity, viral load, and death rate in SARS-CoV-2-infected mice Jide Tian, Barbara J. Dillion, Jill Henley, Lucio Comai, Daniel L. Kaufman
1366 [GO] 2022―Oct―24 In-silico evaluation of adenoviral COVID-19 vaccination protocols: Assessment of immunological memory up to 6 months after the third dose Paola Stolfi, Filippo Castiglione, Enrico Mastrostefano, Immacolata Di Biase, Sebastiano Di Biase, Gianna Palmieri, Antonella Prisco
1367 [GO] 2022―Oct―24 Protection from COVID-19 with a VSV-based vaccine expressing the spike and nucleocapsid proteins Kyle L. O’Donnell, Tylisha Gourdine, Paige Fletcher, Chad S. Clancy, Andrea Marzi
1368 [GO] 2022―Oct―24 New-onset dermatomyositis following COVID-19: A case report Hiroshi Shimizu, Haruki Matsumoto, Tomomi Sasajima, Tomohiro Suzuki, Yoshinori Okubo, Yuya Fujita, et al. (+6)
1369 [GO] 2022―Oct―24 SARS-CoV-2 ORF8: One protein, seemingly one structure, and many functions Smita Vinjamuri, Lenong Li, Marlene Bouvier
1370 [GO] 2022―Oct―24 Short-term safety and immunogenicity of inactivated and peptide-based SARS-CoV-2 vaccines in patients with endocrine-related cancer Rui Song, Li Liu, Qingbo Pan, Jin Liu, Jiahe Tan, Juan Deng, et al. (+6)
1371 [GO] 2022―Oct―21 Humoral immunity and transcriptome differences of COVID-19 inactivated vacciane and protein subunit vaccine as third booster dose in human Yuwei Zhang, Mingxiao Yao, Xingyu Guo, Shanshan Han, Shu Zhang, Jinzhong Zhang, et al. (+8)
1372 [GO] 2022―Oct―21 Risk of COVID-19 infection, hospitalization and mortality in psoriasis patients treated with interleukin-17 inhibitors: A systematic review and meta-analysis Meitong Liu, Huijuan Wang, Lu Liu, Saijin Cui, Xiangran Huo, Zhuoyun Xiao, et al. (+4)
1373 [GO] 2022―Oct―21 Metabolic Reprogramming in SARS-CoV-2 Infection Impacts the Outcome of COVID-19 Patients Laura E. Martínez-Gómez, Isabel Ibarra-González, Cynthia Fernández-Lainez, Teresa Tusie, Hortensia Moreno-Macías, Carlos Martinez-Armenta, et al. (+30)
1374 [GO] 2022―Oct―20 Abrogation of neutrophil inflammatory pathways and potential reduction of neutrophil-related factors in COVID-19 by intravenous immunoglobulin Jorge Adrian Masso-Silva, George Sakoulas, Jarod Olay, Victoria Groysberg, Matthew Geriak, Victor Nizet, et al. (+2)
1375 [GO] 2022―Oct―20 Saliva antibody-fingerprint of reactivated latent viruses after mild/asymptomatic COVID-19 is unique in patients with myalgic-encephalomyelitis/chronic fatigue syndrome Eirini Apostolou, Muhammad Rizwan, Petros Moustardas, Per Sjögren, Bo Christer Bertilson, Björn Bragée, et al. (+2)
1376 [GO] 2022―Oct―20 The lymphatic system and COVID-19 vaccines Masayuki Miyasaka
1377 [GO] 2022―Oct―20 An update on the interaction between COVID-19, vaccines, and diabetic kidney disease Yang Yang, Shubiao Zou, Gaosi Xu
1378 [GO] 2022―Oct―20 Low perforin expression in CD8+ T lymphocytes during the acute phase of severe SARS-CoV-2 infection predicts long COVID Lucy Kundura, Renaud Cezar, Sonia André, Mauricio Campos-Mora, Claire Lozano, Thierry Vincent, et al. (+10)
1379 [GO] 2022―Oct―20 Early suppression of antiviral host response and protocadherins by SARS-CoV-2 Spike protein in THP-1-derived macrophage-like cells Noémi Miltner, Tamás Richárd Linkner, Viktor Ambrus, Aya S. Al-Muffti, Hala Ahmad, János András Mótyán, et al. (+3)
1380 [GO] 2022―Oct―19 Levels of soluble complement regulators predict severity of COVID-19 symptoms Anna L. Tierney, Wajd Mohammed Alali, Thomas Scott, Karen S. Rees-Unwin, Simon J. Clark, Richard D. Unwin
1381 [GO] 2022―Oct―19 Pre-existing humoral immunity to low pathogenic human coronaviruses exhibits limited cross-reactive antibodies response against SARS-CoV-2 in children Nina Li, XueYun Li, Jiani Wu, Shengze Zhang, Lin Zhu, Qiqi Chen, et al. (+9)
1382 [GO] 2022―Oct―18 Evolving understanding of antibody-dependent enhancement (ADE) of SARS-CoV-2 Yalong Yang, Fenghua Xu
1383 [GO] 2022―Oct―18 The IgG glycome of SARS-CoV-2 infected individuals reflects disease course and severity Sterre L. Siekman, Tamas Pongracz, Wenjun Wang, Jan Nouta, Peter G. Kremsner, Pedro Vieira da Silva-Neto, et al. (+7)
1384 [GO] 2022―Oct―17 Macrophage Boolean networks in the time of SARS-CoV-2 Ugo Avila-Ponce de León, Osbaldo Resendis-Antonio
1385 [GO] 2022―Oct―17 Galectin-9 protects humanized-ACE2 immunocompetent mice from SARS-CoV-2 infection Stephen T. Yeung, Thomas A. Premeaux, Li Du, Toshiro Niki, Satish K. Pillai, Kamal M. Khanna, Lishomwa C. Ndhlovu
1386 [GO] 2022―Oct―17 Six-month humoral immune response to inactivated COVID-19 vaccine among people living with HIV Shi Zou, Wei Guo, Songjie Wu, Fangzhao Ming, Yuting Tan, Mengmeng Wu, et al. (+2)
1387 [GO] 2022―Oct―17 HLA-C dysregulation as a possible mechanism of immune evasion in SARS-CoV-2 and other RNA-virus infections Eleonora Loi, Loredana Moi, Paola Cabras, Giulia Arduino, Giulia Costanzo, Stefano Del Giacco, et al. (+4)
1388 [GO] 2022―Oct―14 Increased prevalence of clonal hematopoiesis of indeterminate potential in hospitalized patients with COVID-19 Judith Schenz, Katharina Rump, Benedikt Hermann Siegler, Inga Hemmerling, Tim Rahmel, Jan N. Thon, et al. (+18)
1389 [GO] 2022―Oct―14 Symptomatology during previous SARS-CoV-2 infection and serostatus before vaccination influence the immunogenicity of BNT162b2 COVID-19 mRNA vaccine Sabryna Nantel, Benoîte Bourdin, Kelsey Adams, Julie Carbonneau, Henintsoa Rabezanahary, Marie-Ève Hamelin, et al. (+11)
1390 [GO] 2022―Oct―13 Long-term cellular immune response in immunocompromised unvaccinated COVID-19 patients undergoing monoclonal antibody treatment Laura Thümmler, Margarethe Konik, Monika Lindemann, Neslinur Fisenkci, Michael Koldehoff, Anja Gäckler, et al. (+10)
1391 [GO] 2022―Oct―13 Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseases Catherine E. Raptis, Christoph T. Berger, Adrian Ciurea, Diego O. Andrey, Christos Polysopoulos, Pierre Lescuyer, et al. (+10)
1392 [GO] 2022―Oct―13 Brief Research Report: Serum clara cell 16 kDa protein levels are increased in patients hospitalized for severe SARS-CoV-2 or sepsis infection Nathalie Rohmann, Paula Stürmer, Corinna Geisler, Kristina Schlicht, Katharina Hartmann, Kathrin Türk, et al. (+8)
1393 [GO] 2022―Oct―12 SARS-CoV-2 specific antibody trajectories in mothers and infants over two months following maternal infection Melanie A. Martin, Monica Keith, Ryan M. Pace, Janet E. Williams, Sylvia H. Ley, Celestina Barbosa-Leiker, et al. (+13)
1394 [GO] 2022―Oct―12 Humoral response and neutralising capacity at 6 months post-vaccination against COVID-19 among institutionalised older adults in Argentina Pamela E. Rodriguez, Andrea P. Silva, Esteban A. Miglietta, Pablo Rall, Carla A. Pascuale, Christian Ballejo, et al. (+14)
1395 [GO] 2022―Oct―12 COVID-19 vaccination influences subtypes of γδ-T cells during pregnancy Li Wang, Jiawei Li, Silin Jiang, Yan Li, Rong Guo, Yuyuan Chen, et al. (+8)
1396 [GO] 2022―Oct―12 Booster dose of mRNA vaccine augments waning T cell and antibody responses against SARS-CoV-2 Feyza Gül Özbay Kurt, Alisa Lepper, Catharina Gerhards, Mathis Roemer, Samantha Lasser, Ihor Arkhypov, et al. (+7)
1397 [GO] 2022―Oct―12 Factors influencing the SARS-CoV-2 infection and vaccination induced immune response in rheumatoid arthritis Dora Nemeth, Hajnalka Vago, Laszlo Tothfalusi, Zsuzsanna Ulakcsai, David Becker, Zsofia Szabo, et al. (+3)
1398 [GO] 2022―Oct―12 Serum angiotensin-converting enzyme 2 as a potential biomarker for SARS-CoV-2 infection and vaccine efficacy Matthew P. Lennol, María-Salud García-Ayllón, Mariano Esteban, Juan García-Arriaza, Javier Sáez-Valero
1399 [GO] 2022―Oct―11 Comparing the B and T cell-mediated immune responses in patients with type 2 diabetes receiving mRNA or inactivated COVID-19 vaccines Chi-Ho Lee, Victor Gray, Jia Ming Nickolas Teo, Anthony Raymond Tam, Carol Ho-Yi Fong, David Tak-Wai Lui, et al. (+5)
1400 [GO] 2022―Oct―10 Adaptive immunity to SARS-CoV-2 infection: A systematic review Marcos Jessé Abrahão Silva, Layana Rufino Ribeiro, Karla Valéria Batista Lima, Luana Nepomuceno Gondim Costa Lima
1401 [GO] 2022―Oct―10 Adherence to Sars-CoV2 vaccination in hematological patients Justine Narinx, Margaux Houbiers, Laurence Seidel, Yves Beguin
1402 [GO] 2022―Oct―07 Changes in the urinary proteome before and after quadrivalent influenza vaccine and COVID-19 vaccination Xuanzhen Pan, Yongtao Liu, Yijin Bao, Lilong Wei, Youhe Gao
1403 [GO] 2022―Oct―06 Cytokine levels associated with favorable clinical outcome in the CAPSID randomized trial of convalescent plasma in patients with severe COVID-19 Sixten Körper, Eva Vanessa Schrezenmeier, Hector Rincon-Arevalo, Beate Grüner, Daniel Zickler, Manfred Weiss, et al. (+19)
1404 [GO] 2022―Oct―06 Sustaining surveillance as an intervention during the COVID-19 pandemic in Cabo Verde and implications for malaria elimination Adilson DePina, Helga Barros, Amanda Tiffany, Gillian Stresman
1405 [GO] 2022―Oct―06 Severe COVID-19 patients display hyper-activated NK cells and NK cell-platelet aggregates Bert Malengier-Devlies, Jessica Filtjens, Kourosh Ahmadzadeh, Bram Boeckx, Jessica Vandenhaute, Amber De Visscher, et al. (+21)
1406 [GO] 2022―Oct―06 Divergent SARS-CoV-2-specific T cell responses in intensive care unit workers following mRNA COVID-19 vaccination Estefanía Salgado Del Riego, María Laura Saiz, Viviana Corte-Iglesias, Blanca Leoz Gordillo, Cristina Martin-Martin, Mercedes Rodríguez-Pérez, et al. (+3)
1407 [GO] 2022―Oct―06 Coronavirus disease 2019 vaccination uptake and hesitancy among Polish patients with inborn errors of immunity, autoinflammatory syndromes, and rheumatic diseases: A multicenter survey Ewa Więsik-Szewczyk, Marcin Ziętkiewicz, Agata Będzichowska, Katarzyna Napiórkowska-Baran, Aleksandra Matyja-Bednarczyk, Anna Felis-Giemza, Karina Jahnz-Różyk
1408 [GO] 2022―Oct―06 The interplay between the airway epithelium and tissue macrophages during the SARS-CoV-2 infection Emilia Barreto-Duran, Artur Szczepański, Adrianna Gałuszka-Bulaga, Marcin Surmiak, Maciej Siedlar, Marek Sanak, et al. (+4)
1409 [GO] 2022―Oct―06 Corrigendum: Case report: Persistence of residual antigen and RNA of the SARS-CoV-2 virus in tissues of two patients with long COVID Denise Goh, Jeffrey Chun Tatt Lim, Sonia Bilbao Fernaíndez, Craig Ryan Joseph, Sara Gil Edwards, Zhen Wei Neo, et al. (+4)
1410 [GO] 2022―Oct―05 Association between immunosuppressants and poor antibody responses to SARS-CoV-2 vaccines in patients with autoimmune liver diseases Hu Li, Yuting Wang, Ling Ao, Mingxia Ke, Zhiwei Chen, Min Chen, et al. (+6)
1411 [GO] 2022―Oct―04 Evidence for the heterologous benefits of prior BCG vaccination on COVISHIELD™ vaccine-induced immune responses in SARS-CoV-2 seronegative young Indian adults Srabanti Rakshit, Vasista Adiga, Asma Ahmed, Chaitra Parthiban, Nirutha Chetan Kumar, Pratibha Dwarkanath, et al. (+19)
1412 [GO] 2022―Oct―04 Development and validation of multivariable prediction models of serological response to SARS-CoV-2 vaccination in kidney transplant recipients Bilgin Osmanodja, Johannes Stegbauer, Marta Kantauskaite, Lars Christian Rump, Andreas Heinzel, Roman Reindl-Schwaighofer, et al. (+11)
1413 [GO] 2022―Oct―04 A ubiquitous bone marrow reservoir of preexisting SARS-CoV-2-reactive memory CD4+ T lymphocytes in unexposed individuals Jinchan Li, Simon Reinke, Yu Shen, Lena Schollmeyer, Yuk-Chien Liu, Zixu Wang, et al. (+11)
1414 [GO] 2022―Oct―04 Comprehensive single cell analysis of pandemic influenza A virus infection in the human airways uncovers cell-type specific host transcriptional signatures relevant for disease progression and pathogenesis Jenna N. Kelly, Laura Laloli, Philip V’kovski, Melle Holwerda, Jasmine Portmann, Volker Thiel, Ronald Dijkman
1415 [GO] 2022―Oct―04 Safety and immunogenicity of intradermal administration of fractional dose CoronaVac®, ChAdOx1 nCoV-19 and BNT162b2 as primary series vaccination Somr Chatsiricharoenkul, Suvimol Niyomnaitham, Harry Joshua Posen, Zheng Quan Toh, Paul V. Licciardi, Patimaporn Wongprompitak, et al. (+4)
1416 [GO] 2022―Oct―03 Distinct responses of newly identified monocyte subsets to advanced gastrointestinal cancer and COVID-19 Alessandra Rigamonti, Alessandra Castagna, Marika Viatore, Federico Simone Colombo, Sara Terzoli, Clelia Peano, et al. (+2)
1417 [GO] 2022―Oct―03 Maternal, fetal and neonatal outcomes among pregnant women receiving COVID-19 vaccination: The preg-co-vax study Annamaria Mascolo, Gabriella di Mauro, Federica Fraenza, Mario Gaio, Alessia Zinzi, Ciro Pentella, et al. (+3)
1418 [GO] 2022―Oct―03 MIS-C: A COVID-19-as sociated condition between hypoimmunity and hyperimmunity Monica Gelzo, Alice Castaldo, Antonietta Giannattasio, Giulia Scalia, Maddalena Raia, Maria Valeria Esposito, et al. (+7)
1419 [GO] 2022―Oct―03 A randomized clinical trial to stimulate the cholinergic anti-inflammatory pathway in patients with moderate COVID-19-pneumonia using a slow-paced breathing technique Elisabeth Maria Balint, Beate Grüner, Sophia Haase, Mandakini Kaw-Geppert, Julian F. Thayer, Harald Gündel, Marc N. Jarczok
1420 [GO] 2022―Oct―03 Vaccine models predict rules for updating vaccines against evolving pathogens such as SARS-CoV-2 and influenza in the context of pre-existing immunity Rajat Desikan, Susanne L. Linderman, Carl Davis, Veronika I. Zarnitsyna, Hasan Ahmed, Rustom Antia
1421 [GO] 2022―Oct―03 SARS-CoV-2-Specific IgG and IgA response in maternal blood and breastmilk of vaccinated naïve and convalescent lactating participants Yesica Longueira, Diego S. Ojeda, Rocio B. Antivero Battistelli, Lautaro Sanchez, Santiago Oviedo Rouco, Daniel Albano, et al. (+4)
1422 [GO] 2022―Oct―03 Fast-track development of vaccines for SARS-CoV-2: The shots that saved the world Vivek P. Chavda, Qian Yao, Lalitkumar K. Vora, Vasso Apostolopoulos, Chirag A. Patel, Rajashri Bezbaruah, et al. (+2)
1423 [GO] 2022―Sep―30 Dysfunctional purinergic signaling correlates with disease severity in COVID-19 patients Anna Julia Pietrobon, Roberta Andrejew, Ricardo Wesley Alberca Custódio, Luana de Mendonça Oliveira, Juliete Nathali Scholl, Franciane Mouradian Emidio Teixeira, et al. (+13)
1424 [GO] 2022―Sep―30 Determinants of anti-S immune response at 6 months after COVID-19 vaccination in a multicentric European cohort of healthcare workers - ORCHESTRA project Giulia Collatuzzo, Giovanni Visci, Francesco S. Violante, Stefano Porru, Gianluca Spiteri, Maria Grazia Lourdes Monaco, et al. (+16)
1425 [GO] 2022―Sep―30 SARS-CoV-2 antibody responses before and after a third dose of the BNT162b2 vaccine in Italian healthcare workers aged ≤60 years: One year of surveillance Monica Franzese, Luigi Coppola, Romina Silva, Stefano Angelo Santini, Luigi Cinquanta, Cosimo Ottomano, et al. (+2)
1426 [GO] 2022―Sep―30 SARS-CoV-2 variants Alpha, Beta, Delta and Omicron show a slower host cell interferon response compared to an early pandemic variant Larissa Laine, Marika Skön, Elina Väisänen, Ilkka Julkunen, Pamela Österlund
1427 [GO] 2022―Sep―29 Single cell meta-analysis of EndMT and EMT state in COVID-19 Lanlan Zhang, Chuang Tang, Min Zhang, Xia Tong, Yingying Xie, Ruitong Yan, et al. (+4)
1428 [GO] 2022―Sep―29 The impact of platelets on pulmonary microcirculation throughout COVID-19 and its persistent activating factors Mengqi Xiang, Xiaoming Wu, Haijiao Jing, Langjiao Liu, Chunxu Wang, Yufeng Wang, et al. (+2)
1429 [GO] 2022―Sep―29 Neutralization effect of plasma from vaccinated COVID-19 convalescents on SARS-CoV-2 Omicron variants Yudi Xie, Lei Liu, Jue Wang, Yaqiong Zheng, Chen Luo, Wenxu Ni, et al. (+7)
1430 [GO] 2022―Sep―29 Persistent but dysfunctional mucosal SARS-CoV-2-specific IgA and low lung IL-1β associate with COVID-19 fatal outcome: A cross-sectional analysis Maria Julia Ruiz, Gabriel Siracusano, Andréa Cottignies-Calamarte, Daniela Tudor, Fernando Real, Aiwei Zhu, et al. (+15)
1431 [GO] 2022―Sep―29 Assessment of plasma Catestatin in COVID-19 reveals a hitherto unknown inflammatory activity with impact on morbidity-mortality Francis Schneider, Pierrick Le Borgne, Jean-Etienne Herbrecht, François Danion, Morgane Solis, Sophie Hellé, et al. (+6)
1432 [GO] 2022―Sep―29 Case report: Bilateral panuveitis resembling Vogt-Koyanagi-Harada disease after second dose of BNT162b2 mRNA COVID-19 vaccine Tomohito Sato, Ryotaro Nihei, Daisuke Sora, Yoshiaki Nishio, Masaru Takeuchi
1433 [GO] 2022―Sep―29 Immunological study of COVID-19 vaccine candidate based on recombinant spike trimer protein from different SARS-CoV-2 variants of concern Erika Rudi, Pablo Martin Aispuro, Eugenia Zurita, Maria M. Gonzalez Lopez Ledesma, Daniela Bottero, Juan Malito, et al. (+7)
1434 [GO] 2022―Sep―29 Early immunological responses to the mRNA SARS-CoV-2 vaccine in patients with neuromuscular disorders Hideyuki Iwayama, Naoko Ishihara, Kohei Kawahara, Yuta Madokoro, Yasuko Togawa, Kanji Muramatsu, et al. (+8)
1435 [GO] 2022―Sep―29 The third dose of mRNA SARS-CoV-2 vaccines enhances the spike-specific antibody and memory B cell response in myelofibrosis patients Fabio Fiorino, Annalisa Ciabattini, Anna Sicuranza, Gabiria Pastore, Adele Santoni, Martina Simoncelli, et al. (+7)
1436 [GO] 2022―Sep―28 Correlation of antigen-specific immune response with disease severity among COVID-19 patients in Bangladesh Taufiqur Rahman Bhuiyan, Hasan Al Banna, M. Hasanul Kaisar, Polash Chandra Karmakar, Al Hakim, Afroza Akter, et al. (+14)
1437 [GO] 2022―Sep―28 Coagulation parameters predict COVID-19-related thrombosis in a neural network with a positive predictive value of 98% Romy de Laat-Kremers, Raf De Jongh, Marisa Ninivaggi, Aernoud Fiolet, Rob Fijnheer, Jasper Remijn, Bas de Laat
1438 [GO] 2022―Sep―28 Metabolomics-based investigation of SARS-CoV-2 vaccination (Sinovac) reveals an immune-dependent metabolite biomarker Maozhang He, Yixuan Huang, Yun Wang, Jiling Liu, Maozhen Han, Yixuan Xiao, et al. (+6)
1439 [GO] 2022―Sep―28 Atypical hemolytic uremic syndrome triggered by mRNA vaccination against SARS-CoV-2: Case report Romana Rysava, Martina Peiskerova, Vladimir Tesar, Jan Benes, Martin Kment, Ágnes Szilágyi, et al. (+2)
1440 [GO] 2022―Sep―27 N-3 polyunsaturated fatty acids may affect the course of COVID-19 Barbora Lampova, Ivo Doskocil, Lenka Kourimska, Aneta Kopec
1441 [GO] 2022―Sep―27 Time evolution of cytokine profiles associated with mortality in COVID-19 hospitalized patients Laura Sánchez-de Prada, Óscar Gorgojo-Galindo, Inmaculada Fierro, Ana María Martínez-García, Guillermo Sarmentero-López de Quintana, Rocío Gutiérrez-Bustillo, et al. (+6)
1442 [GO] 2022―Sep―27 Prophylactic treatment of Glycyrrhiza glabra mitigates COVID-19 pathology through inhibition of pro-inflammatory cytokines in the hamster model and NETosis Zaigham Abbas Rizvi, Prabhakar Babele, Srikanth Sadhu, Upasna Madan, Manas Ranjan Tripathy, Sandeep Goswami, et al. (+4)
1443 [GO] 2022―Sep―27 COVID-19 vaccine hesitancy and associated factors among infertile couples undergoing assisted reproductive treatment Xinyan Wang, Huiyan Wang, Aijun Du, Junchao Wang, Jie Shi, Yunshan Zhang, et al. (+5)
1444 [GO] 2022―Sep―27 Maternal and neonatal immune response to SARS-CoV-2, IgG transplacental transfer and cytokine profile Rocío Rubio, Ruth Aguilar, Mariona Bustamante, Erica Muñoz, Miquel Vázquez-Santiago, Rebeca Santano, et al. (+11)
1445 [GO] 2022―Sep―27 OX40 agonist stimulation increases and sustains humoral and cell-mediated responses to SARS-CoV-2 protein and saRNA vaccines Rebekka Duhen, Michael Beymer, Shawn M. Jensen, Srinivas Abbina, Suraj Abraham, Nikita Jain, et al. (+5)
1446 [GO] 2022―Sep―27 3’UTR of SARS-CoV-2 spike gene hijack host miR-296 or miR-520h to disturb cell proliferation and cytokine signaling Jinjin Yuan, Ziheng Feng, Qiaowen Wang, Lifen Han, Shenchan Guan, Lijuan Liu, et al. (+3)
1447 [GO] 2022―Sep―26 Low baseline IFN-γ response could predict hospitalization in COVID-19 patients Marion Cremoni, Jonathan Allouche, Daisy Graça, Kevin Zorzi, Céline Fernandez, Maxime Teisseyre, et al. (+9)
1448 [GO] 2022―Sep―26 Public awareness should be raised on a crucial but neglected factor for COVID-19 vaccination Hao Yuan, Yining Song, Xiu-Xiang Zhang, Jingbo Zhai, Jin Zhang, Zi-Guo Yuan
1449 [GO] 2022―Sep―26 SARS-CoV-2 IgG spike protein antibody response in mRNA-1273 Moderna® vaccinated patients on maintenance immunoapheresis - a cohort study Martina Gaggl, Constantin Aschauer, Christof Aigner, Gregor Bond, Andreas Vychytil, Robert Strassl, et al. (+3)
1450 [GO] 2022―Sep―26 Severity of SARS-CoV-2 infection is associated with high numbers of alveolar mast cells and their degranulation Olga Krysko, Joshua H. Bourne, Elena Kondakova, Elena A. Galova, Katharine Whitworth, Maddy L. Newby, et al. (+11)
1451 [GO] 2022―Sep―26 Comparative analysis of the neutralizing activity against SARS-CoV-2 Wuhan-Hu-1 strain and variants of concern: Performance evaluation of a pseudovirus-based neutralization assay Luciana D’Apice, Maria Trovato, Giulia Gramigna, Francesca Colavita, Massimo Francalancia, Giulia Matusali, et al. (+8)
1452 [GO] 2022―Sep―23 Single-nucleus RNA sequencing reveals the shared mechanisms inducing cognitive impairment between COVID-19 and Alzheimer’s disease Yifan Fu, Zhirong Guo, Yulin Wang, Haonan Zhang, Feifan Zhang, Zihao Xu, et al. (+6)
1453 [GO] 2022―Sep―23 Frontline workers: Mediators of mucosal immunity in community acquired pneumonia and COVID-19 Priyanka S. Hastak, Christopher R. Andersen, Anthony D. Kelleher, Sarah C. Sasson
1454 [GO] 2022―Sep―23 Impact of vaccination on hospitalization and mortality from COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience Adrian M. Shields, Susan Tadros, Adam Al-Hakim, Jeremy M. Nell, Me Me Nay Lin, Michele Chan, et al. (+17)
1455 [GO] 2022―Sep―23 COVID-19 in unvaccinated patients with inborn errors of immunity-polish experience Sylwia Kołtan, Marcin Ziętkiewicz, Elżbieta Grześk, Rafał Becht, Elżbieta Berdej-Szczot, Magdalena Cienkusz, et al. (+23)
1456 [GO] 2022―Sep―23 Real-world effectiveness and protection of SARS-CoV-2 vaccine among patients hospitalized for COVID-19 in Xi’an, China, December 8, 2021, to January 20, 2022: A retrospective study Xiaowei Li, Yinjuan Xu, Xiaomeng Li, Wenbin Liu, Dan Yao, Weichao Chen, et al. (+6)
1457 [GO] 2022―Sep―23 Lymphocyte-C-reactive protein ratio can differentiate disease severity of COVID-19 patients and serve as an assistant screening tool for hospital and ICU admission Jian-Nan Zhang, Yang Gao, Xin-Tong Wang, Na-Na Li, Xue Du, Yu-Jia Tang, et al. (+6)
1458 [GO] 2022―Sep―23 Kinetics of vaccine-induced neutralizing antibody titers and estimated protective immunity against wild-type SARS-CoV-2 and the Delta variant: A prospective nationwide cohort study comparing three COVID-19 vaccination protocols in South Korea Eliel Nham, Jae-Hoon Ko, Kyoung-Ho Song, Ju-Yeon Choi, Eu Suk Kim, Hye-Jin Kim, et al. (+20)
1459 [GO] 2022―Sep―23 Immunogenicity of two COVID-19 vaccines used in India: An observational cohort study in health care workers from a tertiary care hospital Vidya Arankalle, Archana Kulkarni-Munje, Ruta Kulkarni, Sonali Palkar, Rahul Patil, Jitendra Oswal, et al. (+2)
1460 [GO] 2022―Sep―23 Bioinformatics and systems-biology analysis to determine the effects of Coronavirus disease 2019 on patients with allergic asthma Hongwei Fang, Zhun Sun, Zhouyi Chen, Anning Chen, Donglin Sun, Yan Kong, et al. (+2)
1461 [GO] 2022―Sep―23 Reaction of SARS-CoV-2 antibodies with other pathogens, vaccines, and food antigens Aristo Vojdani, Elroy Vojdani, Ashley L. Melgar, Joshua Redd
1462 [GO] 2022―Sep―23 Outcome of SARS-CoV-2 infection among patients with common variable immunodeficiency and a matched control group: A Danish nationwide cohort study Terese L. Katzenstein, Line D. Rasmussen, Camilla Helberg Drabe, Carsten Schade Larsen, Ann-Brit Eg Hansen, Mette Stærkind, et al. (+3)
1463 [GO] 2022―Sep―23 Discovery and characterization of SARS-CoV-2 reactive and neutralizing antibodies from humanized CAMouseHG mice through rapid hybridoma screening and high-throughput single-cell V(D)J sequencing Xi Yang, Hang Chi, Meng Wu, Zhenshan Wang, Qiaoli Lang, Qiuxue Han, et al. (+14)
1464 [GO] 2022―Sep―22 Multiplex protein profiling of bronchial aspirates reveals disease-, mortality- and respiratory sequelae-associated signatures in critically ill patients with ARDS secondary to SARS-CoV-2 infection Marta Molinero, Silvia Gómez, Iván D. Benítez, J. J. Vengoechea, Jessica González, Dinora Polanco, et al. (+22)
1465 [GO] 2022―Sep―20 Blood gene expression predicts intensive care unit admission in hospitalised patients with COVID-19 Rebekah Penrice-Randal, Xiaofeng Dong, Andrew George Shapanis, Aaron Gardner, Nicholas Harding, Jelmer Legebeke, et al. (+14)
1466 [GO] 2022―Sep―20 Neither COVID-19, nor cryopreservation, prevented allogeneic product infusion: A report from the National Marrow Donor Program Nosha Farhadfar, Jeni Newman, Jennifer Novakovich, Jacklyn Barten, Eric T. Ndifon, Jason Oakes, et al. (+6)
1467 [GO] 2022―Sep―20 Complement and endothelial cell activation in COVID-19 patients compared to controls with suspected SARS-CoV-2 infection: A prospective cohort study Flavio Bruni, Panteleimon Charitos, Maurin Lampart, Stephan Moser, Martin Siegemund, Roland Bingisser, et al. (+6)
1468 [GO] 2022―Sep―20 Potential of conserved antigenic sites in development of universal SARS-like coronavirus vaccines Siling Wang, Dinghui Wu, Hualong Xiong, Juan Wang, Zimin Tang, Zihao Chen, et al. (+14)
1469 [GO] 2022―Sep―20 Saliva is suitable for SARS-CoV-2 antibodies detection after vaccination: A rapid systematic review Eliete Neves Silva Guerra, Vitória Tavares de Castro, Juliana Amorim dos Santos, Ana Carolina Acevedo, Hélène Chardin
1470 [GO] 2022―Sep―20 Proteomic insights into SARS-CoV-2 infection mechanisms, diagnosis, therapies and prognostic monitoring methods Shengman Yu, Xiaoyan Li, Zhuoyuan Xin, Liyuan Sun, Jingwei Shi
1471 [GO] 2022―Sep―20 The impact of CoronaVac on the neutralization breadth and magnitude of the antibody response to SARS-CoV-2 viruses Lu Zhang, Hongquan Chen, Su Yang, Yang Zhao, Xiaoyun Shen, Xiaowen He, et al. (+5)
1472 [GO] 2022―Sep―20 The need for more holistic immune profiling in next-generation SARS-CoV-2 vaccine trials Robert L. Murphy, Eustache Paramithiotis, Scott Sugden, Todd Chermak, Bruce Lambert, Damien Montamat-Sicotte, et al. (+2)
1473 [GO] 2022―Sep―16 Prospects of animal models and their application in studies on adaptive immunity to SARS-CoV-2 Xiaohui Wei, Na Rong, Jiangning Liu
1474 [GO] 2022―Sep―16 Isolation of an escape-resistant SARS-CoV-2 neutralizing nanobody from a novel synthetic nanobody library Dmitri Dormeshkin, Michail Shapira, Simon Dubovik, Anton Kavaleuski, Mikalai Katsin, Alexandr Migas, et al. (+2)
1475 [GO] 2022―Sep―16 Immunogenicity and safety of two-dose SARS-CoV-2 vaccination via different platforms in kidney transplantation recipients Chien-Chia Chen, Yi-Jen Huang, Mei-Jun Lai, Min-Huey Lin, Wei-Chou Lin, Hui-Ying Lin, et al. (+5)
1476 [GO] 2022―Sep―16 Bioinformatics and systems biology approach to identify the pathogenetic link of Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Yongbiao Lv, Tian Zhang, Junxiang Cai, Chushuan Huang, Shaofeng Zhan, Jianbo Liu
1477 [GO] 2022―Sep―16 Can exercise attenuate the negative effects of long COVID syndrome on brain health? Wei-Peng Teo, Alicia M. Goodwill
1478 [GO] 2022―Sep―15 Autoantibodies during infectious diseases: Lessons from malaria applied to COVID-19 and other infections Juan Rivera-Correa, Ana Rodriguez
1479 [GO] 2022―Sep―15 Tissue-specific pathway activities: A retrospective analysis in COVID-19 patients Nhung Pham, Finterly Hu, Chris T. Evelo, Martina Kutmon
1480 [GO] 2022―Sep―15 COVID-19 patients exhibit unique transcriptional signatures indicative of disease severity Andrea R. Daamen, Prathyusha Bachali, Catherine A. Bonham, Lindsay Somerville, Jeffrey M. Sturek, Amrie C. Grammer, et al. (+2)
1481 [GO] 2022―Sep―15 IFI44 is an immune evasion biomarker for SARS-CoV-2 and Staphylococcus aureus infection in patients with RA Qingcong Zheng, Du Wang, Rongjie Lin, Qi Lv, Wanming Wang
1482 [GO] 2022―Sep―15 Frequency of positive antiphospholipid antibodies in pregnant women with SARS-CoV-2 infection and impact on pregnancy outcome: A single-center prospective study on 151 pregnancies Giorgia Ingrid Gozzoli, Elda Piovani, Beatrice Negri, Margaret Mascherpa, Rossana Orabona, Cristina Zanardini, et al. (+9)
1483 [GO] 2022―Sep―14 Circulating pyruvate is a potent prognostic marker for critical COVID-19 outcomes Victòria Ceperuelo-Mallafré, Laia Reverté, Joaquim Peraire, Ana Madeira, Elsa Maymó-Masip, Miguel López-Dupla, et al. (+10)
1484 [GO] 2022―Sep―14 Reactogenicity and immunogenicity of the second COVID-19 vaccination in patients with inborn errors of immunity or mannan-binding lectin deficiency Lisa Göschl, Daniel Mrak, Katharina Grabmeier-Pfistershammer, Karin Stiasny, Helmuth Haslacher, Lisa Schneider, et al. (+10)
1485 [GO] 2022―Sep―14 Preclinical characterization of amubarvimab and romlusevimab, a pair of non-competing neutralizing monoclonal antibody cocktail, against SARS-CoV-2 Yun Ji, Qi Zhang, Lin Cheng, Jiwan Ge, Ruoke Wang, Mengqi Fang, et al. (+14)
1486 [GO] 2022―Sep―14 Immunogenicity profiling and distinct immune response in liver transplant recipients vaccinated with SARS-CoV-2 inactivated vaccines Binwei Duan, Gongming Zhang, Wenjing Wang, Jiming Yin, Mengcheng Liu, Jing Zhang, et al. (+3)
1487 [GO] 2022―Sep―14 SARS-CoV-2 neutralizing camelid heavy-chain-only antibodies as powerful tools for diagnostic and therapeutic applications Anja Schlör, Stefan Hirschberg, Ghada Ben Amor, Toni Luise Meister, Prerna Arora, Stefan Pöhlmann, et al. (+5)
1488 [GO] 2022―Sep―14 SP-A binding to the SARS-CoV-2 spike protein using hybrid quantum and classical in silico modeling and molecular pruning by Quantum Approximate Optimization Algorithm (QAOA) Based MaxCut with ZDOCK Sona Aramyan, Kirk McGregor, Samarth Sandeep, Angela Haczku
1489 [GO] 2022―Sep―14 Engineering the common cold to be a live-attenuated SARS-CoV-2 vaccine Laura M. Kasman
1490 [GO] 2022―Sep―13 Capillary leak syndrome following COVID-19 vaccination: Data from the European pharmacovigilance database Eudravigilance Rosanna Ruggiero, Nunzia Balzano, Raffaella Di Napoli, Annamaria Mascolo, Pasquale Maria Berrino, Concetta Rafaniello, et al. (+3)
1491 [GO] 2022―Sep―13 Efficacy, immunogenicity and safety of COVID-19 vaccines in older adults: a systematic review and meta-analysis Zejun Li, Shouhuan Liu, Fengming Li, Yifeng Li, Yilin Li, Pu Peng, et al. (+3)
1492 [GO] 2022―Sep―13 Effects of SARS-CoV-2 Alpha, Beta, and Delta variants, age, vaccination, and prior infection on infectiousness of SARS-CoV-2 infections Suelen H. Qassim, Mohammad R. Hasan, Patrick Tang, Hiam Chemaitelly, Houssein H. Ayoub, Hadi M. Yassine, et al. (+18)
1493 [GO] 2022―Sep―13 The regulation of ISG20 expression on SARS-CoV-2 infection in cancer patients and healthy individuals Jingliang Cheng, Jiewen Fu, Qi Tan, Zhiying Liu, Kan Guo, Lianmei Zhang, et al. (+5)
1494 [GO] 2022―Sep―13 SARS-CoV-2 modulates virus receptor expression in placenta and can induce trophoblast fusion, inflammation and endothelial permeability Chiara Agostinis, Miriam Toffoli, Mariagiulia Spazzapan, Andrea Balduit, Gabriella Zito, Alessandro Mangogna, et al. (+11)
1495 [GO] 2022―Sep―13 SARS-CoV-2 Nsp14 protein associates with IMPDH2 and activates NF-κB signaling Tai-Wei Li, Adam D. Kenney, Jun-Gyu Park, Guillaume N. Fiches, Helu Liu, Dawei Zhou, et al. (+7)
1496 [GO] 2022―Sep―12 Case report: Understanding the impact of persistent tissue-localization of SARS-CoV-2 on immune response activity via spatial transcriptomic analysis of two cancer patients with COVID-19 co-morbidity Mai Chan Lau, Yang Yi, Denise Goh, Chun Chau Lawrence Cheung, Benedict Tan, Jeffrey Chun Tatt Lim, et al. (+20)
1497 [GO] 2022―Sep―12 Intranasal administration of a single dose of MVA-based vaccine candidates against COVID-19 induced local and systemic immune responses and protects mice from a lethal SARS-CoV-2 infection Patricia Pérez, David Astorgano, Guillermo Albericio, Sara Flores, Pedro J. Sánchez-Cordón, Joanna Luczkowiak, et al. (+4)
1498 [GO] 2022―Sep―12 Booster dose of COVID-19 mRNA vaccine does not increase risks of myocarditis and pericarditis compared with primary vaccination: New insights from the vaccine adverse event reporting system Congqin Chen, Fang Fu, Lingqing Ding, Jie Fang, Jie Xiao
1499 [GO] 2022―Sep―12 Could vitamin D supplementation play a role against COVID-19? Bi Li, Shuangshuang Yang, Ning Hou
1500 [GO] 2022―Sep―12 Durable antibody and effector memory T cell responses in breastmilk from women with SARS-CoV-2 Vignesh Narayanaswamy, Brian T. Pentecost, Janice C. Telfer, Amy S. Burnside, Sallie S. Schneider, Dominique Alfandari, et al. (+4)
1501 [GO] 2022―Sep―12 Mucosal nanobody IgA as inhalable and affordable prophylactic and therapeutic treatment against SARS-CoV-2 and emerging variants Qi Li, Fiachra Humphries, Roxie C. Girardin, Aaron Wallace, Monir Ejemel, Alla Amcheslavsky, et al. (+16)
1502 [GO] 2022―Sep―12 Dok3 restrains neutrophil production of calprotectin during TLR4 sensing of SARS-CoV-2 spike protein Jia Tong Loh, Joey Kay Hui Teo, Kong-Peng Lam
1503 [GO] 2022―Sep―12 Corrigendum: The cholesterol-binding sequence in monomeric C-reactive protein binds to the SARS-CoV-2 spike receptor-binding domain and blocks interaction with Angiotensin-converting enzyme 2 Hai-yun Li, Ning Gao, Cheng-yang Liu, Xiao-ling Liu, Feng Wu, Nini Dai, et al. (+2)
1504 [GO] 2022―Sep―09 Factors associated with neutralizing antibody levels induced by two inactivated COVID-19 vaccines for 12 months after primary series vaccination Fuzhen Wang, Baoying Huang, Huakun Lv, Lizhong Feng, Weihong Ren, Xiaoqi Wang, et al. (+17)
1505 [GO] 2022―Sep―09 Differences in systemic and mucosal SARS-CoV-2 antibody prevalence in a prospective cohort of Dutch children Maya W. Keuning, Marloes Grobben, Merijn W. Bijlsma, Beau Anker, Eveline P. Berman-de Jong, Sophie Cohen, et al. (+12)
1506 [GO] 2022―Sep―08 Comparable bidirectional neutrophil immune dysregulation between Kawasaki disease and severe COVID-19 Kuang-Den Chen, Ying-Hsien Huang, Wei-Sheng Wu, Ling-Sai Chang, Chiao-Lun Chu, Ho-Chang Kuo
1507 [GO] 2022―Sep―08 Corrigendum: The effects of COVID-19 on the placenta during pregnancy Habib Sadeghi Rad, Joan Röhl, Nataly Stylianou, Mark C. Allenby, Sajad Razavi Bazaz, Majid E. Warkiani, et al. (+3)
1508 [GO] 2022―Sep―08 Recombinant COVID-19 vaccine based on recombinant RBD/Nucleoprotein and saponin adjuvant induces long-lasting neutralizing antibodies and cellular immunity Amir Ghaemi, Parisa Roshani Asl, Hedieh Zargaran, Delaram Ahmadi, Asim Ali Hashimi, Elahe Abdolalipour, et al. (+2)
1509 [GO] 2022―Sep―08 Are higher antibody levels against seasonal human coronaviruses associated with a more robust humoral immune response after SARS-CoV-2 vaccination? Michael Asamoah-Boaheng, Brian Grunau, Mohammad Ehsanul Karim, Agatha N. Jassem, Jennifer Bolster, Ana Citlali Marquez, et al. (+2)
1510 [GO] 2022―Sep―08 mRNA vaccination drives differential mucosal neutralizing antibody profiles in naïve and SARS-CoV-2 previously-infected individuals Stephanie Longet, Alexander Hargreaves, Saoirse Healy, Rebecca Brown, Hailey R. Hornsby, Naomi Meardon, et al. (+9)
1511 [GO] 2022―Sep―08 Breakthrough infections with the omicron and delta variants of SARS-CoV-2 result in similar re-activation of vaccine-induced immunity Arne Søraas, Gunnveig Grødeland, Beathe Kiland Granerud, Thor Ueland, Andreas Lind, Børre Fevang, et al. (+26)
1512 [GO] 2022―Sep―08 Metabolic dyshomeostasis induced by SARS-CoV-2 structural proteins reveals immunological insights into viral olfactory interactions Mercedes Lachén-Montes, Naroa Mendizuri, Karina Ausín, Miriam Echaide, Ester Blanco, Luisa Chocarro, et al. (+5)
1513 [GO] 2022―Sep―07 Association between IgG responses against the nucleocapsid proteins of alphacoronaviruses and COVID-19 severity Julius Nückel, Elisa Planatscher, Anne Wiebe Mohr, Karolin Deichl, Hrvoje Mijočević, Martin Feuerherd, et al. (+12)
1514 [GO] 2022―Sep―06 Evaluation of the immunomodulatory effects of interleukin-10 on peripheral blood immune cells of COVID-19 patients: Implication for COVID-19 therapy Saeid Najafi-Fard, Elisa Petruccioli, Chiara Farroni, Linda Petrone, Valentina Vanini, Gilda Cuzzi, et al. (+11)
1515 [GO] 2022―Sep―06 Longitudinal profiles of plasma gelsolin, cytokines and antibody expression predict COVID-19 severity and hospitalization outcomes Meshach Asare-Werehene, Michaeline McGuinty, Agatha Vranjkovic, Yannick Galipeau, Juthaporn Cowan, Bill Cameron, et al. (+4)
1516 [GO] 2022―Sep―06 Serial infection with SARS-CoV-2 Omicron BA.1 and BA.2 following three-dose COVID-19 vaccination Hope R. Lapointe, Francis Mwimanzi, Peter K. Cheung, Yurou Sang, Fatima Yaseen, Rebecca Kalikawe, et al. (+21)
1517 [GO] 2022―Sep―06 Developing dendritic cell for SARS-CoV-2 vaccine: Breakthrough in the pandemic Jonny Jonny, Terawan Agus Putranto, Raoulian Irfon, Enda Cindylosa Sitepu
1518 [GO] 2022―Sep―05 Safety monitoring in inactivated COVID-19 vaccines by clinical pharmacists from a single center in China Min Hu, Wei Guo, Li Liu, Yu Yang, Qiling Xu, Fang Cheng, et al. (+2)
1519 [GO] 2022―Sep―05 Autoantibodies elicited with SARS-CoV-2 infection are linked to alterations in double negative B cells Moriah J. Castleman, Megan M. Stumpf, Nicholas R. Therrien, Mia J. Smith, Kelsey E. Lesteberg, Brent E. Palmer, et al. (+6)
1520 [GO] 2022―Sep―05 IL4I1 binds to TMPRSS13 and competes with SARS-CoV-2 spike Jérôme Gatineau, Charlotte Nidercorne, Aurélie Dupont, Marie-Line Puiffe, José L. Cohen, Valérie Molinier-Frenkel, et al. (+2)
1521 [GO] 2022―Sep―05 Case report: Persistence of residual antigen and RNA of the SARS-CoV-2 virus in tissues of two patients with long COVID Denise Goh, Jeffrey Chun Tatt Lim, Sonia Bilbao Fernaíndez, Craig Ryan Joseph, Sara Gil Edwards, Zhen Wei Neo, et al. (+4)
1522 [GO] 2022―Sep―02 COVID-19 vaccine type-dependent differences in immunogenicity and inflammatory response: BNT162b2 and ChAdOx1 nCoV-19 Jung Yeon Heo, Yu Bin Seo, Eun Jin Kim, Jacob Lee, Young Rong Kim, Jin Gu Yoon, et al. (+10)
1523 [GO] 2022―Sep―02 Mapping monoclonal anti-SARS-CoV-2 antibody repertoires against diverse coronavirus antigens Matheus Oliveira de Souza, Bharat Madan, I-Ting Teng, Aric Huang, Lihong Liu, Ahmed S. Fahad, et al. (+9)
1524 [GO] 2022―Sep―02 Potential mouse models of coronavirus-related immune injury Fu-Yao Nan, Cai-Jun Wu, Jia-Hui Su, Lin-Qin Ma
1525 [GO] 2022―Sep―02 Impact of hypertension on long-term humoral and cellular response to SARS-CoV-2 infection Chang Chu, Anne Schönbrunn, Kristin Klemm, Volker von Baehr, Bernhard K. Krämer, Saban Elitok, Berthold Hocher
1526 [GO] 2022―Sep―02 Single-cell analysis of the adaptive immune response to SARS-CoV-2 infection and vaccination Furong Qi, Yingyin Cao, Shuye Zhang, Zheng Zhang
1527 [GO] 2022―Sep―02 SARS-CoV-2 vaccination in androgen sensitive phenotypes - A study on associated factors for SARS-CoV-2 vaccination and its adverse effects among androgenetic alopecia and benign prostate hyperplasia patients Zhihua Fan, Shixin Duan, Fangfen Liu, Wei Shi, Ziye Yang, Ruiyang Bai, et al. (+5)
1528 [GO] 2022―Aug―31 The intersection molecule MDA5 in Cancer and COVID-19 Renjing Jin, Xiaoqing Cao, Mingjun Lu, Qing Gao, Teng Ma
1529 [GO] 2022―Aug―31 Discovering common pathogenetic processes between COVID-19 and sepsis by bioinformatics and system biology approach Lu Lu, Le-Ping Liu, Rong Gui, Hang Dong, Yan-Rong Su, Xiong-Hui Zhou, Feng-Xia Liu
1530 [GO] 2022―Aug―31 Corrigendum: ACTIVATE-2: A double-blind randomized trial of BCG vaccination against COVID-19 in individuals at risk Maria Tsilika, Esther Taks, Konstantinos Dolianitis, Antigone Kotsaki, Konstantinos Leventogiannis, Christina Damoulari, et al. (+26)
1531 [GO] 2022―Aug―31 Serum soluble Fas ligand is a severity and mortality prognostic marker for COVID-19 patients Kiarash Saleki, Moein Shirzad, Mostafa Javanian, Sheyda Mohammadkhani, Mohammad Hossein Alijani, Niloufarsadat Miri, et al. (+2)
1532 [GO] 2022―Aug―31 Immune response in ofatumumab treated multiple sclerosis patients after SARS-CoV-2 vaccination Simon Faissner, Neele Heitmann, Carlos Plaza-Sirvent, Paulina Trendelenburg, Ulas Ceylan, Jeremias Motte, et al. (+9)
1533 [GO] 2022―Aug―30 The role of B cells in COVID-19 infection and vaccination Shiru Chen, Fei Guan, Fabio Candotti, Kamel Benlagha, Niels Olsen Saraiva Camara, Andres A. Herrada, et al. (+6)
1534 [GO] 2022―Aug―30 Immune modulation as a consequence of SARS-CoV-2 infection Metin Yusuf Gelmez, Fatma Betul Oktelik, Ilhan Tahrali, Vuslat Yilmaz, Umut Can Kucuksezer, Nilgun Akdeniz, et al. (+11)
1535 [GO] 2022―Aug―29 Immunogenicity of COVID-19 vaccines in patients with diabetes mellitus: A systematic review Amir Bahador Boroumand, Mahtab Forouhi, Farzaneh Karimi, Arman Soltani Moghadam, Leila Ghanbari Naeini, Pajman Kokabian, Delaram Naderi
1536 [GO] 2022―Aug―29 Efficacy of umbilical cord mesenchymal stromal cells for COVID-19: A systematic review and meta-analysis Cong-wen Yang, Ru-dong Chen, Qing-run Zhu, Shi-jie Han, Ming-jie Kuang
1537 [GO] 2022―Aug―26 A century of BCG vaccination: Immune mechanisms, animal models, non-traditional routes and implications for COVID-19 Shivani Singh, Noemi Alejandra Saavedra-Avila, Sangeeta Tiwari, Steven A. Porcelli
1538 [GO] 2022―Aug―26 Immune responses in COVID-19 and tuberculosis coinfection: A scoping review Kevin Flores-Lovon, Brando Ortiz-Saavedra, Luis A. Cueva-Chicaña, Shalom Aperrigue-Lira, Elizbet S. Montes-Madariaga, David R. Soriano-Moreno, et al. (+2)
1539 [GO] 2022―Aug―26 COVID-19 pandemic: A multidisciplinary perspective on the pathogenesis of a novel coronavirus from infection, immunity and pathological responses Jia Yi, Jiameng Miao, Qingwei Zuo, Felix Owusu, Qiutong Dong, Peizhe Lin, et al. (+4)
1540 [GO] 2022―Aug―26 Anti-SARS-COV-2 specific immunity in HIV immunological non-responders after mRNA-based COVID-19 vaccination Marta Sisteré-Oró, Naina Andrade, Diana D.J. Wortmann, Juan Du, Natalia Garcia-Giralt, María González-Cao, et al. (+2)
1541 [GO] 2022―Aug―26 A comprehensive analysis of the efficacy and effectiveness of COVID-19 vaccines Xiaofeng He, Jiao Su, Yu’nan Ma, Wenping Zhang, Shixing Tang
1542 [GO] 2022―Aug―25 The effects of nutrition bio-shield superfood powder on immune system function: A clinical trial study among patients with COVID-19 Farid Azizi Jalilian, Gheisar Keshavarz, Salman Khazaei, Manije Nezamdoost, Seyed Hamid Hashemi, Mojgan Mamani, et al. (+13)
1543 [GO] 2022―Aug―25 The association between peritraumatic distress, perceived stress, depression in pregnancy, and NR3C1 DNA methylation among Chinese pregnant women who experienced COVID-19 lockdown Liqing Wei, Xiaohong Ying, Mengxi Zhai, Jiayu Li, Dan Liu, Xin Liu, et al. (+2)
1544 [GO] 2022―Aug―25 Charlson comorbidity index, neutrophil-to-lymphocyte ratio and undertreatment with renin-angiotensin-aldosterone system inhibitors predict in-hospital mortality of hospitalized COVID-19 patients during the omicron dominant period Andrea Sonaglioni, Michele Lombardo, Adriana Albini, Douglas M. Noonan, Margherita Re, Roberto Cassandro, et al. (+4)
1545 [GO] 2022―Aug―25 Regulated necrosis in COVID-19: A double-edged sword Chen Sun, Yunze Han, Ruoyu Zhang, Simon Liu, Jing Wang, Yuqing Zhang, et al. (+5)
1546 [GO] 2022―Aug―24 C5a elevation in convalescents from severe COVID-19 is not associated with early complement activation markers C3bBbP or C4d Daria Kowalska, Alicja Kuźniewska, Yaiza Senent, Beatriz Tavira, Susana Inogés, Ascensión López-Díaz de Cerio, et al. (+3)
1547 [GO] 2022―Aug―24 Serum peptidome profiles immune response of COVID-19 Vaccine administration Wenjia Zhang, Dandan Li, Bin Xu, Lanlan Xu, Qian Lyu, Xiangyi Liu, et al. (+6)
1548 [GO] 2022―Aug―24 Facing the Omicron variant-how well do vaccines protect against mild and severe COVID-19? Third interim analysis of a living systematic review Wiebe Külper-Schiek, Vanessa Piechotta, Antonia Pilic, Madeleine Batke, Léa-Sophie Dreveton, Brogan Geurts, et al. (+7)
1549 [GO] 2022―Aug―24 Targeted escape of SARS-CoV-2 in vitro from monoclonal antibody S309, the precursor of sotrovimab Clara Luzia Magnus, Andreas Hiergeist, Philipp Schuster, Anette Rohrhofer, Jan Medenbach, André Gessner, et al. (+2)
1550 [GO] 2022―Aug―23 The striking mimics between COVID-19 and malaria: A review Emadeldin Hassan E. Konozy, Makarim El-fadil M. Osman, George Ghartey-Kwansah, Hind Mohamed Abushama
1551 [GO] 2022―Aug―23 Blockade of TMPRSS2-mediated priming of SARS-CoV-2 by lactoferricin Anna Ohradanova-Repic, Rostislav Skrabana, Laura Gebetsberger, Gabor Tajti, Peter Baráth, Gabriela Ondrovičová, et al. (+5)
1552 [GO] 2022―Aug―22 Identification of key molecules in COVID-19 patients significantly correlated with clinical outcomes by analyzing transcriptomic data Zehua Dong, Qiyu Yan, Wenxiu Cao, Zhixian Liu, Xiaosheng Wang
1553 [GO] 2022―Aug―22 Innate immune responses to three doses of the BNT162b2 mRNA SARS-CoV-2 vaccine Marina Saresella, Federica Piancone, Ivana Marventano, Ambra Hernis, Daria Trabattoni, Mattia Invernizzi, et al. (+2)
1554 [GO] 2022―Aug―19 Is hemolysis a novel therapeutic target in COVID-19? Daiki Ousaka, Masahiro Nishibori
1555 [GO] 2022―Aug―18 Cross-sectional analysis of the humoral response after SARS-CoV-2 vaccination in Sardinian multiple sclerosis patients, a follow-up study Maria Laura Idda, Maristella Pitzalis, Valeria Lodde, Annalisa Loizedda, Jessica Frau, Monia Lobina, et al. (+23)
1556 [GO] 2022―Aug―18 Editorial: Pandemic influenza vaccine approaches: Current status and future directions Michael Schotsaert, Rebecca Jane Cox, Corey P. Mallett
1557 [GO] 2022―Aug―17 SARS-CoV-2 antibody progression and neutralizing potential in mild symptomatic COVID-19 patients - a comparative long term post-infection study Jessica Brehm, Alexander Spaeth, Lars Dreßler, Thomas Masetto, Rainer Dannenberg, Christoph Peter, Matthias Grimmler
1558 [GO] 2022―Aug―17 Mucosal immunity: The missing link in comprehending SARS-CoV-2 infection and transmission Michael W. Russell, Jiri Mestecky
1559 [GO] 2022―Aug―17 Cellular and humoral immune responses and breakthrough infections after three SARS-CoV-2 mRNA vaccine doses Patricia Almendro-Vázquez, Marta Chivite-Lacaba, Alberto Utrero-Rico, Cecilia González-Cuadrado, Rocio Laguna-Goya, Miguel Moreno-Batanero, et al. (+6)
1560 [GO] 2022―Aug―17 Heterologous immunization with adenovirus vectored and inactivated vaccines effectively protects against SARS-CoV-2 variants in mice and macaques Qian He, Qunying Mao, Jialu Zhang, Fan Gao, Yu Bai, Bopei Cui, et al. (+18)
1561 [GO] 2022―Aug―17 Differential gene expression profiling reveals potential biomarkers and pharmacological compounds against SARS-CoV-2: Insights from machine learning and bioinformatics approaches M. Nazmul Hoque, Md. Murshed Hasan Sarkar, Md. Arif Khan, Md. Arju Hossain, Md. Imran Hasan, Md. Habibur Rahman, et al. (+12)
1562 [GO] 2022―Aug―17 Identifying potential pharmacological targets and mechanisms of vitamin D for hepatocellular carcinoma and COVID-19 Yongbiao Huang, Ye Yuan, Sheng Chen, Duo Xu, Lingyan Xiao, Xi Wang, et al. (+2)
1563 [GO] 2022―Aug―16 Bioinformatics analysis of potential pathogenesis and risk genes of immunoinflammation-promoted renal injury in severe COVID-19 Zhimin Chen, Caiming Chen, Fengbin Chen, Ruilong Lan, Guo Lin, Yanfang Xu
1564 [GO] 2022―Aug―16 COVID-19 patients share common, corticosteroid-independent features of impaired host immunity to pathogenic molds Beeke Tappe, Chris D. Lauruschkat, Lea Strobel, Jezreel Pantaleón García, Oliver Kurzai, Silke Rebhan, et al. (+14)
1565 [GO] 2022―Aug―16 High baseline expression of IL-6 and IL-10 decreased CCR7 B cells in individuals with previous SARS-CoV-2 infection during BNT162b2 vaccination Alberto Ponciano-Gómez, Martha Iris Valle-Solis, Myriam Campos-Aguilar, Rafael Jijón-Lorenzo, Elena de la C. Herrera-Cogco, Roberto Ramos-Alor, et al. (+18)
1566 [GO] 2022―Aug―15 A novel virotherapy encoding human interleukin-7 improves ex vivo T lymphocyte functions in immunosuppressed patients with septic shock and critically ill COVID-19 Morgane Crausaz, Guillaume Monneret, Filippo Conti, Anne-Claire Lukaszewicz, Jean-Baptiste Marchand, Perrine Martin, et al. (+2)
1567 [GO] 2022―Aug―15 Clinical and immunological features associated to the development of a sustained immune humoral response in COVID-19 patients: Results from a cohort study Jiram Torres-Ruiz, Julieta Lomelín-Gascón, Ana Sofía Vargas-Castro, Jaquelin Lira-Luna, Alfredo Pérez-Fragoso, Roberto Tapia-Conyer, et al. (+21)
1568 [GO] 2022―Aug―15 Four cases of cytokine storm after COVID-19 vaccination: Case report Kazuhiro Murata, Naoki Nakao, Naoki Ishiuchi, Takafumi Fukui, Narutaka Katsuya, Wataru Fukumoto, et al. (+9)
1569 [GO] 2022―Aug―15 Heterologous immunity induced by 1st generation COVID-19 vaccines and its role in developing a pan-coronavirus vaccine Raj S. Patel, Babita Agrawal
1570 [GO] 2022―Aug―15 Passive immunization with equine RBD-specific Fab protects K18-hACE2-mice against Alpha or Beta variants of SARS-CoV-2 Mariette Barbier, Katherine S. Lee, Mayur S. Vikharankar, Shriram N. Rajpathak, Nandkumar Kadam, Ting Y. Wong, et al. (+14)
1571 [GO] 2022―Aug―15 Prognostic impacts of soluble immune checkpoint regulators and cytokines in patients with SARS-CoV-2 infection Nuri Lee, Seri Jeong, Kibum Jeon, Min-Jeong Park, Wonkeun Song
1572 [GO] 2022―Aug―15 Antibodies against the SARS-CoV-2 S1-RBD cross-react with dengue virus and hinder dengue pathogenesis Yi-Ling Cheng, Chiao-Hsuan Chao, Yen-Chung Lai, Kun-Han Hsieh, Jen-Ren Wang, Shu-Wen Wan, et al. (+4)
1573 [GO] 2022―Aug―12 Chemerin plasma levels are increased in COVID-19 patients and are an independent risk factor of mortality Philomène Lavis, Sofia Morra, Carmen Orte Cano, Nurhan Albayrak, Véronique Corbière, Véronique Olislagers, et al. (+12)
1574 [GO] 2022―Aug―12 Case report: A pediatric case of Bickerstaff brainstem encephalitis after COVID-19 vaccination and Mycoplasma pneumoniae infection: Looking for the culprit Gabriele Monte, Stefano Pro, Fabiana Ursitti, Michela Ada Noris Ferilli, Romina Moavero, Laura Papetti, et al. (+5)
1575 [GO] 2022―Aug―12 Immunogenicity and immune-persistence of the CoronaVac or Covilo inactivated COVID-19 Vaccine: a 6-month population-based cohort study Qianhui Hua, Hangjie Zhang, Pingping Yao, Nani Xu, Yisheng Sun, Hangjing Lu, et al. (+9)
1576 [GO] 2022―Aug―12 I’ve looked at gut from both sides now: Gastrointestinal tract involvement in the pathogenesis of SARS-CoV-2 and HIV/SIV infections Ivona Pandrea, Kelsie Brooks, Rahul P. Desai, Minali Tare, Jason M. Brenchley, Cristian Apetrei
1577 [GO] 2022―Aug―12 Papain-like protease of SARS-CoV-2 inhibits RLR signaling in a deubiquitination-dependent and deubiquitination-independent manner Xiang-Hong Ran, Jia-Wu Zhu, Ya-Yun Chen, Run-Ze Ni, Dan Mu
1578 [GO] 2022―Aug―12 Display of receptor-binding domain of SARS-CoV-2 Spike protein variants on the Saccharomyces cerevisiae cell surface Hongguan Xing, Liyan Zhu, Pingping Wang, Guoping Zhao, Zhihua Zhou, Yi Yang, et al. (+2)
1579 [GO] 2022―Aug―11 Circulating microRNA signatures associated with disease severity and outcome in COVID-19 patients Alessandra Giannella, Silvia Riccetti, Alessandro Sinigaglia, Chiara Piubelli, Elisa Razzaboni, Piero Di Battista, et al. (+6)
1580 [GO] 2022―Aug―11 Defying convention in the time of COVID-19: Insights into the role of γδ T cells Marta Sanz, Brendan T. Mann, Alisha Chitrakar, Natalia Soriano-Sarabia
1581 [GO] 2022―Aug―11 Antibodies against Spike protein correlate with broad autoantigen recognition 8 months post SARS-CoV-2 exposure, and anti-calprotectin autoantibodies associated with better clinical outcomes Rhiane Moody, Sabrina Sonda, Fay H. Johnston, Kylie J. Smith, Nicola Stephens, Michelle McPherson, et al. (+2)
1582 [GO] 2022―Aug―11 Opinion: The use of chicken IgY in the control of pandemics Michael G. Wallach
1583 [GO] 2022―Aug―10 Persistent but atypical germinal center reaction among 3rd SARS-CoV-2 vaccination after rituximab exposure Ana-Luisa Stefanski, Hector Rincon-Arevalo, Eva Schrezenmeier, Kirsten Karberg, Franziska Szelinski, Jacob Ritter, et al. (+7)
1584 [GO] 2022―Aug―09 Protective antigenic epitopes revealed by immunosignatures after three doses of inactivated SARS-CoV-2 vaccine Mian Peng, Xiaowen Dou, Xiuming Zhang, Mingchen Yan, Dan Xiong, Ruiwei Jiang, et al. (+5)
1585 [GO] 2022―Aug―08 T cell perturbations persist for at least 6 months following hospitalization for COVID-19 Melissa Govender, Francis R. Hopkins, Robin Göransson, Cecilia Svanberg, Esaki M. Shankar, Maria Hjorth, et al. (+4)
1586 [GO] 2022―Aug―08 Roles and functions of SARS-CoV-2 proteins in host immune evasion Farooq Rashid, Zhixun Xie, Muhammad Suleman, Abdullah Shah, Suliman Khan, Sisi Luo
1587 [GO] 2022―Aug―05 Strong T-cell activation in response to COVID-19 vaccination in multiple sclerosis patients receiving B-cell depleting therapies Roberto Alfonso-Dunn, Jerry Lin, Vanessa Kirschner, Joyce Lei, Grant Feuer, Michaela Malin, et al. (+3)
1588 [GO] 2022―Aug―05 Kinetics of severe acute respiratory syndrome coronavirus 2 infection antibody responses Yajie Lin, Jiajie Zhu, Zongming Liu, Chaonan Li, Yikai Guo, Ying Wang, Keda Chen
1589 [GO] 2022―Aug―05 Interferon α-2b spray shortened viral shedding time of SARS-CoV-2 Omicron variant: An open prospective cohort study Nan Xu, Jinjin Pan, Li Sun, Cuimei Zhou, Siran Huang, Mingwei Chen, et al. (+5)
1590 [GO] 2022―Aug―05 Safety of inactivated SARS-CoV-2 vaccines in myasthenia gravis: A survey-based study Hong-Yan Li, Li-Yuan Shao, Min Song, Shi-Min Hu, Yao-Xian Yue, Hai-Feng Li
1591 [GO] 2022―Aug―04 Humoral responses to the SARS-CoV-2 spike and receptor binding domain in context of pre-existing immunity confer broad sarbecovirus neutralization Blake M. Hauser, Maya Sangesland, Evan C. Lam, Jared Feldman, Alejandro B. Balazs, Daniel Lingwood, Aaron G. Schmidt
1592 [GO] 2022―Aug―03 Recent malaria does not substantially impact COVID-19 antibody response or rates of symptomatic illness in communities with high malaria and COVID-19 transmission in Mali, West Africa John Woodford, Issaka Sagara, Halimatou Diawara, Mahamadoun Hamady Assadou, Abdoulaye Katile, Oumar Attaher, et al. (+18)
1593 [GO] 2022―Aug―03 Factors that predict severity of infection and seroconversion in immunocompromised children and adolescents with COVID-19 infection Mayada Abu Shanap, Maher Sughayer, Osama Alsmadi, Ismail Elzayat, Abeer Al-Nuirat, Abdelghani Tbakhi, Iyad Sultan
1594 [GO] 2022―Aug―02 Sex hormones and immune system: Menopausal hormone therapy in the context of COVID-19 pandemic Marina Averyanova, Polina Vishnyakova, Svetlana Yureneva, Oksana Yakushevskaya, Timur Fatkhudinov, Andrey Elchaninov, Gennady Sukhikh
1595 [GO] 2022―Aug―01 Robust humoral and cellular immune responses in long-term convalescent COVID-19 individuals following one-dose SARS-CoV-2 inactivated vaccination Boyun Liang, Tiandan Xiang, Hua Wang, Ziwei Li, Xufeng Quan, Xuemei Feng, et al. (+11)
1596 [GO] 2022―Aug―01 Single-cell RNA sequencing to decipher the immunogenicity of ChAdOx1 nCoV-19/AZD1222 and mRNA-1273 vaccines in patients with autoimmune rheumatic diseases Yen-Ju Chen, Po-Liang Cheng, Wen-Nan Huang, Hsin-Hua Chen, Hong-Wei Chen, Jun-Peng Chen, et al. (+7)
1597 [GO] 2022―Jul―29 Serum concentration of extracellular cold-inducible RNA-binding protein is associated with respiratory failure in COVID-19 Felix Schagatay, Klara Diamant, Mats Lidén, Alicia Edin, Simon Athlin, Olof Hultgren, et al. (+6)
1598 [GO] 2022―Jul―29 IFNAR2 relevance in the clinical outcome of individuals with severe COVID-19 Ingrid Fricke-Galindo, Alfonso Martínez-Morales, Leslie Chávez-Galán, Ranferi Ocaña-Guzmán, Ivette Buendía-Roldán, Gloria Pérez-Rubio, et al. (+13)
1599 [GO] 2022―Jul―28 Real-life data on monoclonal antibodies and antiviral drugs in Italian inborn errors of immunity patients during COVID-19 pandemic Giulia Garzi, Francesco Cinetto, Davide Firinu, Giulia Di Napoli, Gianluca Lagnese, Alessandra Punziano, et al. (+9)
1600 [GO] 2022―Jul―28 The efficiency of convalescent plasma in COVID-19 patients: A systematic review and meta-analysis of randomized controlled clinical trials Zhenbei Qian, Zhijin Zhang, Haomiao Ma, Shuai Shao, Hanyujie Kang, Zhaohui Tong
1601 [GO] 2022―Jul―28 Analysis of immunization time, amplitude, and adverse events of seven different vaccines against SARS-CoV-2 across four different countries Maria Elena Romero-Ibarguengoitia, Arnulfo González-Cantú, Chiara Pozzi, Riccardo Levi, Maximiliano Mollura, Riccardo Sarti, et al. (+16)
1602 [GO] 2022―Jul―28 Viral immunogenic footprints conferring T cell cross-protection to SARS-CoV-2 and its variants Eduardo Cheuiche Antonio, Mariana Rost Meireles, Marcelo Alves de Souza Bragatte, Gustavo Fioravanti Vieira
1603 [GO] 2022―Jul―28 BSL2-compliant lethal mouse model of SARS-CoV-2 and variants of concern to evaluate therapeutics targeting the Spike protein Mohanraj Manangeeswaran, Derek D. C. Ireland, Seth G. Thacker, Ha-Na Lee, Logan Kelley-Baker, Aaron P. Lewkowicz, et al. (+7)
1604 [GO] 2022―Jul―28 Human surfactant protein D facilitates SARS-CoV-2 pseudotype binding and entry in DC-SIGN expressing cells, and downregulates spike protein induced inflammation Nazar Beirag, Chandan Kumar, Taruna Madan, Mohamed H. Shamji, Roberta Bulla, Daniel Mitchell, et al. (+6)
1605 [GO] 2022―Jul―28 Antibody response following the third and fourth SARS-CoV-2 vaccine dose in individuals with common variable immunodeficiency Bibi Uhre Nielsen, Camilla Heldbjerg Drabe, Mike Bogetofte Barnkob, Isik Somuncu Johansen, Anne Kirstine Kronborg Hansen, Anna Christine Nilsson, Line Dahlerup Rasmussen
1606 [GO] 2022―Jul―28 Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2 Bruce D. Wines, Liriye Kurtovic, Halina M. Trist, Sandra Esparon, Ester Lopez, Klasina Chappin, et al. (+18)
1607 [GO] 2022―Jul―27 The role of interleukin-22 in lung health and its therapeutic potential for COVID-19 Si Fang, Dianwen Ju, Yong Lin, Wei Chen
1608 [GO] 2022―Jul―27 Coordinated innate and T-cell immune responses in mild COVID-19 patients from household contacts of COVID-19 cases during the first pandemic wave Alessandra Aiello, Adriano Grossi, Silvia Meschi, Marcello Meledandri, Valentina Vanini, Linda Petrone, et al. (+14)
1609 [GO] 2022―Jul―26 Bioinformatics analysis of potential common pathogenic mechanisms for COVID-19 infection and primary Sjogren’s syndrome Hong Luo, Xia Zhou
1610 [GO] 2022―Jul―26 Longitudinal Serum Proteome Characterization of COVID-19 Patients With Different Severities Revealed Potential Therapeutic Strategies Songfeng Wu, Yuan Xu, Jian Zhang, Xiaoju Ran, Xue Jia, Jing Wang, et al. (+7)
1611 [GO] 2022―Jul―26 Case report: Variant-specific pre-exposure prophylaxis of SARS-CoV-2 infection in multiple sclerosis patients lacking vaccination responses Christina Woopen, Urszula Konofalska, Katja Akgün, Tjalf Ziemssen
1612 [GO] 2022―Jul―26 SARS-CoV-2’s Variants of Concern: A Brief Characterization Aline Miranda Scovino, Elizabeth Chen Dahab, Gustavo Fioravanti Vieira, Leonardo Freire-de-Lima, Celio Geraldo Freire-de-Lima, Alexandre Morrot
1613 [GO] 2022―Jul―25 Inflammatory mediators profile in patients hospitalized with COVID-19: A comparative study Abdisa Tufa, Tewodros Haile Gebremariam, Tsegahun Manyazewal, Tewodros Getinet, Dominic-Luc Webb, Per M. Hellström, Solomon Genet
1614 [GO] 2022―Jul―25 BNT162b2 booster after heterologous prime-boost vaccination induces potent neutralizing antibodies and T cell reactivity against SARS-CoV-2 Omicron BA.1 in young adults Alina Seidel, Michelle Zanoni, Rüdiger Groß, Daniela Krnavek, Sümeyye Erdemci-Evin, Pascal von Maltitz, et al. (+12)
1615 [GO] 2022―Jul―22 Immunogenicity of a vaccinia virus-based severe acute respiratory syndrome coronavirus 2 vaccine candidate Shan Mei, Zhangling Fan, Xiaoman Liu, Fei Zhao, Yu Huang, Liang Wei, et al. (+7)
1616 [GO] 2022―Jul―22 Effectiveness and Waning of Protection With Different SARS-CoV-2 Primary and Booster Vaccines During the Delta Pandemic Wave in 2021 in Hungary (HUN-VE 3 Study) Zoltán Vokó, Zoltán Kiss, György Surján, Orsolya Surján, Zsófia Barcza, István Wittmann, et al. (+14)
1617 [GO] 2022―Jul―22 Local and Systemic Immunity Are Impaired in End-Stage-Renal-Disease Patients Treated With Hemodialysis, Peritoneal Dialysis and Kidney Transplant Recipients Immunized With BNT162b2 Pfizer-BioNTech SARS-CoV-2 Vaccine Magdalena Piotrowska, Maciej Zieliński, Leszek Tylicki, Bogdan Biedunkiewicz, Alicja Kubanek, Zuzanna Ślizień, et al. (+11)
1618 [GO] 2022―Jul―20 Editorial: Immunometabolic mechanisms underlying the severity of COVID-19 Julia Kzhyshkowska, Vishwanath Venketaraman, Galileo Escobedo
1619 [GO] 2022―Jul―19 Pyroptotic Patterns in Blood Leukocytes Predict Disease Severity and Outcome in COVID-19 Patients Yingkui Tang, Peidong Zhang, Qiuyu Liu, Luyang Cao, Jingsong Xu
1620 [GO] 2022―Jul―19 The SARS-CoV-2 Nucleoprotein Induces Innate Memory in Human Monocytes Patricia Urbán, Paola Italiani, Diana Boraschi, Sabrina Gioria
1621 [GO] 2022―Jul―19 Different Neutralization Profiles After Primary SARS-CoV-2 Omicron BA.1 and BA.2 Infections Iris Medits, David N. Springer, Marianne Graninger, Jeremy V. Camp, Eva Höltl, Stephan W. Aberle, et al. (+10)
1622 [GO] 2022―Jul―18 Metabolite profile of COVID-19 revealed by UPLC-MS/MS-based widely targeted metabolomics Jun Liu, Zhi-Bin Li, Qi-Qi Lu, Yi Yu, Shan-Qiang Zhang, Pei-Feng Ke, et al. (+2)
1623 [GO] 2022―Jul―18 SARS-CoV-2-Specific Adaptive Immunity in COVID-19 Survivors With Asthma Li Chen, Junqing Yue, Shengding Zhang, Wenxue Bai, Lu Qin, Cong Zhang, et al. (+9)
1624 [GO] 2022―Jul―18 Case Report: Post-COVID-19 Vaccine Recurrence of Guillain-Barré Syndrome Following an Antecedent Parainfectious COVID-19-Related GBS Margherita Bellucci, Francesco Germano, Stefano Grisanti, Chiara Castellano, Francesco Tazza, Emanuela Maria Mobilia, et al. (+9)
1625 [GO] 2022―Jul―15 A Landscape Study on COVID-19 Immunity at the Single-Cell Level Rongguo Wei, Zheng Qin, Qi Huang, Lulu Liu, Fang Cheng, Songdong Meng, Lin Wang
1626 [GO] 2022―Jul―15 Anti-Phospholipid Antibodies and Coronavirus Disease 2019: Vaccination Does Not Trigger Early Autoantibody Production in Healthcare Workers Maria Orietta Borghi, Mauro Bombaci, Caterina Bodio, Paola Adele Lonati, Andrea Gobbini, Mariangela Lorenzo, et al. (+11)
1627 [GO] 2022―Jul―15 Plasticity of natural killer cells in pregnant patients infected with SARS-CoV-2 and their neonates during childbirth Marie Carbonnel, Camille Daclin, Nadine Tarantino, Olivia Groiseau, Véronique Morin, Alice Rousseau, et al. (+5)
1628 [GO] 2022―Jul―15 Specific CD4+ T Cell Responses to Ancestral SARS-CoV-2 in Children Increase With Age and Show Cross-Reactivity to Beta Variant Kevin Paul, Freya Sibbertsen, Daniela Weiskopf, Marc Lütgehetmann, Madalena Barroso, Marta K. Danecka, et al. (+16)
1629 [GO] 2022―Jul―15 Fine Analysis of Lymphocyte Subpopulations in SARS-CoV-2 Infected Patients: Differential Profiling of Patients With Severe Outcome Giovanna Clavarino, Corentin Leroy, Olivier Epaulard, Tatiana Raskovalova, Antoine Vilotitch, Martine Pernollet, et al. (+10)
1630 [GO] 2022―Jul―15 Heterologous saRNA Prime, DNA Dual-Antigen Boost SARS-CoV-2 Vaccination Elicits Robust Cellular Immunogenicity and Cross-Variant Neutralizing Antibodies Adrian Rice, Mohit Verma, Emily Voigt, Peter Battisti, Sam Beaver, Sierra Reed, et al. (+11)
1631 [GO] 2022―Jul―14 SARS-CoV2 Infection During Pregnancy Causes Persistent Immune Abnormalities in Women Without Affecting the Newborns Elena Vazquez-Alejo, Laura Tarancon-Diez, Itzíar Carrasco, Sara Vigil-Vázquez, Mar Muñoz-Chapuli, Elena Rincón-López, et al. (+10)
1632 [GO] 2022―Jul―13 A Complementary Union of SARS-CoV2 Natural and Vaccine Induced Immune Responses Joseph Torresi, Melissa A. Edeling, Terry Nolan, Dale I. Godfrey
1633 [GO] 2022―Jul―12 Effects of Vaccination Against Influenza, Pertussis, and COVID-19 on Human Milk Antibodies: Current Evidence and Implications for Health Equity Soumya Hunagund, Yarden Golan, Ifeyinwa V. Asiodu, Mary Prahl, Stephanie L. Gaw
1634 [GO] 2022―Jul―12 SARS-Arena: Sequence and Structure-Guided Selection of Conserved Peptides from SARS-related Coronaviruses for Novel Vaccine Development Mauricio Menegatti Rigo, Romanos Fasoulis, Anja Conev, Sarah Hall-Swan, Dinler Amaral Antunes, Lydia E. Kavraki
1635 [GO] 2022―Jul―12 Comparison by Age of the Local Interferon Response to SARS-CoV-2 Suggests a Role for IFN-ε and -ω Alessandra Pierangeli, Massimo Gentile, Giuseppe Oliveto, Federica Frasca, Leonardo Sorrentino, Luigi Matera, et al. (+9)
1636 [GO] 2022―Jul―12 Proteomic and Metabolomic Characterization of SARS-CoV-2-Infected Cynomolgus Macaque at Early Stage Tiecheng Wang, Faming Miao, Shengnan Lv, Liang Li, Feng Wei, Lihua Hou, et al. (+18)
1637 [GO] 2022―Jul―11 Immune Cells Profiles In The Peripheral Blood Of Patients With Moderate To Severe COVID-19 And Healthy Subjects With and Without Vaccination With The Pfizer-BioNTech mRNA Vaccine Raja’a Al-Attiyah, Hussain A. Safar, Lotfy Botras, Marina Botras, Fatma Al-Kandari, Wassim Chehadeh, Abu Salim Mustafa
1638 [GO] 2022―Jul―08 A Prospective Study on Risk Factors for Acute Kidney Injury and All-Cause Mortality in Hospitalized COVID-19 Patients From Tehran (Iran) Zohreh Rostami, Giuseppe Mastrangelo, Behzad Einollahi, Eghlim Nemati, Sepehr Shafiee, Mehrdad Ebrahimi, et al. (+6)
1639 [GO] 2022―Jul―08 The Natural Effect of BCG Vaccination on COVID-19: The Debate Continues Wenping Gong, Huiru An, Jie Wang, Peng Cheng, Yong Qi
1640 [GO] 2022―Jul―08 Photobiomodulation Improves Serum Cytokine Response in Mild to Moderate COVID-19: The First Randomized, Double-Blind, Placebo Controlled, Pilot Study Seyed Mehran Marashian, Mohammadreza Hashemian, Mihan Pourabdollah, Mansour Nasseri, Saeed Mahmoudian, Florian Reinhart, Alireza Eslaminejad
1641 [GO] 2022―Jul―08 The Dynamic Role of FOXP3+ Tregs and Their Potential Therapeutic Applications During SARS-CoV-2 Infection Zhan Xu, Xue Jiang, Xueyu Dai, Bin Li
1642 [GO] 2022―Jul―08 Detection of SARS-CoV-2 Specific Antibodies in Saliva Samples Siyang Yu, Peiyan Zhang, Mingfeng Liao, Juanjuan Zhang, Suisui Luo, Jinglei Zhai, et al. (+6)
1643 [GO] 2022―Jul―08 Vascular Endothelial Growth Factor Receptor, fms-Like Tyrosine Kinase-1 (Flt-1), as a Novel Binding Partner for SARS-CoV-2 Spike Receptor-Binding Domain Adel Zaid I. Mutahar, Manjunath Devaramani, Renu Dayal, Dinesh Kumar Saini, Paramahans V. Salimath, Bharathi P. Salimath
1644 [GO] 2022―Jul―08 The Cholesterol-Binding Sequence in Monomeric C-Reactive Protein Binds to the SARS-CoV-2 Spike Receptor-Binding Domain and Blocks Interaction With Angiotensin-Converting Enzyme 2 Hai-yun Li, Ning Gao, Cheng-yang Liu, Xiao-ling Liu, Feng Wu, Nini Dai, et al. (+2)
1645 [GO] 2022―Jul―07 Susceptibility and Severity of COVID-19 Are Both Associated With Lower Overall Viral-Peptide Binding Repertoire of HLA Class I Molecules, Especially in Younger People Hamid Reza Ghasemi Basir, Mohammad Mahdi Majzoobi, Samaneh Ebrahimi, Mina Noroozbeygi, Seyed Hamid Hashemi, Fariba Keramat, et al. (+5)
1646 [GO] 2022―Jul―07 The KIR2DL2/HLA-C1C1 Gene Pairing Is Associated With an Increased Risk of SARS-CoV-2 Infection Song Hu, Zuoyu Shao, Wei Ni, Pan Sun, Jialu Qiao, Hexing Wan, et al. (+5)
1647 [GO] 2022―Jul―07 Multisystem Inflammatory Syndrome in Children and Long COVID: The SARS-CoV-2 Viral Superantigen Hypothesis Magali Noval Rivas, Rebecca A. Porritt, Mary Hongying Cheng, Ivet Bahar, Moshe Arditi
1648 [GO] 2022―Jul―06 Dengue Infection - Recent Advances in Disease Pathogenesis in the Era of COVID-19 Yean Kong Yong, Won Fen Wong, Ramachandran Vignesh, Indranil Chattopadhyay, Vijayakumar Velu, Hong Yien Tan, et al. (+3)
1649 [GO] 2022―Jul―06 A mRNA Vaccine Encoding for a RBD 60-mer Nanoparticle Elicits Neutralizing Antibodies and Protective Immunity Against the SARS-CoV-2 Delta Variant in Transgenic K18-hACE2 Mice Pascal Brandys, Xavier Montagutelli, Irena Merenkova, Güliz T. Barut, Volker Thiel, Nicholas J. Schork, et al. (+9)
1650 [GO] 2022―Jul―05 Exposing and Overcoming Limitations of Clinical Laboratory Tests in COVID-19 by Adding Immunological Parameters; A Retrospective Cohort Analysis and Pilot Study Adrián Sánchez-Montalvá, Daniel Álvarez-Sierra, Mónica Martínez-Gallo, Janire Perurena-Prieto, Iria Arrese-Muñoz, Juan Carlos Ruiz-Rodríguez, et al. (+17)
1651 [GO] 2022―Jul―05 Biobehavioral Implications of Covid-19 for Transplantation and Cellular Therapy Recipients Jennifer M. Knight, Mallory R. Taylor, Kelly E. Rentscher, Elisabeth C. Henley, Hannah A. Uttley, Ashley M. Nelson, et al. (+6)
1652 [GO] 2022―Jul―05 ACTIVATE-2: A Double-Blind Randomized Trial of BCG Vaccination Against COVID-19 in Individuals at Risk Maria Tsilika, Esther Taks, Konstantinos Dolianitis, Antigone Kotsaki, Konstantinos Leventogiannis, Christina Damoulari, et al. (+26)
1653 [GO] 2022―Jul―05 High Number and Specific Comorbidities Could Impact the Immune Response in COVID-19 Patients Dafeng Liu, Xiaoyan Yuan, Fengjiao Gao, Bennan Zhao, Ling Ding, Mingchang Huan, et al. (+2)
1654 [GO] 2022―Jul―05 Brief Research Report: Anti-SARS-CoV-2 Immunity in Long Lasting Responders to Cancer Immunotherapy Through mRNA-Based COVID-19 Vaccination Marta Sisteré-Oró, Diana D. J. Wortmann, Naína Andrade, Andres Aguilar, Clara Mayo de las Casas, Florencia Garcia Casabal, et al. (+11)
1655 [GO] 2022―Jul―05 COVID-19 Vaccination and the Rate of Immune and Autoimmune Adverse Events Following Immunization: Insights From a Narrative Literature Review Naim Mahroum, Noy Lavine, Aviran Ohayon, Ravend Seida, Abdulkarim Alwani, Mahmoud Alrais, et al. (+2)
1656 [GO] 2022―Jul―05 Use of Tumor Necrosis Factor-α Antagonists Is Associated With Attenuated IgG Antibody Response Against SARS-CoV-2 in Vaccinated Patients With Inflammatory Bowel Disease Antonius T. Otten, Arno R. Bourgonje, Petra P. Horinga, Hedwig H. van der Meulen, Eleonora A. M. Festen, Hendrik M. van Dullemen, et al. (+4)
1657 [GO] 2022―Jul―04 Pathogenic Mechanism and Multi-omics Analysis of Oral Manifestations in COVID-19 Ming Hao, Dongxu Wang, Qianyun Xia, Shaoning Kan, Lu Chang, Huimin Liu, et al. (+2)
1658 [GO] 2022―Jul―04 In Vitro Exposure of Primary Human T Cells and Monocytes to Polyclonal Stimuli Reveals a Basal Susceptibility to Display an Impaired Cellular Immune Response and Develop Severe COVID-19 Rebeca Viurcos-Sanabria, Aarón N. Manjarrez-Reyna, Helena Solleiro-Villavicencio, Salma A. Rizo-Téllez, Lucía A. Méndez-García, Victoria Viurcos-Sanabria, et al. (+8)
1659 [GO] 2022―Jul―04 Bone Marrow-Derived Mesenchymal Stromal Cell Therapy in Severe COVID-19: Preliminary Results of a Phase I/II Clinical Trial Céline Grégoire, Nathalie Layios, Bernard Lambermont, Chantal Lechanteur, Alexandra Briquet, Virginie Bettonville, et al. (+5)
1660 [GO] 2022―Jul―04 SARS-CoV-2 Spike- and Nucleoprotein-Specific Antibodies Induced After Vaccination or Infection Promote Classical Complement Activation Rachel E. Lamerton, Edith Marcial-Juarez, Sian E. Faustini, Marisol Perez-Toledo, Margaret Goodall, Siân E. Jossi, et al. (+14)
1661 [GO] 2022―Jul―04 The Flare of Rheumatic Disease After SARS-CoV-2 Vaccination: A Review Yan Xie, Yang Liu, Yi Liu
1662 [GO] 2022―Jul―01 SARS-CoV-2 Achieves Immune Escape by Destroying Mitochondrial Quality: Comprehensive Analysis of the Cellular Landscapes of Lung and Blood Specimens From Patients With COVID-19 Chenyang Duan, Ruiyan Ma, Xue Zeng, Bing Chen, Dongyao Hou, Ruixue Liu, et al. (+4)
1663 [GO] 2022―Jul―01 Editorial: Complement and COVID-19 Disease Zoltán Prohászka, Nicolas S. Merle
1664 [GO] 2022―Jul―01 A Path-Based Analysis of Infected Cell Line and COVID-19 Patient Transcriptome Reveals Novel Potential Targets and Drugs Against SARS-CoV-2 Piyush Agrawal, Narmada Sambaturu, Gulden Olgun, Sridhar Hannenhalli
1665 [GO] 2022―Jul―01 Cellular and Humoral Immune Response to a Third Dose of BNT162b2 COVID-19 Vaccine - A Prospective Observational Study Jonas Herzberg, Bastian Fischer, Heiko Becher, Ann-Kristin Becker, Human Honarpisheh, Salman Yousuf Guraya, et al. (+2)
1666 [GO] 2022―Jun―30 Role of IgM Memory B Cells and Spleen Function in COVID-19 Carlo Maria Rossi, Marco Vincenzo Lenti, Stefania Merli, Antonio Di Sabatino
1667 [GO] 2022―Jun―30 Metabolic Profiling at COVID-19 Onset Shows Disease Severity and Sex-Specific Dysregulation Francisco C. Ceballos, Ana Virseda-Berdices, Salvador Resino, Pablo Ryan, Oscar Martínez-González, Felipe Peréz-García, et al. (+13)
1668 [GO] 2022―Jun―30 Serum Free Zinc Is Associated With Vaccination Response to SARS-CoV-2 Thilo Samson Chillon, Maria Maares, Kamil Demircan, Julian Hackler, Qian Sun, Raban A. Heller, et al. (+5)
1669 [GO] 2022―Jun―30 Seroconversion Rate After SARS-CoV-2 Infection and Two Doses of Either ChAdOx1-nCOV COVISHIELD™ or BBV-152 COVAXIN™ Vaccination in Renal Allograft Recipients: An Experience of Two Public and Private Tertiary Care Center Narayan Prasad, Shyam Bihari Bansal, Brijesh Yadav, Neha Manhas, Deependra Yadav, Sonam Gautam, et al. (+6)
1670 [GO] 2022―Jun―30 Natural Killer Cells in SARS-CoV-2 Infection: Pathophysiology and Therapeutic Implications Clara Di Vito, Francesca Calcaterra, Nicolò Coianiz, Sara Terzoli, Antonio Voza, Joanna Mikulak, et al. (+2)
1671 [GO] 2022―Jun―30 Corrigendum: Brief Research Report: Virus-Specific Humoral Immunity at Admission Predicts the Development of Respiratory Failure in Unvaccinated SARS-CoV-2 Patients Ana Tajuelo, Octavio Carretero, Estéfani García-Ríos, Mireia López-Siles, Olga Cano, Mónica Vázquez, et al. (+9)
1672 [GO] 2022―Jun―30 Immunogenicity of SARS-CoV-2 Trimeric Spike Protein Associated to Poly(I:C) Plus Alum Júlio Souza dos-Santos, Luan Firmino-Cruz, Alessandra Marcia da Fonseca-Martins, Diogo Oliveira-Maciel, Gustavo Guadagnini Perez, Victor A. Roncaglia-Pereira, et al. (+24)
1673 [GO] 2022―Jun―30 Antigenic Determinants of SARS-CoV-2-Specific CD4+ T Cell Lines Reveals M Protein-Driven Dysregulation of Interferon Signaling Pedro H. Gazzinelli-Guimaraes, Gayatri Sanku, Alessandro Sette, Daniela Weiskopf, Paul Schaughency, Justin Lack, Thomas B. Nutman
1674 [GO] 2022―Jun―28 Surface Display of Peptides Corresponding to the Heptad Repeat 2 Domain of the Feline Enteric Coronavirus Spike Protein on Bacillus subtilis Spores Elicits Protective Immune Responses Against Homologous Infection in a Feline Aminopeptidase-N-Transduced Mouse Model Chu Chen, Ya-Li Li, Fang-Li Lv, Ling-Dong Xu, Yao-Wei Huang
1675 [GO] 2022―Jun―28 Mediators of Obesity Do Not Influence SARS-CoV-2 Infection or Activation of Primary Human Lung Microvascular Endothelial Cells In Vitro Bram M. ter Ellen, Jelmer Niewold, Antine Flikweert, Anneke C. Muller Kobold, Peter Heeringa, Matijs van Meurs, et al. (+4)
1676 [GO] 2022―Jun―27 Beneficial Immune Regulation by Biological Response Modifier Glucans in COVID-19 and Their Envisaged Potentials in the Management of Sepsis Senthilkumar Preethy, Kadalraja Raghavan, Vidyasagar Devaprasad Dedeepiya, Vaddi Surya Prakash, Nobunao Ikewaki, Yasunori Ikeue, et al. (+4)
1677 [GO] 2022―Jun―27 Anti-MDA5 Antibody Linking COVID-19, Type I Interferon, and Autoimmunity: A Case Report and Systematic Literature Review Antonio Tonutti, Francesca Motta, Angela Ceribelli, Natasa Isailovic, Carlo Selmi, Maria De Santis
1678 [GO] 2022―Jun―27 Myocarditis Following COVID-19 Vaccine Use: Can It Play a Role for Conditioning Immunization Schedules? Susanna Esposito, Caterina Caminiti, Rosanna Giordano, Alberto Argentiero, Greta Ramundo, Nicola Principi
1679 [GO] 2022―Jun―27 The Robustness of Cellular Immunity Determines the Fate of SARS-CoV-2 Infection Esther Moga, Elionor Lynton-Pons, Pere Domingo
1680 [GO] 2022―Jun―27 Immune Responses Against SARS-CoV-2 WT and Delta Variant in Elderly BNT162b2 Vaccinees Michael Jäger, Sissy Therese Sonnleitner, Stefanie Dichtl, Eliott Lafon, Gabriel Diem, Gernot Walder, et al. (+3)
1681 [GO] 2022―Jun―24 Safety and Immunogenicity of an Inactivated COVID-19 Vaccine, WIBP-CorV, in Healthy Children: Interim Analysis of a Randomized, Double-Blind, Controlled, Phase 1/2 Trial Shengli Xia, Kai Duan, Yuntao Zhang, Xiaoqing Zeng, Dongyang Zhao, Huajun Zhang, et al. (+32)
1682 [GO] 2022―Jun―24 Cytokines and Lipid Mediators of Inflammation in Lungs of SARS-CoV-2 Infected Mice Isabelle Dubuc, Julien Prunier, Émile Lacasse, Annie Gravel, Florian Puhm, Isabelle Allaeys, et al. (+7)
1683 [GO] 2022―Jun―23 Misdiagnosis of Reactive Lymphadenopathy Remotely After COVID-19 Vaccination: A Case Report and Literature Review Qian Yu, Wei Jiang, Ni Chen, Jia Li, Xiaohui Wang, Maoping Li, et al. (+2)
1684 [GO] 2022―Jun―23 Risks of SARS-CoV-2 Infection and Immune Response to COVID-19 Vaccines in Patients With Inflammatory Bowel Disease: Current Evidence Susanna Esposito, Caterina Caminiti, Rosanna Giordano, Alberto Argentiero, Greta Ramundo, Nicola Principi
1685 [GO] 2022―Jun―23 Peptidome Surveillance Across Evolving SARS-CoV-2 Lineages Reveals HLA Binding Conservation in Nucleocapsid Among Variants With Most Potential for T-Cell Epitope Loss in Spike Kamil Wnuk, Jeremi Sudol, Patricia Spilman, Patrick Soon-Shiong
1686 [GO] 2022―Jun―23 Humoral and Cellular Immune Response After a 3-Dose Heterologous SARS-CoV-2 Vaccination Using the mRNA-BNT162b2 and Viral Vector Ad26COVS1 Vaccine in Hemodialysis Patients Tamara Davidovic, Judith Schimpf, Armin Abbassi-Nik, Richard Stockinger, Hannelore Sprenger-Mähr, Karl Lhotta, Emanuel Zitt
1687 [GO] 2022―Jun―23 Nationwide Effectiveness of First and Second SARS-CoV2 Booster Vaccines During the Delta and Omicron Pandemic Waves in Hungary (HUN-VE 2 Study) Zoltán Kiss, István Wittmann, Lőrinc Polivka, György Surján, Orsolya Surján, Zsófia Barcza, et al. (+14)
1688 [GO] 2022―Jun―22 Impaired Kallikrein-Kinin System in COVID-19 Patients' Severity Enrique Alfaro, Elena Díaz-García, Sara García-Tovar, Ester Zamarrón, Alberto Mangas, Raúl Galera, et al. (+5)
1689 [GO] 2022―Jun―22 Persistent Antiphospholipid Antibodies Are Not Associated With Worse Clinical Outcomes in a Prospective Cohort of Hospitalised Patients With SARS-CoV-2 Infection Gerard Espinosa, Carles Zamora-Martínez, Albert Pérez-Isidro, Daniela Neto, Luz Yadira Bravo-Gallego, Sergio Prieto-González, et al. (+4)
1690 [GO] 2022―Jun―21 Comparison of IgA, IgG, and Neutralizing Antibody Responses Following Immunization With Moderna, BioNTech, AstraZeneca, Sputnik-V, Johnson and Johnson, and Sinopharm’s COVID-19 Vaccines Tomabu Adjobimey, Julia Meyer, Leander Sollberg, Michael Bawolt, Christina Berens, Peđa Kovačević, et al. (+3)
1691 [GO] 2022―Jun―21 Case Report: Successful Treatment With Monoclonal Antibodies in One APDS Patient With Prolonged SARS-CoV-2 Infection Not Responsive to Previous Lines of Treatment Beatrice Rivalta, Donato Amodio, Carmela Giancotta, Veronica Santilli, Lucia Pacillo, Paola Zangari, et al. (+11)
1692 [GO] 2022―Jun―20 BNT162b2 Booster Vaccination Elicits Cross-Reactive Immunity Against SARS-CoV-2 Variants B.1.1.529 and B.1.617.2 in Convalescents of All Ages Bernd Jahrsdörfer, Matthias Proffen, Judith Scholz, Janina Hägele, Carolin Ludwig, Christiane Vieweg, et al. (+6)
1693 [GO] 2022―Jun―17 Z-RNA and the Flipside of the SARS Nsp13 Helicase: Is There a Role for Flipons in Coronavirus-Induced Pathology? Alan Herbert, Maria Poptsova
1694 [GO] 2022―Jun―17 The Potential of Purinergic Signaling to Thwart Viruses Including SARS-CoV-2 Davide Ferrari, Michele Rubini, Jorge S. Burns
1695 [GO] 2022―Jun―17 SARS-CoV-2 Omicron Variants Reduce Antibody Neutralization and Acquire Usage of Mouse ACE2 Ruoke Wang, Qi Zhang, Rui Zhang, Zhen Qin Aw, Peng Chen, Yi Hao Wong, et al. (+7)
1696 [GO] 2022―Jun―17 Specific Antibody and the T-Cell Response Elicited by BNT162b2 Boosting After Two ChAdOx1 nCoV-19 in Common Variable Immunodeficiency Vera Goda, Gergely Kriván, Andrea Kulcsár, Márton Gönczi, Szabolcs Tasnády, Zsolt Matula, et al. (+6)
1697 [GO] 2022―Jun―16 Resistin Associated With Cytokines and Endothelial Cell Adhesion Molecules Is Related to Worse Outcome in COVID-19 Takeshi Ebihara, Hisatake Matsumoto, Tsunehiro Matsubara, Yuki Togami, Shunichiro Nakao, Hiroshi Matsuura, et al. (+7)
1698 [GO] 2022―Jun―16 Pathogenesis of SARS-CoV-2 and Mycobacterium tuberculosis Coinfection Taif Shah, Zahir Shah, Nafeesa Yasmeen, Zulqarnain Baloch, Xueshan Xia
1699 [GO] 2022―Jun―15 Preclinical Assessment of IgY Antibodies Against Recombinant SARS-CoV-2 RBD Protein for Prophylaxis and Post-Infection Treatment of COVID-19 Andres Agurto-Arteaga, Astrid Poma-Acevedo, Dora Rios-Matos, Ricardo Choque-Guevara, Ricardo Montesinos-Millán, Ángela Montalván, et al. (+12)
1700 [GO] 2022―Jun―15 Cross-Reactivity of IgG Antibodies and Virus Neutralization in mRNA-Vaccinated People Against Wild-Type SARS-CoV-2 and the Five Most Common SARS-CoV-2 Variants of Concern Mandy Schwarze, Andor Krizsan, Alexandra Brakel, Fabian Pohl, Daniela Volke, Ralf Hoffmann
1701 [GO] 2022―Jun―15 IgG Anti-Spike Antibodies and Surrogate Neutralizing Antibody Levels Decline Faster 3 to 10 Months After BNT162b2 Vaccination Than After SARS-CoV-2 Infection in Healthcare Workers Bram Decru, Jan Van Elslande, Sophie Steels, Gijs Van Pottelbergh, Lode Godderis, Bram Van Holm, et al. (+4)
1702 [GO] 2022―Jun―15 Glucocorticoids Bind to SARS-CoV-2 S1 at Multiple Sites Causing Cooperative Inhibition of SARS-CoV-2 S1 Interaction With ACE2 Hassan Sarker, Rashmi Panigrahi, Eugenio Hardy, J. N. Mark Glover, Shokrollah Elahi, Carlos Fernandez-Patron
1703 [GO] 2022―Jun―15 A Vicious Cycle: In Severe and Critically Ill COVID-19 Patients Peifeng Huang, Qingwei Zuo, Yue Li, Patrick Kwabena Oduro, Fengxian Tan, Yuanyuan Wang, et al. (+6)
1704 [GO] 2022―Jun―14 Risk Factors for Weak Antibody Response of SARS-CoV-2 Vaccine in Adult Solid Organ Transplant Recipients: A Systemic Review and Meta-Analysis Kezhen Zong, Dadi Peng, Hang Yang, Zuotian Huang, Yunhai Luo, Yihua Wang, et al. (+4)
1705 [GO] 2022―Jun―10 Heparanase Is a Putative Mediator of Endothelial Glycocalyx Damage in COVID-19 - A Proof-of-Concept Study Carolin Christina Drost, Alexandros Rovas, Irina Osiaevi, Matthias Rauen, Johan van der Vlag, Baranca Buijsers, et al. (+5)
1706 [GO] 2022―Jun―10 Neutrophil Extracellular Traps, Sepsis and COVID-19 - A Tripod Stand Esmeiry Ventura-Santana, Joshua R. Ninan, Caitlin M. Snyder, Emeka B. Okeke
1707 [GO] 2022―Jun―10 An ADAM17-Neutralizing Antibody Reduces Inflammation and Mortality While Increasing Viral Burden in a COVID-19 Mouse Model Jodi F. Hedges, Deann T. Snyder, Amanda Robison, Heather M. Grifka-Walk, Karlin Blackwell, Kelly Shepardson, et al. (+4)
1708 [GO] 2022―Jun―10 Hallmarks of Severe COVID-19 Pathogenesis: A Pas de Deux Between Viral and Host Factors Roberta Rovito, Matteo Augello, Assaf Ben-Haim, Valeria Bono, Antonella d’Arminio Monforte, Giulia Marchetti
1709 [GO] 2022―Jun―10 Remodeling of T Cell Dynamics During Long COVID Is Dependent on Severity of SARS-CoV-2 Infection Milena Wiech, Piotr Chroscicki, Julian Swatler, Dawid Stepnik, Sara De Biasi, Michal Hampel, et al. (+7)
1710 [GO] 2022―Jun―10 Immunosuppressant Treatment in Rheumatic Musculoskeletal Diseases Does Not Inhibit Elicitation of Humoral Response to SARS-CoV-2 Infection and Preserves Effector Immune Cell Populations Andrea Favalli, Ennio Giulio Favalli, Andrea Gobbini, Elena Zagato, Mauro Bombaci, Gabriella Maioli, et al. (+21)
1711 [GO] 2022―Jun―10 The Cross-Protective Immunity Landscape Among Different SARS-CoV-2 Variant RBDs Wenqiang Sun, Lihong He, Huicong Lou, Wenhui Fan, Limin Yang, Gong Cheng, et al. (+2)
1712 [GO] 2022―Jun―10 Nucleocapsid Specific Diagnostics for the Detection of Divergent SARS-CoV-2 Variants Ariel Isaacs, Alberto A. Amarilla, Julio Aguado, Naphak Modhiran, Eduardo A. Albornoz, Alireza A. Baradar, et al. (+11)
1713 [GO] 2022―Jun―06 Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response After Heterologous Immunizations With ChAdOx1/BNT162b2 in End-Stage Renal Disease Patients on Hemodialysis Dae Kyu Kim, Su Woong Jung, Ju-Young Moon, Kyung Hwan Jeong, Hyeon Seok Hwang, Jin Sug Kim, et al. (+3)
1714 [GO] 2022―Jun―03 Antibody Response to COVID-19 Booster Vaccination in Healthcare Workers Arianna Pani, Alessandra Romandini, Alice Schianchi, Michele Senatore, Oscar M. Gagliardi, Gianluca Gazzaniga, et al. (+18)
1715 [GO] 2022―Jun―03 Antimicrobial Resistance in the COVID-19 Landscape: Is There an Opportunity for Anti-Infective Antibodies and Antimicrobial Peptides? José M. Pérez de la Lastra, Uttpal Anand, Sergio González-Acosta, Manuel R. López, Abhijit Dey, Elza Bontempi, Antonio Morales delaNuez
1716 [GO] 2022―Jun―03 Vaccine Protection Through Placenta and Breastfeeding: The Unmet Topic in COVID-19 Pandemic Ariane Laguila Altoé, Anna Paula Marques Mambriz, Daniela Maira Cardozo, Joana Maira Valentini Zacarias, Jeane Eliete Laguila Visentainer, Larissa Danielle Bahls-Pinto
1717 [GO] 2022―Jun―03 Timeline Kinetics of Systemic and Airway Immune Mediator Storm for Comprehensive Analysis of Disease Outcome in Critically Ill COVID-19 Patients Juan Jonathan Gonçalves, Camila Pacheco Silveira Martins da Mata, Alice Aparecida Lourenço, Ágata Lopes Ribeiro, Geovane Marques Ferreira, Thais Fernanda de Campos Fraga-Silva, et al. (+27)
1718 [GO] 2022―Jun―03 The Correlation Between Immune Invasion and SARS-COV-2 Entry Protein ADAM17 in Cancer Patients by Bioinformatic Analysis Kai Wang, Haoyue Deng, Binghui Song, Jiayue He, Shuguang Liu, Jiewen Fu, et al. (+6)
1719 [GO] 2022―Jun―02 mRNA or ChAd0x1 COVID-19 Vaccination of Adolescents Induces Robust Antibody and Cellular Responses With Continued Recognition of Omicron Following mRNA-1273 Alexander C. Dowell, Annabel A. Powell, Chris Davis, Sam Scott, Nicola Logan, Brian J. Willett, et al. (+32)
1720 [GO] 2022―Jun―02 Mechanism of COVID-19-Related Proteins in Spinal Tuberculosis: Immune Dysregulation Liyi Chen, Chong Liu, Tuo Liang, Zhen Ye, Shengsheng Huang, Jiarui Chen, et al. (+16)
1721 [GO] 2022―Jun―01 Egg-Derived Anti-SARS-CoV-2 Immunoglobulin Y (IgY) With Broad Variant Activity as Intranasal Prophylaxis Against COVID-19 Lyn R. Frumkin, Michaela Lucas, Curtis L. Scribner, Nastassja Ortega-Heinly, Jayden Rogers, Gang Yin, et al. (+20)
1722 [GO] 2022―Jun―01 Editorial: Neutralizing Antibodies in the Prevention and Treatment of COVID-19 Raymund R. Razonable, Peter Chen
1723 [GO] 2022―Jun―01 COVID-19 and Preexisting Comorbidities: Risks, Synergies, and Clinical Outcomes Banafsheh Bigdelou, Mohammad Reza Sepand, Sahar Najafikhoshnoo, Jorge Alfonso Tavares Negrete, Mohammed Sharaf, Jim Q. Ho, et al. (+8)
1724 [GO] 2022―Jun―01 Vaccination With Oral Polio Vaccine Reduces COVID-19 Incidence Nadezhda V. Yagovkina, Lev M. Zheleznov, Ksenia A. Subbotina, Andrey A. Tsaan, Liubov I. Kozlovskaya, Ilya V. Gordeychuk, et al. (+13)
1725 [GO] 2022―Jun―01 Autophagy Hijacking in PBMC From COVID-19 Patients Results in Lymphopenia Cristiana Barbati, Alessandra Ida Celia, Tania Colasanti, Marta Vomero, Mariangela Speziali, Erisa Putro, et al. (+14)
1726 [GO] 2022―Jun―01 Case Report: New-Onset Rheumatoid Arthritis Following COVID-19 Vaccination Tomohiro Watanabe, Kosuke Minaga, Akane Hara, Tomoe Yoshikawa, Ken Kamata, Masatoshi Kudo
1727 [GO] 2022―Jun―01 Neutrophils in COVID-19: Not Innocent Bystanders Ellen McKenna, Richard Wubben, Johana M. Isaza-Correa, Ashanty M. Melo, Aisling Ui Mhaonaigh, Niall Conlon, et al. (+6)
1728 [GO] 2022―Jun―01 Priming With Rhinovirus Protects Mice Against a Lethal Pulmonary Coronavirus Infection Garrison Cox, Andres J. Gonzalez, Emmanuel C. Ijezie, Andres Rodriguez, Craig R. Miller, James T. Van Leuven, Tanya A. Miura
1729 [GO] 2022―Jun―01 Humoral and Cellular Responses to BNT162b2 as a Booster Following Two Doses of ChAdOx1 nCov-19 Determined Using Three SARS-CoV-2 Antibody Assays and an Interferon-Gamma Release Assay: A Prospective Longitudinal Study in Healthcare Workers Seri Jeong, Nuri Lee, Su Kyung Lee, Eun-Jung Cho, Jungwon Hyun, Min-Jeong Park, et al. (+2)
1730 [GO] 2022―Jun―01 Vaccination Against SARS-CoV-2 in Lung Transplant Recipients: Immunogenicity, Efficacy and Safety Monika Svorcova, Rene Novysedlak, Robert Lischke, Jiri Vachtenheim, Zuzana Strizova
1731 [GO] 2022―Jun―01 The Effect of Age, Gender and Comorbidities Upon SARS-CoV-2 Spike Antibody Induction After Two Doses of Sinopharm Vaccine and the Effect of a Pfizer/BioNtech Booster Vaccine Eman Farid, Juber Herrera-Uribe, Nigel J. Stevenson
1732 [GO] 2022―Jun―01 Heterogeneous SARS-CoV-2-Neutralizing Activities After Infection and Vaccination Marianne Graninger, Jeremy V. Camp, Stephan W. Aberle, Marianna T. Traugott, Wolfgang Hoepler, Elisabeth Puchhammer-Stöckl, et al. (+4)
1733 [GO] 2022―Jun―01 Differences in SARS-CoV-2-Specific Antibody Responses After the First, Second, and Third Doses of BNT162b2 in Naïve and Previously Infected Individuals: A 1-Year Observational Study in Healthcare Professionals Manca Ogrič, Polona Žigon, Eva Podovšovnik, Katja Lakota, Snezna Sodin-Semrl, Žiga Rotar, Saša Čučnik
1734 [GO] 2022―May―31 Kinetics and Persistence of the Cellular and Humoral Immune Responses to BNT162b2 mRNA Vaccine in SARS-CoV-2-Naive and -Experienced Subjects: Impact of Booster Dose and Breakthrough Infections Salomé Desmecht, Aleksandr Tashkeev, Majdouline El Moussaoui, Nicole Marechal, Hélène Perée, Yumie Tokunaga, et al. (+17)
1735 [GO] 2022―May―31 Overview of Breastfeeding Under COVID-19 Pandemic Zehan Pang, Ruolan Hu, Lili Tian, Fuxing Lou, Yangzhen Chen, Shuqi Wang, et al. (+7)
1736 [GO] 2022―May―31 Differential Functional Responses of Neutrophil Subsets in Severe COVID-19 Patients Kenneth R. McLeish, Rejeena Shrestha, Aruna Vashishta, Madhavi J. Rane, Michelle T. Barati, Michael E. Brier, et al. (+14)
1737 [GO] 2022―May―31 Evaluation of Antibody-Dependent Fc-Mediated Viral Entry, as Compared With Neutralization, in SARS-CoV-2 Infection Lindsay Wieczorek, Michelle Zemil, Mélanie Merbah, Vincent Dussupt, Erin Kavusak, Sebastian Molnar, et al. (+9)
1738 [GO] 2022―May―30 Case Report: A Severe Paediatric Presentation of COVID-19 in APDS2 Immunodeficiency Nuria Sanchez Clemente, Justin Penner, Judith Breuer, Winnie Ip, Claire Booth
1739 [GO] 2022―May―27 Autoimmune Skin Disease Exacerbations Following COVID-19 Vaccination Grant Sprow, Mohsen Afarideh, Joshua Dan, Rui Feng, Emily Keyes, Madison Grinnell, et al. (+2)
1740 [GO] 2022―May―26 A SARS-CoV-2 Spike Receptor Binding Motif Peptide Induces Anti-Spike Antibodies in Mice andIs Recognized by COVID-19 Patients Federico Pratesi, Fosca Errante, Lorenzo Pacini, Irina Charlot Peña-Moreno, Sebastian Quiceno, Alfonso Carotenuto, et al. (+10)
1741 [GO] 2022―May―26 Cellular Immunity Is Critical for Assessing COVID-19 Vaccine Effectiveness in Immunocompromised Individuals Eustache Paramithiotis, Scott Sugden, Eszter Papp, Marie Bonhomme, Todd Chermak, Stephanie Y. Crawford, et al. (+7)
1742 [GO] 2022―May―26 Post-COVID-19 Fatigue and SARS-CoV-2 Specific Humoral and T-Cell Responses in Male and Female Outpatients Christa Meisinger, Yvonne Goßlau, Tobias D. Warm, Vincenza Leone, Alexander Hyhlik-Dürr, Jakob Linseisen, Inge Kirchberger
1743 [GO] 2022―May―26 Safety and Efficacy of Combined Intramuscular/Intranasal RAZI-COV PARS Vaccine Candidate Against SARS-CoV-2: A Preclinical Study in Several Animal Models Seyed Reza Banihashemi, Ali Es-haghi, Mohammad Hossein Fallah Mehrabadi, Mojtaba Nofeli, Ali Rezaei Mokarram, Alireza Ranjbar, et al. (+12)
1744 [GO] 2022―May―25 C/EBPα Epigenetically Modulates TFF1 Expression via mC-6 Methylation in the Jejunum Inflammation Induced by a Porcine Coronavirus Huan Qu, Qiufang Zong, Haifei Wang, Shenglong Wu, Demin Cai, Wenbin Bao
1745 [GO] 2022―May―25 Reduced Antibodies and Innate Cytokine Changes in SARS-CoV-2 BNT162b2 mRNA Vaccinated Transplant Patients With Hematological Malignancies Cristina Bergamaschi, Maria Pagoni, Margherita Rosati, Matthew Angel, Ifigeneia Tzannou, Margarita Vlachou, et al. (+11)
1746 [GO] 2022―May―24 Distinct Immunological Profiles Help in the Maintenance of Salivary Secretory IgA Production in Mild Symptoms COVID-19 Patients Juliana de Melo Batista dos Santos, Jonatas Bussador do Amaral, Carolina Nunes França, Fernanda Rodrigues Monteiro, Anuska Marcelino Alvares-Saraiva, Sandra Kalil, et al. (+8)
1747 [GO] 2022―May―24 Proteomic and Metabolomic Signatures Associated With the Immune Response in Healthy Individuals Immunized With an Inactivated SARS-CoV-2 Vaccine Yi Wang, Xiaoxia Wang, Laurence Don Wai Luu, Shaojin Chen, Fu Jin, Shufang Wang, et al. (+8)
1748 [GO] 2022―May―20 An Update on Protective Effectiveness of Immune Responses After Recovery From COVID-19 Saeede Soleimanian, Soheila Alyasin, Najmeh Sepahi, Zahra Ghahramani, Zahra Kanannejad, Ramin Yaghobi, Mohammad Hossein Karimi
1749 [GO] 2022―May―20 Role of COVID-19 Vaccines in SARS-CoV-2 Variants Zhou Zhou, Yimiao Zhu, Ming Chu
1750 [GO] 2022―May―20 Effectiveness and Durability of mRNA Vaccine-Induced SARS-CoV-2-Specific Humoral and Cellular Immunity in Severe Asthma Patients on Biological Therapy Michal Podrazil, Pavla Taborska, Dmitry Stakheev, Michal Rataj, Jan Lastovicka, Alena Vlachova, et al. (+3)
1751 [GO] 2022―May―19 Evaluating the Immune Response in Treatment-Naive Hospitalised Patients With Influenza and COVID-19 Jelmer Legebeke, Jenny Lord, Rebekah Penrice-Randal, Andres F. Vallejo, Stephen Poole, Nathan J. Brendish, et al. (+14)
1752 [GO] 2022―May―19 N6-Acetyl-L-Lysine and p-Cresol as Key Metabolites in the Pathogenesis of COVID-19 in Obese Patients Nour Jalaleddine, Mahmood Hachim, Hamza Al-Hroub, Narjes Saheb Sharif-Askari, Abiola Senok, Adel Elmoselhi, et al. (+7)
1753 [GO] 2022―May―19 Longitudinal Dynamics of Cellular Responses in Recovered COVID-19 Patients Meng-Li Cheng, Hui-Ying Liu, Chao Zhou, Rui-Ting Li, Jing Zheng, Yan-Hong Qin, et al. (+11)
1754 [GO] 2022―May―19 Puerarin: A Potential Therapeutic for SARS-CoV-2 and Hantavirus Co-Infection Weizheng Liang, Xiushen Li, Hao Wang, Kechao Nie, Qingxue Meng, Junli He, Chunfu Zheng
1755 [GO] 2022―May―19 Comparison of Immune Responses Elicited by SARS-CoV-2 mRNA and Recombinant Protein Vaccine Candidates Yixin Wu, Huicong Zhang, Liuxian Meng, Fusheng Li, Changyuan Yu
1756 [GO] 2022―May―18 A Potent Neutralizing Nanobody Targeting the Spike Receptor-Binding Domain of SARS-CoV-2 and the Structural Basis of Its Intimate Binding Jing Yang, Sheng Lin, Honglu Sun, Zimin Chen, Fanli Yang, Xi Lin, et al. (+13)
1757 [GO] 2022―May―18 Soluble P2X7 Receptor Is Elevated in the Plasma of COVID-19 Patients and Correlates With Disease Severity Julio García-Villalba, Laura Hurtado-Navarro, Alejandro Peñín-Franch, Cristina Molina-López, Laura Martínez-Alarcón, Diego Angosto-Bazarra, et al. (+2)
1758 [GO] 2022―May―17 Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy Mahdi Eskandarian Boroujeni, Agata Sekrecka, Aleksandra Antonczyk, Sanaz Hassani, Michal Sekrecki, Hanna Nowicka, et al. (+5)
1759 [GO] 2022―May―17 Therapy Targets SARS-CoV-2 Infection-Induced Cell Death Zhoujie Zhu, Jiayi Shi, Long Li, Jinling Wang, Yufen Zhao, Huabin Ma
1760 [GO] 2022―May―17 At Least Three Doses of Leading Vaccines Essential for Neutralisation of SARS-CoV-2 Omicron Variant Nagendrakumar B. Singanallur, Petrus Jansen van Vuren, Alexander J. McAuley, Matthew P. Bruce, Michael J. Kuiper, Stella M. Gwini, et al. (+13)
1761 [GO] 2022―May―17 Long-Lived Immunity in SARS-CoV-2-Recovered Children and Its Neutralizing Capacity Against Omicron Justyna Sieber, Margareta Mayer, Klara Schmidthaler, Sonja Kopanja, Jeremy V. Camp, Amelie Popovitsch, et al. (+7)
1762 [GO] 2022―May―13 Identification of IL-6 Signalling Components as Predictors of Severity and Outcome in COVID-19 María Ángeles Rodríguez-Hernández, David Carneros, María Núñez-Núñez, Ramón Coca, Rosario Baena, Gema M. López-Ruiz, et al. (+9)
1763 [GO] 2022―May―13 Safety and Immunogenicity of Inactivated and Recombinant Protein SARS-CoV-2 Vaccines in Patients With Thyroid Cancer Yuling Han, Jiaxin Yang, Danshuang He, Yang Feng, Xiaoman Liu, Yu Min, et al. (+3)
1764 [GO] 2022―May―12 Upregulating Human Cathelicidin Antimicrobial Peptide LL-37 Expression May Prevent Severe COVID-19 Inflammatory Responses and Reduce Microthrombosis Karim M. Aloul, Josefine Eilsø Nielsen, Erwin B. Defensor, Jennifer S. Lin, John A. Fortkort, Mehrdad Shamloo, et al. (+3)
1765 [GO] 2022―May―12 The Genetic Risk for COVID-19 Severity Is Associated With Defective Immune Responses Yunus Kuijpers, Xiaojing Chu, Martin Jaeger, Simone J. C. F. M. Moorlag, Valerie A. C. M. Koeken, Bowen Zhang, et al. (+12)
1766 [GO] 2022―May―12 Remdesivir and Its Combination With Repurposed Drugs as COVID-19 Therapeutics Bhaswati Chatterjee, Suman S. Thakur
1767 [GO] 2022―May―12 Time-Dependent Increase in Susceptibility and Severity of Secondary Bacterial Infections During SARS-CoV-2 Amanda P. Smith, Evan P. Williams, Taylor R. Plunkett, Muneeswaran Selvaraj, Lindey C. Lane, Lillian Zalduondo, et al. (+5)
1768 [GO] 2022―May―12 Seroconversion to mRNA SARS-CoV-2 Vaccines in Hematologic Patients Bruno Fattizzo, Marta Bortolotti, Nicolò Rampi, Francesca Cavallaro, Juri Alessandro Giannotta, Cristina Bucelli, et al. (+11)
1769 [GO] 2022―May―12 SARS-CoV-2-mRNA Booster Vaccination Reverses Non-Responsiveness and Early Antibody Waning in Immunocompromised Patients - A Phase Four Study Comparing Immune Responses in Patients With Solid Cancers, Multiple Myeloma and Inflammatory Bowel Disease Angelika Wagner, Erika Garner-Spitzer, Anna-Margarita Schötta, Maria Orola, Andrea Wessely, Ines Zwazl, et al. (+15)
1770 [GO] 2022―May―11 Humoral Immune Response Diversity to Different COVID-19 Vaccines: Implications for the “Green Pass” Policy Immacolata Polvere, Alfredina Parrella, Lucrezia Zerillo, Serena Voccola, Gaetano Cardinale, Silvia D’Andrea, et al. (+4)
1771 [GO] 2022―May―10 Systematic Review and Meta-Analyses of The Interaction Between HIV Infection And COVID-19: Two Years’ Evidence Summary Yehua Wang, Yewei Xie, Siyue Hu, Wei Ai, Yusha Tao, Huilin Tang, et al. (+2)
1772 [GO] 2022―May―10 Skewed Cellular Distribution and Low Activation of Functional T-Cell Responses in SARS-CoV-2 Non-Seroconvertors Athina Kilpeläinen, Esther Jimenez-Moyano, Oscar Blanch-Lombarte, Dan Ouchi, Ruth Peña, Bibiana Quirant-Sanchez, et al. (+12)
1773 [GO] 2022―May―09 Weathering the Storm: Harnessing the Resolution of Inflammation to Limit COVID-19 Pathogenesis Esther Silberberg, János G. Filep, Amiram Ariel
1774 [GO] 2022―May―09 From COVID-19 to Sarcoidosis: How Similar Are These Two Diseases? Min Zhao, Chang Tian, Shan Cong, Xin Di, Ke Wang
1775 [GO] 2022―May―09 Rapid Hypermutation B Cell Trajectory Recruits Previously Primed B Cells Upon Third SARS-Cov-2 mRNA Vaccination Lisa Paschold, Bianca Klee, Cornelia Gottschick, Edith Willscher, Sophie Diexer, Christoph Schultheiß, et al. (+6)
1776 [GO] 2022―May―06 Correlation of the Imbalance in the Circulating Lymphocyte Subsets With C-Reactive Protein and Cardio-Metabolic Conditions in Patients With COVID-19 Anton V. Tyurin, Milyausha K. Salimgareeva, Ildar R. Miniakhmetov, Rita I. Khusainova, Alexandr Samorodov, Valentin N. Pavlov, Julia Kzhyshkowska
1777 [GO] 2022―May―06 Cytokine Elevation in Severe COVID-19 From Longitudinal Proteomics Analysis: Comparison With Sepsis Takeshi Ebihara, Hisatake Matsumoto, Tsunehiro Matsubara, Yuki Togami, Shunichiro Nakao, Hiroshi Matsuura, et al. (+6)
1778 [GO] 2022―May―06 Design of a Recombinant Multivalent Epitope Vaccine Based on SARS-CoV-2 and Its Variants in Immunoinformatics Approaches Mingkai Yu, Yuejie Zhu, Yujiao Li, Zhiqiang Chen, Zhiwei Li, Jing Wang, et al. (+3)
1779 [GO] 2022―May―04 Impact of an Immune Modulator Mycobacterium-w on Adaptive Natural Killer Cells and Protection Against COVID-19 Sarita Rani Jaiswal, Jaganath Arunachalam, Ashraf Saifullah, Rohit Lakhchaura, Dhanir Tailor, Anupama Mehta, et al. (+5)
1780 [GO] 2022―May―04 Adaptive Immune Responses and Immunity to SARS-CoV-2 Dragan Primorac, Kristijan Vrdoljak, Petar Brlek, Eduard Pavelić, Vilim Molnar, Vid Matišić, et al. (+2)
1781 [GO] 2022―May―04 A Case Study to Dissect Immunity to SARS-CoV-2 in a Neonate Nonhuman Primate Model Claire-Maëlle Fovet, Camille Pimienta, Mathilde Galhaut, Francis Relouzat, Natalia Nunez, Mariangela Cavarelli, et al. (+15)
1782 [GO] 2022―May―04 Antigenic Cross-Reactivity Between SARS-CoV-2 S1-RBD and Its Receptor ACE2 Yen-Chung Lai, Yu-Wei Cheng, Chiao-Hsuan Chao, Yu-Ying Chang, Chi-De Chen, Wei-Jiun Tsai, et al. (+13)
1783 [GO] 2022―May―03 HDAC Inhibition as Potential Therapeutic Strategy to Restore the Deregulated Immune Response in Severe COVID-19 Chiara Ripamonti, Valeria Spadotto, Pietro Pozzi, Andrea Stevenazzi, Barbara Vergani, Mattia Marchini, et al. (+6)
1784 [GO] 2022―May―03 Intranasal Delivery of Thermostable Subunit Vaccine for Cross-Reactive Mucosal and Systemic Antibody Responses Against SARS-CoV-2 Khue G. Nguyen, Siena M. Mantooth, Maura R. Vrabel, David A. Zaharoff
1785 [GO] 2022―May―03 Pandemic, Epidemic, Endemic: B Cell Repertoire Analysis Reveals Unique Anti-Viral Responses to SARS-CoV-2, Ebola and Respiratory Syncytial Virus Alexander Stewart, Emma Sinclair, Joseph Chi-Fung Ng, Joselli Silva O’Hare, Audrey Page, Ilaria Serangeli, et al. (+17)
1786 [GO] 2022―May―02 Fitness of B-Cell Responses to SARS-CoV-2 WT and Variants Up to One Year After Mild COVID-19 - A Comprehensive Analysis Benjamin Meyer, Paola Andrea Martinez-Murillo, Barbara Lemaitre, Géraldine Blanchard-Rohner, Arnaud M. Didierlaurent, Paola Fontannaz, et al. (+10)
1787 [GO] 2022―May―02 Furin and TMPRSS2 Resistant Spike Induces Robust Humoral and Cellular Immunity Against SARS-CoV-2 Lethal Infection Jhe-Jhih Lin, Chih-Feng Tien, Yi-Ping Kuo, En-Ju Lin, Wei-Hsiang Tsai, Ming-Yu Chen, et al. (+20)
1788 [GO] 2022―May―02 Humoral Response to BNT162b2 Vaccine Against SARS-CoV-2 Variants Decays After Six Months Tulio J. Lopera, Mateo Chvatal-Medina, Lizdany Flórez-Álvarez, Maria I. Zapata-Cardona, Natalia A. Taborda, Maria T. Rugeles, Juan C. Hernandez
1789 [GO] 2022―Apr―29 pcMSC Modulates Immune Dysregulation in Patients With COVID-19-Induced Refractory Acute Lung Injury Mei-Chuan Chen, Kevin Shu-Leung Lai, Ko-Ling Chien, Sing Teck Teng, Yuh-Rong Lin, Wei Chao, et al. (+6)
1790 [GO] 2022―Apr―29 Corrigendum: Children and Adults With Mild COVID-19: Dynamics of the Memory T Cell Response Up to 10 Months Patricia Kaaijk, Verónica Olivo Pimentel, Maarten E. Emmelot, Martien C. M. Poelen, Alper Cevirgel, Rutger M. Schepp, et al. (+8)
1791 [GO] 2022―Apr―29 SARS-CoV-2 Omicron Variant: Epidemiological Features, Biological Characteristics, and Clinical Significance Yifei Guo, Jiajia Han, Yao Zhang, Jingjing He, Weien Yu, Xueyun Zhang, et al. (+6)
1792 [GO] 2022―Apr―29 Evaluation of Humoral and Cellular Immune Responses to the SARS-CoV-2 Vaccine in Patients With Common Variable Immunodeficiency Phenotype and Patient Receiving B-Cell Depletion Therapy Arnau Antolí, Gemma Rocamora-Blanch, Mario Framil, Virgínia Mas-Bosch, Sergio Navarro, Carla Bermudez, et al. (+11)
1793 [GO] 2022―Apr―28 Analysis of the Protective Efficacy of Approved COVID-19 Vaccines Against Various Mutants Chaonan Li, Yikai Guo, Zhongbiao Fang, Haiyan Zhang, Yanjun Zhang, Keda Chen
1794 [GO] 2022―Apr―28 Markers of Memory CD8 T Cells Depicting the Effect of the BNT162b2 mRNA COVID-19 Vaccine in Japan Hiroyuki Kondo, Takahiro Kageyama, Shigeru Tanaka, Kunihiro Otsuka, Shin-ichi Tsukumo, Yoichi Mashimo, et al. (+3)
1795 [GO] 2022―Apr―28 The SARS-CoV-2 B.1.351 Variant Can Transmit in Rats But Not in Mice Cheng Zhang, Huan Cui, Entao Li, Zhendong Guo, Tiecheng Wang, Fang Yan, et al. (+9)
1796 [GO] 2022―Apr―28 Virological and Clinical Determinants of the Magnitude of Humoral Responses to SARS-CoV-2 in Mild-Symptomatic Individuals Edwards Pradenas, Maria Ubals, Víctor Urrea, Clara Suñer, Benjamin Trinité, Eva Riveira-Muñoz, et al. (+10)
1797 [GO] 2022―Apr―27 Laboratory Biomarkers for Diagnosis and Prognosis in COVID-19 Denise Battaglini, Miquéias Lopes-Pacheco, Hugo C. Castro-Faria-Neto, Paolo Pelosi, Patricia R. M. Rocco
1798 [GO] 2022―Apr―27 In Silico Analysis Predicts a Limited Impact of SARS-CoV-2 Variants on CD8 T Cell Recognition Olga I. Isaeva, Steven L. C. Ketelaars, Pia Kvistborg
1799 [GO] 2022―Apr―27 Seroreactivity of the Severe Acute Respiratory Syndrome Coronavirus 2 Recombinant S Protein, Receptor-Binding Domain, and Its Receptor-Binding Motif in COVID-19 Patients and Their Cross-Reactivity With Pre-COVID-19 Samples From Malaria-Endemic Areas Abdouramane Traoré, Merepen A. Guindo, Drissa Konaté, Bourama Traoré, Seidina A. Diakité, Salimata Kanté, et al. (+18)
1800 [GO] 2022―Apr―27 Considerations for the Feasibility of Neutralizing Antibodies as a Surrogate Endpoint for COVID-19 Vaccines Jianyang Liu, Qunying Mao, Xing Wu, Qian He, Lianlian Bian, Yu Bai, et al. (+5)
1801 [GO] 2022―Apr―27 Myeloid-Derived Suppressor Cells in COVID-19: The Paradox of Good Germana Grassi, Stefania Notari, Simona Gili, Veronica Bordoni, Rita Casetti, Eleonora Cimini, et al. (+4)
1802 [GO] 2022―Apr―27 Secondary Complement Deficiency Impairs Anti-Microbial Immunity to Klebsiella pneumoniae and Staphylococcus aureus During Severe Acute COVID-19 Youssif M. Ali, Nicholas J. Lynch, Priyanka Khatri, Ifeoluwa E. Bamigbola, Andrew C. Y. Chan, Munehisa Yabuki, et al. (+5)
1803 [GO] 2022―Apr―27 Vaccines for COVID-19: A Systematic Review of Immunogenicity, Current Development, and Future Prospects Zhan Zhang, Qi Shen, Haocai Chang
1804 [GO] 2022―Apr―27 Underlying Co-Morbidity Reveals Unique Immune Signatures in Type II Diabetes Patients Infected With SARS-CoV2 Soumya Sengupta, Gargee Bhattacharya, Sanchari Chatterjee, Ankita Datey, Shubham K. Shaw, Sandhya Suranjika, et al. (+7)
1805 [GO] 2022―Apr―26 Landscape of Peripheral Blood Mononuclear Cells and Soluble Factors in Severe COVID-19 Patients With Pulmonary Fibrosis Development Zhuolin Wang, Yang Zhang, Rirong Yang, Yujia Wang, Jiapei Guo, Ruya Sun, et al. (+4)
1806 [GO] 2022―Apr―25 Lactoferrin as Immune-Enhancement Strategy for SARS-CoV-2 Infection in Alzheimer’s Disease Patients Fernando Bartolomé, Luigi Rosa, Piera Valenti, Francisco Lopera, Jesús Hernández-Gallego, José Luis Cantero, et al. (+2)
1807 [GO] 2022―Apr―25 Nanobodies Protecting From Lethal SARS-CoV-2 Infection Target Receptor Binding Epitopes Preserved in Virus Variants Other Than Omicron José M. Casasnovas, Yago Margolles, María A. Noriega, María Guzmán, Rocío Arranz, Roberto Melero, et al. (+8)
1808 [GO] 2022―Apr―25 Brief Research Report: Virus-Specific Humoral Immunity at Admission Predicts the Development of Respiratory Failure in Unvaccinated SARS-CoV-2 Patients Ana Tajuelo, Octavio Carretero, Estéfani García-Ríos, Mireia López-Siles, Olga Cano, Mónica Vázquez, et al. (+9)
1809 [GO] 2022―Apr―22 Long-Lasting T Cell Responses in BNT162b2 COVID-19 mRNA Vaccinees and COVID-19 Convalescent Patients Antti Hurme, Pinja Jalkanen, Jemna Heroum, Oona Liedes, Saimi Vara, Merit Melin, et al. (+12)
1810 [GO] 2022―Apr―22 Memory CD4+ T-Cell Lymphocytic Angiopathy in Fatal Forms of COVID-19 Pulmonary Infection Amélie Guihot, Isabelle Plu, Cathia Soulié, Alice Rousseau, Cecilia Nakid-Cordero, Karim Dorgham, et al. (+20)
1811 [GO] 2022―Apr―22 SARS-CoV-2 and Multiple Sclerosis: Potential for Disease Exacerbation Madison MacDougall, Jad El-Hajj Sleiman, Philippe Beauchemin, Manu Rangachari
1812 [GO] 2022―Apr―22 Intranasal Lentiviral Vector-Mediated Antibody Delivery Confers Reduction of SARS-CoV-2 Infection in Elderly and Immunocompromised Mice Yue Du, Shengnan Zhang, Zhaoyong Zhang, Kamran M. Miah, Peilan Wei, Lu Zhang, et al. (+7)
1813 [GO] 2022―Apr―21 Coronavirus Infection and Cholesterol Metabolism Jun Dai, Huan Wang, Ying Liao, Lei Tan, Yingjie Sun, Cuiping Song, et al. (+3)
1814 [GO] 2022―Apr―20 Emulation of a Target Trial From Observational Data to Compare Effectiveness of Casirivimab/Imdevimab and Bamlanivimab/Etesevimab for Early Treatment of Non-Hospitalized Patients With COVID-19 Valentina Mazzotta, Alessandro Cozzi-Lepri, Francesca Colavita, Simone Lanini, Silvia Rosati, Eleonora Lalle, et al. (+15)
1815 [GO] 2022―Apr―20 Identifying Immunological and Clinical Predictors of COVID-19 Severity and Sequelae by Mathematical Modeling Noha M. Elemam, Sarah Hammoudeh, Laila Salameh, Bassam Mahboub, Habiba Alsafar, Iman M. Talaat, et al. (+10)
1816 [GO] 2022―Apr―20 Long-Term, CD4+ Memory T Cell Response to SARS-CoV-2 Sebastian Wirsching, Laura Harder, Markus Heymanns, Britta Gröndahl, Katja Hilbert, Frank Kowalzik, et al. (+2)
1817 [GO] 2022―Apr―19 A Protective HLA Extended Haplotype Outweighs the Major COVID-19 Risk Factor Inherited From Neanderthals in the Sardinian Population Stefano Mocci, Roberto Littera, Stefania Tranquilli, Aldesia Provenzano, Alessia Mascia, Federica Cannas, et al. (+10)
1818 [GO] 2022―Apr―19 Successive Site Translocating Inoculation Improved T Cell Responses Elicited by a DNA Vaccine Encoding SARS-CoV-2 S Protein Xiangxiang Tian, Yifan Zhang, Zhangyufan He, Shaoshuai Li, Dongmei Yan, Zhaoqin Zhu, et al. (+2)
1819 [GO] 2022―Apr―14 Differences in Humoral and Cellular Vaccine Responses to SARS-CoV-2 in Kidney and Liver Transplant Recipients Lucrezia Furian, Francesco Paolo Russo, Gianluigi Zaza, Patrizia Burra, Susan Hartzell, Debora Bizzaro, et al. (+11)
1820 [GO] 2022―Apr―14 Persistence of SARS-CoV-2 Infection in Severely Immunocompromised Patients With Complete Remission B-Cell Lymphoma and Anti-CD20 Monoclonal Antibody Therapy: A Case Report of Two Cases Carlos Martínez-Chinchilla, Lucía Vazquez-Montero, Natalia Palazón-Carrión, Isabel M. Fernández-Román, José López-Barba, Luis de la Cruz-Merino, et al. (+2)
1821 [GO] 2022―Apr―13 BNT162b2, mRNA-1273, and Sputnik V Vaccines Induce Comparable Immune Responses on a Par With Severe Course of COVID-19 Anna Kaznadzey, Maria Tutukina, Tatiana Bessonova, Maria Kireeva, Ilya Mazo
1822 [GO] 2022―Apr―13 High Titers of Low Affinity Antibodies in COVID-19 Patients Are Associated With Disease Severity Jan Hendriks, Richard Schasfoort, Michelle Koerselman, Maureen Dannenberg, Alexander Daniel Cornet, Albertus Beishuizen, et al. (+4)
1823 [GO] 2022―Apr―12 Periodontitis-Derived Dark-NETs in Severe Covid-19 Ljubomir Vitkov, Jasmin Knopf, Jelena Krunić, Christine Schauer, Janina Schoen, Bernd Minnich, et al. (+2)
1824 [GO] 2022―Apr―12 Persistence of SARS-CoV-2 Antibodies in Vaccinated Health Care Workers Analyzed by Coronavirus Antigen Microarray Sina Hosseinian, Kathleen Powers, Milind Vasudev, Anton M. Palma, Rafael de Assis, Aarti Jain, et al. (+18)
1825 [GO] 2022―Apr―12 Response: Commentary: Pattern Recognition Proteins: First Line of Defense Against Coronaviruses Carlos Alberto Labarrere, Ghassan S. Kassab
1826 [GO] 2022―Apr―12 SARS-CoV-2 Spike Protein Expression In Vitro and Hematologic Effects in Mice Vaccinated With AZD1222 (ChAdOx1 nCoV-19) Richard Stebbings, Christopher Jones, Peter Cotton, Gillian Armour, Shaun Maguire, Vicky Skellett, et al. (+7)
1827 [GO] 2022―Apr―11 Asymptomatic SARS-CoV-2 Infection Is Associated With Higher Levels of Serum IL-17C, Matrix Metalloproteinase 10 and Fibroblast Growth Factors Than Mild Symptomatic COVID-19 Alessandra Soares-Schanoski, Natalie Sauerwald, Carl W. Goforth, Sivakumar Periasamy, Dawn L. Weir, Stephen Lizewski, et al. (+18)
1828 [GO] 2022―Apr―11 CSF Biomarkers in COVID-19 Associated Encephalopathy and Encephalitis Predict Long-Term Outcome Mar Guasp, Guillermo Muñoz-Sánchez, Eugenia Martínez-Hernández, Daniel Santana, Álvaro Carbayo, Laura Naranjo, et al. (+6)
1829 [GO] 2022―Apr―11 A Capsid Virus-Like Particle-Based SARS-CoV-2 Vaccine Induces High Levels of Antibodies and Protects Rhesus Macaques Ariane Volkmann, Gerrit Koopman, Petra Mooij, Ernst J. Verschoor, Babs E. Verstrepen, Willy M. J. M. Bogers, et al. (+8)
1830 [GO] 2022―Apr―11 Case Report: Acquired Haemophilia A Following mRNA-1273 Booster Vaccination Against SARS-CoV-2 With Concurrent Diagnosis of Pleomorphic Dermal Sarcoma Marlene Plüß, Christina Mitteldorf, Christoph Johannes Szuszies, Björn Tampe
1831 [GO] 2022―Apr―08 The Effects of COVID-19 Vaccination on Lactating Women: A Systematic Review of the Literature Joke Muyldermans, Louise De Weerdt, Larissa De Brabandere, Kirsten Maertens, Eline Tommelein
1832 [GO] 2022―Apr―08 Th2-Oriented Immune Serum After SARS-CoV-2 Vaccination Does Not Enhance Infection In Vitro Ning Luan, Tao Li, Yunfei Wang, Han Cao, Xingxiao Yin, Kangyang Lin, Cunbao Liu
1833 [GO] 2022―Apr―08 Differences in SARS-CoV-2 Vaccine Response Dynamics Between Class-I- and Class-II-Specific T-Cell Receptors in Inflammatory Bowel Disease Alexander M. Xu, Dalin Li, Joseph E. Ebinger, Emebet Mengesha, Rebecca Elyanow, Rachel M. Gittelman, et al. (+19)
1834 [GO] 2022―Apr―07 Bioinformatics and System Biology Approach to Identify the Influences of COVID-19 on Rheumatoid Arthritis Huan Hu, Nana Tang, Facai Zhang, Li Li, Long Li
1835 [GO] 2022―Apr―07 The Role of Cytokines and Chemokines in Severe Acute Respiratory Syndrome Coronavirus 2 Infections Ren-Jun Hsu, Wei-Chieh Yu, Guan-Ru Peng, Chih-Hung Ye, SuiYun Hu, Patrick Chun Theng Chong, et al. (+4)
1836 [GO] 2022―Apr―07 Regulation of Proinflammatory Molecules and Tissue Factor by SARS-CoV-2 Spike Protein in Human Placental Cells: Implications for SARS-CoV-2 Pathogenesis in Pregnant Women Xiaofang Guo, Nihan Semerci, Viviana De Assis, Umit A. Kayisli, Frederick Schatz, Thora S. Steffensen, et al. (+2)
1837 [GO] 2022―Apr―07 Identifying Small-Molecule Inhibitors of SARS-CoV-2 RNA-Dependent RNA Polymerase by Establishing a Fluorometric Assay Xiaoming Bai, Hongmin Sun, Shuo Wu, Yuhuan Li, Lifei Wang, Bin Hong
1838 [GO] 2022―Apr―07 Persistent Lung Injury and Prothrombotic State in Long COVID Mengqi Xiang, Haijiao Jing, Chengyue Wang, Valerie A. Novakovic, Jialan Shi
1839 [GO] 2022―Apr―06 Case Report: Precision COVID-19 Immunization Strategy to Overcome Individual Fragility: A Case of Generalized Lipodystrophy Type 4 Salvatore Zaffina, Eva Piano Mortari, Reparata Rosa Di Prinzio, Marco Cappa, Antonio Novelli, Emanuele Agolini, et al. (+5)
1840 [GO] 2022―Apr―06 Comprehensive Oncogenic Features of Coronavirus Receptors in Glioblastoma Multiforme Anjing Chen, Wenguo Zhao, Xiaolong Li, Guangyu Sun, Zhaoyin Ma, Lingyu Peng, et al. (+3)
1841 [GO] 2022―Apr―06 Long-Read RNA Sequencing Identifies Polyadenylation Elongation and Differential Transcript Usage of Host Transcripts During SARS-CoV-2 In Vitro Infection Jessie J.-Y. Chang, Josie Gleeson, Daniel Rawlinson, Ricardo De Paoli-Iseppi, Chenxi Zhou, Francesca L. Mordant, et al. (+6)
1842 [GO] 2022―Apr―06 Decreased and Heterogeneous Neutralizing Antibody Responses Against RBD of SARS-CoV-2 Variants After mRNA Vaccination Pablo Hernández-Luis, Ruth Aguilar, Judit Pelegrin-Pérez, Gemma Ruiz-Olalla, Alberto L. García-Basteiro, Marta Tortajada, et al. (+4)
1843 [GO] 2022―Apr―06 Multi-Omics Integration Reveals Only Minor Long-Term Molecular and Functional Sequelae in Immune Cells of Individuals Recovered From COVID-19 Zhaoli Liu, Gizem Kilic, Wenchao Li, Ozlem Bulut, Manoj Kumar Gupta, Bowen Zhang, et al. (+24)
1844 [GO] 2022―Apr―05 Advances in Pathogenesis, Progression, Potential Targets and Targeted Therapeutic Strategies in SARS-CoV-2-Induced COVID-19 Hong Zhou, Wei-Jian Ni, Wei Huang, Zhen Wang, Ming Cai, Yan-Cai Sun
1845 [GO] 2022―Apr―05 Frequent Infection of Cats With SARS-CoV-2 Irrespective of Pre-Existing Enzootic Coronavirus Immunity, Brazil 2020 Edmilson F. de Oliveira-Filho, Otávio V. de Carvalho, Ianei O. Carneiro, Fagner D’ambroso Fernandes, Sara Nunes Vaz, Célia Pedroso, et al. (+17)
1846 [GO] 2022―Apr―04 Molnupiravir and Its Antiviral Activity Against COVID-19 Lili Tian, Zehan Pang, Maochen Li, Fuxing Lou, Xiaoping An, Shaozhou Zhu, et al. (+4)
1847 [GO] 2022―Apr―04 Role of Tocilizumab in Down Regulating sCD163 Plasmatic Levels in a Cohort of COVID-19 Patients Raffaella Marocco, Anna Carraro, Maria Antonella Zingaropoli, Parni Nijhawan, Eeva Tortellini, Mariasilvia Guardiani, et al. (+10)
1848 [GO] 2022―Apr―04 Vaccine-Associated Enhanced Disease and Pathogenic Human Coronaviruses Cillian Gartlan, Tom Tipton, Francisco J. Salguero, Quentin Sattentau, Andrew Gorringe, Miles W. Carroll
1849 [GO] 2022―Apr―04 Genetic Surveillance of Five SARS-CoV-2 Clinical Samples in Henan Province Using Nanopore Sequencing Yanan Wang, Duo Chen, Chaofeng Zhu, Zhenhua Zhao, Shanshan Gao, Jianjun Gou, et al. (+2)
1850 [GO] 2022―Apr―04 Conservation and Evolution of Antigenic Determinants of SARS-CoV-2: An Insight for Immune Escape and Vaccine Design Varun Jaiswal, Hae-Jeung Lee
1851 [GO] 2022―Apr―01 CD8+ T Cells in SARS-CoV-2 Induced Disease and Cancer-Clinical Perspectives Keywan Mortezaee, Jamal Majidpoor
1852 [GO] 2022―Mar―31 Inhibitory Immune Checkpoint Receptors and Ligands as Prognostic Biomarkers in COVID-19 Patients Mohammad A. Al-Mterin, Alhasan Alsalman, Eyad Elkord
1853 [GO] 2022―Mar―31 Combined Subcutaneous-Intranasal Immunization With Epitope-Based Antigens Elicits Binding and Neutralizing Antibody Responses in Serum and Mucosae Against PRRSV-2 and SARS-CoV-2 Mario Fragoso-Saavedra, Carmen Ramírez-Estudillo, Diana L. Peláez-González, Jorge O. Ramos-Flores, Gustavo Torres-Franco, Leandro Núñez-Muñoz, et al. (+10)
1854 [GO] 2022―Mar―31 Humoral and Cellular Immunogenicity and Safety of Five Different SARS-CoV-2 Vaccines in Patients With Autoimmune Rheumatic and Musculoskeletal Diseases in Remission or With Low Disease Activity and in Healthy Controls: A Single Center Study Gábor J. Szebeni, Nikolett Gémes, Dániel Honfi, Enikő Szabó, Patrícia Neuperger, József Á. Balog, et al. (+5)
1855 [GO] 2022―Mar―30 Alterations of Urinary Microbial Metabolites and Immune Indexes Linked With COVID-19 Infection and Prognosis Yixian Jing, Jing Wang, Haiyan Zhang, Kun Yang, Jungang Li, Ting Zhao, et al. (+3)
1856 [GO] 2022―Mar―30 An Integrated Platform for Serological Detection and Vaccination of COVID-19 Sung-Chan Wei, Wei-Ting Hsu, Chun-Hsiang Chiu, Feng-Yee Chang, Huei-Ru Lo, Chuan-Yu Liao, et al. (+4)
1857 [GO] 2022―Mar―30 Translational Control of COVID-19 and Its Therapeutic Implication Dejiu Zhang, Lei Zhu, Yin Wang, Peifeng Li, Yanyan Gao
1858 [GO] 2022―Mar―30 Distinct Expression Patterns of Interleukin-22 Receptor 1 on Blood Hematopoietic Cells in SARS-CoV-2 Infection Nurhan Albayrak, Carmen Orte Cano, Sina Karimi, David Dogahe, Anne Van Praet, Audrey Godefroid, et al. (+6)
1859 [GO] 2022―Mar―30 Computer-Based Immunoinformatic Analysis to Predict Candidate T-Cell Epitopes for SARS-CoV-2 Vaccine Design Xueyin Mei, Pan Gu, Chuanlai Shen, Xue Lin, Jian Li
1860 [GO] 2022―Mar―29 Mechanistic Insights Into the Immune Pathophysiology of COVID-19; An In-Depth Review Areez Shafqat, Shameel Shafqat, Sulaiman Al Salameh, Junaid Kashir, Khaled Alkattan, Ahmed Yaqinuddin
1861 [GO] 2022―Mar―29 Preclinical Studies on Convalescent Human Immune Plasma-Derived Exosome: Omics and Antiviral Properties to SARS-CoV-2 Neslihan Pakize Taşlı, Zeynep Burçin Gönen, Oğuz Kaan Kırbaş, Nur Seda Gökdemir, Batuhan Turhan Bozkurt, Buse Bayrakcı, et al. (+25)
1862 [GO] 2022―Mar―29 Cannabidiol and SARS-CoV-2 Infection Alexandre Vallée
1863 [GO] 2022―Mar―29 Type 2 Diabetes Contributes to Altered Adaptive Immune Responses and Vascular Inflammation in Patients With SARS-CoV-2 Infection Manpreet Singh, Obed Barrera Adame, Michael Nickas, Jeremiah Robison, Christopher Khatchadourian, Vishwanath Venketaraman
1864 [GO] 2022―Mar―29 Computation of Antigenicity Predicts SARS-CoV-2 Vaccine Breakthrough Variants Ye-Fan Hu, Jing-Chu Hu, Hua-Rui Gong, Antoine Danchin, Ren Sun, Hin Chu, et al. (+6)
1865 [GO] 2022―Mar―29 Porcine Respiratory Coronavirus as a Model for Acute Respiratory Coronavirus Disease Sarah Keep, Brigid Veronica Carr, Fabian Z. X. Lean, Albert Fones, Joseph Newman, Giulia Dowgier, et al. (+19)
1866 [GO] 2022―Mar―29 Sex, Age, and Ethnic Background Shape Adaptive Immune Responses Induced by the SARS-CoV-2 mRNA Vaccine Jie Bai, Asako Chiba, Goh Murayama, Taiga Kuga, Naoto Tamura, Sachiko Miyake
1867 [GO] 2022―Mar―29 Revisiting the Principles of Preservation in an Era of Pandemic Obesity John T. Langford, Jenna R. DiRito, Natty Doilicho, Graylen R. Chickering, David A. Stern, Xinshou Ouyang, et al. (+2)
1868 [GO] 2022―Mar―29 An Autoantigen Atlas From Human Lung HFL1 Cells Offers Clues to Neurological and Diverse Autoimmune Manifestations of COVID-19 Julia Y. Wang, Wei Zhang, Victor B. Roehrl, Michael W. Roehrl, Michael H. Roehrl
1869 [GO] 2022―Mar―29 Evaluation of Humoral and Cellular Responses in SARS-CoV-2 mRNA Vaccinated Immunocompromised Patients Matthijs Oyaert, Marie-Angélique De Scheerder, Sophie Van Herrewege, Guy Laureys, Sofie Van Assche, Melissa Cambron, et al. (+10)
1870 [GO] 2022―Mar―28 ACE2 Serum Levels as Predictor of Infectability and Outcome in COVID-19 María del Carmen Maza, María Úbeda, Pilar Delgado, Lydia Horndler, Miguel A. Llamas, Hisse M. van Santen, et al. (+6)
1871 [GO] 2022―Mar―28 Efficacy and Safety of BCG Revaccination With M. bovis BCG Moscow to Prevent COVID-19 Infection in Health Care Workers: A Randomized Phase II Clinical Trial Laura Raniere Borges dos Anjos, Adeliane Castro da Costa, Amanda da Rocha Oliveira Cardoso, Rafael Alves Guimarães, Roberta Luiza Rodrigues, Kaio Mota Ribeiro, et al. (+13)
1872 [GO] 2022―Mar―28 Cardiovascular Dysfunction in COVID-19: Association Between Endothelial Cell Injury and Lactate Kun Yang, Matthew Holt, Min Fan, Victor Lam, Yong Yang, Tuanzhu Ha, et al. (+3)
1873 [GO] 2022―Mar―28 The S1 Subunit of the SARS-CoV-2 Spike Protein Activates Human Monocytes to Produce Cytokines Linked to COVID-19: Relevance to Galectin-3 John T. Schroeder, Anja P. Bieneman
1874 [GO] 2022―Mar―28 Age-Associated Seroprevalence of Coronavirus Antibodies: Population-Based Serosurveys in 2013 and 2020, British Columbia, Canada Guadalein Tanunliong, Aaron C. Liu, Samantha Kaweski, Mike Irvine, Romina C. Reyes, Dale Purych, et al. (+6)
1875 [GO] 2022―Mar―28 Development of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients After 1273-mRNA SARS-CoV-2 Vaccination Maria Gonzalez-Perez, Maria Montes-Casado, Patricia Conde, Isabel Cervera, Jana Baranda, Marcos J. Berges-Buxeda, et al. (+14)
1876 [GO] 2022―Mar―27 Commentary: Is There a Crucial Link Between Vitamin D Status and Inflammatory Response in Patients With COVID-19? Marijn M. Speeckaert, Joris R. Delanghe
1877 [GO] 2022―Mar―26 COVID-19, Anti-NMDA Receptor Encephalitis and MicroRNA Hsiuying Wang
1878 [GO] 2022―Mar―25 Immunogenic SARS-CoV-2 S and N Protein Peptide and Cytokine Combinations as Biomarkers for Early Prediction of Fatal COVID-19 Ekaterina Martynova, Shaimaa Hamza, Maria Markelova, Ekaterina Garanina, Yuriy Davidyuk, Venera Shakirova, et al. (+6)
1879 [GO] 2022―Mar―25 Plasma Cytokine Atlas Reveals the Importance of TH2 Polarization and Interferons in Predicting COVID-19 Severity and Survival Lara Gibellini, Sara De Biasi, Marianna Meschiari, Licia Gozzi, Annamaria Paolini, Rebecca Borella, et al. (+10)
1880 [GO] 2022―Mar―24 Trajectory of IgG to SARS-CoV-2 After Vaccination With BNT162b2 or mRNA-1273 in an Employee Cohort and Comparison With Natural Infection Behnam Keshavarz, Nathan E. Richards, Lisa J. Workman, Jaimin Patel, Lyndsey M. Muehling, Glenda Canderan, et al. (+11)
1881 [GO] 2022―Mar―22 Causal Association and Shared Genetics Between Asthma and COVID-19 Ancha Baranova, Hongbao Cao, Jiu Chen, Fuquan Zhang
1882 [GO] 2022―Mar―21 SARS-COV-2 Infection, Vaccination, and Immune-Mediated Diseases: Results of a Single-Center Retrospective Study Michele Maria Luchetti Gentiloni, Valentino Paci, Valentina Marconi, Marco Gigli, Devis Benfaremo, Raffaella Sordillo, et al. (+5)
1883 [GO] 2022―Mar―18 Evaluation of Spike Protein Epitopes by Assessing the Dynamics of Humoral Immune Responses in Moderate COVID-19 Lingyun Chen, Pengfei Pang, Huan Qi, Keqiang Yan, Yan Ren, Mingliang Ma, et al. (+12)
1884 [GO] 2022―Mar―18 Definition of the Immune Parameters Related to COVID-19 Severity Sarah Birindelli, Maciej S. Tarkowski, Marcello Gallucci, Marco Schiuma, Alice Covizzi, Przemysław Lewkowicz, et al. (+6)
1885 [GO] 2022―Mar―17 Plasma Markers of Neutrophil Extracellular Trap Are Linked to Survival but Not to Pulmonary Embolism in COVID-19-Related ARDS Patients Renaud Prével, Annabelle Dupont, Sylvie Labrouche-Colomer, Geoffrey Garcia, Antoine Dewitte, Antoine Rauch, et al. (+12)
1886 [GO] 2022―Mar―17 Short-Term Instantaneous Prophylaxis and Efficient Treatment Against SARS-CoV-2 in hACE2 Mice Conferred by an Intranasal Nanobody (Nb22) Xilin Wu, Yaxing Wang, Lin Cheng, Fengfeng Ni, Linjing Zhu, Sen Ma, et al. (+13)
1887 [GO] 2022―Mar―17 Case Report: Severe Rhabdomyolysis and Multiorgan Failure After ChAdOx1 nCoV-19 Vaccination Emilia Cirillo, Ciro Esposito, Giuliana Giardino, Gaetano Azan, Simona Fecarotta, Stefania Pittaluga, et al. (+5)
1888 [GO] 2022―Mar―16 Comparison of Lung-Homing Receptor Expression and Activation Profiles on NK Cell and T Cell Subsets in COVID-19 and Influenza Demi Brownlie, Inga Rødahl, Renata Varnaite, Hilmir Asgeirsson, Hedvig Glans, Sara Falck-Jones, et al. (+7)
1889 [GO] 2022―Mar―16 Poxvirus MVA Expressing SARS-CoV-2 S Protein Induces Robust Immunity and Protects Rhesus Macaques From SARS-CoV-2 Petra Mooij, Juan García-Arriaza, Patricia Pérez, Adrian Lázaro-Frías, Babs E. Verstrepen, Kinga P. Böszörményi, et al. (+20)
1890 [GO] 2022―Mar―16 MVA-CoV2-S Vaccine Candidate Neutralizes Distinct Variants of Concern and Protects Against SARS-CoV-2 Infection in Hamsters Robbert Boudewijns, Patricia Pérez, Adrián Lázaro-Frías, Dominique Van Looveren, Thomas Vercruysse, Hendrik Jan Thibaut, et al. (+10)
1891 [GO] 2022―Mar―16 Multiple SARS-CoV-2 Variants Exhibit Variable Target Cell Infectivity and Ability to Evade Antibody Neutralization Haijun Tang, Long Gao, Zhao Wu, Fang Meng, Xin Zhao, Yun Shao, et al. (+3)
1892 [GO] 2022―Mar―15 A Review on Measures to Rejuvenate Immune System: Natural Mode of Protection Against Coronavirus Infection Md. Aminul Islam, Md. Atiqul Haque, Md. Arifur Rahman, Foysal Hossen, Mahin Reza, Abanti Barua, et al. (+7)
1893 [GO] 2022―Mar―14 Autoantibodies Against Proteins Previously Associated With Autoimmunity in Adult and Pediatric Patients With COVID-19 and Children With MIS-C Peter D. Burbelo, Riccardo Castagnoli, Chisato Shimizu, Ottavia M. Delmonte, Kerry Dobbs, Valentina Discepolo, et al. (+29)
1894 [GO] 2022―Mar―14 Longitudinal Tracking of Immune Responses in COVID-19 Convalescents Reveals Absence of Neutralization Activity Against Omicron and Staggered Impairment to Other SARS-CoV-2 Variants of Concern Ivan Odak, Christian R. Schultze-Florey, Swantje I. Hammerschmidt, Christiane Ritter, Stefanie Willenzon, Michaela Friedrichsen, et al. (+14)
1895 [GO] 2022―Mar―14 Activated CD8+CD38+ Cells Are Associated With Worse Clinical Outcome in Hospitalized COVID-19 Patients Anna Bobcakova, Martina Barnova, Robert Vysehradsky, Jela Petriskova, Ivan Kocan, Zuzana Diamant, Milos Jesenak
1896 [GO] 2022―Mar―14 The COVID Complex: A Review of Platelet Activation and Immune Complexes in COVID-19 Stefan D. Jevtic, Ishac Nazy
1897 [GO] 2022―Mar―11 The Inflammatory Cytokine Imbalance for Miscarriage, Pregnancy Loss and COVID-19 Pneumonia Fortunato Vesce, Chiara Battisti, Michele Crudo
1898 [GO] 2022―Mar―11 On the Origin of Neutrophil Extracellular Traps in COVID-19 Michal Pastorek, Martin Dúbrava, Peter Celec
1899 [GO] 2022―Mar―11 Risk Factors for Severe COVID-19 and Hepatitis C Infections: The Dual Role of Apolipoprotein E4 Felipe B. Lima, Karine C. Bezerra, José Carlos R. Nascimento, Gdayllon C. Meneses, Reinaldo B. Oriá
1900 [GO] 2022―Mar―11 Disease Severity in Moderate-to-Severe COVID-19 Is Associated With Platelet Hyperreactivity and Innate Immune Activation Kai Jakobs, Leander Reinshagen, Marianna Puccini, Julian Friebel, Anne-Christin Beatrice Wilde, Ayman Alsheik, et al. (+5)
1901 [GO] 2022―Mar―11 Natural SARS-CoV-2 Infection Affects Neutralizing Activity in Saliva of Vaccinees Micaela Garziano, Olga Utyro, Mariacristina Poliseno, Teresa Antonia Santantonio, Irma Saulle, Sergio Strizzi, et al. (+4)
1902 [GO] 2022―Mar―10 Impact of Hypogammaglobulinemia on the Course of COVID-19 in a Non-Intensive Care Setting: A Single-Center Retrospective Cohort Study Riccardo Scarpa, Alessandro Dell’Edera, Carla Felice, Roberta Buso, Francesco Muscianisi, Renato Finco Gambier, et al. (+9)
1903 [GO] 2022―Mar―10 SARS-CoV-2 T Cell Response in Severe and Fatal COVID-19 in Primary Antibody Deficiency Patients Without Specific Humoral Immunity Sophie Steiner, Tatjana Schwarz, Victor M. Corman, Laura Gebert, Malte C. Kleinschmidt, Alexandra Wald, et al. (+17)
1904 [GO] 2022―Mar―10 Targeting the Interaction Between Spike Protein and Nucleocapsid Protein for Suppression and Detection of Human Coronavirus OC43 Jinsoo Kim, Minyoung Kim, Dongbum Kim, Sangkyu Park, Mijeong Kang, Kyeongbin Baek, et al. (+5)
1905 [GO] 2022―Mar―09 Heterologous Immune Responses of Serum IgG and Secretory IgA Against the Spike Protein of Endemic Coronaviruses During Severe COVID-19 Wouter L. Smit, Sophie van Tol, Sanne van der Wal, Femke van Vulpen, Shannon la Grouw, Lenneke van Lelyveld, et al. (+9)
1906 [GO] 2022―Mar―09 Novel Synthetic Lipopeptides as Potential Mucosal Adjuvants Enhanced SARS-CoV-2 rRBD-Induced Immune Response Ling Mao, Chang Liu, Jing-Yi Liu, Zi-Li Jin, Zhe Jin, Ruo-Yi Xue, et al. (+6)
1907 [GO] 2022―Mar―08 Kinetics of Severity Biomarkers and Immunological Features of Methylprednisolone Therapy for Severe COVID-19 Patients Qinghong Fan, Kai Deng, Huang Huang, Ruiying He, Xizi Deng, Yun Lan, et al. (+6)
1908 [GO] 2022―Mar―08 How the Innate Immune System of the Blood Contributes to Systemic Pathology in COVID-19-Induced ARDS and Provides Potential Targets for Treatment Bo Nilsson, Barbro Persson, Oskar Eriksson, Karin Fromell, Michael Hultström, Robert Frithiof, et al. (+3)
1909 [GO] 2022―Mar―08 Metabolic Landscape of Bronchoalveolar Lavage Fluid in Coronavirus Disease 2019 at Single Cell Resolution Ming-Ming Shao, Meier Shi, Juan Du, Xue-Bin Pei, Bei-Bei Gu, Feng-Shuang Yi
1910 [GO] 2022―Mar―08 Neutralization of SARS-CoV-2 Variants by mRNA and Adenoviral Vector Vaccine-Elicited Antibodies Takuya Tada, Hao Zhou, Marie I. Samanovic, Belinda M. Dcosta, Amber Cornelius, Ramin S. Herati, et al. (+2)
1911 [GO] 2022―Mar―07 SARS-CoV-2 Spike Protein 1 Activates Microvascular Endothelial Cells and Complement System Leading to Platelet Aggregation Luca Perico, Marina Morigi, Miriam Galbusera, Anna Pezzotta, Sara Gastoldi, Barbara Imberti, et al. (+5)
1912 [GO] 2022―Mar―07 Neutralisation Hierarchy of SARS-CoV-2 Variants of Concern Using Standardised, Quantitative Neutralisation Assays Reveals a Correlation With Disease Severity; Towards Deciphering Protective Antibody Thresholds Diego Cantoni, Martin Mayora-Neto, Angalee Nadesalingam, David A. Wells, George W. Carnell, Luis Ohlendorf, et al. (+13)
1913 [GO] 2022―Mar―04 Insights From Early Clinical Trials Assessing Response to mRNA SARS-CoV-2 Vaccination in Immunocompromised Patients Frédéric Baron, Lorenzo Canti, Kevin K. Ariën, Delphine Kemlin, Isabelle Desombere, Margaux Gerbaux, et al. (+4)
1914 [GO] 2022―Mar―03 Understanding the Effects of Age and T-Cell Differentiation on COVID-19 Severity: Implicating a Fas/FasL-mediated Feed-Forward Controller of T-Cell Differentiation Anthony J. Leonardi, Christos P. Argyropoulos, Adam Hamdy, Rui B. Proenca
1915 [GO] 2022―Mar―03 SARS-CoV-2 Omicron (B.1.1.529) Variant: Corticosteroids Treatment/Respiratory Coinfection Zeev Elkoshi
1916 [GO] 2022―Mar―02 NETosis and Neutrophil Extracellular Traps in COVID-19: Immunothrombosis and Beyond Yuanfeng Zhu, Xiaoli Chen, Xin Liu
1917 [GO] 2022―Mar―02 Decline of Humoral and Cellular Immune Responses Against SARS-CoV-2 6 Months After Full BNT162b2 Vaccination in Hospital Healthcare Workers Benjamin Bonnet, Hélène Chabrolles, Christine Archimbaud, Amélie Brebion, Justine Cosme, Frédéric Dutheil, et al. (+9)
1918 [GO] 2022―Mar―01 Reduced T Cell and Antibody Responses to Inactivated Coronavirus Vaccine Among Individuals Above 55 Years Old Giuliana X. Medeiros, Greyce Luri Sasahara, Jhosiene Y. Magawa, João Paulo S. Nunes, Fernanda R. Bruno, Andreia C. Kuramoto, et al. (+14)
1919 [GO] 2022―Feb―28 Risk Factors for Severe COVID-19 and Hospital Admission in Patients With Inborn Errors of Immunity - Results From a Multicenter Nationwide Study Tomas Milota, Marta Sobotkova, Jitka Smetanova, Marketa Bloomfield, Jana Vydlakova, Zita Chovancova, et al. (+11)
1920 [GO] 2022―Feb―28 Associations Between Symptoms, Donor Characteristics and IgG Antibody Response in 2082 COVID-19 Convalescent Plasma Donors Marieke Vinkenoog, Maurice Steenhuis, Anja ten Brinke, J. G. Coen van Hasselt, Mart P. Janssen, Matthijs van Leeuwen, et al. (+8)
1921 [GO] 2022―Feb―28 A Novel Bacterial Protease Inhibitor Adjuvant in RBD-Based COVID-19 Vaccine Formulations Containing Alum Increases Neutralizing Antibodies, Specific Germinal Center B Cells and Confers Protection Against SARS-CoV-2 Infection in Mice Lorena M. Coria, Lucas M. Saposnik, Celeste Pueblas Castro, Eliana F. Castro, Laura A. Bruno, William B. Stone, et al. (+11)
1922 [GO] 2022―Feb―28 Kinetics of the B- and T-Cell Immune Responses After 6 Months From SARS-CoV-2 mRNA Vaccination in Patients With Rheumatoid Arthritis Chiara Farroni, Andrea Picchianti-Diamanti, Alessandra Aiello, Emanuele Nicastri, Bruno Laganà, Chiara Agrati, et al. (+20)
1923 [GO] 2022―Feb―28 Vaccine Type-, Age- and Past Infection-Dependence of the Humoral Response to SARS-CoV-2 Spike S Protein Salvador Romero-Pinedo, Marina Quesada, Lydia Horndler, Stela Álvarez-Fernández, Asunción Olmo, David Abia, et al. (+2)
1924 [GO] 2022―Feb―25 Non-Invasive Monitoring for Rejection in Kidney Transplant Recipients After SARS-CoV-2 mRNA Vaccination Ayman Al Jurdi, Rodrigo B. Gassen, Thiago J. Borges, Zhabiz Solhjou, Frank E. Hullekes, Isadora T. Lape, et al. (+12)
1925 [GO] 2022―Feb―25 Simian Immunodeficiency Virus Infection Mediated Changes in Jejunum and Peripheral SARS-CoV-2 Receptor ACE2 and Associated Proteins or Genes in Rhesus Macaques Nongthombam Boby, Xuewei Cao, Kelsey Williams, Shiva Kumar Goud Gadila, Monica N. Shroyer, Peter J. Didier, et al. (+5)
1926 [GO] 2022―Feb―25 A Thermostable Oral SARS-CoV-2 Vaccine Induces Mucosal and Protective Immunity Bertrand Bellier, Alicia Saura, Lucas A. Luján, Cecilia R. Molina, Hugo D. Luján, David Klatzmann
1927 [GO] 2022―Feb―24 SARS-CoV-2 Induces Cytokine Responses in Human Basophils Srinivasa Reddy Bonam, Camille Chauvin, Laurine Levillayer, Mano Joseph Mathew, Anavaj Sakuntabhai, Jagadeesh Bayry
1928 [GO] 2022―Feb―24 Memory B Cells Induced by Sputnik V Vaccination Produce SARS-CoV-2 Neutralizing Antibodies Upon Ex Vivo Restimulation Maria G. Byazrova, Sergey V. Kulemzin, Ekaterina A. Astakhova, Tatyana N. Belovezhets, Grigory A. Efimov, Anton N. Chikaev, et al. (+4)
1929 [GO] 2022―Feb―24 Cross-Neutralizing Breadth and Longevity Against SARS-CoV-2 Variants After Infections Yukiya Kurahashi, Silvia Sutandhio, Koichi Furukawa, Lidya Handayani Tjan, Sachiyo Iwata, Shigeru Sano, et al. (+10)
1930 [GO] 2022―Feb―24 Multi-Cellular Immunological Interactions Associated With COVID-19 Infections Jitender S. Verma, Claudia R. Libertin, Yash Gupta, Geetika Khanna, Rohit Kumar, Balvinder S. Arora, et al. (+8)
1931 [GO] 2022―Feb―24 DNA Vaccines Expressing the Envelope and Membrane Proteins Provide Partial Protection Against SARS-CoV-2 in Mice Jinni Chen, Yao Deng, Baoying Huang, Di Han, Wen Wang, Mengjing Huang, et al. (+7)
1932 [GO] 2022―Feb―24 Single-Domain Antibodies Efficiently Neutralize SARS-CoV-2 Variants of Concern Irina A. Favorskaya, Dmitry V. Shcheblyakov, Ilias B. Esmagambetov, Inna V. Dolzhikova, Irina A. Alekseeva, Anastasia I. Korobkova, et al. (+15)
1933 [GO] 2022―Feb―23 Soluble Immune Checkpoints Are Dysregulated in COVID-19 and Heavy Alcohol Users With HIV Infection Wei Li, Fahim Syed, Richard Yu, Jing Yang, Ying Xia, Ryan F. Relich, et al. (+7)
1934 [GO] 2022―Feb―23 Case Report: Evolution of Humoral and Cellular Immunity in Two COVID-19 Breakthrough Infections After BNT162b2 Vaccine Floriane Gallais, Pierre Gantner, Delphine Planas, Morgane Solis, Timothée Bruel, Florian Pierre, et al. (+6)
1935 [GO] 2022―Feb―23 Decline in Antibody Concentration 6 Months After Two Doses of SARS-CoV-2 BNT162b2 Vaccine in Solid Organ Transplant Recipients and Healthy Controls Sebastian Rask Hamm, Dina Leth Møller, Laura Pérez-Alós, Cecilie Bo Hansen, Mia Marie Pries-Heje, Line Dam Heftdal, et al. (+18)
1936 [GO] 2022―Feb―22 Immune-Mediated Platelet Activation in COVID-19 and Vaccine-Induced Immune Thrombotic Thrombocytopenia Günalp Uzun, Lisann Pelzl, Anurag Singh, Tamam Bakchoul
1937 [GO] 2022―Feb―22 Identification of Distinct Immune Cell Subsets Associated With Asymptomatic Infection, Disease Severity, and Viral Persistence in COVID-19 Patients Xiaorui Wang, Han Bai, Junpeng Ma, Hongyu Qin, Qiqi Zeng, Fang Hu, et al. (+21)
1938 [GO] 2022―Feb―22 Immunotherapy of COVID-19: Inside and Beyond IL-6 Signalling Gaetano Zizzo, Antonio Tamburello, Laura Castelnovo, Antonella Laria, Nicola Mumoli, Paola Maria Faggioli, et al. (+2)
1939 [GO] 2022―Feb―22 Dominant CD8+ T Cell Nucleocapsid Targeting in SARS-CoV-2 Infection and Broad Spike Targeting From Vaccination Ellie Taus, Christian Hofmann, Francisco Javier Ibarrondo, Mary Ann Hausner, Jennifer A. Fulcher, Paul Krogstad, et al. (+5)
1940 [GO] 2022―Feb―21 Chronic Inflammation Might Protect Hemodialysis Patients From Severe COVID-19 Barbara Prietl, Balazs Odler, Alexander H. Kirsch, Katharina Artinger, Manfred Eigner, Sabine Schmaldienst, et al. (+9)
1941 [GO] 2022―Feb―21 Emerging Insights on Caspases in COVID-19 Pathogenesis, Sequelae, and Directed Therapies Thomas A. Premeaux, Stephen T. Yeung, Zaheer Bukhari, Scott Bowler, Oral Alpan, Raavi Gupta, Lishomwa C. Ndhlovu
1942 [GO] 2022―Feb―21 Depletion and Dysfunction of Dendritic Cells: Understanding SARS-CoV-2 Infection Teding Chang, Jingzhi Yang, Hai Deng, Deng Chen, XiangPing Yang, Zhao-Hui Tang
1943 [GO] 2022―Feb―18 Increased Interleukin 18-Dependent Immune Responses Are Associated With Myopericarditis After COVID-19 mRNA Vaccination Taejoon Won, Nisha Aggarwal Gilotra, Megan Kay Wood, David Matthew Hughes, Monica Vladut Talor, Jana Lovell, et al. (+3)
1944 [GO] 2022―Feb―18 Absolving COVID-19 Vaccination of Autoimmune Bullous Disease Onset Roberto Russo, Giulia Gasparini, Emanuele Cozzani, Federica D’Agostino, Aurora Parodi
1945 [GO] 2022―Feb―18 Simvastatin Downregulates the SARS-CoV-2-Induced Inflammatory Response and Impairs Viral Infection Through Disruption of Lipid Rafts Lívia Teixeira, Jairo R. Temerozo, Filipe S. Pereira-Dutra, André Costa Ferreira, Mayara Mattos, Barbara Simonson Gonçalves, et al. (+19)
1946 [GO] 2022―Feb―17 Potential Anionic Substances Binding to Platelet Factor 4 in Vaccine-Induced Thrombotic Thrombocytopenia of ChAdOx1-S Vaccine for SARS-CoV-2 Xiaocong Pang, Haitao Liu, Xu He, Tianrong Ji, Yizhun Zhu, Yimin Cui
1947 [GO] 2022―Feb―17 Progress and Challenges Toward Generation and Maintenance of Long-Lived Memory T Lymphocyte Responses During COVID-19 Swatantra Kumar, Shailendra K. Saxena, Vimal K. Maurya, Anil K. Tripathi
1948 [GO] 2022―Feb―17 Trained Immunity: An Overview and the Impact on COVID-19 Justin M. Brueggeman, Juan Zhao, Madison Schank, Zhi Q. Yao, Jonathan P. Moorman
1949 [GO] 2022―Feb―17 ACE and ACE2 Gene Variants Are Associated With Severe Outcomes of COVID-19 in Men Laura E. Martínez-Gómez, Brígida Herrera-López, Carlos Martinez-Armenta, Silvestre Ortega-Peña, María del Carmen Camacho-Rea, Carlos Suarez-Ahedo, et al. (+36)
1950 [GO] 2022―Feb―17 Disrupted Peyer’s Patch Microanatomy in COVID-19 Including Germinal Centre Atrophy Independent of Local Virus Silvia C. Trevelin, Suzanne Pickering, Katrina Todd, Cynthia Bishop, Michael Pitcher, Jose Garrido Mesa, et al. (+7)
1951 [GO] 2022―Feb―17 Activation of Complement Components on Circulating Blood Monocytes From COVID-19 Patients Silvia Lucena Lage, Joseph M. Rocco, Elizabeth Laidlaw, Adam Rupert, Frances Galindo, Anela Kellogg, et al. (+6)
1952 [GO] 2022―Feb―17 SARS-CoV-2 Infection Triggers Phosphorylation: Potential Target for Anti-COVID-19 Therapeutics Bhaswati Chatterjee, Suman S. Thakur
1953 [GO] 2022―Feb―16 A Simplified SARS-CoV-2 Mouse Model Demonstrates Protection by an Oral Replicon-Based mRNA Vaccine Vijayakumar Jawalagatti, Perumalraja Kirthika, Chamith Hewawaduge, Ji-Young Park, Myeon-Sik Yang, Byungkwan Oh, et al. (+3)
1954 [GO] 2022―Feb―16 Coping With Stress: The Mitokine GDF-15 as a Biomarker of COVID-19 Severity Darakhshan Sohail Ahmed, Stéphane Isnard, Carolina Berini, John Lin, Jean-Pierre Routy, Léna Royston
1955 [GO] 2022―Feb―16 Increased Expression of Tim-3 Is Associated With Depletion of NKT Cells In SARS-CoV-2 Infection Jingzhi Yang, Teding Chang, Liangsheng Tang, Hai Deng, Deng Chen, Jialiu Luo, et al. (+7)
1956 [GO] 2022―Feb―16 A Novel Glucocorticoid and Androgen Receptor Modulator Reduces Viral Entry and Innate Immune Inflammatory Responses in the Syrian Hamster Model of SARS-CoV-2 Infection Savannah M. Rocha, Anna C. Fagre, Amanda S. Latham, Jason E. Cummings, Tawfik A. Aboellail, Philip Reigan, et al. (+8)
1957 [GO] 2022―Feb―16 Comparative Magnitude and Persistence of Humoral SARS-CoV-2 Vaccination Responses in the Adult Population in Germany Alex Dulovic, Barbora Kessel, Manuela Harries, Matthias Becker, Julia Ortmann, Johanna Griesbaum, et al. (+26)
1958 [GO] 2022―Feb―15 The COVID-19/Tuberculosis Syndemic and Potential Antibody Therapy for TB Based on the Lessons Learnt From the Pandemic Sylvia Annabel Dass, Venugopal Balakrishnan, Norsyahida Arifin, Crystale Siew Ying Lim, Fazlina Nordin, Gee Jun Tye
1959 [GO] 2022―Feb―15 Cannabidiol and Terpene Formulation Reducing SARS-CoV-2 Infectivity Tackling a Therapeutic Strategy Susana Santos, Pedro Barata, Adilia Charmier, Inês Lehmann, Suzilaine Rodrigues, Matteo M. Melosini, et al. (+7)
1960 [GO] 2022―Feb―14 Antigen-Specific CD4+ T-Cell Activation in Primary Antibody Deficiency After BNT162b2 mRNA COVID-19 Vaccination Kai M. T. Sauerwein, Christoph B. Geier, Roman F. Stemberger, Hüseyin Akyaman, Peter Illes, Michael B. Fischer, et al. (+3)
1961 [GO] 2022―Feb―14 Complement Activation via the Lectin and Alternative Pathway in Patients With Severe COVID-19 Janina Niederreiter, Christine Eck, Tajana Ries, Arndt Hartmann, Bruno Märkl, Maike Büttner-Herold, et al. (+2)
1962 [GO] 2022―Feb―14 Circulating Type I Interferon Levels in the Early Phase of COVID-19 Are Associated With the Development of Respiratory Failure Kentaro Nagaoka, Hitoshi Kawasuji, Yushi Murai, Makito Kaneda, Akitoshi Ueno, Yuki Miyajima, et al. (+3)
1963 [GO] 2022―Feb―14 COVID-19 Recovery Patterns Across Alpha (B.1.1.7) and Delta (B.1.617.2) Variants of SARS-CoV-2 Nitya Kumar, Suha Quadri, Abdulla Ismaeel AlAwadhi, Manaf AlQahtani
1964 [GO] 2022―Feb―14 SARS-CoV-2 Immunization Orchestrates the Amplification of IFNγ-Producing T Cell and NK Cell Persistence Lucia La Sala, Sara Gandini, Antonino Bruno, Raffaele Allevi, Matteo Gallazzi, Pamela Senesi, et al. (+6)
1965 [GO] 2022―Feb―11 The Fight Against Severe COVID-19: Can Parasitic Worms Contribute? Pengfei Cai, Yi Mu, Donald P. McManus
1966 [GO] 2022―Feb―11 Pre-COVID-19 Immunity to Common Cold Human Coronaviruses Induces a Recall-Type IgG Response to SARS-CoV-2 Antigens Without Cross-Neutralisation Makoto Miyara, Melissa Saichi, Delphine Sterlin, François Anna, Stéphane Marot, Alexis Mathian, et al. (+27)
1967 [GO] 2022―Feb―10 Pregnant Women Develop a Specific Immunological Long-Lived Memory Against SARS-COV-2 Claudio Fenizia, Irene Cetin, Davide Mileto, Claudia Vanetti, Irma Saulle, Maia Di Giminiani, et al. (+6)
1968 [GO] 2022―Feb―10 Impact on HIV-1 RNA Levels and Antibody Responses Following SARS-CoV-2 Vaccination in HIV-Infected Individuals Vera Portillo, Chiara Fedeli, Pilar Ustero Alonso, Ianis Petignat, Ellen Cristina Mereles Costa, Adi Sulstarova, et al. (+3)
1969 [GO] 2022―Feb―09 Case Report: A Peculiar Case of Inflammatory Colitis After SARS-CoV-2 Infection Mariangela Rutigliani, Matteo Bozzo, Andrea Barberis, Marco Greppi, Emanuela Anelli, Luca Castellaro, et al. (+8)
1970 [GO] 2022―Feb―09 Inflammatory Markers, Pulmonary Function, and Clinical Symptoms in Acute COVID-19 Among Non-Hospitalized Adolescents and Young Adults Lise Lund Berven, Joel Selvakumar, Lise Havdal, Tonje Stiansen-Sonerud, Gunnar Einvik, Truls Michael Leegaard, et al. (+4)
1971 [GO] 2022―Feb―09 A Detailed Overview of Immune Escape, Antibody Escape, Partial Vaccine Escape of SARS-CoV-2 and Their Emerging Variants With Escape Mutations Chiranjib Chakraborty, Ashish Ranjan Sharma, Manojit Bhattacharya, Sang-Soo Lee
1972 [GO] 2022―Feb―09 Influence of Aerosol Delivered BCG Vaccination on Immunological and Disease Parameters Following SARS-CoV-2 Challenge in Rhesus Macaques Andrew D. White, Laura Sibley, Charlotte Sarfas, Alexandra L. Morrison, Kevin Bewley, Colin Churchward, et al. (+23)
1973 [GO] 2022―Feb―07 Characterization of Two Heterogeneous Lethal Mouse-Adapted SARS-CoV-2 Variants Recapitulating Representative Aspects of Human COVID-19 Feihu Yan, Entao Li, Tiecheng Wang, Yuanguo Li, Jun Liu, Weiqi Wang, et al. (+9)
1974 [GO] 2022―Feb―07 Sustained Antibody-Dependent NK Cell Functions in Mild COVID-19 Outpatients During Convalescence Francisco Fuentes-Villalobos, Jose L. Garrido, Matías A. Medina, Nicole Zambrano, Natalia Ross, Felipe Bravo, et al. (+18)
1975 [GO] 2022―Feb―07 Convalescent Plasma Treatment in Patients with Covid-19: A Systematic Review and Meta-Analysis Anselm Jorda, Manuel Kussmann, Nebu Kolenchery, Jolanta M. Siller-Matula, Markus Zeitlinger, Bernd Jilma, Georg Gelbenegger
1976 [GO] 2022―Feb―07 Children and Adults With Mild COVID-19: Dynamics of the Memory T Cell Response up to 10 Months Patricia Kaaijk, Verónica Olivo Pimentel, Maarten E. Emmelot, Martien Poelen, Alper Cevirgel, Rutger M. Schepp, et al. (+8)
1977 [GO] 2022―Feb―04 Immune Response Is Key to Genetic Mechanisms of SARS-CoV-2 Infection With Psychiatric Disorders Based on Differential Gene Expression Pattern Analysis Jing Xia, Shuhan Chen, Yaping Li, Hua Li, Minghong Gan, Jiashuo Wu, et al. (+5)
1978 [GO] 2022―Feb―04 Emerging Role of Platelet-Endothelium Interactions in the Pathogenesis of Severe SARS-CoV-2 Infection-Associated Myocardial Injury Theresa M. Rossouw, Ronald Anderson, Pravin Manga, Charles Feldman
1979 [GO] 2022―Feb―03 New Discovery of Myeloid-Derived Suppressor Cell’s Tale on Viral Infection and COVID-19 Soo-Jeung Park, Da-eun Nam, Hae Chang Seong, Young S. Hahn
1980 [GO] 2022―Feb―03 HLA-C*04:01 Affects HLA Class I Heterozygosity and Predicted Affinity to SARS-CoV-2 Peptides, and in Combination With Age and Sex of Armenian Patients Contributes to COVID-19 Severity Anahit Hovhannisyan, Vergine Madelian, Sevak Avagyan, Mihran Nazaretyan, Armine Hyussyan, Alina Sirunyan, et al. (+5)
1981 [GO] 2022―Feb―03 Robust and Functional Immune Memory Up to 9 Months After SARS-CoV-2 Infection: A Southeast Asian Longitudinal Cohort Hoa Thi My Vo, Alvino Maestri, Heidi Auerswald, Sopheak Sorn, Sokchea Lay, Heng Seng, et al. (+11)
1982 [GO] 2022―Jan―31 Identifying COVID-19 Infections From a Vaccinated Population Using Specific IgA Antibody Test Zhangkai J. Cheng, Peiyan Zheng, Mingshan Xue, Youpeng Chen, Baoqing Sun
1983 [GO] 2022―Jan―31 Neutralizing Antibody Responses to SARS-CoV-2 in Recovered COVID-19 Patients Are Variable and Correlate With Disease Severity and Receptor-Binding Domain Recognition Agnieszka Katarzyna Maciola, Massimo La Raja, Monia Pacenti, Cristiano Salata, Giustina De Silvestro, Antonio Rosato, Giulia Pasqual
1984 [GO] 2022―Jan―31 Role of CD39 in COVID-19 Severity: Dysregulation of Purinergic Signaling and Thromboinflammation Elena Díaz-García, Sara García-Tovar, Enrique Alfaro, Ester Zamarrón, Alberto Mangas, Raúl Galera, et al. (+9)
1985 [GO] 2022―Jan―31 Healthcare Workers in South Korea Maintain a SARS-CoV-2 Antibody Response Six Months After Receiving a Second Dose of the BNT162b2 mRNA Vaccine Jae Hong Choi, Young Ree Kim, Sang Taek Heo, Hyunjoo Oh, Misun Kim, Hyang Ran Lee, Jeong Rae Yoo
1986 [GO] 2022―Jan―28 Low Levels of Granulocytic Myeloid-Derived Suppressor Cells May Be a Good Marker of Survival in the Follow-Up of Patients With Severe COVID-19 Carlos Jiménez-Cortegana, Flora Sánchez-Jiménez, Antonio Pérez-Pérez, Nerissa Álvarez, Alberto Sousa, Luisa Cantón-Bulnes, et al. (+8)
1987 [GO] 2022―Jan―28 Three Specific Potential Epitopes That Could Be Recognized by T Cells of Convalescent COVID-19 Patients Were Identified From Spike Protein Yunwen Zhang, Zhengrong Yang, Mingyuan Tang, Hao Li, Tian Tang, Guilian Li, et al. (+4)
1988 [GO] 2022―Jan―28 SARS-CoV-2 Infection Triggers Auto-Immune Response in ARDS Pablo Juanes-Velasco, Alicia Landeira-Viñuela, Marina L. García-Vaquero, Quentin Lecrevisse, Raquel Herrero, Antonio Ferruelo, et al. (+6)
1989 [GO] 2022―Jan―28 Predicted HLA Class I and Class II Epitopes From Licensed Vaccines Are Largely Conserved in New SARS-CoV-2 Omicron Variant of Concern Daniel López
1990 [GO] 2022―Jan―28 Antigen Specific Humoral and Cellular Immunity Following SARS-CoV-2 Vaccination in ANCA-Associated Vasculitis Patients Receiving B-Cell Depleting Therapy Paige K. Marty, Virginia P. Van Keulen, Courtney L. Erskine, Maleeha Shah, Amber Hummel, Michael Stachowitz, et al. (+11)
1991 [GO] 2022―Jan―27 Association Between Sex Hormone Levels and Clinical Outcomes in Patients With COVID-19 Admitted to Hospital: An Observational, Retrospective, Cohort Study Anna Beltrame, Pedro Salguero, Emanuela Rossi, Ana Conesa, Lucia Moro, Laura Rachele Bettini, et al. (+10)
1992 [GO] 2022―Jan―27 Interleukin-1 Inhibitors and Vaccination Including COVID-19 in Inflammatory Rheumatic Diseases: A Nonsystematic Review Pamir Atagündüz, Gökhan Keser, Mehmet Soy
1993 [GO] 2022―Jan―27 T-Cell Repertoire Characteristics of Asymptomatic and Re-Detectable Positive COVID-19 Patients Yizhe Li, Jian Hu, Yongsi Wang, Dongdong Liu, Yaling Shi, Jiaqi Zhang, et al. (+11)
1994 [GO] 2022―Jan―27 Long-Term Kinetics of SARS-CoV-2 Antibodies and Impact of Inactivated Vaccine on SARS-CoV-2 Antibodies Based on a COVID-19 Patients Cohort Shihan Zhang, Ke Xu, Chuchu Li, Lu Zhou, Xiaoxiao Kong, Jiefu Peng, et al. (+6)
1995 [GO] 2022―Jan―27 Intravenous Immunoglobulin Therapy for Critically Ill COVID-19 Patients With Different Inflammatory Phenotypes: A Multicenter, Retrospective Study Yan Chen, Jianfeng Xie, Wenjuan Wu, Shusheng Li, Yu Hu, Ming Hu, et al. (+19)
1996 [GO] 2022―Jan―27 Heterologous Immunity Between SARS-CoV-2 and Pathogenic Bacteria Peter J. Eggenhuizen, Boaz H. Ng, Janet Chang, Rachel M.Y. Cheong, Anusha Yellapragada, Wey Y. Wong, et al. (+5)
1997 [GO] 2022―Jan―27 Multiplex Antibody Analysis of IgM, IgA and IgG to SARS-CoV-2 in Saliva and Serum From Infected Children and Their Close Contacts Carlota Dobaño, Selena Alonso, Marta Vidal, Alfons Jiménez, Rocío Rubio, Rebeca Santano, et al. (+29)
1998 [GO] 2022―Jan―27 A Single Dose of an MVA Vaccine Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Protein Neutralizes Variants of Concern and Protects Mice From a Lethal SARS-CoV-2 Infection Patricia Pérez, Adrián Lázaro-Frías, Carmen Zamora, Pedro J. Sánchez-Cordón, David Astorgano, Joanna Luczkowiak, et al. (+4)
1999 [GO] 2022―Jan―27 SARS-CoV-2 Variants of Concern and Variants of Interest Receptor Binding Domain Mutations and Virus Infectivity Haolin Liu, Pengcheng Wei, John W. Kappler, Philippa Marrack, Gongyi Zhang
2000 [GO] 2022―Jan―26 Commentary: Pattern Recognition Proteins: First Line of Defense Against Coronaviruses Michael DePietro, Marc Salzberg
 [1]  [2] [ Next > ]

2792 Results       Page 1


[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.101 sec